"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Holzer","Julia","University of Vienna",NA
"2","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Lüftenegger","Marko","University of Vienna",NA
"3","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Korlat","Selma","University of Vienna",NA
"4","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Pelikan","Elisabeth","University of Vienna",NA
"5","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Salmela-Aro","Katariina","University of Helsinki",NA
"6","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Spiel","Christiane","University of Helsinki",NA
"7","34192126","10.1177/23328584211003164","Higher Education in Times of COVID-19: University Students' Basic Need Satisfaction, Self-Regulated Learning, and Well-Being.","In the wake of COVID-19, university students have experienced fundamental changes of their learning and their lives as a whole. The present research identifies psychological characteristics associated with students' well-being in this situation. We investigated relations of basic psychological need satisfaction (experienced competence, autonomy, and relatedness) with positive emotion and intrinsic learning motivation, considering self-regulated learning as a moderator. Self-reports were collecte","2021","07","02","AERA Open","AERA open","COVID-19; higher education; self-determination theory; well-being","Schober","Barbara","University of Vienna",NA
"8","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Harvey","Abigail P","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"9","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Fuhrmeister","Erica R","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"10","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Cantrell","Molly E","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"11","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Pitol","Ana K","Department of Civil and Environmental Engineering, Imperial College London, London SW7 2AZ, United Kingdom",NA
"12","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Swarthout","Jenna M","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"13","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Powers","Julie E","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"14","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Nadimpalli","Maya L","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"15","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Julian","Timothy R","Eawag, Swiss Federal Institute of Aquatic Science and Technology, Dubendorf CH-8600, Switzerland",NA
"16","34192125","10.1021/acs.estlett.0c00875","Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting.","Environmental surveillance of surface contamination is an unexplored tool for understanding transmission of SARS-CoV-2 in community settings. We conducted longitudinal swab sampling of high-touch non-porous surfaces in a Massachusetts town during a COVID-19 outbreak from April to June 2020. Twenty-nine of 348 (8.3%) surface samples were positive for SARS-CoV-2 RNA, including crosswalk buttons, trash can handles, and door handles of essential business entrances (grocery store, liquor store, bank,","2021","07","02","Environ Sci Technol Lett","Environmental science &amp; technology letters",NA,"Pickering","Amy J","Civil and Environmental Engineering, Tufts University, Medford, Massachusetts 02155, United States",NA
"17","34192123","10.4102/sajid.v36i1.228","Obesity and its implications for COVID-19 pandemic in South Africa.",NA,"2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases",NA,"van Vollenstee","Fiona A","School of Medicine, Internal Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa",NA
"18","34192123","10.4102/sajid.v36i1.228","Obesity and its implications for COVID-19 pandemic in South Africa.",NA,"2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases",NA,"van der Merwe","Maria-Teresa","School of Medicine, Internal Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa",NA
"19","34192122","10.4102/sajid.v35i1.208","COVID-19 and the uniqueness of South Africa.",NA,"2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases",NA,"Zamparini","Jarrod","Division of Infectious Diseases, Department of Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa",NA
"20","34192122","10.4102/sajid.v35i1.208","COVID-19 and the uniqueness of South Africa.",NA,"2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases",NA,"Venturas","Jacqui","Division of Infectious Diseases, Department of Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa",NA
"21","34192122","10.4102/sajid.v35i1.208","COVID-19 and the uniqueness of South Africa.",NA,"2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases",NA,"Diana","Nina","Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"22","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Schellack","Natalie","School of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria, South Africa",NA
"23","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Coetzee","Monique","Pharmacy Services, Mediclinic Southern Africa, Stellenbosch, South Africa",NA
"24","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Schellack","Gustav","Pharmaceutical Industry, Pretoria , South Africa",NA
"25","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Gijzelaar","Michelle","Pharmacy Practice Department, Life Healthcare, Johannesburg, South Africa",NA
"26","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Hassim","Zeenat","Pharmacy Department, Dr George Mukhari Academic Hospital, Pretoria, South Africa",NA
"27","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Milne","Marnus","School of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria, South Africa",NA
"28","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Bronkhorst","Elmien","School of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria, South Africa",NA
"29","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Padayachee","Neelaveni","Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"30","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Singh","Nirasha","Clinical Pharmacy Services, Netcare Limited, Johannesburg, South Africa",NA
"31","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Kolman","Sonya","Pharmacy, Nelson Mandela Children's Hospital, Johannesburg, South Africa",NA
"32","34192121","10.4102/sajid.v35i1.206","COVID-19: Guidelines for pharmacists in South Africa.","Since the outbreak of COVID-19, and its declaration as a pandemic by the World Health Organization (WHO), the reliance on pharmacists as one of the first points of contact within the healthcare system has been highlighted. This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. The situation is rapidly evolving, and new evid","2021","07","02","S Afr J Infect Dis","Southern African journal of infectious diseases","COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; chloroquine; corona virus disease; hydroxychloroquine; novel coronavirus (2019-nCoV); pandemic; spill-over","Gray","Andrew L","Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"33","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Yu","Yanting","Department of Nephrology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"34","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Xu","Jianteng","Department of Clinical Laboratory, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"35","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Xie","Anni","Department of Nephrology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"36","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Liu","Sijia","Department of Nephrology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"37","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Wang","Xiaojian","Department of Nephrology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"38","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Zhu","Runzhang","Department of Nephrology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"39","34192120","10.1159/000515278","Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.","The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus contributing to the global understanding of implications of HCQ use. We reviewed 717 cases of nonmalaria patients treated with HCQ (302) or without HCQ (415) in our hospital from 2008 to 2019, analyzed the cardi","2021","07","02","Kidney Dis (Basel)","Kidney diseases (Basel, Switzerland)","Cardiac conduction; Coronavirus disease 2019; Electrocardiogram; Hydroxychloroquine","Wang","Xiaoyan","Department of Nephrology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China",NA
"40","34192119","10.1159/000514364","Can Tofacitinib Offer Protection against COVID-19 Infection?",NA,"2021","07","02","Skin Appendage Disord","Skin appendage disorders",NA,"Goldberger","Tal","Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel",NA
"41","34192119","10.1159/000514364","Can Tofacitinib Offer Protection against COVID-19 Infection?",NA,"2021","07","02","Skin Appendage Disord","Skin appendage disorders",NA,"Zlotogorski","Abraham","Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel",NA
"42","34192116","10.1109/ACCESS.2020.3037474","Secure and Provenance Enhanced Internet of Health Things Framework: A Blockchain Managed Federated Learning Approach.","Recent advancements in the Internet of Health Things (IoHT) have ushered in the wide adoption of IoT devices in our daily health management. For IoHT data to be acceptable by stakeholders, applications that incorporate the IoHT must have a provision for data provenance, in addition to the accuracy, security, integrity, and quality of data. To protect the privacy and security of IoHT data, federated learning (FL) and differential privacy (DP) have been proposed, where private IoHT data can be tra","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Blockchain; Internet of Health Things; federated learning; homomorphic encryption; provenance","Rahman","Mohamed Abdur","Department of Cyber Security and Forensic ComputingCollege of Computing and Cyber SciencesUniversity of Prince MugrinMadinah41499Saudi Arabia",NA
"43","34192116","10.1109/ACCESS.2020.3037474","Secure and Provenance Enhanced Internet of Health Things Framework: A Blockchain Managed Federated Learning Approach.","Recent advancements in the Internet of Health Things (IoHT) have ushered in the wide adoption of IoT devices in our daily health management. For IoHT data to be acceptable by stakeholders, applications that incorporate the IoHT must have a provision for data provenance, in addition to the accuracy, security, integrity, and quality of data. To protect the privacy and security of IoHT data, federated learning (FL) and differential privacy (DP) have been proposed, where private IoHT data can be tra","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Blockchain; Internet of Health Things; federated learning; homomorphic encryption; provenance","Hossain","M Shamim","Department of Software EngineeringCollege of Computer and Information SciencesKing Saud UniversityRiyadh11543Saudi Arabia",NA
"44","34192116","10.1109/ACCESS.2020.3037474","Secure and Provenance Enhanced Internet of Health Things Framework: A Blockchain Managed Federated Learning Approach.","Recent advancements in the Internet of Health Things (IoHT) have ushered in the wide adoption of IoT devices in our daily health management. For IoHT data to be acceptable by stakeholders, applications that incorporate the IoHT must have a provision for data provenance, in addition to the accuracy, security, integrity, and quality of data. To protect the privacy and security of IoHT data, federated learning (FL) and differential privacy (DP) have been proposed, where private IoHT data can be tra","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Blockchain; Internet of Health Things; federated learning; homomorphic encryption; provenance","Islam","Mohammad Saiful","Department of Computing, GoldsmithUniversity of LondonLondonSE14 6NWU",NA
"45","34192116","10.1109/ACCESS.2020.3037474","Secure and Provenance Enhanced Internet of Health Things Framework: A Blockchain Managed Federated Learning Approach.","Recent advancements in the Internet of Health Things (IoHT) have ushered in the wide adoption of IoT devices in our daily health management. For IoHT data to be acceptable by stakeholders, applications that incorporate the IoHT must have a provision for data provenance, in addition to the accuracy, security, integrity, and quality of data. To protect the privacy and security of IoHT data, federated learning (FL) and differential privacy (DP) have been proposed, where private IoHT data can be tra","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Blockchain; Internet of Health Things; federated learning; homomorphic encryption; provenance","Alrajeh","Nabil A","Department of Biomedical EngineeringCollege of Applied Medical SciencesKing Saud UniversityRiyadh11543Saudi Arabia",NA
"46","34192116","10.1109/ACCESS.2020.3037474","Secure and Provenance Enhanced Internet of Health Things Framework: A Blockchain Managed Federated Learning Approach.","Recent advancements in the Internet of Health Things (IoHT) have ushered in the wide adoption of IoT devices in our daily health management. For IoHT data to be acceptable by stakeholders, applications that incorporate the IoHT must have a provision for data provenance, in addition to the accuracy, security, integrity, and quality of data. To protect the privacy and security of IoHT data, federated learning (FL) and differential privacy (DP) have been proposed, where private IoHT data can be tra","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Blockchain; Internet of Health Things; federated learning; homomorphic encryption; provenance","Muhammad","Ghulam","Department of Computer EngineeringCollege of Computer and Information SciencesKing Saud UniversityRiyadh11543Saudi Arabia",NA
"47","34192115","10.1109/ACCESS.2020.3019600","Lies Kill, Facts Save: Detecting COVID-19 Misinformation in Twitter.","Online social networks (ONSs) such as Twitter have grown to be very useful tools for the dissemination of information. However, they have also become a fertile ground for the spread of false information, particularly regarding the ongoing coronavirus disease 2019 (COVID-19) pandemic. Best described as an infodemic, there is a great need, now more than ever, for scientific fact-checking and misinformation detection regarding the dangers posed by these tools with regards to COVID-19. In this artic","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Classification; Twitter; machine learning; misinformation","Al-Rakhami","Mabrook S","Research Chair of Pervasive and Mobile ComputingKing Saud UniversityRiyadh11543Saudi Arabia",NA
"48","34192115","10.1109/ACCESS.2020.3019600","Lies Kill, Facts Save: Detecting COVID-19 Misinformation in Twitter.","Online social networks (ONSs) such as Twitter have grown to be very useful tools for the dissemination of information. However, they have also become a fertile ground for the spread of false information, particularly regarding the ongoing coronavirus disease 2019 (COVID-19) pandemic. Best described as an infodemic, there is a great need, now more than ever, for scientific fact-checking and misinformation detection regarding the dangers posed by these tools with regards to COVID-19. In this artic","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Classification; Twitter; machine learning; misinformation","Al-Amri","Atif M","Research Chair of Pervasive and Mobile ComputingKing Saud UniversityRiyadh11543Saudi Arabia",NA
"49","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Elaziz","Mohamed Abd","Department of MathematicsFaculty of ScienceZagazig UniversityZagazig44519Egypt",NA
"50","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Ewees","Ahmed A","Department of ComputerDamietta UniversityDamietta34511Egypt",NA
"51","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Yousri","Dalia","Electrical Engineering DepartmentFaculty of EngineeringFayoum UniversityFaiyum63514Egypt",NA
"52","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Alwerfali","Husein S Naji","School of Computer Science and TechnologyHuazhong University of Science and TechnologyWuhan430074China",NA
"53","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Awad","Qamar A","Department of MathematicsFaculty of ScienceZagazig UniversityZagazig44519Egypt",NA
"54","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Lu","Songfeng","School of Computer Science and TechnologyHuazhong University of Science and TechnologyWuhan430074China",NA
"55","34192114","10.1109/ACCESS.2020.3007928","An Improved Marine Predators Algorithm With Fuzzy Entropy for Multi-Level Thresholding: Real World Example of COVID-19 CT Image Segmentation.","Medical imaging techniques play a critical role in diagnosing diseases and patient healthcare. They help in treatment, diagnosis, and early detection. Image segmentation is one of the most important steps in processing medical images, and it has been widely used in many applications. Multi-level thresholding (MLT) is considered as one of the simplest and most effective image segmentation techniques. Traditional approaches apply histogram methods; however, these methods face some challenges. In r","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Image segmentation; marine predators algorithm (MPA); moth-?ame optimization (MFO); multi-level thresholding; swarm intelligence","Al-Qaness","Mohammed A A","State Key Laboratory for Information Engineering in Surveying, Mapping, and Remote SensingWuhan UniversityWuhan430079China",NA
"56","34192113","10.1109/ACCESS.2020.3006172","Have You Been a Victim of COVID-19-Related Cyber Incidents? Survey, Taxonomy, and Mitigation Strategies.","Cybercriminals are constantly on the lookout for new attack vectors, and the recent COVID-19 pandemic is no exception. For example, social distancing measures have resulted in travel bans, lockdowns, and stay-at-home orders, consequently increasing the reliance on information and communications technologies, such as Zoom. Cybercriminals have also attempted to exploit the pandemic to facilitate a broad range of malicious activities, such as attempting to take over videoconferencing platforms used","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; cyberattacks; mitigation; potential solutions; security and privacy; taxonomy","Hakak","Saqib","Faculty of Computer ScienceUniversity of Northern British ColumbiaPrince GeorgeBCV2N 4Z9Canada",NA
"57","34192113","10.1109/ACCESS.2020.3006172","Have You Been a Victim of COVID-19-Related Cyber Incidents? Survey, Taxonomy, and Mitigation Strategies.","Cybercriminals are constantly on the lookout for new attack vectors, and the recent COVID-19 pandemic is no exception. For example, social distancing measures have resulted in travel bans, lockdowns, and stay-at-home orders, consequently increasing the reliance on information and communications technologies, such as Zoom. Cybercriminals have also attempted to exploit the pandemic to facilitate a broad range of malicious activities, such as attempting to take over videoconferencing platforms used","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; cyberattacks; mitigation; potential solutions; security and privacy; taxonomy","Khan","Wazir Zada","Faculty of CS &amp",NA
"58","34192113","10.1109/ACCESS.2020.3006172","Have You Been a Victim of COVID-19-Related Cyber Incidents? Survey, Taxonomy, and Mitigation Strategies.","Cybercriminals are constantly on the lookout for new attack vectors, and the recent COVID-19 pandemic is no exception. For example, social distancing measures have resulted in travel bans, lockdowns, and stay-at-home orders, consequently increasing the reliance on information and communications technologies, such as Zoom. Cybercriminals have also attempted to exploit the pandemic to facilitate a broad range of malicious activities, such as attempting to take over videoconferencing platforms used","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; cyberattacks; mitigation; potential solutions; security and privacy; taxonomy","Imran","Muhammad","College of Applied Computer ScienceKing Saud UniversityRiyadh11451Saudi Arabia",NA
"59","34192113","10.1109/ACCESS.2020.3006172","Have You Been a Victim of COVID-19-Related Cyber Incidents? Survey, Taxonomy, and Mitigation Strategies.","Cybercriminals are constantly on the lookout for new attack vectors, and the recent COVID-19 pandemic is no exception. For example, social distancing measures have resulted in travel bans, lockdowns, and stay-at-home orders, consequently increasing the reliance on information and communications technologies, such as Zoom. Cybercriminals have also attempted to exploit the pandemic to facilitate a broad range of malicious activities, such as attempting to take over videoconferencing platforms used","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; cyberattacks; mitigation; potential solutions; security and privacy; taxonomy","Choo","Kim-Kwang Raymond","Department of Information Systems and Cyber SecurityThe University of Texas at San AntonioSan AntonioTX78249USA",NA
"60","34192113","10.1109/ACCESS.2020.3006172","Have You Been a Victim of COVID-19-Related Cyber Incidents? Survey, Taxonomy, and Mitigation Strategies.","Cybercriminals are constantly on the lookout for new attack vectors, and the recent COVID-19 pandemic is no exception. For example, social distancing measures have resulted in travel bans, lockdowns, and stay-at-home orders, consequently increasing the reliance on information and communications technologies, such as Zoom. Cybercriminals have also attempted to exploit the pandemic to facilitate a broad range of malicious activities, such as attempting to take over videoconferencing platforms used","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; cyberattacks; mitigation; potential solutions; security and privacy; taxonomy","Shoaib","Muhammad","College of Computer and Information SciencesKing Saud UniversityRiyadh11451Saudi Arabia",NA
"61","34192112","10.1109/ACCESS.2020.3007502","Underwater Networked Wireless Sensor Data Collection for Computational Intelligence Techniques: Issues, Challenges, and Approaches.","Underwater wireless sensor networks (UWSNs) is emerging as an advance terminology for monitoring and controlling the underwater aquatic life. This technology determines the undiscovered resources present in the water through computational intelligence (CI) techniques. CI here pertains to the capability of a system to acquire a specific task from data or experimental surveillance below the water. In today's time data is considered as the identity for everything that exists in nature, whether that","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Acoustic sensor network; computational intelligence; coronavirus (COVID-19); routing; underwater sensor network","Gupta","Osho","Chitkara University Institute of Engineering and Technology, Chitkara UniversityPunjabIndia",NA
"62","34192112","10.1109/ACCESS.2020.3007502","Underwater Networked Wireless Sensor Data Collection for Computational Intelligence Techniques: Issues, Challenges, and Approaches.","Underwater wireless sensor networks (UWSNs) is emerging as an advance terminology for monitoring and controlling the underwater aquatic life. This technology determines the undiscovered resources present in the water through computational intelligence (CI) techniques. CI here pertains to the capability of a system to acquire a specific task from data or experimental surveillance below the water. In today's time data is considered as the identity for everything that exists in nature, whether that","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Acoustic sensor network; computational intelligence; coronavirus (COVID-19); routing; underwater sensor network","Goyal","Nitin","Chitkara University Institute of Engineering and Technology, Chitkara UniversityPunjabIndia",NA
"63","34192112","10.1109/ACCESS.2020.3007502","Underwater Networked Wireless Sensor Data Collection for Computational Intelligence Techniques: Issues, Challenges, and Approaches.","Underwater wireless sensor networks (UWSNs) is emerging as an advance terminology for monitoring and controlling the underwater aquatic life. This technology determines the undiscovered resources present in the water through computational intelligence (CI) techniques. CI here pertains to the capability of a system to acquire a specific task from data or experimental surveillance below the water. In today's time data is considered as the identity for everything that exists in nature, whether that","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Acoustic sensor network; computational intelligence; coronavirus (COVID-19); routing; underwater sensor network","Anand","Divya","Department of Computer Science and EngineeringLovely Professional UniversityPhagwara144411India",NA
"64","34192112","10.1109/ACCESS.2020.3007502","Underwater Networked Wireless Sensor Data Collection for Computational Intelligence Techniques: Issues, Challenges, and Approaches.","Underwater wireless sensor networks (UWSNs) is emerging as an advance terminology for monitoring and controlling the underwater aquatic life. This technology determines the undiscovered resources present in the water through computational intelligence (CI) techniques. CI here pertains to the capability of a system to acquire a specific task from data or experimental surveillance below the water. In today's time data is considered as the identity for everything that exists in nature, whether that","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Acoustic sensor network; computational intelligence; coronavirus (COVID-19); routing; underwater sensor network","Kadry","Seifedine","Department of Mathematics and Computer ScienceFaculty of ScienceBeirut Arab UniversityBeirut11072809Lebanon",NA
"65","34192112","10.1109/ACCESS.2020.3007502","Underwater Networked Wireless Sensor Data Collection for Computational Intelligence Techniques: Issues, Challenges, and Approaches.","Underwater wireless sensor networks (UWSNs) is emerging as an advance terminology for monitoring and controlling the underwater aquatic life. This technology determines the undiscovered resources present in the water through computational intelligence (CI) techniques. CI here pertains to the capability of a system to acquire a specific task from data or experimental surveillance below the water. In today's time data is considered as the identity for everything that exists in nature, whether that","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Acoustic sensor network; computational intelligence; coronavirus (COVID-19); routing; underwater sensor network","Nam","Yunyoung","Department of Computer Science and EngineeringSoonchunhyang UniversityAsan31538South Korea",NA
"66","34192112","10.1109/ACCESS.2020.3007502","Underwater Networked Wireless Sensor Data Collection for Computational Intelligence Techniques: Issues, Challenges, and Approaches.","Underwater wireless sensor networks (UWSNs) is emerging as an advance terminology for monitoring and controlling the underwater aquatic life. This technology determines the undiscovered resources present in the water through computational intelligence (CI) techniques. CI here pertains to the capability of a system to acquire a specific task from data or experimental surveillance below the water. In today's time data is considered as the identity for everything that exists in nature, whether that","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Acoustic sensor network; computational intelligence; coronavirus (COVID-19); routing; underwater sensor network","Singh","Aman","Department of Computer Science and EngineeringLovely Professional UniversityPhagwara144411India",NA
"67","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Montes-Orozco","Edwin","Posgrado en Ciencias y Tecnologías de la InformaciónUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"68","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Mora-Gutierrez","Roman-Anselmo","Departamento de SistemasUniversidad Autónoma Metropolitana AzcapotzalcoMexico City02200Mexico",NA
"69","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","De-Los-Cobos-Silva","Sergio-Gerardo","Departamento de Ingeniería EléctricaUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"70","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Rincon-Garcia","Eric-Alfredo","Departamento de Ingeniería EléctricaUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"71","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Torres-Cockrell","Gilberto-Sinuhe","Posgrado en Ciencias y Tecnologías de la InformaciónUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"72","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Juarez-Gomez","Jorge","Departamento de QuímicaUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"73","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Obregon-Quintana","Bibiana","Facultad de CienciasUniversidad Nacional Autónoma de MéxicoMexico City04510Mexico",NA
"74","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Lara-Velazquez","Pedro","Departamento de Ingeniería EléctricaUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"75","34192111","10.1109/ACCESS.2020.3007726","Identification of COVID-19 Spreaders Using Multiplex Networks Approach.","In this work, we present a methodology to identify COVID-19 spreaders using the analysis of the relationship between socio-cultural and economic characteristics with the number of infections and deaths caused by the COVID-19 virus in different countries. For this, we analyze the information of each country using the complex networks approach, specifically by analyzing the spreaders countries based on the separator set in 5-layer multiplex networks. The results show that, we obtain a classificati","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Complex networks; complex systems; multiplex networks; optimization; social networks","Gutierrez-Andrade","Miguel-Angel","Departamento de Ingeniería EléctricaUniversidad Autónoma Metropolitana IztapalapaMexico City09340Mexico",NA
"76","34192110","10.1109/ACCESS.2020.3003750","Risk-Aware Identification of Highly Suspected COVID-19 Cases in Social IoT: A Joint Graph Theory and Reinforcement Learning Approach.","The recent outbreak of the coronavirus disease 2019 (COVID-19) has rapidly become a pandemic, which calls for prompt action in identifying suspected cases at an early stage through risk prediction. To suppress its further spread, we exploit the social relationships between mobile devices in the Social Internet of Things (SIoT) to help control its propagation by allocating the limited protective resources to the influential so-called high-degree individuals to stem the tide of precipitated spread","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Social Internet of Thing (SIoT); graph theory; reinforcement learning","Wang","Bowen","Xuzhou Engineering Research Center of Intelligent Industry Safety and Emergency CollaborationXuzhou221116China",NA
"77","34192110","10.1109/ACCESS.2020.3003750","Risk-Aware Identification of Highly Suspected COVID-19 Cases in Social IoT: A Joint Graph Theory and Reinforcement Learning Approach.","The recent outbreak of the coronavirus disease 2019 (COVID-19) has rapidly become a pandemic, which calls for prompt action in identifying suspected cases at an early stage through risk prediction. To suppress its further spread, we exploit the social relationships between mobile devices in the Social Internet of Things (SIoT) to help control its propagation by allocating the limited protective resources to the influential so-called high-degree individuals to stem the tide of precipitated spread","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Social Internet of Thing (SIoT); graph theory; reinforcement learning","Sun","Yanjing","Xuzhou Engineering Research Center of Intelligent Industry Safety and Emergency CollaborationXuzhou221116China",NA
"78","34192110","10.1109/ACCESS.2020.3003750","Risk-Aware Identification of Highly Suspected COVID-19 Cases in Social IoT: A Joint Graph Theory and Reinforcement Learning Approach.","The recent outbreak of the coronavirus disease 2019 (COVID-19) has rapidly become a pandemic, which calls for prompt action in identifying suspected cases at an early stage through risk prediction. To suppress its further spread, we exploit the social relationships between mobile devices in the Social Internet of Things (SIoT) to help control its propagation by allocating the limited protective resources to the influential so-called high-degree individuals to stem the tide of precipitated spread","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Social Internet of Thing (SIoT); graph theory; reinforcement learning","Duong","Trung Q","School of Electronics, Electrical Engineering, and Computer ScienceQueen's University BelfastBelfastBT7 1NNU",NA
"79","34192110","10.1109/ACCESS.2020.3003750","Risk-Aware Identification of Highly Suspected COVID-19 Cases in Social IoT: A Joint Graph Theory and Reinforcement Learning Approach.","The recent outbreak of the coronavirus disease 2019 (COVID-19) has rapidly become a pandemic, which calls for prompt action in identifying suspected cases at an early stage through risk prediction. To suppress its further spread, we exploit the social relationships between mobile devices in the Social Internet of Things (SIoT) to help control its propagation by allocating the limited protective resources to the influential so-called high-degree individuals to stem the tide of precipitated spread","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Social Internet of Thing (SIoT); graph theory; reinforcement learning","Nguyen","Long D","Duy Tan UniversityDa Nang810000Vietnam",NA
"80","34192110","10.1109/ACCESS.2020.3003750","Risk-Aware Identification of Highly Suspected COVID-19 Cases in Social IoT: A Joint Graph Theory and Reinforcement Learning Approach.","The recent outbreak of the coronavirus disease 2019 (COVID-19) has rapidly become a pandemic, which calls for prompt action in identifying suspected cases at an early stage through risk prediction. To suppress its further spread, we exploit the social relationships between mobile devices in the Social Internet of Things (SIoT) to help control its propagation by allocating the limited protective resources to the influential so-called high-degree individuals to stem the tide of precipitated spread","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; Social Internet of Thing (SIoT); graph theory; reinforcement learning","Hanzo","Lajos","School of Electronics and Computer ScienceUniversity of SouthamptonSouthamptonSO17 1BJU",NA
"81","34192109","10.1109/ACCESS.2020.2995763","Envisioning Insight-Driven Learning Based on Thick Data Analytics With Focus on Healthcare.","Detecting and analyzing patient insights from social media enables healthcare givers to better understand what patients want and also to identify their pain points. Healthcare institutions cannot neglect the need to monitor and analyze popular social media outlets such as Twitter and Facebook. To have a study success, a healthcare giver needs to be able to engage with their patients and adapt to their preferences effectively. However, data-driven decision-making is no longer enough, as the best-","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Neo4j; Patient insights; graph based algorithms; graph-based machine learning; graph-based transfer learning; learning patient preferences; thick data; twitter conversation communities","Fiaidhi","Jinan","Department of Computer ScienceLakehead UniversityThunder BayONP7B 5E1Canada",NA
"82","34192108","10.1109/ACCESS.2020.3002445","A Systematic Review of the Digital Interventions for Fighting COVID-19: The Bangladesh Perspective.","The objective of this paper is to synthesize the digital interventions initiatives to fight against COVID-19 in Bangladesh and compare with other countries. In order to obtain our research objective, we conducted a systematic review of the online content. We first reviewed the digital interventions that have been used to fight against COVID-19 across the globe. We then reviewed the initiatives that have been taken place in Bangladesh. Thereafter, we present a comparative analysis between the ini","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Bangladesh; COVID-19; Coronavirus; ICT intervention; developing country; digital intervention; pandemic","Islam","Muhammad Nazrul","Department of Computer Science and EngineeringMilitary Institute of Science and Technology, Mirpur CantonmentDhaka1216Bangladesh",NA
"83","34192108","10.1109/ACCESS.2020.3002445","A Systematic Review of the Digital Interventions for Fighting COVID-19: The Bangladesh Perspective.","The objective of this paper is to synthesize the digital interventions initiatives to fight against COVID-19 in Bangladesh and compare with other countries. In order to obtain our research objective, we conducted a systematic review of the online content. We first reviewed the digital interventions that have been used to fight against COVID-19 across the globe. We then reviewed the initiatives that have been taken place in Bangladesh. Thereafter, we present a comparative analysis between the ini","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Bangladesh; COVID-19; Coronavirus; ICT intervention; developing country; digital intervention; pandemic","Islam","A K M Najmul","Department of Future TechnologiesUniversity of Turku20500TurkuFinland",NA
"84","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Jinia","Abbas Johar","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"85","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Sunbul","Noora Ba","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"86","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Meert","Christopher A","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"87","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Miller","Cameron A","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"88","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Clarke","Shaun D","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"89","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Kearfott","Kimberlee J","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"90","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Matuszak","Martha M","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"91","34192107","10.1109/ACCESS.2020.3002886","Review of Sterilization Techniques for Medical and Personal Protective Equipment Contaminated With SARS-CoV-2.","The outbreak of the novel coronavirus disease, COVID-19 turned into a global pandemic in March 2020. During these unprecedented times, there is an increased demand in medical and personal protective equipment (PPE). Since the supplies may take a long time to meet the global demand, reusing PPEs will help health care workers in their response to the COVID-19 pandemic. To ensure the safety and well-being of the medical first responders, PPE needs to be sterilized before reuse. In this review, we e","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","COVID-19; PPE; SARS-CoV-2; medical equipment; sterilization","Pozzi","Sara A","Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn ArborMI48109-2104USA",NA
"92","34192106","10.1109/ACCESS.2020.3001344","Analysing Recovery From Pandemics by Learning Theory: The Case of CoVid-19.","We present a method for predicting the recovery time from infectious diseases outbreaks such as the recent CoVid-19 virus. The approach is based on the theory of learning from errors, specifically adapted to the control of the virus spread by reducing infection rates using countermeasures such as medical treatment, isolation, social distancing etc. When these are effective, the infection rate, after reaching a peak, declines following what we call the Universal Recovery Curve. We use presently a","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","CoVid-19; learning theory; pandemic; recovery rate; risk","Duffey","Romney B","Idaho FallsIdahoID83402USA",NA
"93","34192106","10.1109/ACCESS.2020.3001344","Analysing Recovery From Pandemics by Learning Theory: The Case of CoVid-19.","We present a method for predicting the recovery time from infectious diseases outbreaks such as the recent CoVid-19 virus. The approach is based on the theory of learning from errors, specifically adapted to the control of the virus spread by reducing infection rates using countermeasures such as medical treatment, isolation, social distancing etc. When these are effective, the infection rate, after reaching a peak, declines following what we call the Universal Recovery Curve. We use presently a","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","CoVid-19; learning theory; pandemic; recovery rate; risk","Zio","Enrico","Centre de Recherche sur les Risques et les Crises (CRC)MINES ParisTech/PSL Universiteí Paris75272ParisFrance",NA
"94","34192105","10.1109/ACCESS.2020.3000860","Data Modeling With Polynomial Representations and Autoregressive Time-Series Representations, and Their Connections.","Two of the data modelling techniques - polynomial representation and time-series representation - are explored in this paper to establish their connections and differences. All theoretical studies are based on uniformly sampled data in the absence of noise. This paper proves that all data from an underlying polynomial model of finite degree [Formula: see text] can be represented perfectly by an autoregressive time-series model of order [Formula: see text] and a constant term [Formula: see text] ","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Covid-19; Data models; autoregressive processes; polynomials; signal representation; time-series","Nandi","Asoke K","Department of Electronic and Computer EngineeringBrunel University LondonUxbridgeUB8 3PHU",NA
"95","34192104","10.1109/ACCESS.2020.3001298","Modelling Strong Control Measures for Epidemic Propagation With Networks-A COVID-19 Case Study.","We show that precise knowledge of epidemic transmission parameters is not required to build an informative model of the spread of disease. We propose a detailed model of the topology of the contact network under various external control regimes and demonstrate that this is sufficient to capture the salient dynamical characteristics and to inform decisions. Contact between individuals in the community is characterised by a contact graph, the structure of that contact graph is selected to mimic co","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Agent based model; complex network; infectious diseases; propagation on networks","Small","Michael","Integrated Energy Pty Ltd.ComoWA6152Australia",NA
"96","34192104","10.1109/ACCESS.2020.3001298","Modelling Strong Control Measures for Epidemic Propagation With Networks-A COVID-19 Case Study.","We show that precise knowledge of epidemic transmission parameters is not required to build an informative model of the spread of disease. We propose a detailed model of the topology of the contact network under various external control regimes and demonstrate that this is sufficient to capture the salient dynamical characteristics and to inform decisions. Contact between individuals in the community is characterised by a contact graph, the structure of that contact graph is selected to mimic co","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Agent based model; complex network; infectious diseases; propagation on networks","Cavanagh","David","Integrated Energy Pty Ltd.ComoWA6152Australia",NA
"97","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Jamshidi","Mohammad Behdad","Department of Electromechanical Engineering and Power Electronics (KEV)University of West Bohemia in Pilsen301 00PilsenCzech Republic",NA
"98","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Lalbakhsh","Ali","School of EngineeringMacquarie UniversitySydneyNSW2109Australia",NA
"99","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Talla","Jakub","Department of Electromechanical Engineering and Power Electronics (KEV)University of West Bohemia in Pilsen301 00PilsenCzech Republic",NA
"100","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Peroutka","Zdenek","Regional Innovation Centre for Electrical engineering (RICE)University of West Bohemia in Pilsen301 00PilsenCzech Republic",NA
"101","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Hadjilooei","Farimah","Department of Radiation OncologyCancer Institute, Tehran University of Medical SciencesTehran1416753955Iran",NA
"102","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Lalbakhsh","Pedram","Department of English Language and LiteratureRazi UniversityKermanshah6714414971Iran",NA
"103","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Jamshidi","Morteza","Young Researchers and Elite Club, Kermanshah BranchIslamic Azad UniversityKermanshah1477893855Iran",NA
"104","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Spada","Luigi La","School of Engineering and the Built EnvironmentEdinburgh Napier UniversityEdinburghEH11 4DYU",NA
"105","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Mirmozafari","Mirhamed","Department of Electrical and Computer EngineeringUniversity of Wisconsin-MadisonMadisonWI53706USA",NA
"106","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Dehghani","Mojgan","Physics and Astronomy DepartmentLouisiana State UniversityBaton RougeLA70803USA",NA
"107","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Sabet","Asal","Irma Lerma Rangel College of PharmacyTexas A&amp",NA
"108","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Roshani","Saeed","Department of Electrical EngineeringKermanshah Branch, Islamic Azad UniversityKermanshah1477893855Iran",NA
"109","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Roshani","Sobhan","Department of Electrical EngineeringKermanshah Branch, Islamic Azad UniversityKermanshah1477893855Iran",NA
"110","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Bayat-Makou","Nima","The Edward S. Rogers, Sr. Department of Electrical and Computer EngineeringUniversity of TorontoTorontoON M5SCanada",NA
"111","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Mohamadzade","Bahare","School of EngineeringMacquarie UniversitySydneyNSW2109Australia",NA
"112","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Malek","Zahra","Medical Sciences Research Center, Faculty of Medicine, Tehran Medical Sciences BranchIslamic Azad UniversityTehran1477893855Iran",NA
"113","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Jamshidi","Alireza","Dentistry SchoolBabol University of Medical SciencesBabol4717647745Iran",NA
"114","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Kiani","Sarah","Medical Biology Research CenterHealth Technology Institute, Kermanshah University of Medical SciencesKermanshah6715847141Iran",NA
"115","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Hashemi-Dezaki","Hamed","Regional Innovation Centre for Electrical engineering (RICE)University of West Bohemia in Pilsen301 00PilsenCzech Republic",NA
"116","34192103","10.1109/ACCESS.2020.3001973","Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment.","COVID-19 outbreak has put the whole world in an unprecedented difficult situation bringing life around the world to a frightening halt and claiming thousands of lives. Due to COVID-19's spread in 212 countries and territories and increasing numbers of infected cases and death tolls mounting to 5,212,172 and 334,915 (as of May 22 2020), it remains a real threat to the public health system. This paper renders a response to combat the virus through Artificial Intelligence (AI). Some Deep Learning (","2021","07","02","IEEE Access","IEEE access : practical innovations, open solutions","Artificial intelligence; COVID-19; big data; bioinformatics; biomedical informatics; deep learning; diagnosis; machine learning; treatment","Mohyuddin","Wahab","Research Institute for Microwave and Millimeter-Wave Studies, National University of Sciences and TechnologyIslamabad24090Pakistan",NA
"117","34192094","10.1021/acssuschemeng.0c06565","Smart and Sustainable Nanotechnological Solutions in a Battle against COVID-19 and Beyond: A Critical Review.","The variety of available biocidal features make nanomaterials promising for fighting infections. To effectively battle COVID-19, categorized as a pandemic by the World Health Organization (WHO), materials scientists and biotechnologists need to combine their knowledge to develop efficient antiviral nanomaterials. By design, nanostructured materials (spherical, two-dimensional, hybrid) can express a diverse bioactivity and unique combination of specific, nonspecific, and mixed mechanisms of antiv","2021","07","02","ACS Sustain Chem Eng","ACS sustainable chemistry &amp; engineering",NA,"Jastrzebska","Agnieszka M","Warsaw University of Technology, Faculty of Materials Science and Engineering, Woloska 141, 02-507 Warsaw, Poland",NA
"118","34192094","10.1021/acssuschemeng.0c06565","Smart and Sustainable Nanotechnological Solutions in a Battle against COVID-19 and Beyond: A Critical Review.","The variety of available biocidal features make nanomaterials promising for fighting infections. To effectively battle COVID-19, categorized as a pandemic by the World Health Organization (WHO), materials scientists and biotechnologists need to combine their knowledge to develop efficient antiviral nanomaterials. By design, nanostructured materials (spherical, two-dimensional, hybrid) can express a diverse bioactivity and unique combination of specific, nonspecific, and mixed mechanisms of antiv","2021","07","02","ACS Sustain Chem Eng","ACS sustainable chemistry &amp; engineering",NA,"Vasilchenko","Alexey S","Institute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, Tyumen, Russia",NA
"119","34192092","10.1097/JAT.0000000000000153","Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series.","To provide an outline of the timeline from acute care admission to inpatient rehabilitation facility discharge and describe the functional progress and tolerance of 2 individuals who were hospitalized but not intubated because of COVID-19. Retrospective data were collected from the electronic medical record to describe the rehabilitation course of the first 2 consecutive patients admitted to the rehabilitation facility who were recovering from COVID-19. Both patients were octogenarian men who ex","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Solon","Kathryn","Therapy Department, MercyOne Clive Rehabilitation Hospital 1401 Campus Dr Clive, IA 50325 (USA). kathryn.solon@mercyrehabdesmoines","kathryn.solon@mercyrehabdesmoines.com"
"120","34192092","10.1097/JAT.0000000000000153","Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series.","To provide an outline of the timeline from acute care admission to inpatient rehabilitation facility discharge and describe the functional progress and tolerance of 2 individuals who were hospitalized but not intubated because of COVID-19. Retrospective data were collected from the electronic medical record to describe the rehabilitation course of the first 2 consecutive patients admitted to the rehabilitation facility who were recovering from COVID-19. Both patients were octogenarian men who ex","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Larson","Allison","Therapy Department, MercyOne Clive Rehabilitation Hospital 1401 Campus Dr Clive, IA 50325 (USA). kathryn.solon@mercyrehabdesmoines","kathryn.solon@mercyrehabdesmoines.com"
"121","34192092","10.1097/JAT.0000000000000153","Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series.","To provide an outline of the timeline from acute care admission to inpatient rehabilitation facility discharge and describe the functional progress and tolerance of 2 individuals who were hospitalized but not intubated because of COVID-19. Retrospective data were collected from the electronic medical record to describe the rehabilitation course of the first 2 consecutive patients admitted to the rehabilitation facility who were recovering from COVID-19. Both patients were octogenarian men who ex","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Ronnebaum","Julie","Therapy Department, MercyOne Clive Rehabilitation Hospital 1401 Campus Dr Clive, IA 50325 (USA). kathryn.solon@mercyrehabdesmoines","kathryn.solon@mercyrehabdesmoines.com"
"122","34192092","10.1097/JAT.0000000000000153","Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series.","To provide an outline of the timeline from acute care admission to inpatient rehabilitation facility discharge and describe the functional progress and tolerance of 2 individuals who were hospitalized but not intubated because of COVID-19. Retrospective data were collected from the electronic medical record to describe the rehabilitation course of the first 2 consecutive patients admitted to the rehabilitation facility who were recovering from COVID-19. Both patients were octogenarian men who ex","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Stevermer","Catherine","Therapy Department, MercyOne Clive Rehabilitation Hospital 1401 Campus Dr Clive, IA 50325 (USA). kathryn.solon@mercyrehabdesmoines","kathryn.solon@mercyrehabdesmoines.com"
"123","34192091","10.1097/JAT.0000000000000143","Applying Telehealth Technologies and Strategies to Provide Acute Care Consultation and Treatment of Patients With Confirmed or Possible COVID-19.","The COVID-19 pandemic continues to grow, with 19% of total confirmed patients classified as severe or critical experiencing complications such as dyspnea, hypoxia, acute respiratory distress syndrome, or multiorgan failure. These complications require rehabilitative care. Considering the contagious nature of COVID-19 and the necessity to decrease the volume of health care professionals entering confirmed COVID-19 patient rooms and becoming a potential disease vector, can audiovisual technologies","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Exum","Emelia","Department of Physical Medicine &amp","Emelia.Exum@BSWHealth.org"
"124","34192091","10.1097/JAT.0000000000000143","Applying Telehealth Technologies and Strategies to Provide Acute Care Consultation and Treatment of Patients With Confirmed or Possible COVID-19.","The COVID-19 pandemic continues to grow, with 19% of total confirmed patients classified as severe or critical experiencing complications such as dyspnea, hypoxia, acute respiratory distress syndrome, or multiorgan failure. These complications require rehabilitative care. Considering the contagious nature of COVID-19 and the necessity to decrease the volume of health care professionals entering confirmed COVID-19 patient rooms and becoming a potential disease vector, can audiovisual technologies","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Hull","Brian L","Department of Physical Medicine &amp","Emelia.Exum@BSWHealth.org"
"125","34192091","10.1097/JAT.0000000000000143","Applying Telehealth Technologies and Strategies to Provide Acute Care Consultation and Treatment of Patients With Confirmed or Possible COVID-19.","The COVID-19 pandemic continues to grow, with 19% of total confirmed patients classified as severe or critical experiencing complications such as dyspnea, hypoxia, acute respiratory distress syndrome, or multiorgan failure. These complications require rehabilitative care. Considering the contagious nature of COVID-19 and the necessity to decrease the volume of health care professionals entering confirmed COVID-19 patient rooms and becoming a potential disease vector, can audiovisual technologies","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Lee","Alan Chong W","Department of Physical Medicine &amp","Emelia.Exum@BSWHealth.org"
"126","34192091","10.1097/JAT.0000000000000143","Applying Telehealth Technologies and Strategies to Provide Acute Care Consultation and Treatment of Patients With Confirmed or Possible COVID-19.","The COVID-19 pandemic continues to grow, with 19% of total confirmed patients classified as severe or critical experiencing complications such as dyspnea, hypoxia, acute respiratory distress syndrome, or multiorgan failure. These complications require rehabilitative care. Considering the contagious nature of COVID-19 and the necessity to decrease the volume of health care professionals entering confirmed COVID-19 patient rooms and becoming a potential disease vector, can audiovisual technologies","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Gumieny","Annie","Department of Physical Medicine &amp","Emelia.Exum@BSWHealth.org"
"127","34192091","10.1097/JAT.0000000000000143","Applying Telehealth Technologies and Strategies to Provide Acute Care Consultation and Treatment of Patients With Confirmed or Possible COVID-19.","The COVID-19 pandemic continues to grow, with 19% of total confirmed patients classified as severe or critical experiencing complications such as dyspnea, hypoxia, acute respiratory distress syndrome, or multiorgan failure. These complications require rehabilitative care. Considering the contagious nature of COVID-19 and the necessity to decrease the volume of health care professionals entering confirmed COVID-19 patient rooms and becoming a potential disease vector, can audiovisual technologies","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Villarreal","Christopher","Department of Physical Medicine &amp","Emelia.Exum@BSWHealth.org"
"128","34192091","10.1097/JAT.0000000000000143","Applying Telehealth Technologies and Strategies to Provide Acute Care Consultation and Treatment of Patients With Confirmed or Possible COVID-19.","The COVID-19 pandemic continues to grow, with 19% of total confirmed patients classified as severe or critical experiencing complications such as dyspnea, hypoxia, acute respiratory distress syndrome, or multiorgan failure. These complications require rehabilitative care. Considering the contagious nature of COVID-19 and the necessity to decrease the volume of health care professionals entering confirmed COVID-19 patient rooms and becoming a potential disease vector, can audiovisual technologies","2021","07","02","J Acute Care Phys Ther","Journal of acute care physical therapy",NA,"Longnecker","Diane","Department of Physical Medicine &amp","Emelia.Exum@BSWHealth.org"
"129","34192090","10.1021/acscatal.0c05522","Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.","We here investigate the mechanism of SARS-CoV-2 3CL protease inhibition by one of the most promising families of inhibitors, those containing an aldehyde group as a warhead. These compounds are covalent inhibitors that inactivate the protease, forming a stable hemithioacetal complex. Inhibitor 11a is a potent inhibitor that has been already tested in vitro and in animals. Using a combination of classical and QM/MM simulations, we determined the binding mode of the inhibitor into the activ","2021","07","02","ACS Catal","ACS catalysis",NA,"Ramos-Guzmán","Carlos A","Departamento de Química Física, Universidad de Valencia, Burjassot 46100, Spain",NA
"130","34192090","10.1021/acscatal.0c05522","Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.","We here investigate the mechanism of SARS-CoV-2 3CL protease inhibition by one of the most promising families of inhibitors, those containing an aldehyde group as a warhead. These compounds are covalent inhibitors that inactivate the protease, forming a stable hemithioacetal complex. Inhibitor 11a is a potent inhibitor that has been already tested in vitro and in animals. Using a combination of classical and QM/MM simulations, we determined the binding mode of the inhibitor into the activ","2021","07","02","ACS Catal","ACS catalysis",NA,"Ruiz-Pernía","J Javier","Departamento de Química Física, Universidad de Valencia, Burjassot 46100, Spain",NA
"131","34192090","10.1021/acscatal.0c05522","Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.","We here investigate the mechanism of SARS-CoV-2 3CL protease inhibition by one of the most promising families of inhibitors, those containing an aldehyde group as a warhead. These compounds are covalent inhibitors that inactivate the protease, forming a stable hemithioacetal complex. Inhibitor 11a is a potent inhibitor that has been already tested in vitro and in animals. Using a combination of classical and QM/MM simulations, we determined the binding mode of the inhibitor into the activ","2021","07","02","ACS Catal","ACS catalysis",NA,"Tuñón","Iñaki","Departamento de Química Física, Universidad de Valencia, Burjassot 46100, Spain",NA
"132","34192086","10.1093/nsr/nwaa123","Autopsy of COVID-19 patients in China.",NA,"2021","07","02","Natl Sci Rev","National science review",NA,"Bian","Xiu-Wu","The initiating member of the COVID-19 Pathology Team, Institute of Pathology &amp",NA
"133","34192085","10.1093/nsr/nwaa147","International collaboration for global accessibility of COVID-19 vaccines.",NA,"2021","06","30","Natl Sci Rev","National science review",NA,"Zhou","Qi","Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, China Editorial Board Member of NSR",NA
"134","34192064","10.1017/cts.2021.25","COVID-19 pandemic response varies by clinical trial sponsor type.","The COVID-19 pandemic has impacted millions of lives globally. To learn more about this disease and find potential diagnostic, therapeutic, and preventative products, the healthcare community has initiated a staggering number of clinical trials. ClinicalTrials.gov was reviewed to determine if trial sponsor type had a relationship to time to COVID-19 response, which was defined as the date from disease discovery in Wuhan, China to ClinicalTrials.gov study ""First Posted"" date. A total of 673 Unite","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; ClinicalTrials.gov; Coronavirus; SARS-Cov-2; pandemic","Cooper","Lisa","Department of Health Informatics, School of Health Professions, Rutgers, The State University of New Jersey, Newark, NJ, USA",NA
"135","34192064","10.1017/cts.2021.25","COVID-19 pandemic response varies by clinical trial sponsor type.","The COVID-19 pandemic has impacted millions of lives globally. To learn more about this disease and find potential diagnostic, therapeutic, and preventative products, the healthcare community has initiated a staggering number of clinical trials. ClinicalTrials.gov was reviewed to determine if trial sponsor type had a relationship to time to COVID-19 response, which was defined as the date from disease discovery in Wuhan, China to ClinicalTrials.gov study ""First Posted"" date. A total of 673 Unite","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; ClinicalTrials.gov; Coronavirus; SARS-Cov-2; pandemic","Lee","Irene","Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA",NA
"136","34192064","10.1017/cts.2021.25","COVID-19 pandemic response varies by clinical trial sponsor type.","The COVID-19 pandemic has impacted millions of lives globally. To learn more about this disease and find potential diagnostic, therapeutic, and preventative products, the healthcare community has initiated a staggering number of clinical trials. ClinicalTrials.gov was reviewed to determine if trial sponsor type had a relationship to time to COVID-19 response, which was defined as the date from disease discovery in Wuhan, China to ClinicalTrials.gov study ""First Posted"" date. A total of 673 Unite","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; ClinicalTrials.gov; Coronavirus; SARS-Cov-2; pandemic","Waldron Lechner","Doreen","Department of Health Informatics, School of Health Professions, Rutgers, The State University of New Jersey, Newark, NJ, USA",NA
"137","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Bookman","Richard J","Department of Molecular and Cell Pharmacology, Clinical and Translational Science Institute, University of Miami, Miami, FL, USA",NA
"138","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Cimino","James J","Informatics Institute, Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA",NA
"139","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Harle","Christopher A","Department of Health Outcomes and Biomedical Informatics, Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA",NA
"140","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Kost","Rhonda G","Center for Clinical and Translational Science, the Rockefeller University, New York, NY, USA",NA
"141","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Mooney","Sean","Institute for Translational Health Sciences, University of Washington, Seattle, WA, USA",NA
"142","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Pfaff","Emily","Department of Medicine, North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"143","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Rojevsky","Svetlana","Clinical and Translational Institute, Tufts Medical Center, Boston, USA",NA
"144","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Tobin","Jonathan N","Clinical Directors Network (CDN), the Rockefeller University Center for Clinical and Translational Science, New York, NY, USA",NA
"145","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Wilcox","Adam","Department of Biomedical Informatics and Medical Education, Institute for Translational Health Sciences, University of Washington, Seattle, WA, USA",NA
"146","34192063","10.1017/cts.2021.26","Research informatics and the COVID-19 pandemic: Challenges, innovations, lessons learned, and recommendations.","The recipients of NIH's Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research. This infrastructure has proved invaluable for supporting responses to the current COVID-19 pandemic through direct patient care, clinical decision support, training researchers and practitioners, as well as public health surveillance and clinical research to levels that could not have been accomplished withou","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; N3C; informatics; research","Tsinoremas","Nick F","Department of Biochemistry and Molecular Biology, Clinical and Translational Science Institute, University of Miami, Miami, FL, USA",NA
"147","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","MacArthur","Robert B","Rockefeller University Hospital Pharmacy, The Rockefeller University, New York, NY, USA",NA
"148","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Bentur","Ohad S","Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY, USA",NA
"149","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","MacArthur","Ian C","Medical Scientist Training Program, Albert Einstein College of Medicine, Bronx, NY, USA",NA
"150","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Bartoo","Anna S","Pharmacy Department, Mayo Clinic, Rochester, MN, USA",NA
"151","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Capozzi","Donna L","Ambulatory Oncology Pharmacy Services, Hospital of the University of Pennsylvania Pharmacy Department, Philadelphia, PA, USA",NA
"152","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Christensen","Jason A","Pharmacy Department, Mayo Clinic, Rochester, MN, USA",NA
"153","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Johnson","Amber L","Rockefeller University Hospital Pharmacy, The Rockefeller University, New York, NY, USA",NA
"154","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Patel","Kuldip","Pharmacy Department, Duke University Hospital, Durham, NC, USA",NA
"155","34192062","10.1017/cts.2021.13","CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic.","In March 2020, academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators. The CTSA program surveyed 60 AMC pharmacy departments. The survey included event timing, impact on pharmacy services, and corrective actions t","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Pharmacy; biomedical research; drug shortage; investigational drugs; supply and distribution; teleworking; vaccination","Coller","Barry S","Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY, USA",NA
"156","34192061","10.1017/cts.2021.27","Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic.","The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. International Review Board (IRB) offices developed plans to rapidly review protocols related to the COVID-19 pandemic. An online survey was conducted with the IRB Directors at Clinical and Translational Science Awards (CTSA) institutions as well as two focus groups. Acro","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Internal review board; informed consent; protection of human subjects; protocol review","Ford","Daniel E","School of Medicine, Institute for Clinical and Translational Research, Johns Hopkins University, Baltimore, MD, USA",NA
"157","34192061","10.1017/cts.2021.27","Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic.","The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. International Review Board (IRB) offices developed plans to rapidly review protocols related to the COVID-19 pandemic. An online survey was conducted with the IRB Directors at Clinical and Translational Science Awards (CTSA) institutions as well as two focus groups. Acro","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Internal review board; informed consent; protection of human subjects; protocol review","Johnson","Ann","School of Medicine, IRB Office, University of Utah, Salt Lake City, UT, USA",NA
"158","34192061","10.1017/cts.2021.27","Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic.","The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. International Review Board (IRB) offices developed plans to rapidly review protocols related to the COVID-19 pandemic. An online survey was conducted with the IRB Directors at Clinical and Translational Science Awards (CTSA) institutions as well as two focus groups. Acro","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Internal review board; informed consent; protection of human subjects; protocol review","Nichols","Jason J","School of Optometry, Department of Vision Sciences, School of Medicine, Center for Clinical and Translational Sciences, The University of Alabama at Birmingham, Birmingham, AL, USA",NA
"159","34192061","10.1017/cts.2021.27","Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic.","The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. International Review Board (IRB) offices developed plans to rapidly review protocols related to the COVID-19 pandemic. An online survey was conducted with the IRB Directors at Clinical and Translational Science Awards (CTSA) institutions as well as two focus groups. Acro","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Internal review board; informed consent; protection of human subjects; protocol review","Rothwell","Erin","School of Medicine, Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, USA",NA
"160","34192061","10.1017/cts.2021.27","Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic.","The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. International Review Board (IRB) offices developed plans to rapidly review protocols related to the COVID-19 pandemic. An online survey was conducted with the IRB Directors at Clinical and Translational Science Awards (CTSA) institutions as well as two focus groups. Acro","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Internal review board; informed consent; protection of human subjects; protocol review","Dubinett","Steve","Department of Medicine, David Geffen School of Medicine at UCLA, Clinical and Translational Sciences Institute, Los Angeles, CA, USA",NA
"161","34192061","10.1017/cts.2021.27","Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic.","The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. International Review Board (IRB) offices developed plans to rapidly review protocols related to the COVID-19 pandemic. An online survey was conducted with the IRB Directors at Clinical and Translational Science Awards (CTSA) institutions as well as two focus groups. Acro","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Internal review board; informed consent; protection of human subjects; protocol review","Naeim","Arash","Department of Medicine, David Geffen School of Medicine at UCLA, Clinical and Translational Sciences Institute, Los Angeles, CA, USA",NA
"162","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Jayaweera","Dushyantha","University of Miami Miller School of Medicine, Miami, FL, USA",NA
"163","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Flume","Patrick A","Medical University of South Carolina, Charleston, SC, USA",NA
"164","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Singer","Nora G","The MetroHealth System at Case Western Reserve University, Cleveland, OH, USA",NA
"165","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Cohen","Myron S","The University of North Carolina School of Medicine, Chapel Hill, NC, USA",NA
"166","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Lachiewicz","Anne M","The University of North Carolina School of Medicine, Chapel Hill, NC, USA",NA
"167","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Cameron","Amanda","Medical University of South Carolina, Charleston, SC, USA",NA
"168","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Kumar","Naresh","University of Miami Miller School of Medicine, Miami, FL, USA",NA
"169","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Thompson","Joel","University of Kentucky, Lexington, KY, USA",NA
"170","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Cabrera","Alyssa","Tufts Medical Center, Boston, MA, USA",NA
"171","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Daudelin","Denise","Tufts Medical Center, Boston, MA, USA",NA
"172","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Shaker","Reza","Medical College of Wisconsin, Milwaukee, WI, USA",NA
"173","34192060","10.1017/cts.2021.784","Prioritizing studies of COVID-19 and lessons learned.","COVID-19 altered research in Clinical and Translational Science Award (CTSA) hubs in an unprecedented manner, leading to adjustments for COVID-19 research. CTSA members volunteered to conduct a review on the impact of CTSA network on COVID-19 pandemic with the assistance from NIH survey team in October 2020. The survey questions included the involvement of CTSAs in decision-making concerning the prioritization of COVID-19 studies. Descriptive and statistical analyses were conducted to analyze th","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Clinical translational research; leadership; lessons learned","Bauer","Philippe R","Mayo Clinic, Rochester, MN, USA",NA
"174","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Rothwell","Erin","Department of Ob/Gyn, School of Medicine, University of Utah, Salt Lake City, UT, USA",NA
"175","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Brassil","Donna","Rockefeller University, New York, NY, USA",NA
"176","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Barton-Baxter","Marietta","University of Kentucky Center for Clinical and Translational Science, Lexington, KY, USA",NA
"177","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Brownley","Kimberly A","Department of Psychiatry, School of Medicine, NC Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"178","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Dickert","Neal W","Emory University School of Medicine, Department of Medicine, and Georgia Clinical and Translational Science Alliancet, Atlanta, GA, USA",NA
"179","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Ford","Daniel E","Johns Hopkins Institute for Clinical and Translational Research, Baltimore, MD, USA",NA
"180","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Kraft","Stephanie A","Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute and Division of Bioethics and Palliative Care, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA",NA
"181","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","McCormick","Jennifer B","Department of Humanities, College of Medicine, Pennsylvania State University, and Penn State Clinical and Translational Science Institute, Hershey, PA, USA",NA
"182","34192059","10.1017/cts.2021.401","Informed consent: Old and new challenges in the context of the COVID-19 pandemic.","In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19. Then, we discuss how informed consent processes were modified or changed to address the pandemic, consider what lessons were learned, and present research and policy steps to prepare for future res","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; Informed consent; clinical research; pandemic","Wilfond","Benjamin S","Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute",NA
"183","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Marsh","Erica E","Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, USA",NA
"184","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Kappelman","Michael D","North Carolina Translational and Clinical Sciences (NCTraCS) Institute, University of North Carolina, Chapel Hill, NC, USA",NA
"185","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Kost","Rhonda G","The Rockefeller University (RU) Center for Clinical and Translational Science (CCTS), New York, NY, USA",NA
"186","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Mudd-Martin","Gia","The University of Kentucky Center for Clinical and Translational Science, Lexington, KY, USA",NA
"187","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Shannon","Jackilen","Oregon Clinical and Translational Research Institute, Oregon Health &amp",NA
"188","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Stark","Louisa A","Center for Clinical and Translational Science, University of Utah, Salt Lake City, UT, USA",NA
"189","34192058","10.1017/cts.2021.785","Community engagement during COVID: A field report from seven CTSAs.","Prior to the COVID pandemic, many CTSAs employed face-to-face interactions to conduct most of their community engagement (CE) activities. During the COVID pandemic, such engagement had to be curtailed and alternatives needed to be formulated. In addition, Community Engaged Research (CEnR) teams refocused their efforts to address this public health crisis. To obtain a general understanding of how CTSAs have conducted CE and CEnR during the COVID pandemic, we invited seven CTSA CE leaders to provi","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","COVID; CTSA; community engagement; health disparities","Carrasquillo","Olveen","University of Miami (UM) Clinical and Translational Science Institute, Miami, FL, USA",NA
"190","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Loucks","Tammy L","South Carolina Clinical and Translational Research (SCTR) Institute, Medical University of South Carolina, Charleston, SC, USA",NA
"191","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Tyson","Clare","South Carolina Clinical and Translational Research (SCTR) Institute, Medical University of South Carolina, Charleston, SC, USA",NA
"192","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Dorr","David","Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, OR, USA",NA
"193","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Garovic","Vesna D","Department of Internal Medicine, Division of Nephrology and Hypertension and Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, Rochester, MN, USA",NA
"194","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Hill","James","Department of Nutrition Sciences, University of Alabama Birmingham, Birmingham, AL, USA",NA
"195","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","McSwain","S David","Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA",NA
"196","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Radovick","Sally","Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA",NA
"197","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Sonnenberg","Frank A","Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA",NA
"198","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Weis","Jennifer A","Center for Clinical and Translational Science (CCATS), Mayo Clinic, Rochester, MN, USA",NA
"199","34192057","10.1017/cts.2021.19","Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.","Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has p","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19 pandemic; clinical trials; virtual systems","Brady","Kathleen T","South Carolina Clinical and Translational Research (SCTR) Institute, Medical University of South Carolina, Charleston, SC, USA",NA
"200","34192056","10.1017/cts.2021.20","Integration of sociocultural and behavioral factors into the clinical framework of cardiovascular studies in Hispanic/Latino populations: Relevance during the SARS-COV-2 pandemic.","Recent reports on the burden of cardiovascular disease (CVD) in the USA indicate that despite significant declines in CVD mortality in the late 20th century, this decline is now decelerating and may be worsened by inequalities in health care. Social factors contribute to most of the cardiovascular health disparities documented to date. Hispanics/Latinos and African-Americans share a higher prevalence of cardiovascular risk factors and experience higher rates of poverty and social stressors than ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Hispanic/Latino; SARS-COV-1; Socio-cultural; behavioral; clinical studies","Suglia","Shakira F","Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia",NA
"201","34192056","10.1017/cts.2021.20","Integration of sociocultural and behavioral factors into the clinical framework of cardiovascular studies in Hispanic/Latino populations: Relevance during the SARS-COV-2 pandemic.","Recent reports on the burden of cardiovascular disease (CVD) in the USA indicate that despite significant declines in CVD mortality in the late 20th century, this decline is now decelerating and may be worsened by inequalities in health care. Social factors contribute to most of the cardiovascular health disparities documented to date. Hispanics/Latinos and African-Americans share a higher prevalence of cardiovascular risk factors and experience higher rates of poverty and social stressors than ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Hispanic/Latino; SARS-COV-1; Socio-cultural; behavioral; clinical studies","Abraido-Lanza","Ana F","School of Global Public Health, New York University, New York, USA",NA
"202","34192056","10.1017/cts.2021.20","Integration of sociocultural and behavioral factors into the clinical framework of cardiovascular studies in Hispanic/Latino populations: Relevance during the SARS-COV-2 pandemic.","Recent reports on the burden of cardiovascular disease (CVD) in the USA indicate that despite significant declines in CVD mortality in the late 20th century, this decline is now decelerating and may be worsened by inequalities in health care. Social factors contribute to most of the cardiovascular health disparities documented to date. Hispanics/Latinos and African-Americans share a higher prevalence of cardiovascular risk factors and experience higher rates of poverty and social stressors than ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Hispanic/Latino; SARS-COV-1; Socio-cultural; behavioral; clinical studies","Guerrero-Preston","Rafael E","Department of Biomarkers Discovery and Development, LifeGene Biomarks, San Juan, Puerto Rico",NA
"203","34192056","10.1017/cts.2021.20","Integration of sociocultural and behavioral factors into the clinical framework of cardiovascular studies in Hispanic/Latino populations: Relevance during the SARS-COV-2 pandemic.","Recent reports on the burden of cardiovascular disease (CVD) in the USA indicate that despite significant declines in CVD mortality in the late 20th century, this decline is now decelerating and may be worsened by inequalities in health care. Social factors contribute to most of the cardiovascular health disparities documented to date. Hispanics/Latinos and African-Americans share a higher prevalence of cardiovascular risk factors and experience higher rates of poverty and social stressors than ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Hispanic/Latino; SARS-COV-1; Socio-cultural; behavioral; clinical studies","Ramos","Kenneth S","Texas A&amp",NA
"204","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Greenberg","Rachel G","Duke Clinical Research Institute, Durham, NC, USA",NA
"205","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Poole","Lori","Duke Clinical Research Institute, Durham, NC, USA",NA
"206","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Ford","Daniel E","Johns Hopkins University, Baltimore, MD, USA",NA
"207","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Hanley","Daniel","Johns Hopkins University, Baltimore, MD, USA",NA
"208","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Selker","Harry P","Tufts University, Boston, MA, USA",NA
"209","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Lane","Karen","Johns Hopkins University, Baltimore, MD, USA",NA
"210","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Dean","J Michael","University of Utah, Salt Lake City, UT, USA",NA
"211","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Burr","Jeri","University of Utah, Salt Lake City, UT, USA",NA
"212","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Harris","Paul","Vanderbilt University Medical Center, Nashville, TN, USA",NA
"213","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Wilkins","Consuelo H","Vanderbilt University Medical Center, Nashville, TN, USA",NA
"214","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Bernard","Gordon","Vanderbilt University Medical Center, Nashville, TN, USA",NA
"215","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Edwards","Terri","Vanderbilt University Medical Center, Nashville, TN, USA",NA
"216","34192055","10.1017/cts.2021.782","Response of the trial innovation network to the COVID-19 pandemic.","The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an established clinical research network that pivoted to respond to the pandemic. The TIN's three Trial Innovation Centers, Recruitment Innovation Center, and 66 Clinical and Translational Science Award Hub institutions, collaborated to adapt to the pandemic's rapidly changing l","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; SARS-CoV-2; Trial innovation network; clinical trial","Benjamin","Daniel K","Duke Clinical Research Institute, Durham, NC, USA",NA
"217","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Nana-Sinkam","Patrick","Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA",NA
"218","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Kraschnewski","Jennifer","Division of General Internal Medicine, Penn State College of Medicine, Hershey, PA, USA",NA
"219","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Sacco","Ralph","Department of Neurology, University of Miami Health, Miami, FL, USA",NA
"220","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Chavez","Jennifer","University of Miami School of Medicine, Miami, FL, USA",NA
"221","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Fouad","Mona","Division of Preventive Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA",NA
"222","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Gal","Tamas","Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA",NA
"223","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","AuYoung","Mona","Scripps Health, San Diego, CA, USA",NA
"224","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Namoos","Asmaa","Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA",NA
"225","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Winn","Robert","Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA",NA
"226","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Sheppard","Vanessa","Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA",NA
"227","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Corbie-Smith","Giselle","Department of Social Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA",NA
"228","34192054","10.1017/cts.2021.23","Health disparities and equity in the era of COVID-19.","Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic ","2021","07","14","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Health disparities; clinical and translational research; health equity","Behar-Zusman","Victoria","School of Nursing and Health Studies, University of Miami, Coral Gables, FL, USA",NA
"229","34192053","10.1017/cts.2021.10","Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics.","The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation. There was simultaneously a need to expand research to obtain crucial data about disease prognosis and therapy and enormous limitations on conducting research as localities and institutions limited travel and person-to-person contact. These imperatives resulted in major changes in the way research was conducted, including e","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; pandemic; translational research","Coller","Barry S","Allen and Frances Adler Laboratory of Vascular Biology, Rockefeller University, New York, NY, USA",NA
"230","34192053","10.1017/cts.2021.10","Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics.","The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation. There was simultaneously a need to expand research to obtain crucial data about disease prognosis and therapy and enormous limitations on conducting research as localities and institutions limited travel and person-to-person contact. These imperatives resulted in major changes in the way research was conducted, including e","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; pandemic; translational research","Buse","John B","Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA",NA
"231","34192053","10.1017/cts.2021.10","Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics.","The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation. There was simultaneously a need to expand research to obtain crucial data about disease prognosis and therapy and enormous limitations on conducting research as localities and institutions limited travel and person-to-person contact. These imperatives resulted in major changes in the way research was conducted, including e","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; pandemic; translational research","Kimberly","Robert P","Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA",NA
"232","34192053","10.1017/cts.2021.10","Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics.","The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation. There was simultaneously a need to expand research to obtain crucial data about disease prognosis and therapy and enormous limitations on conducting research as localities and institutions limited travel and person-to-person contact. These imperatives resulted in major changes in the way research was conducted, including e","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; pandemic; translational research","Powderly","William G","Division of Infectious Diseases and Institute for Public Health, Washington University in St. Louis, St. Louis, MO, USA",NA
"233","34192053","10.1017/cts.2021.10","Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics.","The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation. There was simultaneously a need to expand research to obtain crucial data about disease prognosis and therapy and enormous limitations on conducting research as localities and institutions limited travel and person-to-person contact. These imperatives resulted in major changes in the way research was conducted, including e","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; pandemic; translational research","Zand","Martin S","Department of Medicine, University of Rochester Medical Center, Department of Medicine, Nephrology, Rochester, NY, USA",NA
"234","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Grumbach","Kevin","Department of Family and Community Medicine and Clinical and Translational Science Institute, University of California, San Francisco, CA, USA",NA
"235","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Cottler","Linda B","Department of Epidemiology and Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA",NA
"236","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Brown","Jen","Alliance for Research in Chicagoland Communities and Clinical and Translational Sciences Institute, Northwestern University, Evanston, IL, USA",NA
"237","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","LeSarre","Monique","Rafiki Coalition and African American Community Health Equity Council, San Francisco, CA, USA",NA
"238","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Gonzalez-Fisher","Ricardo F","Servicios de La Raza, Metropolitan State University of Denver, Denver, CO, USA",NA
"239","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Williams","Carla D","Georgetown-Howard University Center for Clinical and Translational Science, Washington, DC, USA",NA
"240","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Michener","J Lloyd","Department of Family Medicine and Community Health, Duke School of Medicine, Durham, NC, USA",NA
"241","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Nease","Donald E","Department of Family Medicine and the Colorado Clinical and Translational Sciences Institute, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA",NA
"242","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Tandon","Darius","Department of Medical Social Sciences and Center for Community Health, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"243","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Varma","Deepthi S","Department of Epidemiology, University of Florida, Gainesville, FL, USA",NA
"244","34192052","10.1017/cts.2021.8","It should not require a pandemic to make community engagement in research leadership essential, not optional.","Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early ","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","Community engagement; equity; translational science","Eder","Milton","Department of Family Medicine and Community Health, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA",NA
"245","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Gravelin","Misty","Michigan Institute for Clinical &amp",NA
"246","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Wright","Jeanne","Michigan Institute for Clinical &amp",NA
"247","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Holbein","M E Blair","Data and Population Sciences, University of Texas Southwestern, Dallas, TX, USA",NA
"248","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Berro","Marlene","Clinical and Translational Institute, University of California Los Angeles, Los Angeles, CA, USA",NA
"249","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Brown","Jennifer S","Clinical Research Quality, School of Medicine Research Office, Stanford University, Stanford, CA, USA",NA
"250","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Mashour","George A","Michigan Institute for Clinical &amp",NA
"251","34192051","10.1017/cts.2021.15","Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic.","With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units within an Academic Medical Center (AMC), including those part of the Clinical and Translational Science Award (CTSA) consortium, have provided support for clinicians in navigating these options prior to the pandem","2021","07","09","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; academic medical centers; preapproval access; regulatory support","Weatherwax","Kevin J","Michigan Institute for Clinical &amp",NA
"252","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Moran","Jeffery H","Departments of Pharmacology and Toxicology, Microbiology, Pathology, and Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA",NA
"253","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Kessler","Larry","Department of Health Services, School of Public Health, University of Washington, Seattle, WA, USA",NA
"254","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Moylan","Jennifer","Department of Physiology, College of Medicine, University of Kentucky, Lexington, Kentucky, USA",NA
"255","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Forrest","Craig","Departments of Pharmacology and Toxicology, Microbiology, Pathology, and Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA",NA
"256","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Boehme","Karl","Departments of Pharmacology and Toxicology, Microbiology, Pathology, and Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA",NA
"257","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Kennedy","Josh","Departments of Pharmacology and Toxicology, Microbiology, Pathology, and Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA",NA
"258","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Greninger","Alex","Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, Washington, USA",NA
"259","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Baird","Geoff","Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, Washington, USA",NA
"260","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","Olgaard","Ericka","Departments of Pharmacology and Toxicology, Microbiology, Pathology, and Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA",NA
"261","34192050","10.1017/cts.2021.5","Modifying laboratory testing via home brew during the COVID-19 pandemic.","Rapid development and deployment of diagnostic testing for COVID-19 have been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands. In addition to constraints on local testing supplies and equipment, a rapidly changing regulatory framework created challenges for translational scientists. Illustrative examples of approaches used to develop lab","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Diagnostic tests; laboratory developed tests","James","Laura","Departments of Pharmacology and Toxicology, Microbiology, Pathology, and Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA",NA
"262","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Croker","Jennifer A","Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA",NA
"263","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Patel","Robin","Division of Clinical Microbiology, Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA",NA
"264","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Campbell","Kenneth S","Center for Clinical and Translational Science, University of Kentucky, Lexington, KY, USA",NA
"265","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Barton-Baxter","Marietta","Center for Clinical and Translational Science, University of Kentucky, Lexington, KY, USA",NA
"266","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Wallet","Shannon","North Carolina Translational and Clinical Sciences Institute, University of North Carolina, Chapel Hill, NC, USA",NA
"267","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Firestein","Gary S","Altman Clinical &amp",NA
"268","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Kimberly","Robert P","Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA",NA
"269","34192049","10.1017/cts.2021.6","Building biorepositories in the midst of a pandemic.","Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention. They rely on the complex integration of scientific need, regulatory oversight, quality control in collection, processing and tracking, and linkage to robust phenotype information. The COVID-19 pandemic amplified many of these co","2021","07","08","J Clin Transl Sci","Journal of clinical and translational science","Biorepository; COVID-19; CTSA; SARS-CoV-2; biobanking IRB; informed consent; regulatory; sample; specimen","Elemento","Olivier","Clinical &amp",NA
"270","34192048","10.1017/cts.2020.562","Leveraging community engagement capacity to address COVID-19 disparities among Pacific Islander and Latinx Communities in Arkansas.","Northwest Arkansas, particularly Benton and Washington counties, is one of the highest COVID-19 hot spots in the United States (US), with more than half of all reported cases in this area identifying as Latinx or Pacific Islander, even though these communities account for less than 20% of the overall population. The University of Arkansas for Medical Sciences (UAMS) leveraged their existing relationship with 18 key community partners. Partners collaboratively developed a COVID-19 Response Strate","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Latinx; Pacific Islanders; community engagement; disparities","McElfish","Pearl A","Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR, USA",NA
"271","34192048","10.1017/cts.2020.562","Leveraging community engagement capacity to address COVID-19 disparities among Pacific Islander and Latinx Communities in Arkansas.","Northwest Arkansas, particularly Benton and Washington counties, is one of the highest COVID-19 hot spots in the United States (US), with more than half of all reported cases in this area identifying as Latinx or Pacific Islander, even though these communities account for less than 20% of the overall population. The University of Arkansas for Medical Sciences (UAMS) leveraged their existing relationship with 18 key community partners. Partners collaboratively developed a COVID-19 Response Strate","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Latinx; Pacific Islanders; community engagement; disparities","Cleek","Anna B","Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR, USA",NA
"272","34192048","10.1017/cts.2020.562","Leveraging community engagement capacity to address COVID-19 disparities among Pacific Islander and Latinx Communities in Arkansas.","Northwest Arkansas, particularly Benton and Washington counties, is one of the highest COVID-19 hot spots in the United States (US), with more than half of all reported cases in this area identifying as Latinx or Pacific Islander, even though these communities account for less than 20% of the overall population. The University of Arkansas for Medical Sciences (UAMS) leveraged their existing relationship with 18 key community partners. Partners collaboratively developed a COVID-19 Response Strate","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Latinx; Pacific Islanders; community engagement; disparities","Willis","Don E","Office of Community Health and Research, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR, USA",NA
"273","34192048","10.1017/cts.2020.562","Leveraging community engagement capacity to address COVID-19 disparities among Pacific Islander and Latinx Communities in Arkansas.","Northwest Arkansas, particularly Benton and Washington counties, is one of the highest COVID-19 hot spots in the United States (US), with more than half of all reported cases in this area identifying as Latinx or Pacific Islander, even though these communities account for less than 20% of the overall population. The University of Arkansas for Medical Sciences (UAMS) leveraged their existing relationship with 18 key community partners. Partners collaboratively developed a COVID-19 Response Strate","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Latinx; Pacific Islanders; community engagement; disparities","Purvis","Rachel S","Office of Community Health and Research, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR, USA",NA
"274","34192048","10.1017/cts.2020.562","Leveraging community engagement capacity to address COVID-19 disparities among Pacific Islander and Latinx Communities in Arkansas.","Northwest Arkansas, particularly Benton and Washington counties, is one of the highest COVID-19 hot spots in the United States (US), with more than half of all reported cases in this area identifying as Latinx or Pacific Islander, even though these communities account for less than 20% of the overall population. The University of Arkansas for Medical Sciences (UAMS) leveraged their existing relationship with 18 key community partners. Partners collaboratively developed a COVID-19 Response Strate","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Latinx; Pacific Islanders; community engagement; disparities","James","Laura P","Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"275","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Bobb","Leslie","Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA",NA
"276","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Ballance","Lisa Richman","Clinical Research and Compliance, Virginia Commonwealth University, Richmond, VA, USA",NA
"277","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Abbate","Antonio","Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA",NA
"278","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Bain","Jesse C","Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, USA",NA
"279","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Sime","Patricia J","School of Medicine, Virginia Commonwealth University, Richmond, VA, USA",NA
"280","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Moeller","F Gerard","Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA",NA
"281","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Lessard","Margaret K","Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, USA",NA
"282","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Montpetit","Alison J","Nursing Research &amp",NA
"283","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Harmon","Mary P","Clinical Research, Virginia Commonwealth University Health System, Richmond, VA, USA",NA
"284","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","Stevens","Michael P","School of Medicine, Virginia Commonwealth University, Richmond, VA, USA",NA
"285","34192047","10.1017/cts.2021.4","Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic.","The rate at which the coronavirus disease (COVID-19) spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and developing a collaborative system for assessment, decision making, and implementation. Our institution formed a team with diverse representation from multiple stakeholders to review and prioritize all res","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; CTSA; clinical research; collaboration; translational research","DiazGranados","Deborah","Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA",NA
"286","34192046","10.1017/cts.2020.570","Assessing the impact of remote work during COVID-19 on clinical and translational scientists and staff in Colorado.","The COVID-19 pandemic has required many clinical and translational scientists and staff to work remotely to prevent the spread of the virus. To understand the impact on research programs, we assessed barriers to remote work and strategies implemented to support virtual engagement and productivity. A mixed-methods RedCap survey querying the remote work experience was emailed to Colorado Clinical and Translational Sciences Institute (CCTSI) scientists and staff in April 2020. Descriptive analyses,","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Remote work; clinical and translational science","Gilmartin","Heather M","Denver/Seattle Center of Innovation for Veteran-Centered and Value Driven Care, VHA Eastern Colorado Healthcare System, Aurora, CO, USA",NA
"287","34192046","10.1017/cts.2020.570","Assessing the impact of remote work during COVID-19 on clinical and translational scientists and staff in Colorado.","The COVID-19 pandemic has required many clinical and translational scientists and staff to work remotely to prevent the spread of the virus. To understand the impact on research programs, we assessed barriers to remote work and strategies implemented to support virtual engagement and productivity. A mixed-methods RedCap survey querying the remote work experience was emailed to Colorado Clinical and Translational Sciences Institute (CCTSI) scientists and staff in April 2020. Descriptive analyses,","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Remote work; clinical and translational science","Connelly","Brigid","Denver/Seattle Center of Innovation for Veteran-Centered and Value Driven Care, VHA Eastern Colorado Healthcare System, Aurora, CO, USA",NA
"288","34192046","10.1017/cts.2020.570","Assessing the impact of remote work during COVID-19 on clinical and translational scientists and staff in Colorado.","The COVID-19 pandemic has required many clinical and translational scientists and staff to work remotely to prevent the spread of the virus. To understand the impact on research programs, we assessed barriers to remote work and strategies implemented to support virtual engagement and productivity. A mixed-methods RedCap survey querying the remote work experience was emailed to Colorado Clinical and Translational Sciences Institute (CCTSI) scientists and staff in April 2020. Descriptive analyses,","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Remote work; clinical and translational science","Hebbe","Annika","Denver/Seattle Center of Innovation for Veteran-Centered and Value Driven Care, VHA Eastern Colorado Healthcare System, Aurora, CO, USA",NA
"289","34192046","10.1017/cts.2020.570","Assessing the impact of remote work during COVID-19 on clinical and translational scientists and staff in Colorado.","The COVID-19 pandemic has required many clinical and translational scientists and staff to work remotely to prevent the spread of the virus. To understand the impact on research programs, we assessed barriers to remote work and strategies implemented to support virtual engagement and productivity. A mixed-methods RedCap survey querying the remote work experience was emailed to Colorado Clinical and Translational Sciences Institute (CCTSI) scientists and staff in April 2020. Descriptive analyses,","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Remote work; clinical and translational science","Battaglia","Catherine","Denver/Seattle Center of Innovation for Veteran-Centered and Value Driven Care, VHA Eastern Colorado Healthcare System, Aurora, CO, USA",NA
"290","34192046","10.1017/cts.2020.570","Assessing the impact of remote work during COVID-19 on clinical and translational scientists and staff in Colorado.","The COVID-19 pandemic has required many clinical and translational scientists and staff to work remotely to prevent the spread of the virus. To understand the impact on research programs, we assessed barriers to remote work and strategies implemented to support virtual engagement and productivity. A mixed-methods RedCap survey querying the remote work experience was emailed to Colorado Clinical and Translational Sciences Institute (CCTSI) scientists and staff in April 2020. Descriptive analyses,","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Remote work; clinical and translational science","Kwan","Bethany M","Colorado Clinical &amp",NA
"291","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Smith","Jeffrey S","Providence Portland Medical Center, Department of Medicine, Portland, Oregon, USA",NA
"292","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Hanseler","Haley","OHSU Medical School, Portland, Oregon, USA",NA
"293","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Welle","John","Regional Pathology, Providence St. Joseph Health, Portland, Oregon, USA",NA
"294","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Rattray","Rogan","Regional Pathology, Providence St. Joseph Health, Portland, Oregon, USA",NA
"295","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Campbell","Mary","Regional Pathology, Providence St. Joseph Health, Portland, Oregon, USA",NA
"296","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Brotherton","Tacy","Cancer Research Animal Division, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA",NA
"297","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Moudgil","Tarsem","Molecular &amp",NA
"298","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Pack","Thomas F","Axovant Gene Therapies, Ltd, Durham, North Carolina, USA",NA
"299","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Wegmann","Keith","Molecular &amp",NA
"300","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Jensen","Shawn","Molecular &amp",NA
"301","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Jin","Justin","Providence Portland Medical Center, Department of Medicine, Portland, Oregon, USA",NA
"302","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Bifulco","Carlo B","Regional Pathology, Providence St. Joseph Health, Portland, Oregon, USA",NA
"303","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Prahl","Scott A","Electrical Engineering and Renewable Energy, Oregon Institute of Technology, Wilsonville, Oregon, USA",NA
"304","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Fox","Bernard A","Molecular &amp",NA
"305","34192045","10.1017/cts.2020.494","Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity.","The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. Disposable N95 masks, including medical grade (1860, 1870+) and industrial grade (8511) masks, were treated by VHP, UV, and ethanol decontam","2021","07","02","J Clin Transl Sci","Journal of clinical and translational science","COVID-19; Infectious diseases; N95; SARS-CoV-2; mask decontamination; ultraviolet germicidal irradiation; vaporized hydrogen peroxide","Stucky","Nicholas L","Providence Portland Medical Center, Department of Medicine, Portland, Oregon, USA",NA
"306","34192043","10.1192/bjo.2020.158","Investigating the relationship between COVID-19-related and distress and ICD-11 adjustment disorder: two cross-sectional studies.","To assess the prevalence of elevated risk of serious mental illness and probable ICD-11 adjustment disorder in the UK population at two time points during COVID-19, and their association with COVID-19-related stressful events. To check the dose-response model for stress between the number of COVID-19-related stressful events and mental health indices. We conducted two cross-sectional studies, using internet survey samples across the UK (N = 1293 for study 1; N = 1073 for study 2). Samples used i","2021","07","02","BJPsych Open","BJPsych open","COVID-19; ICD-11; adjustment disorder; health; serious mental illness","Ben-Ezra","Menachem","School of Social Work, Ariel University, Israel",NA
"307","34192043","10.1192/bjo.2020.158","Investigating the relationship between COVID-19-related and distress and ICD-11 adjustment disorder: two cross-sectional studies.","To assess the prevalence of elevated risk of serious mental illness and probable ICD-11 adjustment disorder in the UK population at two time points during COVID-19, and their association with COVID-19-related stressful events. To check the dose-response model for stress between the number of COVID-19-related stressful events and mental health indices. We conducted two cross-sectional studies, using internet survey samples across the UK (N = 1293 for study 1; N = 1073 for study 2). Samples used i","2021","07","02","BJPsych Open","BJPsych open","COVID-19; ICD-11; adjustment disorder; health; serious mental illness","Hou","Wai Kai","Department of Psychology, Centre for Psychosocial Health, The Education University of Hong Kong, Hong Kong, China",NA
"308","34192043","10.1192/bjo.2020.158","Investigating the relationship between COVID-19-related and distress and ICD-11 adjustment disorder: two cross-sectional studies.","To assess the prevalence of elevated risk of serious mental illness and probable ICD-11 adjustment disorder in the UK population at two time points during COVID-19, and their association with COVID-19-related stressful events. To check the dose-response model for stress between the number of COVID-19-related stressful events and mental health indices. We conducted two cross-sectional studies, using internet survey samples across the UK (N = 1293 for study 1; N = 1073 for study 2). Samples used i","2021","07","02","BJPsych Open","BJPsych open","COVID-19; ICD-11; adjustment disorder; health; serious mental illness","Goodwin","Robin","Department of Psychology, University of Warwick, UK",NA
"309","34192042","10.1177/2056305120949268","""Mischievous Uncles"" as Rule Breakers: Intersectional Stereotypes and Risk Perceptions During the Coronavirus Pandemic in Turkey.","Responses to crises can highlight and exacerbate class inequalities. Seemingly neutral policy measures taken during the COVID-19 pandemic that aim to protect high-risk groups can lead to a shift in the public discourse that deprives citizens of their agency based not only on their age but also their class. In this article, we focus on the case of Turkey, one of the countries with the fastest growth of novel coronavirus cases in late March 2020, where the government introduced a curfew for people","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Turkey; Twitter and news media; age; and gender; class; intersectionality","Türkoglu","Didem","New York University Abu Dhabi, United Arab Emirates",NA
"310","34192042","10.1177/2056305120949268","""Mischievous Uncles"" as Rule Breakers: Intersectional Stereotypes and Risk Perceptions During the Coronavirus Pandemic in Turkey.","Responses to crises can highlight and exacerbate class inequalities. Seemingly neutral policy measures taken during the COVID-19 pandemic that aim to protect high-risk groups can lead to a shift in the public discourse that deprives citizens of their agency based not only on their age but also their class. In this article, we focus on the case of Turkey, one of the countries with the fastest growth of novel coronavirus cases in late March 2020, where the government introduced a curfew for people","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Turkey; Twitter and news media; age; and gender; class; intersectionality","Odabas","Meltem","Indiana University Bloomington, USA",NA
"311","34192041","10.1177/2056305120948258","Tweeting in the Time of Coronavirus: How Social Media Use and Academic Research Evolve during Times of Global Uncertainty.","Our international research team was in the midst of a comparative study about the day-to-day experience of Twitter users in Berlin and Jerusalem through a series of daily short surveys, when our Jerusalem data were becoming increasingly ""compromised"" by the growing public concern, and tightening government measures, around the spread of the Coronavirus in Israel. During the two waves of our 10-day survey of salient Twitter users in Jerusalem (March 9-March 19, N = 34; March 23-April 2, <i","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Israel; Twitter; crisis communication; survey research","Kligler-Vilenchik","Neta","The Hebrew University of Jerusalem, Israel",NA
"312","34192041","10.1177/2056305120948258","Tweeting in the Time of Coronavirus: How Social Media Use and Academic Research Evolve during Times of Global Uncertainty.","Our international research team was in the midst of a comparative study about the day-to-day experience of Twitter users in Berlin and Jerusalem through a series of daily short surveys, when our Jerusalem data were becoming increasingly ""compromised"" by the growing public concern, and tightening government measures, around the spread of the Coronavirus in Israel. During the two waves of our 10-day survey of salient Twitter users in Jerusalem (March 9-March 19, N = 34; March 23-April 2, <i","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Israel; Twitter; crisis communication; survey research","Stoltenberg","Daniela","WWU Munster, Germany",NA
"313","34192041","10.1177/2056305120948258","Tweeting in the Time of Coronavirus: How Social Media Use and Academic Research Evolve during Times of Global Uncertainty.","Our international research team was in the midst of a comparative study about the day-to-day experience of Twitter users in Berlin and Jerusalem through a series of daily short surveys, when our Jerusalem data were becoming increasingly ""compromised"" by the growing public concern, and tightening government measures, around the spread of the Coronavirus in Israel. During the two waves of our 10-day survey of salient Twitter users in Jerusalem (March 9-March 19, N = 34; March 23-April 2, <i","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Israel; Twitter; crisis communication; survey research","de Vries Kedem","Maya","The Hebrew University of Jerusalem, Israel",NA
"314","34192041","10.1177/2056305120948258","Tweeting in the Time of Coronavirus: How Social Media Use and Academic Research Evolve during Times of Global Uncertainty.","Our international research team was in the midst of a comparative study about the day-to-day experience of Twitter users in Berlin and Jerusalem through a series of daily short surveys, when our Jerusalem data were becoming increasingly ""compromised"" by the growing public concern, and tightening government measures, around the spread of the Coronavirus in Israel. During the two waves of our 10-day survey of salient Twitter users in Jerusalem (March 9-March 19, N = 34; March 23-April 2, <i","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Israel; Twitter; crisis communication; survey research","Gur-Ze'ev","Hadas","The Hebrew University of Jerusalem, Israel",NA
"315","34192041","10.1177/2056305120948258","Tweeting in the Time of Coronavirus: How Social Media Use and Academic Research Evolve during Times of Global Uncertainty.","Our international research team was in the midst of a comparative study about the day-to-day experience of Twitter users in Berlin and Jerusalem through a series of daily short surveys, when our Jerusalem data were becoming increasingly ""compromised"" by the growing public concern, and tightening government measures, around the spread of the Coronavirus in Israel. During the two waves of our 10-day survey of salient Twitter users in Jerusalem (March 9-March 19, N = 34; March 23-April 2, <i","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Israel; Twitter; crisis communication; survey research","Waldherr","Annie","WWU Munster, Germany",NA
"316","34192041","10.1177/2056305120948258","Tweeting in the Time of Coronavirus: How Social Media Use and Academic Research Evolve during Times of Global Uncertainty.","Our international research team was in the midst of a comparative study about the day-to-day experience of Twitter users in Berlin and Jerusalem through a series of daily short surveys, when our Jerusalem data were becoming increasingly ""compromised"" by the growing public concern, and tightening government measures, around the spread of the Coronavirus in Israel. During the two waves of our 10-day survey of salient Twitter users in Jerusalem (March 9-March 19, N = 34; March 23-April 2, <i","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Israel; Twitter; crisis communication; survey research","Pfetsch","Barbara","Free University of Berlin, Germany",NA
"317","34192040","10.1177/2056305120948257","It Is All About Location: Smartphones and Tracking the Spread of COVID-19.","Mobile phone location data have become tied to understandings of and responses to the COVID-19 pandemic. Data visualizations have used mobile phone data to inform people about how mobility practices may be linked to the spread of the virus, and governments have explored contact tracing that relies upon mobile phone data. This article examines how these uses of location data implicate three particular issues that have been present in the growing body of locative media research: (1) anonymized dat","2021","07","02","Soc Media Soc","Social media + society","COVID-19; locative media; privacy; smartphones; surveillance","Frith","Jordan","Clemson University, USA",NA
"318","34192040","10.1177/2056305120948257","It Is All About Location: Smartphones and Tracking the Spread of COVID-19.","Mobile phone location data have become tied to understandings of and responses to the COVID-19 pandemic. Data visualizations have used mobile phone data to inform people about how mobility practices may be linked to the spread of the virus, and governments have explored contact tracing that relies upon mobile phone data. This article examines how these uses of location data implicate three particular issues that have been present in the growing body of locative media research: (1) anonymized dat","2021","07","02","Soc Media Soc","Social media + society","COVID-19; locative media; privacy; smartphones; surveillance","Saker","Michael","City, University of London, UK",NA
"319","34192039","10.1177/2056305120948255","Changes in Digital Communication During the COVID-19 Global Pandemic: Implications for Digital Inequality and Future Research.","Governments and public health institutions across the globe have set social distancing and stay-at-home guidelines to battle the COVID-19 pandemic. With reduced opportunities to spend time together in person come new challenges to remain socially connected. This essay addresses how the pandemic has changed people's use of digital communication methods, and how inequalities in the use of these methods may arise. We draw on data collected from 1,374 American adults between 4 and 8 April 2020, abou","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital communication; digital inequality; social connection","Nguyen","Minh Hao","University of Zurich, Switzerland",NA
"320","34192039","10.1177/2056305120948255","Changes in Digital Communication During the COVID-19 Global Pandemic: Implications for Digital Inequality and Future Research.","Governments and public health institutions across the globe have set social distancing and stay-at-home guidelines to battle the COVID-19 pandemic. With reduced opportunities to spend time together in person come new challenges to remain socially connected. This essay addresses how the pandemic has changed people's use of digital communication methods, and how inequalities in the use of these methods may arise. We draw on data collected from 1,374 American adults between 4 and 8 April 2020, abou","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital communication; digital inequality; social connection","Gruber","Jonathan","University of Zurich, Switzerland",NA
"321","34192039","10.1177/2056305120948255","Changes in Digital Communication During the COVID-19 Global Pandemic: Implications for Digital Inequality and Future Research.","Governments and public health institutions across the globe have set social distancing and stay-at-home guidelines to battle the COVID-19 pandemic. With reduced opportunities to spend time together in person come new challenges to remain socially connected. This essay addresses how the pandemic has changed people's use of digital communication methods, and how inequalities in the use of these methods may arise. We draw on data collected from 1,374 American adults between 4 and 8 April 2020, abou","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital communication; digital inequality; social connection","Fuchs","Jaelle","University of Zurich, Switzerland",NA
"322","34192039","10.1177/2056305120948255","Changes in Digital Communication During the COVID-19 Global Pandemic: Implications for Digital Inequality and Future Research.","Governments and public health institutions across the globe have set social distancing and stay-at-home guidelines to battle the COVID-19 pandemic. With reduced opportunities to spend time together in person come new challenges to remain socially connected. This essay addresses how the pandemic has changed people's use of digital communication methods, and how inequalities in the use of these methods may arise. We draw on data collected from 1,374 American adults between 4 and 8 April 2020, abou","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital communication; digital inequality; social connection","Marler","Will","University of Zurich, Switzerland",NA
"323","34192039","10.1177/2056305120948255","Changes in Digital Communication During the COVID-19 Global Pandemic: Implications for Digital Inequality and Future Research.","Governments and public health institutions across the globe have set social distancing and stay-at-home guidelines to battle the COVID-19 pandemic. With reduced opportunities to spend time together in person come new challenges to remain socially connected. This essay addresses how the pandemic has changed people's use of digital communication methods, and how inequalities in the use of these methods may arise. We draw on data collected from 1,374 American adults between 4 and 8 April 2020, abou","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital communication; digital inequality; social connection","Hunsaker","Amanda","University of Zurich, Switzerland",NA
"324","34192039","10.1177/2056305120948255","Changes in Digital Communication During the COVID-19 Global Pandemic: Implications for Digital Inequality and Future Research.","Governments and public health institutions across the globe have set social distancing and stay-at-home guidelines to battle the COVID-19 pandemic. With reduced opportunities to spend time together in person come new challenges to remain socially connected. This essay addresses how the pandemic has changed people's use of digital communication methods, and how inequalities in the use of these methods may arise. We draw on data collected from 1,374 American adults between 4 and 8 April 2020, abou","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital communication; digital inequality; social connection","Hargittai","Eszter","University of Zurich, Switzerland",NA
"325","34192038","10.1177/2056305120948254","One Platform, a Thousand Worlds: On Twitter Irony in the Early Response to the COVID-19 Pandemic in Italy.","On 22 February 2020, 11 municipalities in Northern Italy became the first COVID-19 red zone of Europe. Two days later, when it became evident that the virus had been spreading in the country for weeks, Italy entered a ""buffer zone,"" a temporal zone between normality and pandemic. The buffer zone lasted around 2 weeks and thrived with irony flowing on social media through memes, multimedia remixes, and jokes. As a collective ritual, irony allowed people to temporarily background the mounting feel","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Twitter; digital methods; irony; platform studie","Vicari","Stefania","The University of Sheffield, UK",NA
"326","34192038","10.1177/2056305120948254","One Platform, a Thousand Worlds: On Twitter Irony in the Early Response to the COVID-19 Pandemic in Italy.","On 22 February 2020, 11 municipalities in Northern Italy became the first COVID-19 red zone of Europe. Two days later, when it became evident that the virus had been spreading in the country for weeks, Italy entered a ""buffer zone,"" a temporal zone between normality and pandemic. The buffer zone lasted around 2 weeks and thrived with irony flowing on social media through memes, multimedia remixes, and jokes. As a collective ritual, irony allowed people to temporarily background the mounting feel","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Twitter; digital methods; irony; platform studie","Murru","Maria Francesca","The University of Bergamo, Italy",NA
"327","34192037","10.1177/2056305120948251","Online Temptations: COVID-19 and Religious Misinformation in the MENA Region.","During the coronavirus pandemic, religious misinformation has been found on social media platforms causing fear, confusion, and polluting the Middle East and North Africa (MENA) region's online sphere. Exploring cases of religious clickbait in the form of false hadiths and viral religious advice from religious figures entrenched in the MENA's political elite, this essay discusses how new dynamics for religion in the age of the Internet are contributing to a uniquely regional and religious form o","2021","07","02","Soc Media Soc","Social media + society","digital religion; religious misinformation; the MENA region","Alimardani","Mahsa","University of Oxford, UK",NA
"328","34192037","10.1177/2056305120948251","Online Temptations: COVID-19 and Religious Misinformation in the MENA Region.","During the coronavirus pandemic, religious misinformation has been found on social media platforms causing fear, confusion, and polluting the Middle East and North Africa (MENA) region's online sphere. Exploring cases of religious clickbait in the form of false hadiths and viral religious advice from religious figures entrenched in the MENA's political elite, this essay discusses how new dynamics for religion in the age of the Internet are contributing to a uniquely regional and religious form o","2021","07","02","Soc Media Soc","Social media + society","digital religion; religious misinformation; the MENA region","Elswah","Mona","University of Oxford, UK",NA
"329","34192036","10.1177/2056305120948250","More Than Just Privacy: Using Contextual Integrity to Evaluate the Long-Term Risks from COVID-19 Surveillance Technologies.","The global coronavirus pandemic has raised important questions regarding how to balance public health concerns with privacy protections for individual citizens. In this essay, we evaluate contact tracing apps, which have been offered as a technological solution to minimize the spread of COVID-19. We argue that apps such as those built on Google and Apple's ""exposure notification system"" should be evaluated in terms of the contextual integrity of information flows; in other words, the appropriate","2021","07","02","Soc Media Soc","Social media + society","COVID-19; contact tracing; contextual integrity; privacy; surveillance","Vitak","Jessica","University of Maryland, USA",NA
"330","34192036","10.1177/2056305120948250","More Than Just Privacy: Using Contextual Integrity to Evaluate the Long-Term Risks from COVID-19 Surveillance Technologies.","The global coronavirus pandemic has raised important questions regarding how to balance public health concerns with privacy protections for individual citizens. In this essay, we evaluate contact tracing apps, which have been offered as a technological solution to minimize the spread of COVID-19. We argue that apps such as those built on Google and Apple's ""exposure notification system"" should be evaluated in terms of the contextual integrity of information flows; in other words, the appropriate","2021","07","02","Soc Media Soc","Social media + society","COVID-19; contact tracing; contextual integrity; privacy; surveillance","Zimmer","Michael","Marquette University, USA",NA
"331","34192035","10.1177/2056305120948233","The Rise of the Data Poor: The COVID-19 Pandemic Seen From the Margins.","Quantification is central to the narration of the COVID-19 pandemic. Numbers determine the existence of the problem and affect our ability to care and contribute to relief efforts. Yet many communities at the margins, including many areas of the Global South, are virtually absent from this number-based narration of the pandemic. This essay builds on critical data studies to warn against the universalization of problems, narratives, and responses to the virus. To this end, it explores two types o","2021","07","02","Soc Media Soc","Social media + society","COVID-19 pandemic; critical data studies; data gaps; data poverty; margins","Milan","Stefania","University of Amsterdam, The Netherlands",NA
"332","34192035","10.1177/2056305120948233","The Rise of the Data Poor: The COVID-19 Pandemic Seen From the Margins.","Quantification is central to the narration of the COVID-19 pandemic. Numbers determine the existence of the problem and affect our ability to care and contribute to relief efforts. Yet many communities at the margins, including many areas of the Global South, are virtually absent from this number-based narration of the pandemic. This essay builds on critical data studies to warn against the universalization of problems, narratives, and responses to the virus. To this end, it explores two types o","2021","07","02","Soc Media Soc","Social media + society","COVID-19 pandemic; critical data studies; data gaps; data poverty; margins","Treré","Emiliano","Cardiff University, UK",NA
"333","34192034","10.1177/2056305120948232","Curating and Exhibiting for the Pandemic: Participatory Virtual Art Practices During the COVID-19 Outbreak in China.","Since China's lockdown of major cities in response to COVID-19, different forms of online participatory initiatives led by self-organizing groups of volunteers have greatly contributed to information circulation, patient admission support, and other aspects of coping with the pandemic. Although often overlooked by those studying online cultural production during the pandemic, a massive spontaneous and participatory creative outpouring of individual and collaborative artworks related to ""fight th","2021","06","30","Soc Media Soc","Social media + society","COVID-19; China; digital in-between space; online exhibitions; participatory art; state media discourse","Feng","Xiaodan","Vrije Universiteit Amsterdam, The Netherlands",NA
"334","34192033","10.1177/2056305120948224","A Relationship-Centered and Culturally Informed Approach to Studying Misinformation on COVID-19.","The panic and anxiety that accompanies a global pandemic is only exacerbated by the spread of misinformation. For COVID-19, in many parts of the world, such misinformation is circulating through globally popular mobile instant messaging services (MIMS) like WhatsApp and Telegram. Compared to more public social media platforms like Facebook and Twitter, these services offer private, intimate, and often encrypted spaces for users to chat with family members and friends, making it difficult for the","2021","07","02","Soc Media Soc","Social media + society","COVID-19; WhatsApp; misinformation; mobile instant messaging services","Malhotra","Pranav","University of Washington, USA",NA
"335","34192032","10.1177/2056305120948223","Feeling Asian Together: Coping With #COVIDRacism on Subtle Asian Traits.","Since the onset of COVID-19, incidents of racism and xenophobia have been occurring globally, especially toward people of East Asian appearance and descent. In response, this article investigates how an online Asian community has utilized social media to engage in cathartic expressions, mutual care, and discursive activism amid the rise of anti-Asian racism and xenophobia during COVID-19. Specifically, we focus on the 1.7-million-strong Facebook group ""Subtle Asian Traits"" (SAT). Throughout the ","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Facebook groups; Subtle Asian Traits; anti-Asian racism; discursive activism","Abidin","Crystal","Curtin University, Australia",NA
"336","34192032","10.1177/2056305120948223","Feeling Asian Together: Coping With #COVIDRacism on Subtle Asian Traits.","Since the onset of COVID-19, incidents of racism and xenophobia have been occurring globally, especially toward people of East Asian appearance and descent. In response, this article investigates how an online Asian community has utilized social media to engage in cathartic expressions, mutual care, and discursive activism amid the rise of anti-Asian racism and xenophobia during COVID-19. Specifically, we focus on the 1.7-million-strong Facebook group ""Subtle Asian Traits"" (SAT). Throughout the ","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Facebook groups; Subtle Asian Traits; anti-Asian racism; discursive activism","Zeng","Jing","University of Zurich, Switzerland",NA
"337","34192031","10.1177/2056305120948197","On the Overlap of Systemic Events: Covid-19, Climate, and Journalism.","Covid-19 represents a systemic event-a state of emergency-that disrupts the routines of societies from the level of individuals to institutions, nations, and global interaction. Revealing the vulnerability of the intensively interconnected world suggests a juxtaposition with another systemic crisis: the climate emergency. Drawing on some key literature on the different aspects of ""events""-as heightened political semiosis (Wagner-Pacifi), as (possible) transformation of social and symbolic struct","2021","06","30","Soc Media Soc","Social media + society","Covid-19; climate change; events; expertise; journalism","Kunelius","Risto","University of Helsinki, Finland",NA
"338","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Hargittai","Eszter","University of Zurich, Switzerland",NA
"339","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Nguyen","Minh Hao","University of Zurich, Switzerland",NA
"340","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Fuchs","Jaelle","University of Zurich, Switzerland",NA
"341","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Gruber","Jonathan","University of Zurich, Switzerland",NA
"342","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Marler","Will","University of Zurich, Switzerland",NA
"343","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Hunsaker","Amanda","University of Zurich, Switzerland",NA
"344","34192030","10.1177/2056305120948196","From Zero to a National Data Set in 2 Weeks: Reflections on a COVID-19 Collaborative Survey Project.","In March 2020, like much of the rest of the world, we went into lockdown. A week into our new reality, we decided to do a survey study about how people were experiencing the COVID-19 pandemic. In this piece, we describe what motivated us to do the study, how we went about it, and what others can learn from our experiences.","2021","06","30","Soc Media Soc","Social media + society","COVID-19; collaboration; reflections; survey; teamwork","Karaoglu","Gökçe","University of Zurich, Switzerland",NA
"345","34192029","10.1177/2056305120948190","Fighting the 'Infodemic': Legal Responses to COVID-19 Disinformation.","Online disinformation has been on the rise in recent years. A digital outbreak of disinformation has spread around the COVID-19 pandemic, often referred to as an ""infodemic."" Since January 2020, digital media have been both the culprits of and antidotes to misinformation. The first months of the pandemic have shown that countering disinformation online has become as important as ensuring much needed medical equipment and supplies for health workers. For many governments around the world, priorit","2021","06","30","Soc Media Soc","Social media + society","COVID-19; access to information; legislation; online disinformation; online trust","Radu","Roxana","University of Oxford, UK",NA
"346","34192028","10.1177/2056305120948186","The COVID-19 Mental Health Content Moderation Conundrum.","At the time of writing (mid-May 2020), mental health charities around the world have experienced an unprecedented surge in demand. At the same time, record-high numbers of people are turning to social media to maintain personal connections due to restrictions on physical movement. But organizations like the mental health charity Mind and even the UK Government have expressed concerns about the possible strain on mental health that may come from spending more time online during COVID-19. These co","2021","06","30","Soc Media Soc","Social media + society","COVID-19; content moderation; mental health; social media","Gerrard","Ysabel","The University of Sheffield, UK",NA
"347","34192027","10.1177/2056305120948168","A Second-Order Disaster? Digital Technologies During the COVID-19 Pandemic.","One of the most striking features of the COVID-19 pandemic in the United Kingdom has been the disproportionate way in which it has affected Black, Asian, ethnic minority, and working class people. In this article, I argue that digital technologies and data practices in the response to COVID-19 amplify social inequalities, which are already accentuated by the pandemic, thus leading to a ""second-order disaster""-a human-made disaster which further traps disadvantaged people into precarity. Inequali","2021","06","30","Soc Media Soc","Social media + society","COVID-19; digital contact tracing; digital welfare state; social inequalities; surveillance","Madianou","Mirca","Goldsmiths, University of London, UK",NA
"348","34192026","10.1177/2056305120948158","""Coronavirus EXPLAINED"": YouTube, COVID-19, and the Socio-Technical Mediation of Expertise.","Since the coronavirus outbreak, YouTube has altered its content moderation policies to surface more ""authoritative information"" while removing videos that contain ""medically unsubstantiated claims."" This was made urgent by incidents like a live-stream interview of renowned British conspiracy theorist David Icke-in which he falsely linked the spread of the coronavirus to 5G technology-that gained substantial traction online. Behind these events, however, lies a tension between the need for author","2021","07","02","Soc Media Soc","Social media + society","YouTube; content analysis; expertise; socio-technical mediation; visual media","Marchal","Nahema","University of Oxford, UK",NA
"349","34192026","10.1177/2056305120948158","""Coronavirus EXPLAINED"": YouTube, COVID-19, and the Socio-Technical Mediation of Expertise.","Since the coronavirus outbreak, YouTube has altered its content moderation policies to surface more ""authoritative information"" while removing videos that contain ""medically unsubstantiated claims."" This was made urgent by incidents like a live-stream interview of renowned British conspiracy theorist David Icke-in which he falsely linked the spread of the coronavirus to 5G technology-that gained substantial traction online. Behind these events, however, lies a tension between the need for author","2021","07","02","Soc Media Soc","Social media + society","YouTube; content analysis; expertise; socio-technical mediation; visual media","Au","Hubert","University of Oxford, UK",NA
"350","34192024","10.1177/2056305120947661","The Biopolitics of Social Distancing.","As COVID-19 spreads across the globe, new technologies are being leveraged to enforce social distancing requirements. I explore social distancing through the theoretical lens of Michel Foucault's biopolitics, with an emphasis on recognizing unauthorized movement and controlling circulation. Although reporting and widely shared data visualizations about COVID-19 have made many people newly aware that their movements are being tracked and surveilled, governments are already implementing new measur","2021","06","30","Soc Media Soc","Social media + society","COVID-19; Michel Foucault; biopolitics; media genealogy; social distancing","Sylvia","J J","Fitchburg State University, USA",NA
"351","34192023","10.1177/2056305120947657","COVID-19 and Health Code: How Digital Platforms Tackle the Pandemic in China.","As COVID-19 is rapidly spreading around the world, some countries have launched or plan to implement contact-tracing apps to detect exposure risks. In China, the government relies on Health Code, developed by Alipay and WeChat, for identifying people potentially exposed to COVID-19. The color-based code can determine people's exposure risks and freedom of movement based on factors like travel history, duration of time spent in risky areas, and relationships to potential carriers. This essay disc","2021","07","02","Soc Media Soc","Social media + society","COVID-19; Health Code; contact-tracing apps; digital platforms; health surveillance","Liang","Fan","University of Michigan, USA",NA
"352","34192022","10.1136/bmjinnov-2021-000668","End-to-end convolutional neural network enables COVID-19 detection from breath and cough audio: a pilot study.","Since the emergence of COVID-19 in December 2019, multidisciplinary research teams have wrestled with how best to control the pandemic in light of its considerable physical, psychological and economic damage. Mass testing has been advocated as a potential remedy; however, mass testing using physical tests is a costly and hard-to-scale solution. This study demonstrates the feasibility of an alternative form of COVID-19 detection, harnessing digital technology through the use of audio biomarkers a","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; diagnosis; virus diseases","Coppock","Harry","Computing, Imperial College London, London, UK",NA
"353","34192022","10.1136/bmjinnov-2021-000668","End-to-end convolutional neural network enables COVID-19 detection from breath and cough audio: a pilot study.","Since the emergence of COVID-19 in December 2019, multidisciplinary research teams have wrestled with how best to control the pandemic in light of its considerable physical, psychological and economic damage. Mass testing has been advocated as a potential remedy; however, mass testing using physical tests is a costly and hard-to-scale solution. This study demonstrates the feasibility of an alternative form of COVID-19 detection, harnessing digital technology through the use of audio biomarkers a","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; diagnosis; virus diseases","Gaskell","Alex","Computing, Imperial College London, London, UK",NA
"354","34192022","10.1136/bmjinnov-2021-000668","End-to-end convolutional neural network enables COVID-19 detection from breath and cough audio: a pilot study.","Since the emergence of COVID-19 in December 2019, multidisciplinary research teams have wrestled with how best to control the pandemic in light of its considerable physical, psychological and economic damage. Mass testing has been advocated as a potential remedy; however, mass testing using physical tests is a costly and hard-to-scale solution. This study demonstrates the feasibility of an alternative form of COVID-19 detection, harnessing digital technology through the use of audio biomarkers a","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; diagnosis; virus diseases","Tzirakis","Panagiotis","Computing, Imperial College London, London, UK",NA
"355","34192022","10.1136/bmjinnov-2021-000668","End-to-end convolutional neural network enables COVID-19 detection from breath and cough audio: a pilot study.","Since the emergence of COVID-19 in December 2019, multidisciplinary research teams have wrestled with how best to control the pandemic in light of its considerable physical, psychological and economic damage. Mass testing has been advocated as a potential remedy; however, mass testing using physical tests is a costly and hard-to-scale solution. This study demonstrates the feasibility of an alternative form of COVID-19 detection, harnessing digital technology through the use of audio biomarkers a","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; diagnosis; virus diseases","Baird","Alice","Chair of Embedded Intelligence for Health Care and Wellbeing, University of Augsburg, Augsburg, Germany",NA
"356","34192022","10.1136/bmjinnov-2021-000668","End-to-end convolutional neural network enables COVID-19 detection from breath and cough audio: a pilot study.","Since the emergence of COVID-19 in December 2019, multidisciplinary research teams have wrestled with how best to control the pandemic in light of its considerable physical, psychological and economic damage. Mass testing has been advocated as a potential remedy; however, mass testing using physical tests is a costly and hard-to-scale solution. This study demonstrates the feasibility of an alternative form of COVID-19 detection, harnessing digital technology through the use of audio biomarkers a","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; diagnosis; virus diseases","Jones","Lyn","North Bristol NHS Trust, Bristol, UK",NA
"357","34192022","10.1136/bmjinnov-2021-000668","End-to-end convolutional neural network enables COVID-19 detection from breath and cough audio: a pilot study.","Since the emergence of COVID-19 in December 2019, multidisciplinary research teams have wrestled with how best to control the pandemic in light of its considerable physical, psychological and economic damage. Mass testing has been advocated as a potential remedy; however, mass testing using physical tests is a costly and hard-to-scale solution. This study demonstrates the feasibility of an alternative form of COVID-19 detection, harnessing digital technology through the use of audio biomarkers a","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; diagnosis; virus diseases","Schuller","Björn","Computing, Imperial College London, London, UK",NA
"358","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Graça","Tamiris Uracs de Sales","Escritório de Compromisso Social, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"359","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Santos","Alice Lopes","Escritório de Compromisso Social, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"360","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Yamamoto","Guilherme","Escritório de Compromisso Social, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"361","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","de Souza","Rodrigo Wilson","Escritório de Compromisso Social, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"362","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Srougé","Marcella Pedroso Peternelli","Escritório de Compromisso Social, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"363","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Pacheco","Rafael Leite","Núcleo de Avaliação de Tecnologias em Saúde, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"364","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Lima","Carlos","Escritório de Compromisso Social, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"365","34192021","10.1136/bmjinnov-2020-000619","Telemonitoring programme on COVID-19 for a low-income community in Brazil: case study.",NA,"2021","06","30","BMJ Innov","BMJ innovations","COVID-19; general practice; primary healthcare","Riera","Rachel","Núcleo de Avaliação de Tecnologias em Saúde, Hospital Sírio-Libanês, São Paulo, Brazil",NA
"366","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Ayoub","Houssein H","Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar",NA
"367","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Chemaitelly","Hiam","Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar",NA
"368","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Makhoul","Monia","Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar",NA
"369","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Al Kanaani","Zaina","Hamad Medical Corporation, Doha, Qatar",NA
"370","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Al Kuwari","Einas","Hamad Medical Corporation, Doha, Qatar",NA
"371","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Butt","Adeel A","Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York City, New York, USA",NA
"372","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Coyle","Peter","Hamad Medical Corporation, Doha, Qatar",NA
"373","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Jeremijenko","Andrew","Hamad Medical Corporation, Doha, Qatar",NA
"374","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Kaleeckal","Anvar Hassan","Hamad Medical Corporation, Doha, Qatar",NA
"375","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Latif","Ali Nizar","Hamad Medical Corporation, Doha, Qatar",NA
"376","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Shaik","Riyazuddin Mohammad","Hamad Medical Corporation, Doha, Qatar",NA
"377","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Abdul Rahim","Hanan F","College of Health Sciences, QU Health, Qatar University, Doha, Qatar",NA
"378","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Nasrallah","Gheyath K","Biomedical Research Center, Qatar University, Doha, Qatar",NA
"379","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Yassine","Hadi M","Biomedical Research Center, Qatar University, Doha, Qatar",NA
"380","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Al Kuwari","Mohamed G","Primary Health Care Corporation, Doha, Qatar",NA
"381","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Al Romaihi","Hamad Eid","Ministry of Public Health, Doha, Qatar",NA
"382","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Al-Thani","Mohamed H","Ministry of Public Health, Doha, Qatar",NA
"383","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Bertollini","Roberto","Ministry of Public Health, Doha, Qatar",NA
"384","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Al Khal","Abdullatif","Hamad Medical Corporation, Doha, Qatar",NA
"385","34192020","10.1136/bmjinnov-2021-000677","Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.","Vaccines against SARS-CoV-2 have been developed, but their availability falls far short of global needs. This study aimed to investigate the impact of prioritising available doses on the basis of recipient antibody status, that is by exposure status, using Qatar as an example. Vaccination impact (defined as the reduction in infection incidence and the number of vaccinations needed to avert one infection or one adverse disease outcome) was assessed under different scale-up scenarios using a deter","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; communicable diseases; public health; vaccination","Abu-Raddad","Laith J","Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar",NA
"386","34192019","10.1136/bmjinnov-2021-000717","Exploring the challenges and hidden opportunities of hosting a virtual innovation competition in the time of COVID-19.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; health; public health","El Akoum","Maha","Department of Content, World Innovation Summit for Health, Doha, Ad Dawhah, Qatar",NA
"387","34192019","10.1136/bmjinnov-2021-000717","Exploring the challenges and hidden opportunities of hosting a virtual innovation competition in the time of COVID-19.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; health; public health","El Achi","Mahmoud","Department of Content, World Innovation Summit for Health, Doha, Ad Dawhah, Qatar",NA
"388","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Ganeshan","Smitha","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"389","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Hsiang","Esther","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"390","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Peng","Theodore","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"391","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Thomas","Nicholas","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"392","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Garcia-Grossman","Ilana","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"393","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Javaherian","Kavon","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"394","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Lyon","Zoe","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"395","34192018","10.1136/bmjinnov-2020-000636","Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","access; and evaluation; delivery of health care; health care quality; hospital medicine","Vidyarthi","Arpana","Department of Hospital Medicine, University of California San Francisco, San Francisco, California, USA",NA
"396","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Sadeghi","Amir H","Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"397","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Wahadat","Ali R","Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"398","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Dereci","Adem","Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"399","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Budde","Ricardo P J","Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"400","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Tanis","Wilco","Department of Cardiology, Haga Hospital, Den Haag, The Netherlands",NA
"401","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Roos-Hesselink","Jolien W","Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"402","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Takkenberg","Hanneke","Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"403","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Taverne","Yannick J H J","Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"404","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Mahtab","Edris A F","Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"405","34192017","10.1136/bmjinnov-2021-000662","Remote multidisciplinary heart team meetings in immersive virtual reality: a first experience during the COVID-19 pandemic.",NA,"2021","07","02","BMJ Innov","BMJ innovations","COVID-19; cardiology; cardiovascular diseases; health","Bogers","Ad J J C","Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"406","34192016","10.1136/bmjinnov-2020-000557","Rapid implementation of Inpatient eConsult Programme addresses new challenges for patient care during COVID-19 pandemic.","At the early epicentre of the COVID-19 crisis in the USA, our institution saw a surge in the demand for inpatient consultations for areas impacted by COVID-19 (eg, infectious diseases, nephrology, palliative care) and shortages in personal protective equipment (PPE). We aimed to provide timely specialist input for consult requests during the COVID-19 pandemic by implementing an Inpatient eConsult Programme. We used the reach, effectiveness, adoption, implementation and maintenance implementation","2021","07","02","BMJ Innov","BMJ innovations","access and evaluation; health care quality; health services research; hospital medicine; infectious disease medicine; information science","Rikin","Sharon","Department of Medicine, Montefiore Medical Center, Bronx, New York, USA",NA
"407","34192016","10.1136/bmjinnov-2020-000557","Rapid implementation of Inpatient eConsult Programme addresses new challenges for patient care during COVID-19 pandemic.","At the early epicentre of the COVID-19 crisis in the USA, our institution saw a surge in the demand for inpatient consultations for areas impacted by COVID-19 (eg, infectious diseases, nephrology, palliative care) and shortages in personal protective equipment (PPE). We aimed to provide timely specialist input for consult requests during the COVID-19 pandemic by implementing an Inpatient eConsult Programme. We used the reach, effectiveness, adoption, implementation and maintenance implementation","2021","07","02","BMJ Innov","BMJ innovations","access and evaluation; health care quality; health services research; hospital medicine; infectious disease medicine; information science","Epstein","Eric J","Department of Medicine, Montefiore Medical Center, Bronx, New York, USA",NA
"408","34192016","10.1136/bmjinnov-2020-000557","Rapid implementation of Inpatient eConsult Programme addresses new challenges for patient care during COVID-19 pandemic.","At the early epicentre of the COVID-19 crisis in the USA, our institution saw a surge in the demand for inpatient consultations for areas impacted by COVID-19 (eg, infectious diseases, nephrology, palliative care) and shortages in personal protective equipment (PPE). We aimed to provide timely specialist input for consult requests during the COVID-19 pandemic by implementing an Inpatient eConsult Programme. We used the reach, effectiveness, adoption, implementation and maintenance implementation","2021","07","02","BMJ Innov","BMJ innovations","access and evaluation; health care quality; health services research; hospital medicine; infectious disease medicine; information science","Gendlina","Inessa","Department of Medicine, Montefiore Medical Center, Bronx, New York, USA",NA
"409","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Kulkarni","Anoop R","Innotomy Consulting, Bengaluru, India",NA
"410","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Athavale","Ambarish M","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"411","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Sahni","Ashima","Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois Hospital and Health Sciences System, Chicago, Illinois, USA",NA
"412","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Sukhal","Shashvat","Department of Medicine, Division of Pulmonary and Critical Care, Cook County Hospital, Chicago, Illinois, USA",NA
"413","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Saini","Abhimanyu","Department of Medicine, Division of Cardiology, Cook County Hospital, Chicago, Illinois, USA",NA
"414","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Itteera","Mathew","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"415","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Zhukovsky","Sara","Rush Medical College, Rush University Medical Center, Chicago, Illinois, USA",NA
"416","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Vernik","Jane","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"417","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Abraham","Mohan","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"418","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Joshi","Amit","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"419","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Amarah","Amatur","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"420","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Ruiz","Juan","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"421","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Hart","Peter D","Department of Medicine, Division of Nephrology, Cook County Hospital, Chicago, Illinois, USA",NA
"422","34192015","10.1136/bmjinnov-2020-000593","Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19.","There exists a wide gap in the availability of mechanical ventilator devices and their acute need in the context of the COVID-19 pandemic. An initial triaging method that accurately identifies the need for mechanical ventilation in hospitalised patients with COVID-19 is needed. We aimed to investigate if a potentially deteriorating clinical course in hospitalised patients with COVID-19 can be detected using all X-ray images taken during hospitalisation. We exploited the well-established DenseNet","2021","07","02","BMJ Innov","BMJ innovations","COVID-19; critical care; radiology","Kulkarni","Hemant","Lata Medical Research Foundation, Nagpur, India",NA
"423","34192014","10.1136/bmjinnov-2020-000498","Use of symptom checkers for COVID-19-related symptoms among university students: a qualitative study.","Symptom checkers are potentially beneficial tools during pandemics. To increase the use of the platform, perspectives of end users must be gathered. Our objectives were to understand the perspectives and experiences of young adults related to the use of symptom checkers for assessing COVID-19-related symptoms and to identify areas for improvement. We conducted semistructured qualitative interviews with 22 young adults (18-34 years of age) at a university in Ontario, Canada. Interviews were audio","2021","07","02","BMJ Innov","BMJ innovations","health services research; public health; self care","Aboueid","Stephanie","Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada",NA
"424","34192014","10.1136/bmjinnov-2020-000498","Use of symptom checkers for COVID-19-related symptoms among university students: a qualitative study.","Symptom checkers are potentially beneficial tools during pandemics. To increase the use of the platform, perspectives of end users must be gathered. Our objectives were to understand the perspectives and experiences of young adults related to the use of symptom checkers for assessing COVID-19-related symptoms and to identify areas for improvement. We conducted semistructured qualitative interviews with 22 young adults (18-34 years of age) at a university in Ontario, Canada. Interviews were audio","2021","07","02","BMJ Innov","BMJ innovations","health services research; public health; self care","Meyer","Samantha B","Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada",NA
"425","34192014","10.1136/bmjinnov-2020-000498","Use of symptom checkers for COVID-19-related symptoms among university students: a qualitative study.","Symptom checkers are potentially beneficial tools during pandemics. To increase the use of the platform, perspectives of end users must be gathered. Our objectives were to understand the perspectives and experiences of young adults related to the use of symptom checkers for assessing COVID-19-related symptoms and to identify areas for improvement. We conducted semistructured qualitative interviews with 22 young adults (18-34 years of age) at a university in Ontario, Canada. Interviews were audio","2021","07","02","BMJ Innov","BMJ innovations","health services research; public health; self care","Wallace","James R","Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada",NA
"426","34192014","10.1136/bmjinnov-2020-000498","Use of symptom checkers for COVID-19-related symptoms among university students: a qualitative study.","Symptom checkers are potentially beneficial tools during pandemics. To increase the use of the platform, perspectives of end users must be gathered. Our objectives were to understand the perspectives and experiences of young adults related to the use of symptom checkers for assessing COVID-19-related symptoms and to identify areas for improvement. We conducted semistructured qualitative interviews with 22 young adults (18-34 years of age) at a university in Ontario, Canada. Interviews were audio","2021","07","02","BMJ Innov","BMJ innovations","health services research; public health; self care","Mahajan","Shreya","Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada",NA
"427","34192014","10.1136/bmjinnov-2020-000498","Use of symptom checkers for COVID-19-related symptoms among university students: a qualitative study.","Symptom checkers are potentially beneficial tools during pandemics. To increase the use of the platform, perspectives of end users must be gathered. Our objectives were to understand the perspectives and experiences of young adults related to the use of symptom checkers for assessing COVID-19-related symptoms and to identify areas for improvement. We conducted semistructured qualitative interviews with 22 young adults (18-34 years of age) at a university in Ontario, Canada. Interviews were audio","2021","07","02","BMJ Innov","BMJ innovations","health services research; public health; self care","Nur","Teeyaa","Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada",NA
"428","34192014","10.1136/bmjinnov-2020-000498","Use of symptom checkers for COVID-19-related symptoms among university students: a qualitative study.","Symptom checkers are potentially beneficial tools during pandemics. To increase the use of the platform, perspectives of end users must be gathered. Our objectives were to understand the perspectives and experiences of young adults related to the use of symptom checkers for assessing COVID-19-related symptoms and to identify areas for improvement. We conducted semistructured qualitative interviews with 22 young adults (18-34 years of age) at a university in Ontario, Canada. Interviews were audio","2021","07","02","BMJ Innov","BMJ innovations","health services research; public health; self care","Chaurasia","Ashok","Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada",NA
"429","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Cross","Troy J","Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia",NA
"430","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Isautier","Jennifer M J","School of Public Health, The University of Sydney, Sydney, New South Wales, Australia",NA
"431","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Stamatakis","Emmanuel","Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia",NA
"432","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Morris","Sarah Jane","Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia",NA
"433","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Johnson","Bruce D","Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA",NA
"434","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Wheatley-Guy","Courtney","Cardiopulmonary Research, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA",NA
"435","34192013","10.1136/bmjsem-2021-001088","Self-reported physical activity before a COVID-19 'lockdown': is it just a matter of opinion?","There are growing concerns that the COVID-19 pandemic has facilitated a sedentary shift in our physical activity habits. A reduction in physical activity during the pandemic may be secondary to restrictive policies implemented at the government-level, typically those policies which limit interpersonal contact; for example, physical/social distancing. It is without question that social distancing is a necessary measure to mitigate community transmission of the novel virus; however, these policies","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","exercise; physical activity; public health","Taylor","Bryan J","Mayo Clinic Hospital Jacksonville, Jacksonville, Florida, USA",NA
"436","34192012","10.1136/bmjsem-2021-001089","Public health considerations regarding golf during the COVID-19 pandemic: a narrative review.","Golf is a sport played worldwide by &gt;60 million people from a variety of backgrounds and abilities. Golf's contribution to physical and mental health benefits are becoming increasingly recognised. Countries have adopted a range of restrictions to playing golf during the COVID-19 pandemic. The purpose of this narrative review was to (1) explore the literature related to the possible health benefits and risks of playing golf during the COVID-19 pandemic and (2) provide recommendations on golf-r","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","COVID-19; golf; health promotion; physical activity; public health","Robinson","Patrick Gordon","Department of Trauma and Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK",NA
"437","34192012","10.1136/bmjsem-2021-001089","Public health considerations regarding golf during the COVID-19 pandemic: a narrative review.","Golf is a sport played worldwide by &gt;60 million people from a variety of backgrounds and abilities. Golf's contribution to physical and mental health benefits are becoming increasingly recognised. Countries have adopted a range of restrictions to playing golf during the COVID-19 pandemic. The purpose of this narrative review was to (1) explore the literature related to the possible health benefits and risks of playing golf during the COVID-19 pandemic and (2) provide recommendations on golf-r","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","COVID-19; golf; health promotion; physical activity; public health","Foster","Charlie","Centre for Exercise, Nutrition and Health Sciences, University of Bristol, Bristol, UK",NA
"438","34192012","10.1136/bmjsem-2021-001089","Public health considerations regarding golf during the COVID-19 pandemic: a narrative review.","Golf is a sport played worldwide by &gt;60 million people from a variety of backgrounds and abilities. Golf's contribution to physical and mental health benefits are becoming increasingly recognised. Countries have adopted a range of restrictions to playing golf during the COVID-19 pandemic. The purpose of this narrative review was to (1) explore the literature related to the possible health benefits and risks of playing golf during the COVID-19 pandemic and (2) provide recommendations on golf-r","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","COVID-19; golf; health promotion; physical activity; public health","Murray","Andrew","Physical Activity for Health Research Centre, University of Edinburgh, Edinburgh, UK",NA
"439","34192011","10.1136/bmjsem-2020-001025","Mental health among elite athletes in Norway during a selected period of the COVID-19 pandemic.","To investigate the prevalence of mental health problems and satisfaction with life among different groups of elite athletes during a selected period of the COVID-19 pandemic and examine how COVID-19 related consequences were associated with these variables. Cross-sectional data collection during a selected period of the COVID-19 pandemic in Norway. 378 elite athletes, mean age 26.86 (range 18-59), 159 females and 219 males, divided into Olympic-level and Paralympic-level athletes (n=194) and eli","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","COVID-19; anxiety; depression; elite performance; mental","Pensgaard","Anne Marte","Department of Sport and Social Sciences, Norwegian School of Sports Sciences, Oslo, Akershus, Norway",NA
"440","34192011","10.1136/bmjsem-2020-001025","Mental health among elite athletes in Norway during a selected period of the COVID-19 pandemic.","To investigate the prevalence of mental health problems and satisfaction with life among different groups of elite athletes during a selected period of the COVID-19 pandemic and examine how COVID-19 related consequences were associated with these variables. Cross-sectional data collection during a selected period of the COVID-19 pandemic in Norway. 378 elite athletes, mean age 26.86 (range 18-59), 159 females and 219 males, divided into Olympic-level and Paralympic-level athletes (n=194) and eli","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","COVID-19; anxiety; depression; elite performance; mental","Oevreboe","Tom Henning","Department of Sport and Social Sciences, Norwegian School of Sports Sciences, Oslo, Akershus, Norway",NA
"441","34192011","10.1136/bmjsem-2020-001025","Mental health among elite athletes in Norway during a selected period of the COVID-19 pandemic.","To investigate the prevalence of mental health problems and satisfaction with life among different groups of elite athletes during a selected period of the COVID-19 pandemic and examine how COVID-19 related consequences were associated with these variables. Cross-sectional data collection during a selected period of the COVID-19 pandemic in Norway. 378 elite athletes, mean age 26.86 (range 18-59), 159 females and 219 males, divided into Olympic-level and Paralympic-level athletes (n=194) and eli","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","COVID-19; anxiety; depression; elite performance; mental","Ivarsson","Andreas","Centre of research on Welfare, Health and Sport, School of Health and Social Science, Halmstad, Sweden",NA
"442","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Stockwell","Stephanie","Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University - Cambridge Campus, Cambridge, UK",NA
"443","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Trott","Mike","Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University - Cambridge Campus, Cambridge, UK",NA
"444","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Tully","Mark","Institute of Mental Health Sciences, School of Health Sciences, University of Ulster, Newtownabbey, UK",NA
"445","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Shin","Jae","Department of Pediatrics, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea",NA
"446","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Barnett","Yvonne","Anglia Ruskin University - Cambridge Campus, Cambridge, UK",NA
"447","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Butler","Laurie","Faculty of Science and Engineering, Anglia Ruskin University, Cambridge, UK",NA
"448","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","McDermott","Daragh","Faculty of Science and Engineering, Anglia Ruskin University, Cambridge, UK",NA
"449","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Schuch","Felipe","Department of Sports Methods and Techniques, Federal University of Santa Maria, Santa Maria, Brazil",NA
"450","34192010","10.1136/bmjsem-2020-000960","Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review.","In March 2020, several countries banned unnecessary outdoor activities during COVID-19, commonly called 'lockdowns. These lockdowns have the potential to impact associated levels of physical activity and sedentary behaviour. Given the numerous health outcomes associated with physical activity and sedentary behaviour, the aim of this review was to summarise literature that investigated differences in physical activity and sedentary behaviour before vs during the COVID-19 lockdown. Electronic data","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","Review; physical activity; sedentary","Smith","Lee","Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University - Cambridge Campus, Cambridge, UK",NA
"451","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Randers","Morten B","Department of Sports Science and Clinichal Biomechanics, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark",NA
"452","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Knudsen","Nikolas Sten","Section for Sport Science, Department of Public Health, Aarhus Universitet, Aarhus, Denmark",NA
"453","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Thomasen","Manuel Mounir Demetry","Section for Sport Science, Department of Public Health, Aarhus Universitet, Aarhus, Denmark",NA
"454","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Panduro","Jeppe","Department of Sports Science and Clinichal Biomechanics, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark",NA
"455","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Larsen","Malte Nejst","Department of Sports Science and Clinichal Biomechanics, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark",NA
"456","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Mohr","Magni","Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark",NA
"457","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Milanovic","Zoran","Faculty of Sport and Physical Education, University of Nis, Nis, Serbia",NA
"458","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Krustrup","Peter","Department of Sports Science and Clinichal Biomechanics, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark",NA
"459","34192009","10.1136/bmjsem-2020-000911","Danger zone assessment in small-sided recreational football: providing data for consideration in relation to COVID-19 transmission.","During the COVID-19 pandemic, physical inactivity has increased, and a wide range of sporting activities locked down, with possible long-term implications for public health. Football is the most popular sport worldwide, and recreational football training leads to broad-spectrum health effects. Football is, however, deemed a contact sport with frequent close contact important to consider during COVID-19 pandemic. This study investigated time spent with close contact (danger zone (DZ) within 1.5 m","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","football; health promotion; soccer; training; virus","Andersen","Thomas Bull","Section for Sport Science, Department of Public Health, Aarhus Universitet, Aarhus, Denmark",NA
"460","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Löllgen","Herbert","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"461","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Bachl","Norbert","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"462","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Papadopoulou","Theodora","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"463","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Shafik","Andrew","South Tyneside NHS Foundation Trust, Sunderland, UK",NA
"464","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Holloway","Graham","British Association of Sport and Exercise Medicine, Doncaster, UK",NA
"465","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Vonbank","Karin","Department of Pneumology, Pulmonary Function Laboratory, Medicine Clinic (KIMII), University of Vienna, Vienna, Austria",NA
"466","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Jones","Nigel Edward","British Association of Sport and Exercise Medicine, Doncaster, UK",NA
"467","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Bigard","Xavier","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"468","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Niederseer","David","Heart Centre, University of Zurich, Zurich, Switzerland",NA
"469","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Meyer","Joachim","Lung Center, Clinic Bogenhausen, Munich, Germany",NA
"470","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Muniz-Pardos","Borja","GENUD (Growth, Exercise, Nutrition and Development), University of Zaragoza, Zaragoza, Spain",NA
"471","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Debruyne","Andre","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"472","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Zupet","Petra","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"473","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Steinacker","Jürgen M","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"474","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Wolfarth","Bernd","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"475","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Bilzon","James Lee John","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"476","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Ionescu","Anca","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"477","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Dohi","Michiko","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"478","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Swart","Jeroen","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"479","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Badtieva","Victoriya","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"480","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Zelenkova","Irina","GENUD (Growth, Exercise, Nutrition and Development), University of Zaragoza, Zaragoza, Spain",NA
"481","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Casasco","Maurizio","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"482","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Geistlinger","Michael","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"483","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Di Luigi","Luigi","International Federation of Sports Medicine (FIMS), Lausanne, Switzerland",NA
"484","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Webborn","Nick","School of Sport and Service Management, Eastbourne, UK",NA
"485","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Singleton","Patrick","World Olympians Association, Lausanne, Switzerland",NA
"486","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Miller","Mike","World Olympians Association, Lausanne, Switzerland",NA
"487","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Pigozzi","Fabio","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"488","34192007","10.1136/bmjsem-2020-000858","Recommendations for return to sport during the SARS-CoV-2 pandemic.","In this viewpoint we make specific recommendations that can assist and make the return to sport/exercise as safe as possible for all those impacted - from the recreational athlete to the elite athlete. We acknowledge that there are varying rules and regulations around the world, not to mention the varying philosophies and numerous schools of thought as it relates to return to sport/exercise and we have been cognisant of this in our recommendations. Despite the varying rules and circumstances aro","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","athlete; communicable disease; physical fitness; sports rehabilitation programs","Pitsiladis","Yannis P","European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland",NA
"489","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Smith","Lee","The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, United Kingdom",NA
"490","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Jacob","Louis","Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le- Bretonneux, France",NA
"491","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Butler","Laurie","Faculty of Science and Engineering, Anglia Ruskin University, Cambridge, United Kingdom",NA
"492","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Schuch","Felipe","Department of Sports Methods and Techniques, Federal University of Santa Maria, Santa Maria, Brazil",NA
"493","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Barnett","Yvonne","Anglia Ruskin University, Cambridge, UK",NA
"494","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Grabovac","Igor","Department of Social and Preventive Medicine, Centre for Public Health, Medical University Vienna, Vienna, Austria",NA
"495","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Veronese","Nicola","Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy",NA
"496","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Caperchione","Cristina","School of Sport, Exercise and Rehabilitation, University of Technology, Sydney, New South Wales, Australia",NA
"497","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Lopez-Sanchez","Guillermo F","Faculty of Sport Science, University of Murcia, Murcia, Spain",NA
"498","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Meyer","Jacob","Department of Kinesiology, Iowa State University, Iowa, Missouri, USA",NA
"499","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Abufaraj","Mohammad","Department of Special Surgery, University of Jordan, Amman, Jordan",NA
"500","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Yakkundi","Anita","Northern Ireland Public Health Research Network, School of Health Sciences, Ulster University, Ulster, Ireland",NA
"501","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Armstrong","Nicola","HSC R&amp",NA
"502","34192006","10.1136/bmjsem-2020-000850","Prevalence and correlates of physical activity in a sample of UK adults observing social distancing during the COVID-19 pandemic.","To investigate the levels and correlates of physical activity during COVID-19 social distancing in a sample of the UK public. This paper presents analyses of data from a cross-sectional study. Levels of physical activity during COVID-19 social distancing were self-reported. Participants also reported on sociodemographic and clinical data. The association between several factors and physical activity was studied using regression models. Nine hundred and eleven adults were included (64.0% were wom","2021","07","02","BMJ Open Sport Exerc Med","BMJ open sport &amp; exercise medicine","epidemiology; physical activity; public health","Tully","Mark A","Institute of Mental Health Sciences, School of Health Sciences, Ulster University, Newtownabbey, Ireland",NA
"503","34192005","10.1093/workar/waaa021","The Psychological Consequences of the COVID-19 on Residents and Staff in Nursing Homes.","In this commentary, we overview the existing research on psychological consequences caused by COVID-19 for both residents and staff in the nursing homes. We identify loneliness and emotional anxiety as main psychological consequences for nursing home residents, whereas uncertainty, hopelessness, work overload, and role conflicts are the most salient psychological challenges for the staff in the nursing homes during the pandemic. We then summarize the existing strategies and interventions respons","2021","07","02","Work Aging Retire","Work, aging and retirement",NA,"Mo","Shenjiang","Zhejiang University, Hangzhou, China",NA
"504","34192005","10.1093/workar/waaa021","The Psychological Consequences of the COVID-19 on Residents and Staff in Nursing Homes.","In this commentary, we overview the existing research on psychological consequences caused by COVID-19 for both residents and staff in the nursing homes. We identify loneliness and emotional anxiety as main psychological consequences for nursing home residents, whereas uncertainty, hopelessness, work overload, and role conflicts are the most salient psychological challenges for the staff in the nursing homes during the pandemic. We then summarize the existing strategies and interventions respons","2021","07","02","Work Aging Retire","Work, aging and retirement",NA,"Shi","Junqi","Zhejiang University, Hangzhou, China",NA
"505","34192004","10.1093/workar/waaa022","Pandemic Ponderings on the Limited Lens of Our Age Stereotyping Research: Considering Privilege and Racism.","In this commentary, I observe the assumption of privilege of many of the age stereotypes that emerged to characterize both older and younger age groups at the start of the COVID-19 pandemic. This leads to a reflection of how much extant age stereotype research may be limited by the typical centering of a white and a middle- or upper-class perspective. I make acknowledgment of strides toward intersectional research and suggest some further research questions to move this work forward.","2021","06","30","Work Aging Retire","Work, aging and retirement",NA,"Finkelstein","Lisa M","Northern Illinois University",NA
"506","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Hook","Kimberly","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"507","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Carroll","Haley A","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"508","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Louis","Elizabeth F","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"509","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Prom","Maria C","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"510","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Stanton","Amelia M","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"511","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Bogdanov","Sergiy","National University of Kyiv-Mohyla Academy, Center for Mental Health and Psychosocial Support, Kyiv, Ukraine",NA
"512","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Chiliza","Bonginkosi","Department of Psychiatry, University of KwaZulu-Natal, Nelson R. Mandela School of Medicine, KwaZulu-Natal, South Africa",NA
"513","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Freier","Luisa Feline","Department of Social and Political Sciences, Universidad del Pacífico, Lima, Perú",NA
"514","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Rukundo","Godfrey Zari","Department of Psychiatry, Mbarara University of Science and Technology, Mbarara, Uganda",NA
"515","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Ghebrehiwet","Senait","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"516","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Borba","Christina P C","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"517","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Fricchione","Gregory L","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA",NA
"518","34192003","10.1017/gmh.2021.20","Global mental health: the role of collaboration during the COVID-19 pandemic.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Henderson","David C","Department of Psychiatry, Boston Medical Center, Boston, MA, USA",NA
"519","34192002","10.1017/gmh.2021.13","Subjective accelerated aging moderates the association between COVID-19 health worries and peritraumatic distress among older adults.","The present study examined whether subjective accelerated aging moderated the relationship between COVID-19 health worries and COVID-19 peritraumatic distress among older adults. The sample consisted of 277 older adults (M = 69.58, s.d. = 6.73, range 60-92) who answered an online questionnaire during the outbreak of COVID-19 pandemic in Israel. Participants completed the measures of background characteristics, exposure to COVID-19, COVID-19 health worries, subjective accelerated aging and COVID-","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; health worries; peritraumatic distress; subjective accelerated aging","Greenblatt-Kimron","Lee","School of Social Work, Ariel University, Ariel, Israel",NA
"520","34192002","10.1017/gmh.2021.13","Subjective accelerated aging moderates the association between COVID-19 health worries and peritraumatic distress among older adults.","The present study examined whether subjective accelerated aging moderated the relationship between COVID-19 health worries and COVID-19 peritraumatic distress among older adults. The sample consisted of 277 older adults (M = 69.58, s.d. = 6.73, range 60-92) who answered an online questionnaire during the outbreak of COVID-19 pandemic in Israel. Participants completed the measures of background characteristics, exposure to COVID-19, COVID-19 health worries, subjective accelerated aging and COVID-","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; health worries; peritraumatic distress; subjective accelerated aging","Ring","Lia","Department of Gerontology, University of Haifa, Haifa, Israel",NA
"521","34192002","10.1017/gmh.2021.13","Subjective accelerated aging moderates the association between COVID-19 health worries and peritraumatic distress among older adults.","The present study examined whether subjective accelerated aging moderated the relationship between COVID-19 health worries and COVID-19 peritraumatic distress among older adults. The sample consisted of 277 older adults (M = 69.58, s.d. = 6.73, range 60-92) who answered an online questionnaire during the outbreak of COVID-19 pandemic in Israel. Participants completed the measures of background characteristics, exposure to COVID-19, COVID-19 health worries, subjective accelerated aging and COVID-","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; health worries; peritraumatic distress; subjective accelerated aging","Hoffman","Yaakov","Interdisciplinary Department of Social Sciences, Bar-Ilan University, Ramat-Gan, Israel",NA
"522","34192002","10.1017/gmh.2021.13","Subjective accelerated aging moderates the association between COVID-19 health worries and peritraumatic distress among older adults.","The present study examined whether subjective accelerated aging moderated the relationship between COVID-19 health worries and COVID-19 peritraumatic distress among older adults. The sample consisted of 277 older adults (M = 69.58, s.d. = 6.73, range 60-92) who answered an online questionnaire during the outbreak of COVID-19 pandemic in Israel. Participants completed the measures of background characteristics, exposure to COVID-19, COVID-19 health worries, subjective accelerated aging and COVID-","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; health worries; peritraumatic distress; subjective accelerated aging","Shrira","Amit","Interdisciplinary Department of Social Sciences, Bar-Ilan University, Ramat-Gan, Israel",NA
"523","34192002","10.1017/gmh.2021.13","Subjective accelerated aging moderates the association between COVID-19 health worries and peritraumatic distress among older adults.","The present study examined whether subjective accelerated aging moderated the relationship between COVID-19 health worries and COVID-19 peritraumatic distress among older adults. The sample consisted of 277 older adults (M = 69.58, s.d. = 6.73, range 60-92) who answered an online questionnaire during the outbreak of COVID-19 pandemic in Israel. Participants completed the measures of background characteristics, exposure to COVID-19, COVID-19 health worries, subjective accelerated aging and COVID-","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; health worries; peritraumatic distress; subjective accelerated aging","Bodner","Ehud","Interdisciplinary Department of Social Sciences, Bar-Ilan University, Ramat-Gan, Israel",NA
"524","34192002","10.1017/gmh.2021.13","Subjective accelerated aging moderates the association between COVID-19 health worries and peritraumatic distress among older adults.","The present study examined whether subjective accelerated aging moderated the relationship between COVID-19 health worries and COVID-19 peritraumatic distress among older adults. The sample consisted of 277 older adults (M = 69.58, s.d. = 6.73, range 60-92) who answered an online questionnaire during the outbreak of COVID-19 pandemic in Israel. Participants completed the measures of background characteristics, exposure to COVID-19, COVID-19 health worries, subjective accelerated aging and COVID-","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; health worries; peritraumatic distress; subjective accelerated aging","Palgi","Yuval","Department of Gerontology, University of Haifa, Haifa, Israel",NA
"525","34192001","10.1017/gmh.2021.14","Teacher stress, anxiety and depression at the beginning of the academic year during the COVID-19 pandemic.","Faced with the situation of COVID-19, teachers are dealing with new measures, insecurity and a lack of clear guidelines. The aim of this study is to analyse the levels of stress, anxiety and depression of teachers in the north of Spain. This study was conducted with 1633 teachers from the Department of Education of the Basque Autonomous Community (BAC) and Navarre, all of whom are professionals working in various educational centres, from nursery education to university studies, with an average ","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","Age; COVID-19; anxiety; chronic disease; depression; education; gender; stress","Santamaría","María Dosil","Department of Research and Diagnostic Methods in Education, University of the Basque Country UPV/EHU, Leioa, Spain",NA
"526","34192001","10.1017/gmh.2021.14","Teacher stress, anxiety and depression at the beginning of the academic year during the COVID-19 pandemic.","Faced with the situation of COVID-19, teachers are dealing with new measures, insecurity and a lack of clear guidelines. The aim of this study is to analyse the levels of stress, anxiety and depression of teachers in the north of Spain. This study was conducted with 1633 teachers from the Department of Education of the Basque Autonomous Community (BAC) and Navarre, all of whom are professionals working in various educational centres, from nursery education to university studies, with an average ","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","Age; COVID-19; anxiety; chronic disease; depression; education; gender; stress","Mondragon","Nahia Idoiaga","Department of Developmental and Educational Psychology, University of the Basque Country UPV/EHU, Leioa, Spain",NA
"527","34192001","10.1017/gmh.2021.14","Teacher stress, anxiety and depression at the beginning of the academic year during the COVID-19 pandemic.","Faced with the situation of COVID-19, teachers are dealing with new measures, insecurity and a lack of clear guidelines. The aim of this study is to analyse the levels of stress, anxiety and depression of teachers in the north of Spain. This study was conducted with 1633 teachers from the Department of Education of the Basque Autonomous Community (BAC) and Navarre, all of whom are professionals working in various educational centres, from nursery education to university studies, with an average ","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","Age; COVID-19; anxiety; chronic disease; depression; education; gender; stress","Santxo","Naiara Berasategi","Department of Didactics and School Organization, University of the Basque Country UPV/EHU, Leioa, Spain",NA
"528","34192001","10.1017/gmh.2021.14","Teacher stress, anxiety and depression at the beginning of the academic year during the COVID-19 pandemic.","Faced with the situation of COVID-19, teachers are dealing with new measures, insecurity and a lack of clear guidelines. The aim of this study is to analyse the levels of stress, anxiety and depression of teachers in the north of Spain. This study was conducted with 1633 teachers from the Department of Education of the Basque Autonomous Community (BAC) and Navarre, all of whom are professionals working in various educational centres, from nursery education to university studies, with an average ","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","Age; COVID-19; anxiety; chronic disease; depression; education; gender; stress","Ozamiz-Etxebarria","Naiara","Department of Developmental and Educational Psychology, University of the Basque Country UPV/EHU, Leioa, Spain",NA
"529","34192000","10.1017/gmh.2021.12","Mental distress in ongoing conflict and non-conflict settings during COVID-19: a study on Syrians in different countries.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Kakaje","Ameer","Faculty of Medicine, Damascus University, Damascus, Syria",NA
"530","34192000","10.1017/gmh.2021.12","Mental distress in ongoing conflict and non-conflict settings during COVID-19: a study on Syrians in different countries.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Fadel","Ammar","Faculty of Medicine, Damascus University, Damascus, Syria",NA
"531","34192000","10.1017/gmh.2021.12","Mental distress in ongoing conflict and non-conflict settings during COVID-19: a study on Syrians in different countries.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Ghareeb","Ayham","Faculty of Medicine, Damascus University, Damascus, Syria",NA
"532","34192000","10.1017/gmh.2021.12","Mental distress in ongoing conflict and non-conflict settings during COVID-19: a study on Syrians in different countries.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Al Zohbi","Ragheed","Faculty of Medicine, Aleppo University, Aleppo, Syria",NA
"533","34191998","10.1017/gmh.2020.27","Building a strategic educator-psychiatrist alliance to support the mental health of students during the outbreak of COVID-19 in China.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Ren","Ding","Department of Medical Psychology, PLA Navy No. 905 Hospital, Second Military Medical University, Shanghai, 200052, P.R. China",NA
"534","34191998","10.1017/gmh.2020.27","Building a strategic educator-psychiatrist alliance to support the mental health of students during the outbreak of COVID-19 in China.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Wang","Lixia","Shanghai Teacher Training Center, Shanghai, 200234, P.R. China",NA
"535","34191998","10.1017/gmh.2020.27","Building a strategic educator-psychiatrist alliance to support the mental health of students during the outbreak of COVID-19 in China.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Pan","Xiao","Department of Medical Psychology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, 200003, P.R. China",NA
"536","34191998","10.1017/gmh.2020.27","Building a strategic educator-psychiatrist alliance to support the mental health of students during the outbreak of COVID-19 in China.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Bai","Yonghai","Department of Medical Psychology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, 200003, P.R. China",NA
"537","34191998","10.1017/gmh.2020.27","Building a strategic educator-psychiatrist alliance to support the mental health of students during the outbreak of COVID-19 in China.",NA,"2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)",NA,"Xu","Zhengmei","Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, 200003, P.R. China",NA
"538","34191997","10.1017/gmh.2020.22","Pandemic anxiety and its correlates among young doctors working frontline in Pakistan.","The study explores the challenges and threats young doctors in Pakistan working frontline toward the pandemic face, and how it translates into their personal and social lives. Thirteen resident doctors working frontline with COVID-19 cases were approached and interviewed in-depth until the point of data saturation. Interpretative phenomenological analysis was used as a method for analysis. Four themes emerged in the analysis: pandemic anxiety, organizational lack of readiness for change, impact ","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; Challenges and Threats; Frontline Workers; Pakistan; Pandemic Anxiety","Rashid","Alina","Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan",NA
"539","34191997","10.1017/gmh.2020.22","Pandemic anxiety and its correlates among young doctors working frontline in Pakistan.","The study explores the challenges and threats young doctors in Pakistan working frontline toward the pandemic face, and how it translates into their personal and social lives. Thirteen resident doctors working frontline with COVID-19 cases were approached and interviewed in-depth until the point of data saturation. Interpretative phenomenological analysis was used as a method for analysis. Four themes emerged in the analysis: pandemic anxiety, organizational lack of readiness for change, impact ","2021","07","02","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19; Challenges and Threats; Frontline Workers; Pakistan; Pandemic Anxiety","Faisal","Kanza","Institute of Applied Psychology, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan",NA
"540","34191995","10.1177/2053951720952088","COVID-19 is spatial: Ensuring that mobile Big Data is used for social good.","The mobility restrictions related to COVID-19 pandemic have resulted in the biggest disruption to individual mobilities in modern times. The crisis is clearly spatial in nature, and examining the geographical aspect is important in understanding the broad implications of the pandemic. The avalanche of mobile Big Data makes it possible to study the spatial effects of the crisis with spatiotemporal detail at the national and global scales. However, the current crisis also highlights serious limita","2021","07","02","Big Data Soc","Big data &amp; society","COVID-19; Mobile Big Data; mobile phone data, social media data, privacy; mobility; social good; spatial data infrastructure","Poom","Age","Digital Geography Lab, Department of Geosciences and Geography, University of Helsinki, Helsinki, Finland",NA
"541","34191995","10.1177/2053951720952088","COVID-19 is spatial: Ensuring that mobile Big Data is used for social good.","The mobility restrictions related to COVID-19 pandemic have resulted in the biggest disruption to individual mobilities in modern times. The crisis is clearly spatial in nature, and examining the geographical aspect is important in understanding the broad implications of the pandemic. The avalanche of mobile Big Data makes it possible to study the spatial effects of the crisis with spatiotemporal detail at the national and global scales. However, the current crisis also highlights serious limita","2021","07","02","Big Data Soc","Big data &amp; society","COVID-19; Mobile Big Data; mobile phone data, social media data, privacy; mobility; social good; spatial data infrastructure","Järv","Olle","Digital Geography Lab, Department of Geosciences and Geography, University of Helsinki, Helsinki, Finland",NA
"542","34191995","10.1177/2053951720952088","COVID-19 is spatial: Ensuring that mobile Big Data is used for social good.","The mobility restrictions related to COVID-19 pandemic have resulted in the biggest disruption to individual mobilities in modern times. The crisis is clearly spatial in nature, and examining the geographical aspect is important in understanding the broad implications of the pandemic. The avalanche of mobile Big Data makes it possible to study the spatial effects of the crisis with spatiotemporal detail at the national and global scales. However, the current crisis also highlights serious limita","2021","07","02","Big Data Soc","Big data &amp; society","COVID-19; Mobile Big Data; mobile phone data, social media data, privacy; mobility; social good; spatial data infrastructure","Zook","Matthew","Department of Geography, University of Kentucky, Lexington, KY, USA",NA
"543","34191995","10.1177/2053951720952088","COVID-19 is spatial: Ensuring that mobile Big Data is used for social good.","The mobility restrictions related to COVID-19 pandemic have resulted in the biggest disruption to individual mobilities in modern times. The crisis is clearly spatial in nature, and examining the geographical aspect is important in understanding the broad implications of the pandemic. The avalanche of mobile Big Data makes it possible to study the spatial effects of the crisis with spatiotemporal detail at the national and global scales. However, the current crisis also highlights serious limita","2021","07","02","Big Data Soc","Big data &amp; society","COVID-19; Mobile Big Data; mobile phone data, social media data, privacy; mobility; social good; spatial data infrastructure","Toivonen","Tuuli","Digital Geography Lab, Department of Geosciences and Geography, University of Helsinki, Helsinki, Finland",NA
"544","34191994","10.1177/2053951720939236","Learning from lines: Critical COVID data visualizations and the quarantine quotidian.","In response to the ubiquitous graphs and maps of COVID-19, artists, designers, data scientists, and public health officials are teaming up to create counter-plots and subaltern maps of the pandemic. In this intervention, we describe the various functions served by these projects. First, they offer tutorials and tools for both dataviz practitioners and their publics to encourage critical thinking about how COVID-19 data is sourced and modeled-and to consider which subjects are not interpellated i","2021","06","30","Big Data Soc","Big data &amp; society","Counter-mapping; data visualization; embodiment","Bowe","Emily","The New School, New York, NY, USA",NA
"545","34191994","10.1177/2053951720939236","Learning from lines: Critical COVID data visualizations and the quarantine quotidian.","In response to the ubiquitous graphs and maps of COVID-19, artists, designers, data scientists, and public health officials are teaming up to create counter-plots and subaltern maps of the pandemic. In this intervention, we describe the various functions served by these projects. First, they offer tutorials and tools for both dataviz practitioners and their publics to encourage critical thinking about how COVID-19 data is sourced and modeled-and to consider which subjects are not interpellated i","2021","06","30","Big Data Soc","Big data &amp; society","Counter-mapping; data visualization; embodiment","Simmons","Erin","The New School, New York, NY, USA",NA
"546","34191994","10.1177/2053951720939236","Learning from lines: Critical COVID data visualizations and the quarantine quotidian.","In response to the ubiquitous graphs and maps of COVID-19, artists, designers, data scientists, and public health officials are teaming up to create counter-plots and subaltern maps of the pandemic. In this intervention, we describe the various functions served by these projects. First, they offer tutorials and tools for both dataviz practitioners and their publics to encourage critical thinking about how COVID-19 data is sourced and modeled-and to consider which subjects are not interpellated i","2021","06","30","Big Data Soc","Big data &amp; society","Counter-mapping; data visualization; embodiment","Mattern","Shannon","The New School, New York, NY, USA",NA
"547","34191993","10.1093/comnet/cnaa041","The impact of human mobility networks on the global spread of COVID-19.","Human mobility networks are crucial for a better understanding and controlling the spread of epidemics. Here, we study the impact of human mobility networks on the COVID-19 onset in 203 different countries. We use exponential random graph models to perform an analysis of the country-to-country global spread of COVID-19. We find that most countries had similar levels of virus spreading, with only a few acting as the main global transmitters. Our evidence suggests that migration and tourism inflow","2021","07","02","J Complex Netw","Journal of complex networks","COVID-19 case importations; complex networks; human mobility networks; inbound tourism; incoming migration","Hâncean","Marian-Gabriel","Department of Sociology, University of Bucharest, Bucharest, Romania",NA
"548","34191993","10.1093/comnet/cnaa041","The impact of human mobility networks on the global spread of COVID-19.","Human mobility networks are crucial for a better understanding and controlling the spread of epidemics. Here, we study the impact of human mobility networks on the COVID-19 onset in 203 different countries. We use exponential random graph models to perform an analysis of the country-to-country global spread of COVID-19. We find that most countries had similar levels of virus spreading, with only a few acting as the main global transmitters. Our evidence suggests that migration and tourism inflow","2021","07","02","J Complex Netw","Journal of complex networks","COVID-19 case importations; complex networks; human mobility networks; inbound tourism; incoming migration","Slavinec","Mitja","Faculty of Natural Sciences and Mathematics, University of Maribor, Maribor, Slovenia",NA
"549","34191993","10.1093/comnet/cnaa041","The impact of human mobility networks on the global spread of COVID-19.","Human mobility networks are crucial for a better understanding and controlling the spread of epidemics. Here, we study the impact of human mobility networks on the COVID-19 onset in 203 different countries. We use exponential random graph models to perform an analysis of the country-to-country global spread of COVID-19. We find that most countries had similar levels of virus spreading, with only a few acting as the main global transmitters. Our evidence suggests that migration and tourism inflow","2021","07","02","J Complex Netw","Journal of complex networks","COVID-19 case importations; complex networks; human mobility networks; inbound tourism; incoming migration","Perc","Matja","Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan &amp",NA
"550","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Sharifpour","Ali","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"551","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Safanavaei","Sepideh","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"552","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Tabaripour","Rabeeh","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"553","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Taghizadeh","Fatemeh","Student Researches Committee, Psychiatry and Behavioral Sciences Centre, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"554","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Nakhaei","Maryam","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"555","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Abadi","Atikeh","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"556","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Fakhar","Mahdi","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"557","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Banimostafavi","Elham Sadat","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"558","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Nazar","Eisa","Student Research Committee, Department of Epidemiology and Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"559","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Aliyali","Masoud","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"560","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Abedi","Siavash","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"561","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Mehravaran","Hossein","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"562","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Zakariaei","Zakaria","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"563","34191992","10.1016/j.amsu.2021.102519","Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.","The clinical symptoms, blood laboratory data, O2 saturation and high-resolution computed tomography (HRCT) findings are critical factors in diagnosis of COVID-19 infection. In this study, 105 hospitalized patients suspected of having COVID-19 were evaluated. Finally, the laboratory and HRCT and related factors data of 83 confirmed cases by HRCT and RT-PCR were analyzed. To compare the median of quantitative variables in the two groups, the Mann-Whitney U test was used. Also, to determine the fac","2021","07","02","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Blood laboratory data; COVID-19; Clinical symptoms; HRCT","Azadeh","Hossein","Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Sari, Iran",NA
"564","34191991","10.1017/ATSIP.2021.5","Analyzing public opinion on COVID-19 through different perspectives and stages.","In recent months, COVID-19 has become a global pandemic and had a huge impact on the world. People under different conditions have very different attitudes toward the epidemic. Due to the real-time and large-scale nature of social media, we can continuously obtain a massive amount of public opinion information related to the epidemic from social media. In particular, researchers may ask questions such as ""how is the public reacting to COVID-19 in China during different stages of the pandemic?"", ","2021","07","02","APSIPA Trans Signal Inf Process","APSIPA Transactions on Signal and Information Processing","COVID-19; Data analysis; Public opinion; Sentiment tracking","Gao","Yuqi","University of Rochester, Rochester, NY, USA",NA
"565","34191991","10.1017/ATSIP.2021.5","Analyzing public opinion on COVID-19 through different perspectives and stages.","In recent months, COVID-19 has become a global pandemic and had a huge impact on the world. People under different conditions have very different attitudes toward the epidemic. Due to the real-time and large-scale nature of social media, we can continuously obtain a massive amount of public opinion information related to the epidemic from social media. In particular, researchers may ask questions such as ""how is the public reacting to COVID-19 in China during different stages of the pandemic?"", ","2021","07","02","APSIPA Trans Signal Inf Process","APSIPA Transactions on Signal and Information Processing","COVID-19; Data analysis; Public opinion; Sentiment tracking","Hua","Hang","University of Rochester, Rochester, NY, USA",NA
"566","34191991","10.1017/ATSIP.2021.5","Analyzing public opinion on COVID-19 through different perspectives and stages.","In recent months, COVID-19 has become a global pandemic and had a huge impact on the world. People under different conditions have very different attitudes toward the epidemic. Due to the real-time and large-scale nature of social media, we can continuously obtain a massive amount of public opinion information related to the epidemic from social media. In particular, researchers may ask questions such as ""how is the public reacting to COVID-19 in China during different stages of the pandemic?"", ","2021","07","02","APSIPA Trans Signal Inf Process","APSIPA Transactions on Signal and Information Processing","COVID-19; Data analysis; Public opinion; Sentiment tracking","Luo","Jiebo","University of Rochester, Rochester, NY, USA",NA
"567","34191990","10.1080/20009666.2021.1883814","Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.","There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlig","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; Hemorrhagic infarct; coronavirus; ischemia","Owolabi","Lukman Femi","Department of Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia",NA
"568","34191990","10.1080/20009666.2021.1883814","Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.","There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlig","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; Hemorrhagic infarct; coronavirus; ischemia","Raafat","Ahmed","King Abdullah Hospital, Bisha, Saudi Arabia",NA
"569","34191990","10.1080/20009666.2021.1883814","Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.","There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlig","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; Hemorrhagic infarct; coronavirus; ischemia","Enwere","Okezie Oguamanam","King Abdullah Hospital, Bisha, Saudi Arabia",NA
"570","34191990","10.1080/20009666.2021.1883814","Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.","There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlig","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; Hemorrhagic infarct; coronavirus; ischemia","Mustapha","Adekunle F","King Abdullah Hospital, Bisha, Saudi Arabia",NA
"571","34191990","10.1080/20009666.2021.1883814","Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.","There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlig","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; Hemorrhagic infarct; coronavirus; ischemia","Adamu","Bappa","Department of Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia",NA
"572","34191990","10.1080/20009666.2021.1883814","Hemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature.","There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlig","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; Hemorrhagic infarct; coronavirus; ischemia","AlGhamdi","Mushabab","Department of Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia",NA
"573","34191989","10.1080/20009666.2021.1896429","COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature.","The novel coronavirus disease (Covid-19) continues to spread all over the world with acute respiratory distress syndrome and multiorgan failure being a significant cause of morbidity and mortality. The involvement of the cardiovascular system is associated with increased mortality and there have been various manifestations reported in the literature. We present a case of a patient requiring intensive care unit (ICU) admission for acute respiratory distress syndrome from Covid-19 who developed ST","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus; covid-19; myocardial ischemia; pericarditis; viral pericarditis","Bhandari","Binita","Department of Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA",NA
"574","34191989","10.1080/20009666.2021.1896429","COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature.","The novel coronavirus disease (Covid-19) continues to spread all over the world with acute respiratory distress syndrome and multiorgan failure being a significant cause of morbidity and mortality. The involvement of the cardiovascular system is associated with increased mortality and there have been various manifestations reported in the literature. We present a case of a patient requiring intensive care unit (ICU) admission for acute respiratory distress syndrome from Covid-19 who developed ST","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus; covid-19; myocardial ischemia; pericarditis; viral pericarditis","Neupane","Sunita","Department of Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA",NA
"575","34191989","10.1080/20009666.2021.1896429","COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature.","The novel coronavirus disease (Covid-19) continues to spread all over the world with acute respiratory distress syndrome and multiorgan failure being a significant cause of morbidity and mortality. The involvement of the cardiovascular system is associated with increased mortality and there have been various manifestations reported in the literature. We present a case of a patient requiring intensive care unit (ICU) admission for acute respiratory distress syndrome from Covid-19 who developed ST","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus; covid-19; myocardial ischemia; pericarditis; viral pericarditis","Khanal","Resha","Department of Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA",NA
"576","34191989","10.1080/20009666.2021.1896429","COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature.","The novel coronavirus disease (Covid-19) continues to spread all over the world with acute respiratory distress syndrome and multiorgan failure being a significant cause of morbidity and mortality. The involvement of the cardiovascular system is associated with increased mortality and there have been various manifestations reported in the literature. We present a case of a patient requiring intensive care unit (ICU) admission for acute respiratory distress syndrome from Covid-19 who developed ST","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus; covid-19; myocardial ischemia; pericarditis; viral pericarditis","Lnu","Kriti","Department of Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA",NA
"577","34191989","10.1080/20009666.2021.1896429","COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature.","The novel coronavirus disease (Covid-19) continues to spread all over the world with acute respiratory distress syndrome and multiorgan failure being a significant cause of morbidity and mortality. The involvement of the cardiovascular system is associated with increased mortality and there have been various manifestations reported in the literature. We present a case of a patient requiring intensive care unit (ICU) admission for acute respiratory distress syndrome from Covid-19 who developed ST","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus; covid-19; myocardial ischemia; pericarditis; viral pericarditis","Wert","Yijin","Department of Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA",NA
"578","34191989","10.1080/20009666.2021.1896429","COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature.","The novel coronavirus disease (Covid-19) continues to spread all over the world with acute respiratory distress syndrome and multiorgan failure being a significant cause of morbidity and mortality. The involvement of the cardiovascular system is associated with increased mortality and there have been various manifestations reported in the literature. We present a case of a patient requiring intensive care unit (ICU) admission for acute respiratory distress syndrome from Covid-19 who developed ST","2021","07","02","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus; covid-19; myocardial ischemia; pericarditis; viral pericarditis","Komanduri","Saketram","Department of Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA",NA
"579","34191987","10.4102/jamba.v13i1.1013","Simple rules and self-organisation: A complex systems' perspective on South Africa's COVID-19 response.",NA,"2021","07","02","Jamba","Jamba (Potchefstroom, South Africa)",NA,"Coetzee","Christo","School for Geo-Spatial Science, Faculty of Natural Science, North-West University, Potchefstroom, South Africa",NA
"580","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Zame","William R","Department of Economics and Mathematics, UCLA, Los Angeles, CA, USA",NA
"581","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Bica","Ioana","University of Oxford, Oxford, UK",NA
"582","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Shen","Cong","Department of Electrical and Computer Engineering, University of Virginia, Charlottesville, VA, USA",NA
"583","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Curth","Alicia","University of Oxford, Oxford, UK",NA
"584","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Lee","Hyun-Suk","Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK",NA
"585","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Bailey","Stuart","Novartis Pharmaceuticals, Cambridge, MA, USA",NA
"586","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Weatherall","James","AstraZeneca, Cambridge, UK",NA
"587","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Wright","David","AstraZeneca, Cambridge, UK",NA
"588","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","Bretz","Frank","Novartis Pharma AG, Basel, Switzerland",NA
"589","34191983","10.1080/19466315.2020.1797867","Machine learning for clinical trials in the era of COVID-19.","The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside from managing symptoms). We do not know if recovery from COVID-19 produces immunity, and if so for how long, hence we do not know if ""herd immunity"" will eventually reduce the risk or if a successful vaccine can be developed - and this knowledge may be a long time coming. In the meantime, the COVID-19 pandemic is p","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; SARS-CoV-2; clinical trials; machine learning","van der Schaar","Mihaela","The Alan Turing Institute, London, UK",NA
"590","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Nilsson","Mary","Eli Lilly and Company, Indianapolis, IN",NA
"591","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Crowe","Brenda","Eli Lilly and Company, Indianapolis, IN",NA
"592","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Anglin","Greg","Eli Lilly Canada Inc., Toronto, ON, Canada",NA
"593","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Ball","Greg","Merck &amp",NA
"594","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Munsaka","Melvin","AbbVie Inc., North Chicago, IL",NA
"595","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Shahin","Seta","Amgen Inc., Thousand Oaks, CA",NA
"596","34191982","10.1080/19466315.2020.1804444","Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.","Abstract-In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative locations for assessments (such as local labs), and study drug interruptions. Starting from the safety analyses typically included in Clinical Study Reports for Phase 2-4 clinical trials and ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trial; Coronavirus; Harms; Safety analysis; Safety review","Wang","Wei","Eli Lilly Canada Inc., Toronto, ON, Canada",NA
"597","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Stallard","Nigel","Statistics and Epidemiology, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK",NA
"598","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Hampson","Lisa","Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland",NA
"599","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Benda","Norbert","The Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany",NA
"600","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Brannath","Werner","Institute for Statistics, University of Bremen, Bremen, Germany",NA
"601","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Burnett","Thomas","Department of Mathematics and Statistics, Lancaster University, Lancaster, UK",NA
"602","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Friede","Tim","Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany",NA
"603","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Kimani","Peter K","Statistics and Epidemiology, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK",NA
"604","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Koenig","Franz","Section for Medical Statistics, CeMSIIS, Medical University of Vienna, Vienna, Austria",NA
"605","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Krisam","Johannes","Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany",NA
"606","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Mozgunov","Pavel","Department of Mathematics and Statistics, Lancaster University, Lancaster, UK",NA
"607","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Posch","Martin","Section for Medical Statistics, CeMSIIS, Medical University of Vienna, Vienna, Austria",NA
"608","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Wason","James","Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK",NA
"609","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Wassmer","Gernot","RPACT GbR, Sereetz, Germany",NA
"610","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Whitehead","John","Department of Mathematics and Statistics, Lancaster University, Lancaster, UK",NA
"611","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Williamson","S Faye","Department of Mathematics and Statistics, Lancaster University, Lancaster, UK",NA
"612","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Zohar","Sarah","INSERM, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France",NA
"613","34191981","10.1080/19466315.2020.1790415","Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.","The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results from this research need to be obtained as rapidly as possible. This presents a number of challenges associated with considerable uncertainty over the natural history of the disease and the number and characteristics of patients affected, and the emer","2021","07","14","Stat Biopharm Res","Statistics in biopharmaceutical research","Adaptive trial; Group sequential design; Multi-arm multi-stage; Pandemic research; Platform trial; SARS-CoV-2","Jaki","Thomas","Department of Mathematics and Statistics, Lancaster University, Lancaster, UK",NA
"614","34191980","10.1080/19466315.2020.1800509","Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience.","The Cape-Covid trial is an embedded clinical trial within the ongoing Cape-Cod trial. The Covid-19 pandemic appeared while we were conducting a randomized trial assessing the effectiveness of corticosteroids in severe community-acquired pneumonia. We took advantage of this ongoing trial to embed a sub-trial assessing hydrocortisone in SARS-CoV-2 infected patients. In this manuscript, we wish to share our experience when we needed to make fast and robust methodological decisions during the Covid-","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","SARS-CoV-2 virus; group-sequential designs","Dequin","Pierre-François","Service de Médecine Intensive-Réanimation, CHRU de Tours, France",NA
"615","34191980","10.1080/19466315.2020.1800509","Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience.","The Cape-Covid trial is an embedded clinical trial within the ongoing Cape-Cod trial. The Covid-19 pandemic appeared while we were conducting a randomized trial assessing the effectiveness of corticosteroids in severe community-acquired pneumonia. We took advantage of this ongoing trial to embed a sub-trial assessing hydrocortisone in SARS-CoV-2 infected patients. In this manuscript, we wish to share our experience when we needed to make fast and robust methodological decisions during the Covid-","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","SARS-CoV-2 virus; group-sequential designs","Gouge","Amélie Le","INSERM CIC1415, CHRU de Tours, Tours, France",NA
"616","34191980","10.1080/19466315.2020.1800509","Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience.","The Cape-Covid trial is an embedded clinical trial within the ongoing Cape-Cod trial. The Covid-19 pandemic appeared while we were conducting a randomized trial assessing the effectiveness of corticosteroids in severe community-acquired pneumonia. We took advantage of this ongoing trial to embed a sub-trial assessing hydrocortisone in SARS-CoV-2 infected patients. In this manuscript, we wish to share our experience when we needed to make fast and robust methodological decisions during the Covid-","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","SARS-CoV-2 virus; group-sequential designs","Tavernier","Elsa","INSERM CIC1415, CHRU de Tours, Tours, France",NA
"617","34191980","10.1080/19466315.2020.1800509","Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience.","The Cape-Covid trial is an embedded clinical trial within the ongoing Cape-Cod trial. The Covid-19 pandemic appeared while we were conducting a randomized trial assessing the effectiveness of corticosteroids in severe community-acquired pneumonia. We took advantage of this ongoing trial to embed a sub-trial assessing hydrocortisone in SARS-CoV-2 infected patients. In this manuscript, we wish to share our experience when we needed to make fast and robust methodological decisions during the Covid-","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","SARS-CoV-2 virus; group-sequential designs","Giraudeau","Bruno","INSERM CIC1415, CHRU de Tours, Tours, France",NA
"618","34191980","10.1080/19466315.2020.1800509","Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience.","The Cape-Covid trial is an embedded clinical trial within the ongoing Cape-Cod trial. The Covid-19 pandemic appeared while we were conducting a randomized trial assessing the effectiveness of corticosteroids in severe community-acquired pneumonia. We took advantage of this ongoing trial to embed a sub-trial assessing hydrocortisone in SARS-CoV-2 infected patients. In this manuscript, we wish to share our experience when we needed to make fast and robust methodological decisions during the Covid-","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","SARS-CoV-2 virus; group-sequential designs","Zohar","Sarah","INSERM, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France",NA
"619","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Kunz","Cornelia Ursula","Boehringer Ingelheim Pharma GmbH &amp",NA
"620","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Jörgens","Silke","Janssen-Cilag GmbH, Neuss, Germany",NA
"621","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Bretz","Frank","Novartis Pharma AG, Basel, Switzerland",NA
"622","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Stallard","Nigel","Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK",NA
"623","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Van Lancker","Kelly","Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium",NA
"624","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Xi","Dong","Novartis Pharmaceuticals, East Hanover, NJ",NA
"625","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Zohar","Sarah","INSERM, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France",NA
"626","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Gerlinger","Christoph","Statistics and Data Insights, Bayer AG, Berlin, Germany",NA
"627","34191979","10.1080/19466315.2020.1799857","Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?","Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is ","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Design changes; Heterogeneity; Interim analysis; SARS-CoV-2","Friede","Tim","Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany",NA
"628","34191978","10.1080/19466315.2020.1811148","Assessing via Simulation the Operating Characteristics of the WHO Scale for COVID-19 Endpoints.","Many clinical trials of treatments for patients hospitalised for COVID-19 use an ordinal scale recommended by the World Heath Organisation. The scale represents intensity of medical intervention, with higher scores for interventions more burdensome for the patient, and highest score for death. There is uncertainty about use of this ordinal scale in testing hypotheses. With the objective of assessing the power and Type I error of potential endpoints and analyses based on the ordinal scale, trajec","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Type I error; health trajectory; modelling and simulation; ordinal response; power; transition probability","O'Kelly","Michael","IQVIA, East Point Business Park, Dublin 3, Ireland",NA
"629","34191978","10.1080/19466315.2020.1811148","Assessing via Simulation the Operating Characteristics of the WHO Scale for COVID-19 Endpoints.","Many clinical trials of treatments for patients hospitalised for COVID-19 use an ordinal scale recommended by the World Heath Organisation. The scale represents intensity of medical intervention, with higher scores for interventions more burdensome for the patient, and highest score for death. There is uncertainty about use of this ordinal scale in testing hypotheses. With the objective of assessing the power and Type I error of potential endpoints and analyses based on the ordinal scale, trajec","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Type I error; health trajectory; modelling and simulation; ordinal response; power; transition probability","Li","Siying","IQVIA, Durham, NC",NA
"630","34191977","10.1080/19466315.2020.1788983","The Impact of Major Events on Ongoing Noninferiority Trials, With Application to COVID-19.","Abstract-The COVID-19 pandemic has impacted ongoing clinical trials. We consider particular impacts on noninferiority clinical trials, which aim to show that an investigational treatment is not markedly worse than an existing active control with known benefit. Because interpretation of noninferiority trials requires cross-trial validation involving untestable assumptions, it is vital that they be run to very high standards. The COVID-19 pandemic has introduced an unexpected impact on c","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Estimand; Missing data; Multiple imputation; Simulation","Wiens","Brian L","Horizon Therapeutics, South San Francisco, CA",NA
"631","34191977","10.1080/19466315.2020.1788983","The Impact of Major Events on Ongoing Noninferiority Trials, With Application to COVID-19.","Abstract-The COVID-19 pandemic has impacted ongoing clinical trials. We consider particular impacts on noninferiority clinical trials, which aim to show that an investigational treatment is not markedly worse than an existing active control with known benefit. Because interpretation of noninferiority trials requires cross-trial validation involving untestable assumptions, it is vital that they be run to very high standards. The COVID-19 pandemic has introduced an unexpected impact on c","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Estimand; Missing data; Multiple imputation; Simulation","Lipkovich","Ilya","Eli Lilly and Company, Indianapolis, IN",NA
"632","34191976","10.1080/19466315.2020.1797866","Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic.","The COVID-19 outbreak is impacting clinical trials in many ways, such as patient recruitment, data collection and data analysis. To proceed in this difficult time, the adoption of new technologies and new approaches for conducting clinical trials needs to be accelerated. Simultaneously, regulatory agencies such as the US FDA and EMA have issued guidance to help the pharmaceutical industry conduct clinical trials of medical products during the COVID-19 pandemic. In this article, we will address s","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; protocol modifications; remote data monitoring","Guo","Tong","Gem Flower Pharm Tech. (Beijing) Co., Ltd., Dongcheng District, Beijing, China",NA
"633","34191976","10.1080/19466315.2020.1797866","Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic.","The COVID-19 outbreak is impacting clinical trials in many ways, such as patient recruitment, data collection and data analysis. To proceed in this difficult time, the adoption of new technologies and new approaches for conducting clinical trials needs to be accelerated. Simultaneously, regulatory agencies such as the US FDA and EMA have issued guidance to help the pharmaceutical industry conduct clinical trials of medical products during the COVID-19 pandemic. In this article, we will address s","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; protocol modifications; remote data monitoring","Chen","Chian","Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan",NA
"634","34191976","10.1080/19466315.2020.1797866","Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic.","The COVID-19 outbreak is impacting clinical trials in many ways, such as patient recruitment, data collection and data analysis. To proceed in this difficult time, the adoption of new technologies and new approaches for conducting clinical trials needs to be accelerated. Simultaneously, regulatory agencies such as the US FDA and EMA have issued guidance to help the pharmaceutical industry conduct clinical trials of medical products during the COVID-19 pandemic. In this article, we will address s","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; protocol modifications; remote data monitoring","Chiang","Chieh","Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan",NA
"635","34191976","10.1080/19466315.2020.1797866","Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic.","The COVID-19 outbreak is impacting clinical trials in many ways, such as patient recruitment, data collection and data analysis. To proceed in this difficult time, the adoption of new technologies and new approaches for conducting clinical trials needs to be accelerated. Simultaneously, regulatory agencies such as the US FDA and EMA have issued guidance to help the pharmaceutical industry conduct clinical trials of medical products during the COVID-19 pandemic. In this article, we will address s","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; protocol modifications; remote data monitoring","Chen","Chi-Tian","StatPlus Inc., Taipei, Taiwan",NA
"636","34191976","10.1080/19466315.2020.1797866","Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic.","The COVID-19 outbreak is impacting clinical trials in many ways, such as patient recruitment, data collection and data analysis. To proceed in this difficult time, the adoption of new technologies and new approaches for conducting clinical trials needs to be accelerated. Simultaneously, regulatory agencies such as the US FDA and EMA have issued guidance to help the pharmaceutical industry conduct clinical trials of medical products during the COVID-19 pandemic. In this article, we will address s","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; protocol modifications; remote data monitoring","Hsiao","Chin-Fu","Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan",NA
"637","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Degtyarev","Evgeny","Novartis Pharma AG, Basel, Switzerland",NA
"638","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Rufibach","Kaspar","F. Hoffmann-La Roche, Basel, Switzerland",NA
"639","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Shentu","Yue","Merck &amp",NA
"640","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Yung","Godwin","Takeda Pharmaceuticals, Cambridge, MA",NA
"641","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Casey","Michelle","Pfizer, Collegeville, PA",NA
"642","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Englert","Stefan","AbbVie Deutschland GmbH &amp",NA
"643","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Liu","Feng","AstraZeneca, Gaithersburg, MD",NA
"644","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Liu","Yi","Nektar Therapeutics, San Francisco, CA",NA
"645","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Sailer","Oliver","Boehringer Ingelheim Pharma GmbH &amp",NA
"646","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Siegel","Jonathan","Bayer US Inc., Whippany, NJ",NA
"647","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Sun","Steven","Janssen R&amp",NA
"648","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Tang","Rui","Servier Pharmaceuticals, Boston, MA",NA
"649","34191975","10.1080/19466315.2020.1785543","Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework.","Abstract-Coronavirus disease 2019 (COVID-19) outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and its broad applicability for future clinical practice. We identify key intercurrent events (ICEs) that may occur due to COVID-19 in oncology clinical trials with a focus on time-to-event endpoints and discuss considerations pertaining to the other estimand attributes introduce","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Coronavirus disease 2019; Estimand; Oncology clinical trial; Time-to-event","Zhou","Jiangxiu","GlaxoSmithKline, Collegeville, PA",NA
"650","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Akacha","Mouna","Clinical Development &amp",NA
"651","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Branson","Janice","Clinical Development &amp",NA
"652","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Bretz","Frank","Clinical Development &amp",NA
"653","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Dharan","Bharani","Clinical Development &amp",NA
"654","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Gallo","Paul","Clinical Development &amp",NA
"655","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Gathmann","Insa","Clinical Development &amp",NA
"656","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Hemmings","Robert","CONSILIUM Salmonson &amp",NA
"657","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Jones","Julie","Clinical Development &amp",NA
"658","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Xi","Dong","Clinical Development &amp",NA
"659","34191974","10.1080/19466315.2020.1788984","Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials.","Abstract-The COVID-19 pandemic has a global impact on the conduct of clinical trials of medical products. This article discusses implications of the COVID-19 pandemic on clinical research methodology aspects and provides points to consider to assess and mitigate the risk of seriously compromising the integrity and interpretability of clinical trials. The information in this article will support discussions that need to occur cross-functionally on an ongoing basis to ""integrate all avai","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","Adherence; Estimand; Intercurrent event; Missing data; Protocol deviations","Zuber","Emmanuel","Clinical Development &amp",NA
"660","34191973","10.1080/19466315.2020.1785931","Under a Black Cloud Glimpsing a Silver Lining: Comment on Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Hemmings","Rob","Consilium Salmonson and Hemmings, Woking, UK",NA
"661","34191972","10.1080/19466315.2020.1779123","Comment on ""Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic"".",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Collins","Sylva H","Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD",NA
"662","34191972","10.1080/19466315.2020.1779123","Comment on ""Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic"".",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Levenson","Mark S","Division of Biometrics VII, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD",NA
"663","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Meyer","R Daniel","Pfizer Inc., Groton, CT",NA
"664","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Ratitch","Bohdana","Bayer, Montreal, QC, Canada",NA
"665","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Wolbers","Marcel","F. Hoffmann-La Roche Ltd, Basel, Switzerland",NA
"666","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Marchenko","Olga","Bayer, Whippany, NJ",NA
"667","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Quan","Hui","Sanofi, Bridgewater, NJ",NA
"668","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Li","Daniel","Bristol Myers Squibb, Princeton, NJ",NA
"669","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Fletcher","Christine","GlaxoSmithKline, Stevenage, Hertfordshire, UK",NA
"670","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Li","Xin","Genentech/Roche, South San Francisco, CA",NA
"671","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Wright","David","AstraZeneca, Cambridge, Cambridgeshire, UK",NA
"672","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Shentu","Yue","Merck &amp",NA
"673","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Englert","Stefan","Abbvie Deutschland GmbH &amp",NA
"674","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Shen","Wei","Eli Lilly and Company, Indianapolis, IN",NA
"675","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Dey","Jyotirmoy","Abbvie Inc., North Chicago, IL",NA
"676","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Liu","Thomas","Amgen Inc., Thousand Oaks, CA",NA
"677","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Zhou","Ming","Bristol Myers Squibb, Princeton, NJ",NA
"678","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Bohidar","Norman","Johnson&amp",NA
"679","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Zhao","Peng-Liang","Sanofi, Bridgewater, NJ",NA
"680","34191971","10.1080/19466315.2020.1779122","Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.","Abstract-The COVID-19 pandemic has had and continues to have major impacts on planned and ongoing clinical trials. Its effects on trial data create multiple potential statistical issues. The scale of impact is unprecedented, but when viewed individually, many of the issues are well defined and feasible to address. A number of strategies and recommendations are put forward to assess and address issues related to estimands, missing data, validity and modifications of statistical analysis","2021","07","02","Stat Biopharm Res","Statistics in biopharmaceutical research","COVID-19; Clinical trials; Estimands; Missing data; Pandemic; Statistical strategy; Supportive analyses","Hale","Michael","Takeda, Cambridge, MA",NA
"681","34191970","10.1080/19466315.2020.1828692","Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic.",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Hamasaki","Toshimitsu","The George Washington University Biostatistics Center, Rockville, MD",NA
"682","34191970","10.1080/19466315.2020.1828692","Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic.",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Bretz","Frank","Clinical Development &amp",NA
"683","34191970","10.1080/19466315.2020.1828692","Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic.",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Cooner","Freda","Statistical Innovation, Amgen, Thousand Oaks, CA",NA
"684","34191970","10.1080/19466315.2020.1828692","Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic.",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"LaVange","Lisa M","Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC",NA
"685","34191970","10.1080/19466315.2020.1828692","Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic.",NA,"2021","06","30","Stat Biopharm Res","Statistics in biopharmaceutical research",NA,"Posch","Martin","Section for Medical Statistics, Medical University of Vienna, Vienna, Austria",NA
"686","34191969","10.1097/JDN.0000000000000595","COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin.","Isotretinoin is a highly efficacious medication for the treatment of acne vulgaris; however, its prescription is subject to the strict requirements of the iPLEDGE restricted distribution program. These requirements have placed significant financial, time, and logistical burdens on patients taking the medication. The stay-at-home ordinances enacted by many states during the 2019 novel coronavirus (COVID-19) global pandemic have accelerated previous trends toward utilization of telehealth and decr","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association","Acne; COVID-19 Pandemic; Isotretinoin; Stay-at-Home Ordinance; Telehealth","Kane","Sierra","Department of Dermatology, Stanford Health Care, Palo Alto, CA",NA
"687","34191969","10.1097/JDN.0000000000000595","COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin.","Isotretinoin is a highly efficacious medication for the treatment of acne vulgaris; however, its prescription is subject to the strict requirements of the iPLEDGE restricted distribution program. These requirements have placed significant financial, time, and logistical burdens on patients taking the medication. The stay-at-home ordinances enacted by many states during the 2019 novel coronavirus (COVID-19) global pandemic have accelerated previous trends toward utilization of telehealth and decr","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association","Acne; COVID-19 Pandemic; Isotretinoin; Stay-at-Home Ordinance; Telehealth","Admani","Shehla","Department of Dermatology, Stanford Health Care, Palo Alto, CA",NA
"688","34191968","10.1097/JDN.0000000000000586","Reflections of COVID-19 on Dermatology Practice.","When the COVID-19 pandemic struck the United States in early 2020, few healthcare workers were prepared for what lay ahead. Dermatology nurses, medical assistants, and nurse practitioners experienced rapid changes in the way they conducted their daily practice. This article discusses many of those changes and explores the challenges these healthcare workers faced and continue to face. Almost every aspect of how dermatologic care was delivered prepandemic was affected. Some dermatology nurses, me","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association",NA,"Richardson","Veronica L","Department of Dermatology, University of Pennsylvania, Philadelphia, PA",NA
"689","34191968","10.1097/JDN.0000000000000586","Reflections of COVID-19 on Dermatology Practice.","When the COVID-19 pandemic struck the United States in early 2020, few healthcare workers were prepared for what lay ahead. Dermatology nurses, medical assistants, and nurse practitioners experienced rapid changes in the way they conducted their daily practice. This article discusses many of those changes and explores the challenges these healthcare workers faced and continue to face. Almost every aspect of how dermatologic care was delivered prepandemic was affected. Some dermatology nurses, me","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association",NA,"Garcia-Albea","Victoria R","Department of Dermatology, University of Pennsylvania, Philadelphia, PA",NA
"690","34191968","10.1097/JDN.0000000000000586","Reflections of COVID-19 on Dermatology Practice.","When the COVID-19 pandemic struck the United States in early 2020, few healthcare workers were prepared for what lay ahead. Dermatology nurses, medical assistants, and nurse practitioners experienced rapid changes in the way they conducted their daily practice. This article discusses many of those changes and explores the challenges these healthcare workers faced and continue to face. Almost every aspect of how dermatologic care was delivered prepandemic was affected. Some dermatology nurses, me","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association",NA,"Bort","Nicole L","Department of Dermatology, University of Pennsylvania, Philadelphia, PA",NA
"691","34191968","10.1097/JDN.0000000000000586","Reflections of COVID-19 on Dermatology Practice.","When the COVID-19 pandemic struck the United States in early 2020, few healthcare workers were prepared for what lay ahead. Dermatology nurses, medical assistants, and nurse practitioners experienced rapid changes in the way they conducted their daily practice. This article discusses many of those changes and explores the challenges these healthcare workers faced and continue to face. Almost every aspect of how dermatologic care was delivered prepandemic was affected. Some dermatology nurses, me","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association",NA,"Mayne","Susan L","Department of Dermatology, University of Pennsylvania, Philadelphia, PA",NA
"692","34191968","10.1097/JDN.0000000000000586","Reflections of COVID-19 on Dermatology Practice.","When the COVID-19 pandemic struck the United States in early 2020, few healthcare workers were prepared for what lay ahead. Dermatology nurses, medical assistants, and nurse practitioners experienced rapid changes in the way they conducted their daily practice. This article discusses many of those changes and explores the challenges these healthcare workers faced and continue to face. Almost every aspect of how dermatologic care was delivered prepandemic was affected. Some dermatology nurses, me","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association",NA,"Nolen","Mary E","Department of Dermatology, University of Pennsylvania, Philadelphia, PA",NA
"693","34191968","10.1097/JDN.0000000000000586","Reflections of COVID-19 on Dermatology Practice.","When the COVID-19 pandemic struck the United States in early 2020, few healthcare workers were prepared for what lay ahead. Dermatology nurses, medical assistants, and nurse practitioners experienced rapid changes in the way they conducted their daily practice. This article discusses many of those changes and explores the challenges these healthcare workers faced and continue to face. Almost every aspect of how dermatologic care was delivered prepandemic was affected. Some dermatology nurses, me","2021","07","02","J Dermatol Nurses Assoc","Journal of the Dermatology Nurses' Association",NA,"Bobonich","Margaret A","Department of Dermatology, University of Pennsylvania, Philadelphia, PA",NA
"694","34191966","10.1093/ahr/rhab010","Slow History.","All historians realize how much COVID-19 has interfered with our scholarship and teaching. Everything has slowed down, from preparing for classes, to doing research, to completing the simplest tasks of everyday life. Yet in the upheaval we are currently experiencing, and as we struggle to remain productive, perhaps we should also seize the opportunity to think more deeply about the ""doing"" of history and to isolate what really matters in research, writing, and instruction. Scholars in other disc","2021","06","30","Am Hist Rev","The American historical review","Historiography; scholarship; slow history; teaching","Lindemann","Mary",NA,NA
"695","34191965","10.1021/acs.chas.0c00091","Creating Effective eLearning to Help Drive Change.","Covid-19 has forced many institutions into rapid adoption of eLearning, but course designers who are used to live classrooms are often unsure how to design for virtual ones. The purpose of creating a course is to help drive change; if learners could already do what they needed to do, there would not be a need for the course. However, courses themselves are rarely sufficient to create change. Therefore, leaders in charge of driving a particular change should be thinking about evaluation and exist","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Mulcahy","Robert S","RSM US LLP, 801 Nicollet Mall, West Tower, Suite 1100, Minneapolis, Minnesota 55402, United States",NA
"696","34191964","10.1021/acs.chas.0c00089","COVID-19: The Use of 3D Printing to Address PPE Shortage during a Pandemic-A Safety Perspective.","The COVID-19 pandemic created a global health crisis that impacted the supply of personal protective equipment and created a shortage of much-needed face shields and masks for essential workers. During this time, a community of manufacturers, academic institutes, and hobbyists came together and tried to address the supply shortage by providing 3D-printed face shields and masks. Although the Secretary of U.S. Department of Human and Health Services and the Food and Drug Administration relaxed som","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Bharti","Neelam","University Libraries, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States",NA
"697","34191964","10.1021/acs.chas.0c00089","COVID-19: The Use of 3D Printing to Address PPE Shortage during a Pandemic-A Safety Perspective.","The COVID-19 pandemic created a global health crisis that impacted the supply of personal protective equipment and created a shortage of much-needed face shields and masks for essential workers. During this time, a community of manufacturers, academic institutes, and hobbyists came together and tried to address the supply shortage by providing 3D-printed face shields and masks. Although the Secretary of U.S. Department of Human and Health Services and the Food and Drug Administration relaxed som","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Singh","Shailendra","Environmental Health and Safety, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States",NA
"698","34191963","10.1021/acs.chas.0c00054","Collection Efficiency Comparison of N95 Respirators Saturated with Artificial Perspiration.","Due to the COVID-19 pandemic, current high demand for N95 filtering facepiece respirators has placed them in short supply. Filtering facepiece respirator wearers have traditionally been instructed to discard their respirator and don a new one should the respirator become saturated with perspiration or damp from exhaled breath. However, today's shortage may prohibit many N95 respirator wearers from replacing their filtering facepieces at this desired frequency. Previously unpublished research tha","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Larson","Diana L","Lawrence Livermore National Laboratory, ES&amp",NA
"699","34191962","10.1021/acs.chas.0c00065","Overcoming the Regulatory Hurdles for the Production of Hand Sanitizer for Public Health Protection: The UK and US Academic Perspective.","The COVID-19 pandemic has led to an acute shortage of hand sanitizer, which is crucial to keeping people safe and to preventing the spread of the SARS-CoV-2 virus. However, universities across the world have used their expertise to help to meet urgent demand from public bodies and the emergency services for supplies of safe and effective sanitizer. We explore here the experience of the University of Bristol, UK, in negotiating the regulatory demands and logistical challenges facing its own sanit","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Dicken","Rachel D","Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States",NA
"700","34191962","10.1021/acs.chas.0c00065","Overcoming the Regulatory Hurdles for the Production of Hand Sanitizer for Public Health Protection: The UK and US Academic Perspective.","The COVID-19 pandemic has led to an acute shortage of hand sanitizer, which is crucial to keeping people safe and to preventing the spread of the SARS-CoV-2 virus. However, universities across the world have used their expertise to help to meet urgent demand from public bodies and the emergency services for supplies of safe and effective sanitizer. We explore here the experience of the University of Bristol, UK, in negotiating the regulatory demands and logistical challenges facing its own sanit","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Gallagher","Timothy","School of Chemistry, University of Bristol, Bristol BS8 1TS, United Kingdom",NA
"701","34191962","10.1021/acs.chas.0c00065","Overcoming the Regulatory Hurdles for the Production of Hand Sanitizer for Public Health Protection: The UK and US Academic Perspective.","The COVID-19 pandemic has led to an acute shortage of hand sanitizer, which is crucial to keeping people safe and to preventing the spread of the SARS-CoV-2 virus. However, universities across the world have used their expertise to help to meet urgent demand from public bodies and the emergency services for supplies of safe and effective sanitizer. We explore here the experience of the University of Bristol, UK, in negotiating the regulatory demands and logistical challenges facing its own sanit","2021","07","02","J Chem Health Saf","Journal of chemical health &amp; safety",NA,"Perks","Simon","www.simonperks.com, 4 Goss Lane, Nailsea BS48 2BD, United Kingdom",NA
"702","34191960","10.1017/err.2020.119","The Elusive Legitimacy of EU Soft Law: An Analysis of Consultation and Participation in the Process of Adopting COVID-19 Soft Law in the EU.","This article takes issue with the legitimacy of EU soft law instruments issued to deal with the COVID-19 crisis. Up to August 2020, we identified a total of 197 such instruments, and analysed the procedures for their adoption. We found little evidence of parliamentary involvement or stakeholder consultation, with COVID-19 soft law replicating decision-making patterns which have been constantly criticised in the literature as illegitimate and opaque. Giving due consideration to the exceptional na","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Eliantonio","Mariolina","University of Maastricht, The Netherlands","m.eliantonio@maastrichtuniversity.nl"
"703","34191960","10.1017/err.2020.119","The Elusive Legitimacy of EU Soft Law: An Analysis of Consultation and Participation in the Process of Adopting COVID-19 Soft Law in the EU.","This article takes issue with the legitimacy of EU soft law instruments issued to deal with the COVID-19 crisis. Up to August 2020, we identified a total of 197 such instruments, and analysed the procedures for their adoption. We found little evidence of parliamentary involvement or stakeholder consultation, with COVID-19 soft law replicating decision-making patterns which have been constantly criticised in the literature as illegitimate and opaque. Giving due consideration to the exceptional na","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Stefan","Oana","King's College London, UK",NA
"704","34191959","10.1017/err.2020.118","""This Is Not A Rule"": COVID-19 in England &amp; Wales and Criminal Justice Governance via Guidance.","While soft law is an integral part of the efficient and effective functioning of public administration in England &amp; Wales, the extent to which it was deployed in response to COVID-19 is striking, with over 400 pieces of ""guidance and regulations"" created. In this article, we consider the general place of soft law in administrative law in England &amp; Wales and the broad regulatory framework, including soft law, that governs the COVID-19 pandemic. This allows us to take a deep dive into COVI","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Sorabji","John","University College London, UK",NA
"705","34191959","10.1017/err.2020.118","""This Is Not A Rule"": COVID-19 in England &amp; Wales and Criminal Justice Governance via Guidance.","While soft law is an integral part of the efficient and effective functioning of public administration in England &amp; Wales, the extent to which it was deployed in response to COVID-19 is striking, with over 400 pieces of ""guidance and regulations"" created. In this article, we consider the general place of soft law in administrative law in England &amp; Wales and the broad regulatory framework, including soft law, that governs the COVID-19 pandemic. This allows us to take a deep dive into COVI","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Vaughan","Steven","University College London, UK","steven.vaughan@ucl.ac.uk"
"706","34191958","10.1017/err.2021.2","Sweden: Non-binding Rules against the Pandemic - Formalism, Pragmatism and Some Legal Realism.","Swedish measures to fight the spread of COVID-19 differ from the strategies used in other comparable countries. In contrast to the lockdown approach that has been applied in many European countries, the Swedish strategy has been based to a substantial extent on individuals taking responsibility under non-binding recommendations. This contribution explores the Swedish strategy from a constitutional and administrative law perspective, highlighting the tension between the formalist system for deleg","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Wenander","Henrik","Lund University, Sweden","Henrik.Wenander@jur.lu.se"
"707","34191957","10.1017/err.2020.117","Soft Law Governance in Times of Coronavirus in Spain.","Early in the COVID-19 pandemic, between March and July 2020, Spanish national and regional authorities made extensive use of soft law mechanisms to fight the spread of the virus and to tackle the consequences of the crisis. Soft law was used either as an instrument in and of itself, or as a justification for hard law instruments, with more than 200 non-binding measures being enacted by the state and by the Autonomous Communities. Spanish courts also used soft law as a tool to interpret existing ","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Utrilla Fernández-Bermejo","Dolores","Universidad de Castilla - La Mancha, Spain","MDolores.Utrilla@uclm.es"
"708","34191956","10.1017/err.2020.116","The Role of COVID-19 Soft Law Measures in Italy: Much Ado about Nothing?","This article considers the role of non-binding legal instruments adopted in Italy against the SARS-CoV-2 virus in the early months of 2020. To verify whether the use of such instruments restricted fundamental and human rights beyond constitutional and legal limits, the article first gives an overview of hard law measures adopted in Italy against the coronavirus. It then focuses on soft law measures, the use of which became significant only in Phase II of Italy's response to COVID-19 and argues t","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Aperio Bella","Flaminia","Assistant Professor in Administrative Law, Roma Tre University, Italy","flaminia.aperio.bella@gmail.com"
"709","34191956","10.1017/err.2020.116","The Role of COVID-19 Soft Law Measures in Italy: Much Ado about Nothing?","This article considers the role of non-binding legal instruments adopted in Italy against the SARS-CoV-2 virus in the early months of 2020. To verify whether the use of such instruments restricted fundamental and human rights beyond constitutional and legal limits, the article first gives an overview of hard law measures adopted in Italy against the coronavirus. It then focuses on soft law measures, the use of which became significant only in Phase II of Italy's response to COVID-19 and argues t","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Lauri","Cristiana","Lecturer in Administrative Law, University of Macerata, Italy",NA
"710","34191956","10.1017/err.2020.116","The Role of COVID-19 Soft Law Measures in Italy: Much Ado about Nothing?","This article considers the role of non-binding legal instruments adopted in Italy against the SARS-CoV-2 virus in the early months of 2020. To verify whether the use of such instruments restricted fundamental and human rights beyond constitutional and legal limits, the article first gives an overview of hard law measures adopted in Italy against the coronavirus. It then focuses on soft law measures, the use of which became significant only in Phase II of Italy's response to COVID-19 and argues t","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Capra","Giorgio","PhD candidate, Roma Tre University, Italy",NA
"711","34191955","10.1017/err.2020.115","Domestic Soft Law Regulation during the COVID-19 Lockdown in Hungary: A Novel Regulatory Approach to a Unique Global Challenge.","On 13 March 2020 the Hungarian Government announced the immediate closure of all schools throughout the country to prevent the spread of COVID-19 forcing several hundred thousand children to learn from home, and teachers to ensure their education. The Hungarian Educational Authority hurried to issue recommendations on the use of digital education tools. During the COVID-19 pandemic and the special legal order consequently introduced by the Hungarian Government, Hungary has seen the emergence of ","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Láncos","Petra Lea","Associate Professor, Péter Pázmány Catholic University","lancos.petra.lea@jak.ppke.hu"
"712","34191955","10.1017/err.2020.115","Domestic Soft Law Regulation during the COVID-19 Lockdown in Hungary: A Novel Regulatory Approach to a Unique Global Challenge.","On 13 March 2020 the Hungarian Government announced the immediate closure of all schools throughout the country to prevent the spread of COVID-19 forcing several hundred thousand children to learn from home, and teachers to ensure their education. The Hungarian Educational Authority hurried to issue recommendations on the use of digital education tools. During the COVID-19 pandemic and the special legal order consequently introduced by the Hungarian Government, Hungary has seen the emergence of ","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Christián","László","Associate Professor, Vice Rector for Education, University of Public Service, Budapest, Hungary",NA
"713","34191954","10.1017/err.2020.114","Killing me Softly? Scrutinising the Role of Soft Law in Greece's Response to COVID-19.","Greece emerged as the EU's poster child in the fight against COVID-19 during the first few months of the pandemic. In this contribution, we assess Greece's use of soft regulation in its regulatory response to COVID-19. Using ""acts of legislative content"", which can be broadly conceptualised as softly adopted hard law, the Greek government largely achieved flexibility and simplified adoption procedures without having to resort to soft law per se. The role of soft law was limited - it complemented","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Tsourdi","Evangelia Lilian","Assistant Professor and Dutch Research Council (NWO) grantee, University of Maastricht, Faculty of Law and Maastricht Centre for European Law, Maastricht, The Netherlands","e.tsourdi@maastrichtuniversity.nl"
"714","34191954","10.1017/err.2020.114","Killing me Softly? Scrutinising the Role of Soft Law in Greece's Response to COVID-19.","Greece emerged as the EU's poster child in the fight against COVID-19 during the first few months of the pandemic. In this contribution, we assess Greece's use of soft regulation in its regulatory response to COVID-19. Using ""acts of legislative content"", which can be broadly conceptualised as softly adopted hard law, the Greek government largely achieved flexibility and simplified adoption procedures without having to resort to soft law per se. The role of soft law was limited - it complemented","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Vavoula","Niovi","Lecturer in Migration and Security, Queen Mary University of London, School of Law, London, UK",NA
"715","34191953","10.1017/err.2020.113","Coronavirus and Soft Law in Germany: Business as Usual?","In combating the coronavirus pandemic in Germany, soft law has played an important, albeit not a central, role. Its use basically corresponds with that of ""normal circumstances"". In accordance with the German constitutional order, almost all substantial decisions are made in a legally binding form. However, these are often prepared through or supplemented by soft law. This article shows that soft law has played an important role in fighting the pandemic and its effects in Germany, although there","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Knauff","Matthias","Friedrich Schiller University Jena, Thuringia, Germany",NA
"716","34191952","10.1017/err.2020.112","""Could You, Would You, Should You?"" Regulating Cross-Border Travel Through COVID-19 Soft Law in Finland.","In the coronavirus pandemic that has swept the world, the Finnish Government, like many of its peers, has issued policy measures to combat the virus. Many of these measures have been implemented in law, including measures taken under the Emergency Powers Act, or by ministries and regional and local authorities exercising their legal powers. However, some governmental policy measures have been implemented using non-binding guidelines and recommendations. Using border travel recommendations as a c","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Korkea-Aho","Emilia","University of Eastern Finland","aho@uef.fi"
"717","34191952","10.1017/err.2020.112","""Could You, Would You, Should You?"" Regulating Cross-Border Travel Through COVID-19 Soft Law in Finland.","In the coronavirus pandemic that has swept the world, the Finnish Government, like many of its peers, has issued policy measures to combat the virus. Many of these measures have been implemented in law, including measures taken under the Emergency Powers Act, or by ministries and regional and local authorities exercising their legal powers. However, some governmental policy measures have been implemented using non-binding guidelines and recommendations. Using border travel recommendations as a c","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Scheinin","Martin","European University Institute, Florence, Italy and Bonavero Institute, University of Oxford, UK",NA
"718","34191951","10.1017/err.2020.111","Soft Law in the Prevention and Control of the COVID-19 Pandemic in China: Between Legality Concerns and Limited Participatory Possibilities.","As a previously unknown virus, the spread of the coronavirus challenged not only medical science and public health systems, but also public governance in all countries. In order to tackle the COVID-19 crisis in China, public authorities at various levels have issued a large number of measures that have no legally binding force, but produce practical effects. A closer look at selected COVID-19 measures in China shows that both the advantages and drawbacks of soft law are brought to the fore by th","2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Cheng","Xiezhong","Professor, School of Law, China University of Political Science and Law","chengxiezhong@vip.163.com"
"719","34191950","10.1017/err.2021.1","EJRR Special Issue Editorial: COVID-19 and Soft Law: Is Soft Law Pandemic-Proof?",NA,"2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Eliantonio","Mariolina","University of Maastricht, The Netherlands","m.eliantonio@maastrichtuniversity.nl"
"720","34191950","10.1017/err.2021.1","EJRR Special Issue Editorial: COVID-19 and Soft Law: Is Soft Law Pandemic-Proof?",NA,"2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Korkea-Aho","Emilia","University of Eastern Finland, Finland","aho@uef.fi"
"721","34191950","10.1017/err.2021.1","EJRR Special Issue Editorial: COVID-19 and Soft Law: Is Soft Law Pandemic-Proof?",NA,"2021","06","30","Eur J Risk Regul","European journal of risk regulation : EJRR",NA,"Vaughan","Steven","University College London, UK","steven.vaughan@ucl.ac.uk"
"722","34191949","10.1111/jphs.12385","Healthcare professionals' knowledge, perception and practice towards COVID-19: A cross-sectional web-survey.","COVID-19 is a highly contagious disease. Healthcare professionals (HCPs) are increasingly facing suspected and confirmed cases of COVID-19. To evaluate Iraqi HCPs (physicians, dentists and pharmacists) knowledge, perception and practice towards COVID-19. This was a cross-sectional, anonymised web-survey, using an electronic application (Surveyheart®). The web-survey link was posted via the closed groups of physicians, dentists and pharmacists in Iraq on Facebook and Twitter. The questionnaire wa","2021","07","02","J Pharm Health Serv Res","Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain","COVID-19; corona virus; healthcare professionals; knowledge; perception","Aladul","Mohammed I","College of Pharmacy, University of Mosul, Nineveh, Iraq",NA
"723","34191949","10.1111/jphs.12385","Healthcare professionals' knowledge, perception and practice towards COVID-19: A cross-sectional web-survey.","COVID-19 is a highly contagious disease. Healthcare professionals (HCPs) are increasingly facing suspected and confirmed cases of COVID-19. To evaluate Iraqi HCPs (physicians, dentists and pharmacists) knowledge, perception and practice towards COVID-19. This was a cross-sectional, anonymised web-survey, using an electronic application (Surveyheart®). The web-survey link was posted via the closed groups of physicians, dentists and pharmacists in Iraq on Facebook and Twitter. The questionnaire wa","2021","07","02","J Pharm Health Serv Res","Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain","COVID-19; corona virus; healthcare professionals; knowledge; perception","Kh Al-Qazaz","Harith","College of Pharmacy, University of Mosul, Nineveh, Iraq",NA
"724","34191949","10.1111/jphs.12385","Healthcare professionals' knowledge, perception and practice towards COVID-19: A cross-sectional web-survey.","COVID-19 is a highly contagious disease. Healthcare professionals (HCPs) are increasingly facing suspected and confirmed cases of COVID-19. To evaluate Iraqi HCPs (physicians, dentists and pharmacists) knowledge, perception and practice towards COVID-19. This was a cross-sectional, anonymised web-survey, using an electronic application (Surveyheart®). The web-survey link was posted via the closed groups of physicians, dentists and pharmacists in Iraq on Facebook and Twitter. The questionnaire wa","2021","07","02","J Pharm Health Serv Res","Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain","COVID-19; corona virus; healthcare professionals; knowledge; perception","Allela","Omer Q B","Pharmacy Department, Al-Noor College University, Nineveh, Iraq",NA
"725","34191948","10.1093/jhuman/huaa036","The Implications of and Responses to COVID-19: Localizing Human Rights in the City of York (UK).","This essay attempts to capture the human rights implications of COVID-19, and responses to it, in the city of York (UK). Three human rights contributions are identified: ensuring that responses enhance dignity, the right to life, non-discrimination, and protect the most vulnerable; using human rights when balancing priorities and making difficult decisions; and optimizing the link between disease and democracy. The overarching aim is to localize and contextualize human rights in a meaningful way","2021","06","30","J Hum Rights Pract","Journal of human rights practice","COVID-19; balancing rights; human rights city; localism; non-discrimination; rights and democracy","Gready","Paul",NA,NA
"726","34191944","10.1017/S1754470X21000040","Cognitive therapy for moral injury in post-traumatic stress disorder.","Moral injury is the profound psychological distress that can arise following participating in, or witnessing, events that transgress an individual's morals and include harming, betraying, or failure to help others, or being subjected to such events, e.g. being betrayed by leaders. It has been primarily researched in the military, but it also found in other professionals such as healthcare workers coping with the COVID-19 pandemic and civilians following a wide range of traumas. In this article, ","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","PTSD; betrayal; cognitive therapy; moral injury; trauma","Murray","Hannah","Department of Experimental Psychology, University of Oxford, Oxford, UK and Oxford Health NHS Foundation Trust, Oxford, UK",NA
"727","34191944","10.1017/S1754470X21000040","Cognitive therapy for moral injury in post-traumatic stress disorder.","Moral injury is the profound psychological distress that can arise following participating in, or witnessing, events that transgress an individual's morals and include harming, betraying, or failure to help others, or being subjected to such events, e.g. being betrayed by leaders. It has been primarily researched in the military, but it also found in other professionals such as healthcare workers coping with the COVID-19 pandemic and civilians following a wide range of traumas. In this article, ","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","PTSD; betrayal; cognitive therapy; moral injury; trauma","Ehlers","Anke","Department of Experimental Psychology, University of Oxford, Oxford, UK and Oxford Health NHS Foundation Trust, Oxford, UK",NA
"728","34191943","10.1017/S1754470X20000379","Beyond the COVID-19 pandemic: 'Learning the hard way' - adapting long-term IAPT service provision using lessons from past outbreaks.","Infectious disease outbreaks have occurred sporadically over the centuries. The most significant ones of this century, as reported by the World Health Organization, include the EVD epidemic, SARS pandemic, Swine Flu pandemic and MERS pandemic. The long-term mental health consequences of outbreaks are as profound as physical ones and can last for years post-outbreak. This highlights the need for enhancing the preparedness of pragmatic mental health service provision. Due to its magnitude, the nov","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","IAPT; outbreak; pandemic; responsiveness","Skilbeck","Lilian","East London NHS Foundation Trust, Newham Talking Therapies, Vicarage Lane Health Centre, 10 Vicarage Lane, Stratford, London E15 4ES, UK",NA
"729","34191943","10.1017/S1754470X20000379","Beyond the COVID-19 pandemic: 'Learning the hard way' - adapting long-term IAPT service provision using lessons from past outbreaks.","Infectious disease outbreaks have occurred sporadically over the centuries. The most significant ones of this century, as reported by the World Health Organization, include the EVD epidemic, SARS pandemic, Swine Flu pandemic and MERS pandemic. The long-term mental health consequences of outbreaks are as profound as physical ones and can last for years post-outbreak. This highlights the need for enhancing the preparedness of pragmatic mental health service provision. Due to its magnitude, the nov","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","IAPT; outbreak; pandemic; responsiveness","Spanton","Christopher","East London NHS Foundation Trust, Newham Talking Therapies, Vicarage Lane Health Centre, 10 Vicarage Lane, Stratford, London E15 4ES, UK",NA
"730","34191943","10.1017/S1754470X20000379","Beyond the COVID-19 pandemic: 'Learning the hard way' - adapting long-term IAPT service provision using lessons from past outbreaks.","Infectious disease outbreaks have occurred sporadically over the centuries. The most significant ones of this century, as reported by the World Health Organization, include the EVD epidemic, SARS pandemic, Swine Flu pandemic and MERS pandemic. The long-term mental health consequences of outbreaks are as profound as physical ones and can last for years post-outbreak. This highlights the need for enhancing the preparedness of pragmatic mental health service provision. Due to its magnitude, the nov","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","IAPT; outbreak; pandemic; responsiveness","Roylance","Ian","East London NHS Foundation Trust, Newham Talking Therapies, Vicarage Lane Health Centre, 10 Vicarage Lane, Stratford, London E15 4ES, UK",NA
"731","34191942","10.1017/S1754470X20000343","Remote delivery of CBT training, clinical supervision and services: in times of crisis or business as usual.","The worldwide coronavirus pandemic has forced health services to adapt their delivery to protect the health of all concerned, and avoid service users facing severe disruption. Improving Access to Psychological Therapies (IAPT) services in particular are having to explore remote working methods to continue functioning. Australian IAPT services have utilised remote delivery methods and disruptive technologies at their core from inception. This was to maintain fidelity and clinical governance acros","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Improving Access to Psychological Therapies (IAPT); clinical supervision; cognitive behaviour therapy (CBT); remote delivery; training","Cromarty","Paul","CBT Institute, Adelaide, Australia",NA
"732","34191942","10.1017/S1754470X20000343","Remote delivery of CBT training, clinical supervision and services: in times of crisis or business as usual.","The worldwide coronavirus pandemic has forced health services to adapt their delivery to protect the health of all concerned, and avoid service users facing severe disruption. Improving Access to Psychological Therapies (IAPT) services in particular are having to explore remote working methods to continue functioning. Australian IAPT services have utilised remote delivery methods and disruptive technologies at their core from inception. This was to maintain fidelity and clinical governance acros","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Improving Access to Psychological Therapies (IAPT); clinical supervision; cognitive behaviour therapy (CBT); remote delivery; training","Gallagher","Dominic","CBT Institute, Adelaide, Australia",NA
"733","34191942","10.1017/S1754470X20000343","Remote delivery of CBT training, clinical supervision and services: in times of crisis or business as usual.","The worldwide coronavirus pandemic has forced health services to adapt their delivery to protect the health of all concerned, and avoid service users facing severe disruption. Improving Access to Psychological Therapies (IAPT) services in particular are having to explore remote working methods to continue functioning. Australian IAPT services have utilised remote delivery methods and disruptive technologies at their core from inception. This was to maintain fidelity and clinical governance acros","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Improving Access to Psychological Therapies (IAPT); clinical supervision; cognitive behaviour therapy (CBT); remote delivery; training","Watson","Julianne","CBT Institute, Adelaide, Australia",NA
"734","34191941","10.1017/S1754470X2000029X","Towards a model of uncertainty distress in the context of Coronavirus (COVID-19).","The paper forms part of a series of papers outlining the theoretical framework for a new model of uncertainty distress (this paper), treatment implications arising from the model, and empirical tests of the model. We define uncertainty distress as the subjective negative emotions experienced in response to the as yet unknown aspects of a given situation. In the first paper we draw on a robust body of research on distinct areas including: threat models of anxiety, perceived illness uncertainty an","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Coronavirus; distress; uncertainty","Freeston","Mark","School of Psychology, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK",NA
"735","34191941","10.1017/S1754470X2000029X","Towards a model of uncertainty distress in the context of Coronavirus (COVID-19).","The paper forms part of a series of papers outlining the theoretical framework for a new model of uncertainty distress (this paper), treatment implications arising from the model, and empirical tests of the model. We define uncertainty distress as the subjective negative emotions experienced in response to the as yet unknown aspects of a given situation. In the first paper we draw on a robust body of research on distinct areas including: threat models of anxiety, perceived illness uncertainty an","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Coronavirus; distress; uncertainty","Tiplady","Ashley","Newcastle Hospitals Occupational Health Service, Regent Point, Regent Farm Road, Gosforth NE3 3HD, UK",NA
"736","34191941","10.1017/S1754470X2000029X","Towards a model of uncertainty distress in the context of Coronavirus (COVID-19).","The paper forms part of a series of papers outlining the theoretical framework for a new model of uncertainty distress (this paper), treatment implications arising from the model, and empirical tests of the model. We define uncertainty distress as the subjective negative emotions experienced in response to the as yet unknown aspects of a given situation. In the first paper we draw on a robust body of research on distinct areas including: threat models of anxiety, perceived illness uncertainty an","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Coronavirus; distress; uncertainty","Mawn","Lauren","School of Psychology, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK",NA
"737","34191941","10.1017/S1754470X2000029X","Towards a model of uncertainty distress in the context of Coronavirus (COVID-19).","The paper forms part of a series of papers outlining the theoretical framework for a new model of uncertainty distress (this paper), treatment implications arising from the model, and empirical tests of the model. We define uncertainty distress as the subjective negative emotions experienced in response to the as yet unknown aspects of a given situation. In the first paper we draw on a robust body of research on distinct areas including: threat models of anxiety, perceived illness uncertainty an","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Coronavirus; distress; uncertainty","Bottesi","Gioia","Department of General Psychology, University of Padova, via Venezia 8, 35131 Padova, Italy",NA
"738","34191941","10.1017/S1754470X2000029X","Towards a model of uncertainty distress in the context of Coronavirus (COVID-19).","The paper forms part of a series of papers outlining the theoretical framework for a new model of uncertainty distress (this paper), treatment implications arising from the model, and empirical tests of the model. We define uncertainty distress as the subjective negative emotions experienced in response to the as yet unknown aspects of a given situation. In the first paper we draw on a robust body of research on distinct areas including: threat models of anxiety, perceived illness uncertainty an","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; Coronavirus; distress; uncertainty","Thwaites","Sarah","School of Psychology, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK",NA
"739","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Warnock-Parkes","Emma","Department of Experimental Psychology, University of Oxford, Oxford, UK",NA
"740","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Wild","Jennifer","Department of Experimental Psychology, University of Oxford, Oxford, UK",NA
"741","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Thew","Graham R","Department of Experimental Psychology, University of Oxford, Oxford, UK",NA
"742","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Kerr","Alice","King's College London, London, UK",NA
"743","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Grey","Nick","Sussex Partnership NHS Foundation Trust, UK",NA
"744","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Stott","Richard","King's College London, London, UK",NA
"745","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Ehlers","Anke","Department of Experimental Psychology, University of Oxford, Oxford, UK",NA
"746","34191940","10.1017/S1754470X2000032X","Treating social anxiety disorder remotely with cognitive therapy.","Remote delivery of evidence-based psychological therapies via video conference has become particularly relevant following the COVID-19 pandemic, and is likely to be an on-going method of treatment delivery post-COVID. Remotely delivered therapy could be of particular benefit for people with social anxiety disorder (SAD), who tend to avoid or delay seeking face-to-face therapy, often due to anxiety about travelling to appointments and meeting mental health professionals in person. Individual cogn","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","CBT; COVID-19; cognitive therapy; distance therapy; remote therapy; social anxiety disorder; social phobia","Clark","David M","Department of Experimental Psychology, University of Oxford, Oxford, UK",NA
"747","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Jassi","Amita","National Specialist Clinic for Young People with OCD, BDD and Related Disorders, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"748","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Shahriyarmolki","Khodayar","Centre for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"749","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Taylor","Tracey","Centre for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"750","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Peile","Lauren","National Specialist Clinic for Young People with OCD, BDD and Related Disorders, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"751","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Challacombe","Fiona","Centre for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"752","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Clark","Bruce","National Specialist Clinic for Young People with OCD, BDD and Related Disorders, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"753","34191939","10.1017/S1754470X20000318","OCD and COVID-19: a new frontier.","People with obsessive compulsive disorder (OCD) are likely to be more susceptible to the mental health impact of COVID-19. This paper shares the perspectives of expert clinicians working with OCD considering how to identify OCD in the context of COVID-19, changes in the presentation, and importantly what to consider when undertaking cognitive behaviour therapy (CBT) for OCD in the current climate. The expert consensus is that although the presentation of OCD and treatment may have become more di","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","cognitive appraisals; cognitive behaviour therapy; obsessive compulsive disorder","Veale","David","Centre for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK",NA
"754","34191938","10.1017/S1754470X20000215","Death anxiety in the time of COVID-19: theoretical explanations and clinical implications.","The recent COVID-19 pandemic has triggered a surge in anxiety across the globe. Much of the public's behavioural and emotional response to the virus can be understood through the framework of terror management theory, which proposes that fear of death drives much of human behaviour. In the context of the current pandemic, death anxiety, a recently proposed transdiagnostic construct, appears especially relevant. Fear of death has recently been shown to predict not only anxiety related to COVID-19","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; death anxiety; existential; transdiagnostic","Menzies","Rachel E","School of Psychology, University of Sydney, Sydney, Australia",NA
"755","34191938","10.1017/S1754470X20000215","Death anxiety in the time of COVID-19: theoretical explanations and clinical implications.","The recent COVID-19 pandemic has triggered a surge in anxiety across the globe. Much of the public's behavioural and emotional response to the virus can be understood through the framework of terror management theory, which proposes that fear of death drives much of human behaviour. In the context of the current pandemic, death anxiety, a recently proposed transdiagnostic construct, appears especially relevant. Fear of death has recently been shown to predict not only anxiety related to COVID-19","2021","07","02","Cogn Behav Therap","Cognitive behaviour therapist","COVID-19; death anxiety; existential; transdiagnostic","Menzies","Ross G","Graduate School of Health, University of Technology Sydney, Sydney, Australia",NA
"756","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Boutoleau-Bretonnière","Claire","CHU Nantes, Inserm CIC04, Nantes, France",NA
"757","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Pouclet-Courtemanche","Hélène","CHU Nantes, Inserm CIC04, Nantes, France",NA
"758","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Gillet","Aurélie","CHU Nantes, Inserm CIC04, Nantes, France",NA
"759","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Bernard","Amélie","CHU Nantes, Inserm CIC04, Nantes, France",NA
"760","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Deruet","Anne-Laure","CHU Nantes, Inserm CIC04, Nantes, France",NA
"761","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Gouraud","Inès","CHU Nantes, Inserm CIC04, Nantes, France",NA
"762","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Lamy","Estelle","CHU Nantes, Inserm CIC04, Nantes, France",NA
"763","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Mazoué","Aurélien","Service de Neurologie, Centre Mémoire de Ressources et Recherche, CHU Nantes, Nantes, France",NA
"764","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Rocher","Laëtitia","CHU Nantes, Inserm CIC04, Nantes, France",NA
"765","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","Bretonnière","Cédric","CHU Nantes, Inserm CIC04, Nantes, France",NA
"766","34191932","10.1159/000511416","Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.","The clinical presentation of the behavioral variant of frontotemporal dementia (bvFTD) differs from that of Alzheimer disease (AD), with major impairments in behavioral functions in bvFTD and cognitive impairment in AD. Both behavioral disturbances in bvFTD and cognitive impairment in AD contribute to caregiver burden. To investigate the impact of home confinement during the COVID-19 crisis on the burden of caregivers of bvFTD or AD patients. During the COVID-19 lockdown in France, neurologists ","2021","07","02","Dement Geriatr Cogn Dis Extra","Dementia and geriatric cognitive disorders extra","Alzheimer disease; Behavioral disorders; Behavioral variant of frontotemporal dementia; COVID-19; Confinement","El Haj","Mohamad","Laboratoire de Psychologie des Pays de la Loire (LPPL - EA 4638), Universités d'Angers et Nantes, Nantes, France",NA
"767","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Leonardi","Maria Cristina","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"768","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Montagna","Emilia","Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"769","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Galimberti","Viviana Enrica","Division of Breast Surgery, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"770","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Zaffaroni","Mattia","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"771","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Rojas","Damaris Patricia","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"772","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Dicuonzo","Samantha","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"773","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Zerella","Maria Alessia","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"774","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Morra","Anna","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"775","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Sangalli","Claudia","Division of Data Management, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"776","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Gandini","Sara","Department of Experimental Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"777","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Colleoni","Marco","Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"778","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Veronesi","Paolo","Division of Breast Surgery, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"779","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Gerardi","Marianna Alessandra","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"780","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Alterio","Daniela","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"781","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Lazzari","Roberta","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"782","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Sarra Fiore","Massimo","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"783","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Bufi","Giammaria","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"784","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Cattani","Federica","Unit of Medical Physics, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"785","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Mastrilli","Fabrizio","Medical Administration, CMO, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"786","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Orecchia","Roberto","Scientific Direction, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"787","34191930","10.1159/000513227","Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy.","During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with <U+03C7><sup>2</sup> ","2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)","Breast cancer; COVID-19; Hub; Oncologic care; Pandemic","Jereczek-Fossa","Barbara Alicja","Division of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milan, Italy",NA
"788","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Ferro","Antonella","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"789","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Cristofolini","Paolo","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"790","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Garcia-Etienne","Carlos A","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"791","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Caffo","Orazio","Medical Oncology Department, Ospedale Santa Chiara, Trento, Italy",NA
"792","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Pellegrini","Marco","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"793","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Fantò","Carmine","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"794","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Mussari","Salvatore","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"795","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Campregher","Monica","Breast Center, Ospedale Santa Chiara, Trento, Italy",NA
"796","34191929","10.1159/000511943","Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy.",NA,"2021","07","02","Breast Care (Basel)","Breast care (Basel, Switzerland)",NA,"Guarrera","Giovanni Maria","Hospital Care Department, Ospedale Santa Chiara, Trento, Italy",NA
"797","34191928","10.1093/cesifo/ifaa018","Gender Equality and Public Policy during COVID-19.","The outbreak of COVID-19 has affected men and women worldwide. The gender dimension of COVID-19 has attracted the attention of researchers and policymakers: while women seem to be less severely hit by the virus and are more compliant with the restricting rules imposed to reduce the spread of the contagion, they risk to suffer more the economic consequences of the pandemic, because they are more vulnerable on the labor market and because they are carrying on most of the burden of housework and ch","2021","07","02","CESifo Econ Stud","CESifo economic studies","childcare; female employment; female leadership; housework","Profeta","Paola","Department of Social and Political Sciences, Bocconi University and Dondena",NA
"798","34191927","10.1093/cesifo/ifaa014","COVID-19: guaranteed Loans and Zombie Firms.","Based on a survey (7-13 April 2020) we evaluate the reaction of Swiss firms towards the COVID-19 crisis. Firms show little pro-active reactions towards the crisis, but decrease their business activities. The firms in the survey report that the decline in foreign demand is the single most important reason for their deteriorating business situation. Firms that faced a more difficult business situation before the crisis are affected more severely during the crisis. Moreover, we investigate the impa","2021","07","02","CESifo Econ Stud","CESifo economic studies","COVID-19; expectations; financial constraints; firm behavior; zombie firms","Zoller-Rydzek","Benedikt","ZHAW School of Management and Law, Theaterstrasse 17, 8400 Winterthur, Switzerland",NA
"799","34191927","10.1093/cesifo/ifaa014","COVID-19: guaranteed Loans and Zombie Firms.","Based on a survey (7-13 April 2020) we evaluate the reaction of Swiss firms towards the COVID-19 crisis. Firms show little pro-active reactions towards the crisis, but decrease their business activities. The firms in the survey report that the decline in foreign demand is the single most important reason for their deteriorating business situation. Firms that faced a more difficult business situation before the crisis are affected more severely during the crisis. Moreover, we investigate the impa","2021","07","02","CESifo Econ Stud","CESifo economic studies","COVID-19; expectations; financial constraints; firm behavior; zombie firms","Keller","Florian","ZHAW School of Management and Law, Theaterstrasse 17, 8400 Winterthur, Switzerland",NA
"800","34191926","10.1093/cesifo/ifaa004","Should Contact Bans Have Been Lifted More in Germany?: A Quantitative Prediction of Its Effects.","Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of Covid-19 if RSC had been upheld after 20 April. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would have been reached already end of April. The number of sick individuals would have fallen below 1000 at the beginning of Jul","2021","07","02","CESifo Econ Stud","CESifo economic studies","C63; Covid-19; E17; I18; SARS-CoV-2; epidemic; forecast Germany; pandemic","Donsimoni","Jean Roch","Gutenberg School of Management and Economics, Johannes Gutenberg University Mainz, Jakob-Welder-Weg 4, D-55128 Mainz, Germany",NA
"801","34191926","10.1093/cesifo/ifaa004","Should Contact Bans Have Been Lifted More in Germany?: A Quantitative Prediction of Its Effects.","Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of Covid-19 if RSC had been upheld after 20 April. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would have been reached already end of April. The number of sick individuals would have fallen below 1000 at the beginning of Jul","2021","07","02","CESifo Econ Stud","CESifo economic studies","C63; Covid-19; E17; I18; SARS-CoV-2; epidemic; forecast Germany; pandemic","Glawion","René","Department of Economics, Hamburg University",NA
"802","34191926","10.1093/cesifo/ifaa004","Should Contact Bans Have Been Lifted More in Germany?: A Quantitative Prediction of Its Effects.","Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of Covid-19 if RSC had been upheld after 20 April. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would have been reached already end of April. The number of sick individuals would have fallen below 1000 at the beginning of Jul","2021","07","02","CESifo Econ Stud","CESifo economic studies","C63; Covid-19; E17; I18; SARS-CoV-2; epidemic; forecast Germany; pandemic","Plachter","Bodo","Institute for Virology of the University Medical Center Mainz, Mainz, Germany",NA
"803","34191926","10.1093/cesifo/ifaa004","Should Contact Bans Have Been Lifted More in Germany?: A Quantitative Prediction of Its Effects.","Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of Covid-19 if RSC had been upheld after 20 April. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would have been reached already end of April. The number of sick individuals would have fallen below 1000 at the beginning of Jul","2021","07","02","CESifo Econ Stud","CESifo economic studies","C63; Covid-19; E17; I18; SARS-CoV-2; epidemic; forecast Germany; pandemic","Wälde","Klaus","Gutenberg School of Management and Economics, Johannes Gutenberg University Mainz, Jakob-Welder-Weg 4, D-55128 Mainz, Germany",NA
"804","34191926","10.1093/cesifo/ifaa004","Should Contact Bans Have Been Lifted More in Germany?: A Quantitative Prediction of Its Effects.","Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of Covid-19 if RSC had been upheld after 20 April. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would have been reached already end of April. The number of sick individuals would have fallen below 1000 at the beginning of Jul","2021","07","02","CESifo Econ Stud","CESifo economic studies","C63; Covid-19; E17; I18; SARS-CoV-2; epidemic; forecast Germany; pandemic","Weiser","Constantin","Gutenberg School of Management and Economics, Johannes Gutenberg University Mainz, Jakob-Welder-Weg 4, D-55128 Mainz, Germany",NA
"805","34191925","10.1016/j.asoc.2021.107645","Coronavirus disease (COVID-19) detection using X-ray images and enhanced DenseNet.","The 2019 novel coronavirus (COVID-19) originating from China, has spread rapidly among people living in other countries. According to the World Health Organization (WHO), by the end of January, more than 104 million people have been affected by COVID-19, including more than 2 million deaths. The number of COVID-19 test kits available in hospitals is reduced due to the increase in regular cases. Therefore, an automatic detection system should be introduced as a fast, alternative diagnostic to pre","2021","07","02","Appl Soft Comput","Applied soft computing","Biomedical imaging; COVID-19; Convolutional neural network; Deep learning; DenseNet; ResNet","Albahli","Saleh","Department of Information Technology, Qassim University, Buraydah, Saudi Arabia",NA
"806","34191925","10.1016/j.asoc.2021.107645","Coronavirus disease (COVID-19) detection using X-ray images and enhanced DenseNet.","The 2019 novel coronavirus (COVID-19) originating from China, has spread rapidly among people living in other countries. According to the World Health Organization (WHO), by the end of January, more than 104 million people have been affected by COVID-19, including more than 2 million deaths. The number of COVID-19 test kits available in hospitals is reduced due to the increase in regular cases. Therefore, an automatic detection system should be introduced as a fast, alternative diagnostic to pre","2021","07","02","Appl Soft Comput","Applied soft computing","Biomedical imaging; COVID-19; Convolutional neural network; Deep learning; DenseNet; ResNet","Ayub","Nasir","Department of Computer Science, Federal Urdu University, Islamabad, 44000, Pakistan",NA
"807","34191925","10.1016/j.asoc.2021.107645","Coronavirus disease (COVID-19) detection using X-ray images and enhanced DenseNet.","The 2019 novel coronavirus (COVID-19) originating from China, has spread rapidly among people living in other countries. According to the World Health Organization (WHO), by the end of January, more than 104 million people have been affected by COVID-19, including more than 2 million deaths. The number of COVID-19 test kits available in hospitals is reduced due to the increase in regular cases. Therefore, an automatic detection system should be introduced as a fast, alternative diagnostic to pre","2021","07","02","Appl Soft Comput","Applied soft computing","Biomedical imaging; COVID-19; Convolutional neural network; Deep learning; DenseNet; ResNet","Shiraz","Muhammad","Department of Computer Science, Federal Urdu University, Islamabad, 44000, Pakistan",NA
"808","34191924","10.1109/TR.2020.3006408","Guest Editorial: Crisis Management-From Nuclear Accidents to Outbreaks of COVID-19 and Infectious Diseases.",NA,"2021","06","30","IEEE Trans Reliab","IEEE transactions on reliability",NA,"Kuo","Way","City University of Hong KongHong Kong",NA
"809","34191924","10.1109/TR.2020.3006408","Guest Editorial: Crisis Management-From Nuclear Accidents to Outbreaks of COVID-19 and Infectious Diseases.",NA,"2021","06","30","IEEE Trans Reliab","IEEE transactions on reliability",NA,"He","Jufang","City University of Hong KongHong Kong",NA
"810","34191922","10.1097/JWH.0000000000000180","Pelvic Floor Considerations in COVID-19.","Much of the research and clinical commentary on COVID-19 have been focused on respiratory function. Pelvic floor therapists understand that both respiratory dysfunction and hospitalization can have an impact on pelvic floor function. This clinical commentary provides context as to how the long-term effects of COVID-19 could affect the pelvic floor as well as some generalized treatment considerations. The respiratory diaphragm has an impact on the ability of the pelvic floor to contract and relax","2021","07","02","J Womens Health Phys Therap","Journal of women's health physical therapy","constipation; incontinence; post-intensive care syndrome (PICS); weakness","Siracusa","Carina","Department of Rehabilitation, OhioHealth, Columbus, Ohio",NA
"811","34191922","10.1097/JWH.0000000000000180","Pelvic Floor Considerations in COVID-19.","Much of the research and clinical commentary on COVID-19 have been focused on respiratory function. Pelvic floor therapists understand that both respiratory dysfunction and hospitalization can have an impact on pelvic floor function. This clinical commentary provides context as to how the long-term effects of COVID-19 could affect the pelvic floor as well as some generalized treatment considerations. The respiratory diaphragm has an impact on the ability of the pelvic floor to contract and relax","2021","07","02","J Womens Health Phys Therap","Journal of women's health physical therapy","constipation; incontinence; post-intensive care syndrome (PICS); weakness","Gray","Amelia","Department of Rehabilitation, OhioHealth, Columbus, Ohio",NA
"812","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Akindele","Abidemi J","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"813","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Agunbiade","Foluso O","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"814","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Sofidiya","Margaret O","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"815","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Awodele","Olufunsho","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"816","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Sowemimo","Abimbola","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"817","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Ade-Ademilua","Omobolanle","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"818","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Akinleye","Moshood O","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"819","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Ishola","Ismail O","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"820","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Orabueze","Ifeoma","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"821","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Salu","Olumuyiwa B","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"822","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Oreagba","Ibrahim A","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"823","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Asekun","Olayinka T","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"824","34191921","10.1177/1934578X20945086","COVID-19 Pandemic: A Case for Phytomedicines.","Coronavirus disease 2019 (COVID-19) is an infection caused by a newly discovered coronavirus which was identified in Wuhan, China. The race is on globally to repurpose drugs for COVID-19 and develop a safe and effective vaccine against the disease. There is an urgent need to search for effective remedies against COVID-19 from the rich and extensive flora of Africa and the world. A literature search was conducted to obtain information on drugs with the potential for effectiveness in the treatment","2021","07","02","Nat Prod Commun","Natural product communications","COVID-19; collaboration; phytomedicines; safety; strategic interventions; therapeutic management","Odukoya","Olukemi","African Center of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS), University of Lagos (UNILAG), Lagos, Nigeria",NA
"825","34191919","10.1097/ADT.0000000000000233","The COVID-19 Rapid and Swab Tests Takes the Lives of Pregnant Women and Their Babies: Does It Violate Human Rights?",NA,"2021","07","02","Addict Disord Their Treat","Addictive disorders &amp; their treatment",NA,"Situmorang","Dominikus David Biondi","Department of Guidance and Counseling, Atma Jaya Catholic University of Indonesia, Jakarta Indonesia",NA
"826","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Fitzpatrick","Courtney L",NA,NA
"827","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Alter","S Elizabeth",NA,NA
"828","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Boughman","Janette W",NA,NA
"829","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Débarre","Florence",NA,NA
"830","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Edmands","Suzanne",NA,NA
"831","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Moehring","Amanda",NA,NA
"832","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Moyle","Leonie",NA,NA
"833","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Otto","Sarah P",NA,NA
"834","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Ronce","Ophélie",NA,NA
"835","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Rubin","Matthew J",NA,NA
"836","34191918","10.1093/biosci/biab037","The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Sweigart","Andrea L",NA,NA
"837","34191917","10.1093/icon/moaa049","Engendering a constitutional moment: The quest for parity in the Chilean Constitutional Convention.","Chile is living a constitutional moment, and the achievement of parity democracy might be part of it. The constitutional roadmap includes a plebiscite where citizens will decide whether they want a new constitution. The plebiscite was to be held in April 2020 but, due to the COVID-19 emergency, it had to be rescheduled to take place in October this year. If the option for a new constitution wins, a constituent body must be elected. To ensure parity in that election, a group of feminist political","2021","06","30","Int J Const Law","International journal of constitutional law",NA,"Undurraga","Verónica","Associate Professor, Universidad Adolfo Ibáñez (Santiago, Chile)",NA
"838","34191916","10.1093/ia/iiaa135","Why the COVID-19 response needs International Relations.","The COVID-19 pandemic affects all countries, but how governments respond is dictated by politics. Amid this, the World Health Organization (WHO) has tried to coordinate advice to states and offer ongoing management of the outbreak. Given the political drivers of COVID-19, we argue this is an important moment to advance International Relations knowledge as a necessary and distinctive method for inclusion in the WHO repertoire of knowledge inputs for epidemic control. Historical efforts to assert ","2021","06","30","Int Aff","International affairs","Covid-19; International Relations; World Health Organization; diplomacy; human rights; sovereignty","Davies","Sara E",NA,NA
"839","34191916","10.1093/ia/iiaa135","Why the COVID-19 response needs International Relations.","The COVID-19 pandemic affects all countries, but how governments respond is dictated by politics. Amid this, the World Health Organization (WHO) has tried to coordinate advice to states and offer ongoing management of the outbreak. Given the political drivers of COVID-19, we argue this is an important moment to advance International Relations knowledge as a necessary and distinctive method for inclusion in the WHO repertoire of knowledge inputs for epidemic control. Historical efforts to assert ","2021","06","30","Int Aff","International affairs","Covid-19; International Relations; World Health Organization; diplomacy; human rights; sovereignty","Wenham","Clare",NA,NA
"840","34191915","10.1093/joc/jqab006","The Global Trust Deficit Disorder: A Communications Perspective on Trust in the Time of Global Pandemics.","There has been much discussion worldwide about the crisis of trust, with evidence of declining trust in social, economic, political and media institutions. The rise of populism, and the differing impacts of the COVID-19 pandemic between nations, has been drawing attention to wider implications of pervasive distrust, including distrust of the media. In this article, I develop three propositions. First, I identify trust studies as a rich interdisciplinary field, linking communication to other bran","2021","07","02","J Commun","The Journal of communication","COVID-19; Trust; communications; conspiracy theories; digital platforms; mistrust; news; populism; truth","Flew","Terry",NA,NA
"841","34191914","10.1093/oxrep/graa067","Regional inequalities: causes and cures.","Significant regional inequalities of income and wealth exist in every Western European country and in North America, but their extent varies from country to country. In both Europe and the US, it is generally thought that they tended to narrow from the early 1900s until about 1980, since when they have widened. This widening has become associated with the rise of populism, while the Covid-19 crisis has thrown regional disadvantage into sharp relief. This article discusses measurement issues, tra","2021","06","30","Oxf Rev Econ Policy","Oxford review of economic policy","agglomerations; economic shocks; labour markets; regional inequalities; regional policies; structural shocks","Cörvers","Frank","Maastricht University, Netherlands",NA
"842","34191914","10.1093/oxrep/graa067","Regional inequalities: causes and cures.","Significant regional inequalities of income and wealth exist in every Western European country and in North America, but their extent varies from country to country. In both Europe and the US, it is generally thought that they tended to narrow from the early 1900s until about 1980, since when they have widened. This widening has become associated with the rise of populism, while the Covid-19 crisis has thrown regional disadvantage into sharp relief. This article discusses measurement issues, tra","2021","06","30","Oxf Rev Econ Policy","Oxford review of economic policy","agglomerations; economic shocks; labour markets; regional inequalities; regional policies; structural shocks","Mayhew","Ken","Pembroke College, Oxford, UK, and Maastricht University, Netherlands",NA
"843","34191913","10.1017/mit.2020.36","The invisible enemy: a historian's short tale of Covid-19 in Italy.","When on 8 March 2020 lockdown was declared in Lombardy, I had a national flag in a drawer waiting for 17 March - the birthday of unified Italy - to be hung down from my balcony just for one single day. Suddenly it seemed to me very natural to begin the ritual early, fixing it carefully and looking at it while it was moving softly in the mild evening breeze, amidst the surreal silence of the neighbourhood riven only by so many, too many ambulance sirens: a suspended time, a time of fear and resis","2021","06","30","Mod Italy","Modern Italy : journal of the Association for the Study of Modern Italy",NA,"Arisi Rota","Arianna","Department of Political and Social Sciences, University of Pavia, Italy",NA
"844","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Alagona","Peter",NA,NA
"845","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Carruthers","Jane",NA,NA
"846","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Chen","Hao",NA,NA
"847","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Dagenais","Michèle",NA,NA
"848","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Dutra E Silva","Sandro",NA,NA
"849","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Fitzgerald","Gerard",NA,NA
"850","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Hou","Shen",NA,NA
"851","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Jørgensen","Dolly",NA,NA
"852","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Leal","Claudia",NA,NA
"853","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"McNeill","John",NA,NA
"854","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Mitman","Gregg",NA,NA
"855","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Petrick","Gabriella",NA,NA
"856","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Piper","Liza",NA,NA
"857","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Robin","Libby",NA,NA
"858","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Russell","Edmund",NA,NA
"859","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Sellers","Christopher",NA,NA
"860","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Stewart","Mart A",NA,NA
"861","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Uekötter","Frank",NA,NA
"862","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Valencius","Conevery Bolton",NA,NA
"863","34191912","10.1093/envhis/emaa053","Reflections: Environmental History in the Era of COVID-19.",NA,"2021","06","30","Environ Hist Durh N C","Environmental history",NA,"Armiero","Marco",NA,NA
"864","34191910","10.1097/IPC.0000000000000999","Music Therapy for the Treatment of Patients With COVID-19: Psychopathological Problems Intervention and Well-Being Improvement.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Biondi Situmorang","Dominikus David","Department of Guidance and Counseling, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia david.biondi@atmajaya.ac","david.biondi@atmajaya.ac.id"
"865","34191909","10.1097/IPC.0000000000000992","Diabetes and Risk of COVID-19 Mortality: A Systematic Review and Meta-Analysis.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Kandil","Hend","Faculty of Medicine, Menoufia University Menoufia, Egypt","ahmed011172@med.bsu.edu.eg"
"866","34191909","10.1097/IPC.0000000000000992","Diabetes and Risk of COVID-19 Mortality: A Systematic Review and Meta-Analysis.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Ibrahim","Ahmed Elsayed","Faculty of Medicine, Alexandria University Alexandria, Egypt","ahmed011172@med.bsu.edu.eg"
"867","34191909","10.1097/IPC.0000000000000992","Diabetes and Risk of COVID-19 Mortality: A Systematic Review and Meta-Analysis.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Afifi","Naglaa","Department of Internal Medicine, Faculty of Medicine Ain Shams University Cairo, Egypt","ahmed011172@med.bsu.edu.eg"
"868","34191909","10.1097/IPC.0000000000000992","Diabetes and Risk of COVID-19 Mortality: A Systematic Review and Meta-Analysis.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Arafa","Ahmed","Department of Public Health Graduate School of Medicine, Osaka University Osaka, Japan ahmed011172@med.bsu.edu","ahmed011172@med.bsu.edu.eg"
"869","34191908","10.1097/IPC.0000000000000985","Postinfectious Interstitial Pneumonia After COVID-19 Infection.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Salcedo","Ricardo M","Clinica El Golf, Lima, Peru","Madariaga.miguel@gmail.com"
"870","34191908","10.1097/IPC.0000000000000985","Postinfectious Interstitial Pneumonia After COVID-19 Infection.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Flores","Roberto G","Clinica El Golf, Lima, Peru","Madariaga.miguel@gmail.com"
"871","34191908","10.1097/IPC.0000000000000985","Postinfectious Interstitial Pneumonia After COVID-19 Infection.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Medina","Carlos A","Clinica El Golf, Lima, Peru","Madariaga.miguel@gmail.com"
"872","34191908","10.1097/IPC.0000000000000985","Postinfectious Interstitial Pneumonia After COVID-19 Infection.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Mogollon","Renzo J","Clinica El Golf, Lima, Peru","Madariaga.miguel@gmail.com"
"873","34191908","10.1097/IPC.0000000000000985","Postinfectious Interstitial Pneumonia After COVID-19 Infection.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Madariaga","Miguel G","Naples Community Hospital, Naples, FL Madariaga.miguel@gmail","Madariaga.miguel@gmail.com"
"874","34191907","10.1097/IPC.0000000000000996","Multisystem Inflammatory Syndrome in an Adult With COVID-19.","Multisystem inflammatory syndrome (MIS) in children is a severe illness characterized by fever, laboratory evidence of inflammation, and multisystem organ dysfunction resulting from severe acute respiratory syndrome coronavirus 2 infection in a patient younger than 21 years. We present the case of a 39-year-old man with evidence of prior COVID-19 who seemed to meet all non-age-related criteria for MIS in children as well as criteria for the working definition of MIS in adults, and who improved a","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID; MIS; SARS-CoV-2; case report; coronavirus; inflammation; multisystem inflammatory syndrome","Brown","Leah M","Department of Medicine",NA
"875","34191907","10.1097/IPC.0000000000000996","Multisystem Inflammatory Syndrome in an Adult With COVID-19.","Multisystem inflammatory syndrome (MIS) in children is a severe illness characterized by fever, laboratory evidence of inflammation, and multisystem organ dysfunction resulting from severe acute respiratory syndrome coronavirus 2 infection in a patient younger than 21 years. We present the case of a 39-year-old man with evidence of prior COVID-19 who seemed to meet all non-age-related criteria for MIS in children as well as criteria for the working definition of MIS in adults, and who improved a","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID; MIS; SARS-CoV-2; case report; coronavirus; inflammation; multisystem inflammatory syndrome","Semler","Matthew W","Division of Allergy, Pulmonary, and Critical Care Medicine",NA
"876","34191907","10.1097/IPC.0000000000000996","Multisystem Inflammatory Syndrome in an Adult With COVID-19.","Multisystem inflammatory syndrome (MIS) in children is a severe illness characterized by fever, laboratory evidence of inflammation, and multisystem organ dysfunction resulting from severe acute respiratory syndrome coronavirus 2 infection in a patient younger than 21 years. We present the case of a 39-year-old man with evidence of prior COVID-19 who seemed to meet all non-age-related criteria for MIS in children as well as criteria for the working definition of MIS in adults, and who improved a","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID; MIS; SARS-CoV-2; case report; coronavirus; inflammation; multisystem inflammatory syndrome","Hansen","Megan","Division of Rheumatology",NA
"877","34191907","10.1097/IPC.0000000000000996","Multisystem Inflammatory Syndrome in an Adult With COVID-19.","Multisystem inflammatory syndrome (MIS) in children is a severe illness characterized by fever, laboratory evidence of inflammation, and multisystem organ dysfunction resulting from severe acute respiratory syndrome coronavirus 2 infection in a patient younger than 21 years. We present the case of a 39-year-old man with evidence of prior COVID-19 who seemed to meet all non-age-related criteria for MIS in children as well as criteria for the working definition of MIS in adults, and who improved a","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID; MIS; SARS-CoV-2; case report; coronavirus; inflammation; multisystem inflammatory syndrome","Person","Anna K","Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN",NA
"878","34191907","10.1097/IPC.0000000000000996","Multisystem Inflammatory Syndrome in an Adult With COVID-19.","Multisystem inflammatory syndrome (MIS) in children is a severe illness characterized by fever, laboratory evidence of inflammation, and multisystem organ dysfunction resulting from severe acute respiratory syndrome coronavirus 2 infection in a patient younger than 21 years. We present the case of a 39-year-old man with evidence of prior COVID-19 who seemed to meet all non-age-related criteria for MIS in children as well as criteria for the working definition of MIS in adults, and who improved a","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID; MIS; SARS-CoV-2; case report; coronavirus; inflammation; multisystem inflammatory syndrome","Kelly","Sean G","Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN",NA
"879","34191906","10.1097/IPC.0000000000000968","Rhabdomyolysis With COVID-19.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Mahmood","Uzair Ahmed","Department of Internal Medicine, The University of Kansas Health System, Kansas City, KS uzair.ehmed@gmail","uzair.ehmed@gmail.com"
"880","34191906","10.1097/IPC.0000000000000968","Rhabdomyolysis With COVID-19.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Mermis","Joel D","Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The University of Kansas Health System, Kansas City, KS",NA
"881","34191906","10.1097/IPC.0000000000000968","Rhabdomyolysis With COVID-19.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"Khan","Noor-Mah","Aga Khan University Medical College, Karachi, Pakistan",NA
"882","34191906","10.1097/IPC.0000000000000968","Rhabdomyolysis With COVID-19.",NA,"2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)",NA,"El Atrouni","Wissam","Division of Infectious Diseases, Department of Internal Medicine, The University of Kansas Health System, Kansas City, KS",NA
"883","34191905","10.1097/IPC.0000000000000998","COVID Calls.",NA,"2021","06","30","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; polymerase chain reaction","Dylewski","Joe","Division of Microbiology and Infectious Diseases, St Mary's Hospital Center, Montreal, Quebec, Canada",NA
"884","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Voisin","Olivier","Department of Internal Medicine",NA
"885","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Deluca","Nina","Department of Internal Medicine",NA
"886","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Mahé","Annabelle","Department of Internal Medicine",NA
"887","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Lelorc'h","Erwan","Department of Internal Medicine",NA
"888","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Hubert","Sidonie","Department of Internal Medicine",NA
"889","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Ménage","Elodie","Department of Internal Medicine",NA
"890","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Borie","Marie-Françoise","Department of Internal Medicine",NA
"891","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Azria","Philippe","Department of Internal Medicine",NA
"892","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Fite","Charlotte","Department of Dermatology",NA
"893","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Pilmis","Benoit","Department of Infectious Disease, Groupe Hospitalier Paris Saint-Joseph, Paris, France",NA
"894","34191904","10.1097/IPC.0000000000000971","Disseminated Herpes Zoster During COVID-19.","During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symp","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus","Mourad","Jean-Jacques","Department of Internal Medicine",NA
"895","34191903","10.1097/IPC.0000000000000960","Prolonged Detection of SARS-CoV-2 in a Patient With the Development of New Clinical Symptoms.","We present a case of a 65-year-old woman with a persistently positive nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 PCR who developed new complications of coronavirus disease 2019 (COVID-19) 63 days from illness onset. She presented with intermittent fevers, fluctuating disorientation, gait instability, diffuse corticospinal tract signs, and acute venous thromboembolism. No alternate diagnosis was identified. This case highlights the potential for prolonged SARS-CoV-2 P","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; neurological manifestations; persistent detection","Awoniyi","Amaka","Department of Internal Medicine",NA
"896","34191903","10.1097/IPC.0000000000000960","Prolonged Detection of SARS-CoV-2 in a Patient With the Development of New Clinical Symptoms.","We present a case of a 65-year-old woman with a persistently positive nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 PCR who developed new complications of coronavirus disease 2019 (COVID-19) 63 days from illness onset. She presented with intermittent fevers, fluctuating disorientation, gait instability, diffuse corticospinal tract signs, and acute venous thromboembolism. No alternate diagnosis was identified. This case highlights the potential for prolonged SARS-CoV-2 P","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; neurological manifestations; persistent detection","Rohm","Zachery","Department of Neurology",NA
"897","34191903","10.1097/IPC.0000000000000960","Prolonged Detection of SARS-CoV-2 in a Patient With the Development of New Clinical Symptoms.","We present a case of a 65-year-old woman with a persistently positive nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 PCR who developed new complications of coronavirus disease 2019 (COVID-19) 63 days from illness onset. She presented with intermittent fevers, fluctuating disorientation, gait instability, diffuse corticospinal tract signs, and acute venous thromboembolism. No alternate diagnosis was identified. This case highlights the potential for prolonged SARS-CoV-2 P","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; neurological manifestations; persistent detection","Paranjape","Neha","Division of Infectious Diseases, Wellstar Health System, Marietta, GA",NA
"898","34191903","10.1097/IPC.0000000000000960","Prolonged Detection of SARS-CoV-2 in a Patient With the Development of New Clinical Symptoms.","We present a case of a 65-year-old woman with a persistently positive nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 PCR who developed new complications of coronavirus disease 2019 (COVID-19) 63 days from illness onset. She presented with intermittent fevers, fluctuating disorientation, gait instability, diffuse corticospinal tract signs, and acute venous thromboembolism. No alternate diagnosis was identified. This case highlights the potential for prolonged SARS-CoV-2 P","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; SARS-CoV-2; neurological manifestations; persistent detection","Arinze","Folasade","Department of Internal Medicine",NA
"899","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Marsh","Kassandra","Tisch Hospital Department of Pharmacy",NA
"900","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Decano","Arnold","Brooklyn Hospital Department of Pharmacy",NA
"901","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Siegfried","Justin","Tisch Hospital Department of Pharmacy",NA
"902","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Ahmed","Nabeela","Brooklyn Hospital Department of Pharmacy",NA
"903","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Blum","Sharon","Winthrop Hospital Department of Pharmacy, NYU Langone Health",NA
"904","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Tirmizi","Samad","Winthrop Hospital Department of Pharmacy, NYU Langone Health",NA
"905","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Dong","Mei Qin","Bellevue Hospital Department of Pharmacy, NYC Health and Hospitals",NA
"906","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Mehta","Dhara","Bellevue Hospital Department of Pharmacy, NYC Health and Hospitals",NA
"907","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Pham","Vinh P","Division of Infectious Diseases, NYU Langone Health, New York, NY",NA
"908","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Papadopoulos","John","Tisch Hospital Department of Pharmacy",NA
"909","34191902","10.1097/IPC.0000000000000982","Outcomes of COVID-19 Patients Hospitalized at Acute Care Services: Real-World Experience in the New York Metropolitan Area During the Early Pandemic Before Initiation of Clinical Trials.","As New York became the epicenter of the COVID-19 pandemic early on, clinicians were challenged to provide optimal medical and pharmaceutical care, despite the paucity of supporting literature and guidance. We sought to describe prescribing patterns and outcomes of physician response to the urgent need to treat COVID-19 patients before initiation of randomized clinical trials. This was a retrospective cohort study of adult patients with COVID-19 initially admitted to acute care services during Ma","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; hydroxychloroquine; lopinavir ritonavir; safety; treatment","Dubrovskaya","Yanina","Tisch Hospital Department of Pharmacy",NA
"910","34191901","10.1097/IPC.0000000000000973","Coronavirus Disease 2019 in Children: Is It Really Mild?","Coronavirus disease 2019 pandemic has spread rapidly to the world. The disease can vary from mild cases to severe respiratory distress; this may increase rapidly and overwhelm the pediatric intensive care units. Lately, there have been various reports about a de novo multisystem inflammatory syndrome in children or pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 infection. We classified the disease into 2 spectrums: the acute","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; Kawasaki-like syndrome; SARS-CoV-2; multisystem inflammatory syndrome in children; pediatric complications","Osorio","María F","School of Medicine, Universidad Espíritu Santo",NA
"911","34191901","10.1097/IPC.0000000000000973","Coronavirus Disease 2019 in Children: Is It Really Mild?","Coronavirus disease 2019 pandemic has spread rapidly to the world. The disease can vary from mild cases to severe respiratory distress; this may increase rapidly and overwhelm the pediatric intensive care units. Lately, there have been various reports about a de novo multisystem inflammatory syndrome in children or pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 infection. We classified the disease into 2 spectrums: the acute","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","COVID-19; Kawasaki-like syndrome; SARS-CoV-2; multisystem inflammatory syndrome in children; pediatric complications","Vaca","Richard G","School of Medicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador",NA
"912","34191900","10.1097/IPC.0000000000000939","Infection Risk of COVID-19 in Dentistry Remains Unknown: A Preliminary Systematic Review.","COVID-19 is a novel viral respiratory disease caused by a member of the coronavirus family, SARS-CoV-2, and has been declared as a pandemic on March 2020. Dental practitioners are routinely exposed to infectious bodily excretions, for example, saliva, blood, and respiratory excretions. Therefore, they are in the first line of SARS-CoV-2 infection-prone health care providers. The purposes of the current review are to trace documented cases of COVID-19 transmission inside dental settings worldwide","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","community dentistry; epidemiology; infection control; occupational dentistry; pandemics; virology","Levit","Michael","Department of Prosthodontics, Hebrew University Hadassah School of Dental Medicine",NA
"913","34191900","10.1097/IPC.0000000000000939","Infection Risk of COVID-19 in Dentistry Remains Unknown: A Preliminary Systematic Review.","COVID-19 is a novel viral respiratory disease caused by a member of the coronavirus family, SARS-CoV-2, and has been declared as a pandemic on March 2020. Dental practitioners are routinely exposed to infectious bodily excretions, for example, saliva, blood, and respiratory excretions. Therefore, they are in the first line of SARS-CoV-2 infection-prone health care providers. The purposes of the current review are to trace documented cases of COVID-19 transmission inside dental settings worldwide","2021","07","02","Infect Dis Clin Pract (Baltim Md)","Infectious diseases in clinical practice (Baltimore, Md.)","community dentistry; epidemiology; infection control; occupational dentistry; pandemics; virology","Levit","Leah","Research Fund of the Hadassah Medical Organization, Jerusalem, Israel",NA
"914","34191894","10.1080/08927022.2020.1800691","Conformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors.","Multivariate image analysis applied to quantitative structure-activity relationships (MIA-QSAR) has proved to be a high-performance 2D tool for drug design purposes. Nonetheless, MIA-QSAR strategy does not efficiently incorporate conformational information. Therefore, understanding the implications of including this type of data into the MIA-QSAR model, in terms of predictability and interpretability, seems a crucial task. Conformational information was included considering the optimised geometr","2021","07","02","Mol Simul","Molecular simulation","QSAR; SARS-CoV; conformation; molecular docking","Daré","Joyce K","Department of Chemistry, Federal University of Lavras, Lavras, Brazil",NA
"915","34191894","10.1080/08927022.2020.1800691","Conformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors.","Multivariate image analysis applied to quantitative structure-activity relationships (MIA-QSAR) has proved to be a high-performance 2D tool for drug design purposes. Nonetheless, MIA-QSAR strategy does not efficiently incorporate conformational information. Therefore, understanding the implications of including this type of data into the MIA-QSAR model, in terms of predictability and interpretability, seems a crucial task. Conformational information was included considering the optimised geometr","2021","07","02","Mol Simul","Molecular simulation","QSAR; SARS-CoV; conformation; molecular docking","Silva","Daniela R","Department of Chemistry, Federal University of Lavras, Lavras, Brazil",NA
"916","34191894","10.1080/08927022.2020.1800691","Conformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors.","Multivariate image analysis applied to quantitative structure-activity relationships (MIA-QSAR) has proved to be a high-performance 2D tool for drug design purposes. Nonetheless, MIA-QSAR strategy does not efficiently incorporate conformational information. Therefore, understanding the implications of including this type of data into the MIA-QSAR model, in terms of predictability and interpretability, seems a crucial task. Conformational information was included considering the optimised geometr","2021","07","02","Mol Simul","Molecular simulation","QSAR; SARS-CoV; conformation; molecular docking","Ramalho","Teodorico C","Department of Chemistry, Federal University of Lavras, Lavras, Brazil",NA
"917","34191894","10.1080/08927022.2020.1800691","Conformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors.","Multivariate image analysis applied to quantitative structure-activity relationships (MIA-QSAR) has proved to be a high-performance 2D tool for drug design purposes. Nonetheless, MIA-QSAR strategy does not efficiently incorporate conformational information. Therefore, understanding the implications of including this type of data into the MIA-QSAR model, in terms of predictability and interpretability, seems a crucial task. Conformational information was included considering the optimised geometr","2021","07","02","Mol Simul","Molecular simulation","QSAR; SARS-CoV; conformation; molecular docking","Freitas","Matheus P","Department of Chemistry, Federal University of Lavras, Lavras, Brazil",NA
"918","34191893","10.1097/JCE.0000000000000423","US Food and Drug Administration Seeks Input From Healthcare Technology Management Community on Medical Device Supply Disruption During COVID-19 Pandemic.","The US Food and Drug Administration (FDA) is currently seeking information from the clinical community about existing and anticipated disruptions in the supply of medical devices related to COVID-19. This information is important to FDA's fulfillment of its mission to ensure that healthcare providers and patients have continued access to safe and effective medical products. Insights from the clinical community, including clinical engineers and biomedical equipment technicians, bring device suppl","2021","06","30","J Clin Eng","Journal of clinical engineering",NA,"Morabito","Julie",NA,NA
"919","34191892","10.1097/JCE.0000000000000424","Observations on COVID-19.",NA,"2021","06","30","J Clin Eng","Journal of clinical engineering",NA,"Keil","Ode R",NA,NA
"920","34191891","10.1177/0301574220963495","Customized Orthodontic Triage During COVID-19 Pandemic.","COVID-19 pandemic necessitates streamlining patient influx in orthodontic office to avoid cross infection between patients, clinicians, and dental health care workers. A customized orthodontic triage has been proposed in this article to schedule patient appointments through priority triaging and, at the same time, provide self-care advice, virtual assistance, and remote monitoring for patient management in elective circumstances.","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; SARS-CoV-2; orthodontic emergency; orthodontic triage; pandemic","Aziz","Sana Bint","Dental Department, Dr N.C. Joshi Memorial Hospital, Karol Bagh, Govt of NCT of Delhi, New Delhi, Delhi, India",NA
"921","34191891","10.1177/0301574220963495","Customized Orthodontic Triage During COVID-19 Pandemic.","COVID-19 pandemic necessitates streamlining patient influx in orthodontic office to avoid cross infection between patients, clinicians, and dental health care workers. A customized orthodontic triage has been proposed in this article to schedule patient appointments through priority triaging and, at the same time, provide self-care advice, virtual assistance, and remote monitoring for patient management in elective circumstances.","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; SARS-CoV-2; orthodontic emergency; orthodontic triage; pandemic","Kapoor","Priyanka","Faculty of Dentistry, Department of Orthodontics, Jamia Millia Islamia, New Delhi, Delhi, India",NA
"922","34191890","10.1177/0301574220963433","Can Orthodontic Informatics Combat the Pandemic Pitfalls?","The largest public health crisis of our time, COVID-19 has recklessly squandered many of the channelized healthcare facilities globally with execution of newer guidelines over the standard architectural norms. There has been unparalleled use of smartphones and internet services to bear the major pitfall- social distancing- especially for elective treatment services. This demands a new paradigm shift from offline to online doctor-patient, student-educator, researcher-researcher operations. This a","2021","07","02","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Clinical informatics; data analysis; electronic health records; orthodontic care","Kaur","Harneet","Department of Orthodontics &amp",NA
"923","34191890","10.1177/0301574220963433","Can Orthodontic Informatics Combat the Pandemic Pitfalls?","The largest public health crisis of our time, COVID-19 has recklessly squandered many of the channelized healthcare facilities globally with execution of newer guidelines over the standard architectural norms. There has been unparalleled use of smartphones and internet services to bear the major pitfall- social distancing- especially for elective treatment services. This demands a new paradigm shift from offline to online doctor-patient, student-educator, researcher-researcher operations. This a","2021","07","02","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Clinical informatics; data analysis; electronic health records; orthodontic care","Izhar","Arisha","Department of Orthodontics &amp",NA
"924","34191889","10.1177/0301574220964634","COVID-19-Orthodontic Care During and After the Pandemic: A Narrative Review.","To provide comprehensive information regarding the implications of the coronavirus disease 2019 (COVID-19), mode of transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and its effects on orthodontic care during the pandemic and post-pandemic outbreak of the disease, based on currently available literature and information. A comprehensive research for studies that focused on the COVID-19 pandemic and orthodontic care up to August 18, 2020, with no language restriction. T","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Dental practice; SARS-CoV-2; infection control; orthodontic care; pandemic; transmission","Sharan","Jitendra","Department of Dentistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India",NA
"925","34191889","10.1177/0301574220964634","COVID-19-Orthodontic Care During and After the Pandemic: A Narrative Review.","To provide comprehensive information regarding the implications of the coronavirus disease 2019 (COVID-19), mode of transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and its effects on orthodontic care during the pandemic and post-pandemic outbreak of the disease, based on currently available literature and information. A comprehensive research for studies that focused on the COVID-19 pandemic and orthodontic care up to August 18, 2020, with no language restriction. T","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Dental practice; SARS-CoV-2; infection control; orthodontic care; pandemic; transmission","Chanu","Nameirakpam Ibemcha","Orthodontic Consultant, Imphal, Manipur, India",NA
"926","34191889","10.1177/0301574220964634","COVID-19-Orthodontic Care During and After the Pandemic: A Narrative Review.","To provide comprehensive information regarding the implications of the coronavirus disease 2019 (COVID-19), mode of transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and its effects on orthodontic care during the pandemic and post-pandemic outbreak of the disease, based on currently available literature and information. A comprehensive research for studies that focused on the COVID-19 pandemic and orthodontic care up to August 18, 2020, with no language restriction. T","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Dental practice; SARS-CoV-2; infection control; orthodontic care; pandemic; transmission","Jena","Ashok Kumar","Department of Dentistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India",NA
"927","34191889","10.1177/0301574220964634","COVID-19-Orthodontic Care During and After the Pandemic: A Narrative Review.","To provide comprehensive information regarding the implications of the coronavirus disease 2019 (COVID-19), mode of transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and its effects on orthodontic care during the pandemic and post-pandemic outbreak of the disease, based on currently available literature and information. A comprehensive research for studies that focused on the COVID-19 pandemic and orthodontic care up to August 18, 2020, with no language restriction. T","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Dental practice; SARS-CoV-2; infection control; orthodontic care; pandemic; transmission","Arunachalam","Sivakumar","Head-Children and Community Oral Health Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia",NA
"928","34191889","10.1177/0301574220964634","COVID-19-Orthodontic Care During and After the Pandemic: A Narrative Review.","To provide comprehensive information regarding the implications of the coronavirus disease 2019 (COVID-19), mode of transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and its effects on orthodontic care during the pandemic and post-pandemic outbreak of the disease, based on currently available literature and information. A comprehensive research for studies that focused on the COVID-19 pandemic and orthodontic care up to August 18, 2020, with no language restriction. T","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","Dental practice; SARS-CoV-2; infection control; orthodontic care; pandemic; transmission","Choudhary","Prabhat Kumar","Department of Orthodontics and Dentofacial Deformities, Centre for Dental Education and Research, All India Institute of Medical Sciences, New Delhi, Delhi, India",NA
"929","34191888","10.1177/0301574220957539","COVID-19 and Progressive Orthodontics.","The coronavirus disease (COVID-19) was declared as a pandemic by the World Health Organization on 30th January 2020 so the practice of dentistry and orthodontics has come to a standstill. The COVID-19 affects different people in different ways. The most common symptoms resemble very much to that of seasonal flu. Patients experience dry cough, rising fever and tiredness or shortness of breath. Clinical practice of Orthodontics during COVID-19 pandemic, facing such a difficult and highly contagiou","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; orthodontic care; orthodontic treatment","Mote","Nilesh","Rural Dental College, Pravara Institute of Medical Sciences (Deemed to be University), Loni, Maharashtra, India",NA
"930","34191888","10.1177/0301574220957539","COVID-19 and Progressive Orthodontics.","The coronavirus disease (COVID-19) was declared as a pandemic by the World Health Organization on 30th January 2020 so the practice of dentistry and orthodontics has come to a standstill. The COVID-19 affects different people in different ways. The most common symptoms resemble very much to that of seasonal flu. Patients experience dry cough, rising fever and tiredness or shortness of breath. Clinical practice of Orthodontics during COVID-19 pandemic, facing such a difficult and highly contagiou","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; orthodontic care; orthodontic treatment","Dhanjani","Vishal","Rural Dental College, Pravara Institute of Medical Sciences (Deemed to be University), Loni, Maharashtra, India",NA
"931","34191888","10.1177/0301574220957539","COVID-19 and Progressive Orthodontics.","The coronavirus disease (COVID-19) was declared as a pandemic by the World Health Organization on 30th January 2020 so the practice of dentistry and orthodontics has come to a standstill. The COVID-19 affects different people in different ways. The most common symptoms resemble very much to that of seasonal flu. Patients experience dry cough, rising fever and tiredness or shortness of breath. Clinical practice of Orthodontics during COVID-19 pandemic, facing such a difficult and highly contagiou","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; orthodontic care; orthodontic treatment","Toshniwal","N G","Rural Dental College, Pravara Institute of Medical Sciences (Deemed to be University), Loni, Maharashtra, India",NA
"932","34191888","10.1177/0301574220957539","COVID-19 and Progressive Orthodontics.","The coronavirus disease (COVID-19) was declared as a pandemic by the World Health Organization on 30th January 2020 so the practice of dentistry and orthodontics has come to a standstill. The COVID-19 affects different people in different ways. The most common symptoms resemble very much to that of seasonal flu. Patients experience dry cough, rising fever and tiredness or shortness of breath. Clinical practice of Orthodontics during COVID-19 pandemic, facing such a difficult and highly contagiou","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; orthodontic care; orthodontic treatment","Pallan","Kunal","Rural Dental College, Pravara Institute of Medical Sciences (Deemed to be University), Loni, Maharashtra, India",NA
"933","34191888","10.1177/0301574220957539","COVID-19 and Progressive Orthodontics.","The coronavirus disease (COVID-19) was declared as a pandemic by the World Health Organization on 30th January 2020 so the practice of dentistry and orthodontics has come to a standstill. The COVID-19 affects different people in different ways. The most common symptoms resemble very much to that of seasonal flu. Patients experience dry cough, rising fever and tiredness or shortness of breath. Clinical practice of Orthodontics during COVID-19 pandemic, facing such a difficult and highly contagiou","2021","07","06","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; orthodontic care; orthodontic treatment","Rathod","Rishikesh","Rural Dental College, Pravara Institute of Medical Sciences (Deemed to be University), Loni, Maharashtra, India",NA
"934","34191887","10.1177/0301574220930173","Financial Aspect of COVID-19 on Orthodontic Practice in India.",NA,"2021","07","09","J Indian Orthod Soc","The Journal of Indian Orthodontic Society",NA,"Singh Kochhar","Anuraj","BDS, MDS (WFO Fellow), Former Consultant Orthodontist, Max Hospital, Gurgaon, India. Email: Anuraj_kochhar@yahoo.co","kochhar@yahoo.co.in"
"935","34191887","10.1177/0301574220930173","Financial Aspect of COVID-19 on Orthodontic Practice in India.",NA,"2021","07","09","J Indian Orthod Soc","The Journal of Indian Orthodontic Society",NA,"Singh","Gurkeerat","BDS, MDS, M Orth Diplomate, Indian Board of Orthodontics (IBO), Vice Principal, Professor and Head, Department of Orthodontics &amp","drgurkeeratsingh@gmail.com"
"936","34191884","10.1177/0301574220942233","Impact of COVID-19 Lockdown on Patients Undergoing Orthodontic Treatment: A Questionnaire Study.","With COVID-19 declared as a worldwide pandemic, a nationwide lockdown was implemented overnight in India on March 24, 2020. With no prior warning or anticipation, patient appointments were temporarily ceased as institutions and clinics were indefinitely closed. To our knowledge, no study addresses the orthodontic patient perspective in such testing times, where they are entirely restricted to the confines of their homes. To assess the impact of the COVID-19-related lockdown on the treatment and ","2021","07","20","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; Challenges; corona; lockdown; orthodontic; orthodontic patient; patient psychology; treatment","Shenoi","Susmita Bala","Department of Orthodontics and Dentofacial Orthopaedics, KLE Vishwananth Katti Institute of Dental Sciences, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India",NA
"937","34191884","10.1177/0301574220942233","Impact of COVID-19 Lockdown on Patients Undergoing Orthodontic Treatment: A Questionnaire Study.","With COVID-19 declared as a worldwide pandemic, a nationwide lockdown was implemented overnight in India on March 24, 2020. With no prior warning or anticipation, patient appointments were temporarily ceased as institutions and clinics were indefinitely closed. To our knowledge, no study addresses the orthodontic patient perspective in such testing times, where they are entirely restricted to the confines of their homes. To assess the impact of the COVID-19-related lockdown on the treatment and ","2021","07","20","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; Challenges; corona; lockdown; orthodontic; orthodontic patient; patient psychology; treatment","Deshpande","Sumedh","Department of Orthodontics and Dentofacial Orthopaedics, KLE Vishwananth Katti Institute of Dental Sciences, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India",NA
"938","34191884","10.1177/0301574220942233","Impact of COVID-19 Lockdown on Patients Undergoing Orthodontic Treatment: A Questionnaire Study.","With COVID-19 declared as a worldwide pandemic, a nationwide lockdown was implemented overnight in India on March 24, 2020. With no prior warning or anticipation, patient appointments were temporarily ceased as institutions and clinics were indefinitely closed. To our knowledge, no study addresses the orthodontic patient perspective in such testing times, where they are entirely restricted to the confines of their homes. To assess the impact of the COVID-19-related lockdown on the treatment and ","2021","07","20","J Indian Orthod Soc","The Journal of Indian Orthodontic Society","COVID-19; Challenges; corona; lockdown; orthodontic; orthodontic patient; patient psychology; treatment","Jatti","Roopa","Department of Orthodontics and Dentofacial Orthopaedics, KLE Vishwananth Katti Institute of Dental Sciences, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India",NA
"939","34191883","10.1177/0301574220947536","Financial Advice for Difficult Times: 2 Sides of a Coin.","This article invites 2 experts having knowledge of financial management: one from within the dental fraternity and one from outside to assist the orthodontists (academic and practitioners alike) to help provide some guidance to sail through these turbulent times. With the COVID-19 pandemic, we are witnessing an unprecedented moment in history that has impacted the entire globe at a never before seen scale. This coronavirus has resulted in a double black swan event where there is a health ","2021","07","02","J Indian Orthod Soc","The Journal of Indian Orthodontic Society",NA,"Anshul","Kumar","Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India",NA
"940","34191883","10.1177/0301574220947536","Financial Advice for Difficult Times: 2 Sides of a Coin.","This article invites 2 experts having knowledge of financial management: one from within the dental fraternity and one from outside to assist the orthodontists (academic and practitioners alike) to help provide some guidance to sail through these turbulent times. With the COVID-19 pandemic, we are witnessing an unprecedented moment in history that has impacted the entire globe at a never before seen scale. This coronavirus has resulted in a double black swan event where there is a health ","2021","07","02","J Indian Orthod Soc","The Journal of Indian Orthodontic Society",NA,"Mehta","Shrey","Sanjay Mehta Financial Services, B 149, Sector 36, Noida, Uttar Pradesh, India",NA
"941","34191881","10.1093/publius/pjaa021","The State of American Federalism 2019-2020: Polarized and Punitive Intergovernmental Relations.","The state of American federalism is characterized by polarization and punitiveness. As in previous years, political polarization continues to shape intergovernmental relations. But we also identify punitiveness as an increasingly prevalent aspect of vertical power sharing. Punitive federalism describes the national government's use of threats and punishment to suppress state and local actions that run contrary to its policy preferences. In this Annual Review of American Federalism overview artic","2021","07","02","Publius","Publius",NA,"Goelzhauser","Greg","Utah State University",NA
"942","34191881","10.1093/publius/pjaa021","The State of American Federalism 2019-2020: Polarized and Punitive Intergovernmental Relations.","The state of American federalism is characterized by polarization and punitiveness. As in previous years, political polarization continues to shape intergovernmental relations. But we also identify punitiveness as an increasingly prevalent aspect of vertical power sharing. Punitive federalism describes the national government's use of threats and punishment to suppress state and local actions that run contrary to its policy preferences. In this Annual Review of American Federalism overview artic","2021","07","02","Publius","Publius",NA,"Konisky","David M","Indiana University",NA
"943","34191880","10.1093/bjsw/bcaa110","Editorial: Unprecedented Times? Social Work and Society post-COVID-19.",NA,"2021","06","30","Br J Soc Work","British journal of social work",NA,"Golightley","Malcolm","University of Lincoln",NA
"944","34191880","10.1093/bjsw/bcaa110","Editorial: Unprecedented Times? Social Work and Society post-COVID-19.",NA,"2021","06","30","Br J Soc Work","British journal of social work",NA,"Holloway","Margaret","University of Hull",NA
"945","34191879","10.1093/pastj/gtaa024","The Human, The Animal and the Prehistory of COVID-19.","In Asia, pangolins have generated a rich set of indigenous oral traditions. These contrast with the often confused, or failed, colonial and Western scientific practices of classifying, domesticating and collecting the pangolin. More recently this long-standing encounter between the pangolin and human has shifted into exponential killing. The pangolin has become the mammal which is most trafficked by humans. This trade has been a global one, a fact that is important to remember given the racist i","2021","06","30","Past Present","Past &amp; present",NA,"Sivasundaram","Sujit","Gonville and Caius College, Cambridge",NA
"946","34191877","10.1017/jfm.2020.720","Effects of ventilation on the indoor spread of COVID-19.",NA,"2021","07","02","J Fluid Mech","Journal of fluid mechanics","drops; plumes/thermals; turbulent mixing","Bhagat","Rajesh K","Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, UK",NA
"947","34191877","10.1017/jfm.2020.720","Effects of ventilation on the indoor spread of COVID-19.",NA,"2021","07","02","J Fluid Mech","Journal of fluid mechanics","drops; plumes/thermals; turbulent mixing","Davies Wykes","M S","Department of Engineering, University of Cambridge, Trumpington Street, Cambridge CB2 1PZ, UK",NA
"948","34191877","10.1017/jfm.2020.720","Effects of ventilation on the indoor spread of COVID-19.",NA,"2021","07","02","J Fluid Mech","Journal of fluid mechanics","drops; plumes/thermals; turbulent mixing","Dalziel","Stuart B","Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, UK",NA
"949","34191877","10.1017/jfm.2020.720","Effects of ventilation on the indoor spread of COVID-19.",NA,"2021","07","02","J Fluid Mech","Journal of fluid mechanics","drops; plumes/thermals; turbulent mixing","Linden","P F","Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, UK",NA
"950","34191876","10.1017/S0021911820002338","Afterword: Lives Interrupted, Trends Continued?","The COVID-19 pandemic is nowhere near over. Some things, however, seem relatively clear. So far, the agendas of the world's most powerful actors seem unchanged-or, indeed, accelerated. Partly as a result, disease mortality and economic losses have fallen largely on poorer people, though deaths so far have been concentrated among poorer people in rich countries. Consequently, the pandemic's implications look very different at the local, subnational, and international levels-although at all levels","2021","06","30","J Asian Stud","The Journal of Asian studies","COVID-19; East Asia; South Asia; environmental crisis; global politics; inequality; migrants; poverty; racism; telecommunications","Pomeranz","Kenneth","Kenneth Pomeranz (kpomeranz1@uchicago.edu) is University Professor of Modern Chinese History, East Asian Languages and Civilization, and in the College at the University of Chicago","kpomeranz1@uchicago.edu"
"951","34191875","10.1017/S0021911820002314","""Responding to an Epidemic Requires a Compassionate State"": How Has the Indian State Been Doing in the Time of COVID-19?","In response to the COVID-19 pandemic, the Indian government, led by Narendra Modi, imposed a stringent lockdown with only four hours notice. It paid no attention to the millions of migrants who work on a temporary basis in Indian cities. Most lost their livelihoods as a result of the lockdown, and millions sought to return to their native villages. At the same time, the rural economy confronted its own difficulties caused by the lockdown. The relief that the Modi government offered to the large ","2021","06","30","J Asian Stud","The Journal of Asian studies","Authoritarian populism; Narendra Modi; circular migration; citizenship; democracy; informal economy","Harriss","John","John Harriss (jharriss@sfu.ca) is Professor Emeritus of International Studies at Simon Fraser University","jharriss@sfu.ca"
"952","34191874","10.1017/S0021911820002296","Olympic Recoveries.","In March 2020, Prime Minister Abe Shinzo, the Tokyo Olympic Organising Committee, and the International Olympic Committee postponed the 2020 Tokyo Olympics for one year. The delay is the most prominent consequence of the COVID-19 crisis in Japan thus far. But the ""Corona Calamity"" (korona ka) is bigger than the Olympics. The totality of the disaster is impossible to capture. The very thing that makes it a calamity are the myriad rhythms of crisis that intersect at COVID-19. If there is a ","2021","06","30","J Asian Stud","The Journal of Asian studies","2011 Triple Disaster; Abenomics; COVID-19; Japan; Olympics; cultural diplomacy; national disaster; parcel delivery; recovery; tourism","McDonald","Kate","Kate McDonald (kmcdonald@history.ucsb.edu) is Associate Professor of History at the University of California, Santa Barbara","kmcdonald@history.ucsb.edu"
"953","34191873","10.1017/S0021911820002302","The Media Spectacle of a Techno-City: COVID-19 and the South Korean Experience of the State of Emergency.","This essay provides a critical observation of the South Korean government's distinctive management of COVID-19 with particular reference to the state of emergency. It reveals that the success of South Korea's handling of the pandemic is largely attributed by a majority of Western media to the efficient deployment of both information and communication technologies and Confucian collectivism, two components that seem contradictory yet not incompatible under the rubric of techno-Orientalism. Analyz","2021","07","02","J Asian Stud","The Journal of Asian studies","COVID-19; Orientalism; datafication; media spectacle; state of emergency; surveillance","Kang","Jaeho","Jaeho Kang (jaekang@snu.ac.kr) is Associate Professor of Communication at Seoul National University","jaekang@snu.ac.kr"
"954","34191872","10.1017/S0021911820002284","Viral Reflections: Placing China in Global Health Histories.","Public health in China has become a global concern as a consequence of the outbreak and worldwide spread of COVID-19. This article examines the historical place of China in international and global health. Contrary to prevalent narratives in the history of medicine, China and Chinese historical actors played key roles in this field throughout the twentieth century. Several episodes illustrate this argument: the Qing organization of the International Plague Conference in 1911; the role of China i","2021","07","02","J Asian Stud","The Journal of Asian studies","COVID-19; World Health Organization; global health; international health; medical diplomacy; plague; primary health care; twentieth-century China","Brazelton","Mary Augusta","Mary Augusta Brazelton (mab94@cam.ac.uk) is University Lecturer in Global Studies of Science, Technology, and Medicine in the Department of History and Philosophy of Science at Cambridge University","mab94@cam.ac.uk"
"955","34191871","10.1017/S0021911820002272","Pandemic India: Coronavirus and the Uses of History.","The onset of the COVID-19 pandemic has produced two different narratives in India. One, here described as ""historical,"" looks back to the pandemics of the colonial past-bubonic plague from 1896, influenza in 1918-19-as a source of comparisons, lessons, and dire warnings for the present. This narrative envisages the reenactment of past scenes, including flight from the cities, victimization of the poor, and the questioning of state authority. The other narrative, here called ""insurgent,"" question","2021","07","02","J Asian Stud","The Journal of Asian studies","India; coronavirus; history; influenza; pandemics; plague","Arnold","David","David Arnold (d.arnold@warwick.ac.uk) is Professor Emeritus in the Department of History, University of Warwick, United Kingdom, and the author of Colonizing the Body: State Medicine and Epidemic Disease in Nineteenth-Century India (1993) and Burning the Dead: Hindu Nationhood and the Global Construction of Indian Tradition (forthcoming)","d.arnold@warwick.ac.uk"
"956","34191870","10.1093/ia/iiaa134","Is COVID-19 the end of US hegemony? Public bads, leadership failures and monetary hegemony.","COVID-19 is the most invasive global crisis in the postwar era, jeopardizing all dimensions of human activity. By theorizing COVID-19 as a public bad, I shed light on one of the great debates of the twentieth and twenty-first centuries regarding the relationship between the United States and liberal international order (LIO). Conceptualizing the pandemic as a public bad, I analyze its consequences for US hegemony. Unlike other international public bads and many of the most important public goods","2021","06","30","Int Aff","International affairs","Covid-19; Great Powers; Liberal democracy; hegemony; liberal international order; monetary hegemony","Norrlöf","Carla",NA,NA
"957","34191869","10.1093/ia/iiaa136","The consequence of COVID-19: how the United States moved from security provider to security consumer.","Deliberations over the COVID-19 pandemic's long-term effects on the global balance of power have spurred a large and rancorous debate, including speculation about a shift in the definition of national security and prescriptions about where it should focus. That argument will no doubt continue. But we argue that one consequence is already evident: the United States has spent the last seventy years portraying itself as a security provider in all key domains-for many an intrinsic component of its s","2021","06","30","Int Aff","International affairs","domestic politics; global health; international security","Reich","Simon",NA,NA
"958","34191869","10.1093/ia/iiaa136","The consequence of COVID-19: how the United States moved from security provider to security consumer.","Deliberations over the COVID-19 pandemic's long-term effects on the global balance of power have spurred a large and rancorous debate, including speculation about a shift in the definition of national security and prescriptions about where it should focus. That argument will no doubt continue. But we argue that one consequence is already evident: the United States has spent the last seventy years portraying itself as a security provider in all key domains-for many an intrinsic component of its s","2021","06","30","Int Aff","International affairs","domestic politics; global health; international security","Dombrowski","Peter",NA,NA
"959","34191865","10.1093/biosci/biaa071","Researchers Continue Quest to Contain Spread of COVID-19: Digital technologies aim to accelerate contact tracing.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Tibbetts","John H","Freelance science writer based, Charleston, South Carolina",NA
"960","34191864","10.1093/biosci/biaa056","COVID-19 and the Bioeconomy.",NA,"2021","06","30","Bioscience","Bioscience",NA,"Gropp","Robert E","Executive Director",NA
"961","34191863","10.1093/ahr/rhaa293","From the Editor's Desk: Teaching History in the Time of COVID-19.",NA,"2021","06","30","Am Hist Rev","The American historical review",NA,NA,NA,NA,NA
"962","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","McDowell","Michal J","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"963","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Fry","Carrie E","Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, United States of America",NA
"964","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Nisavic","Mladen","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"965","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Grossman","Mila","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"966","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Masaki","Charles","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"967","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Sorg","Emily","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"968","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Bird","Suzanne","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"969","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Smith","Felicia","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"970","34191850","10.1371/journal.pone.0253805","Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department.","To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal ideation. Using an interrupted time series design, we analyzed psychiatric presentations using electronic health record data in an academic medical center ED between 2018 and 2020. We used regression models to assess the association between the onset of the COVID-19 outbreak and certain psychiatric presentations. The period February 26-March 6, 2020 was used to define patterns","2021","07","08","PLoS One","PloS one","Adult; COVID-19; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Mental Disorders; Pandemics; Suicidal Ideation; Tertiary Care Centers","Beach","Scott R","Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States of America",NA
"971","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Marino","Silvia","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"972","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Ciurleo","Rosella","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"973","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Todaro","Antonino","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"974","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Alagna","Antonella","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"975","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Logiudice","Anna Lisa","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"976","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Corallo","Francesco","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"977","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Formica","Caterina","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"978","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Rifici","Carmela","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"979","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Pollicino","Patrizia","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"980","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Caminiti","Fabrizia","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"981","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Morini","Elisabetta","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"982","34191844","10.1371/journal.pone.0253958","The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit.","Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state-VS (can appear to be awake, but unable to purposefully interact) and minimally conscious state-MCS (minimal but definite awareness). The objective of this study is to assess the impact of the SARS-CoV-2 infection on the Disorder of Consciousness (DOC) Rehabilitation Unit. This is a retrospective, longitudinal, descriptive, observational, pilot study. We consecutively enrolled 18 patients (age range: ","2021","07","08","PLoS One","PloS one","Adult; Aged; COVID-19; Consciousness Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pandemics; Pilot Projects; Retrospective Studies","Bramanti","Placido","IRCCS Centro Neurolesi ""Bonino Pulejo"", Messina, Italy",NA
"983","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","van Dijk","Willian J","Department of Public Health &amp",NA
"984","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Saadah","Nicholas H","Department of Public Health &amp",NA
"985","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Numans","Mattijs E","Department of Public Health &amp",NA
"986","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Aardoom","Jiska J","Department of Public Health &amp",NA
"987","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Bonten","Tobias N","Department of Public Health &amp",NA
"988","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Brandjes","Menno","LogiqCare, Ortec B.V., Zoetermeer, The Netherlands",NA
"989","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Brust","Michelle","Department of Public Health &amp",NA
"990","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","le Cessie","Saskia","Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands",NA
"991","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Chavannes","Niels H","Department of Public Health &amp",NA
"992","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Middelburg","Rutger A","Department of Public Health &amp",NA
"993","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Rosendaal","Frits","Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands",NA
"994","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Visser","Leo G","Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands",NA
"995","34191828","10.1371/journal.pone.0253566","COVID RADAR app: Description and validation of population surveillance of symptoms and behavior in relation to COVID-19.","Monitoring of symptoms and behavior may enable prediction of emerging COVID-19 hotspots. The COVID Radar smartphone app, active in the Netherlands, allows users to self-report symptoms, social distancing behaviors, and COVID-19 status daily. The objective of this study is to describe the validation of the COVID Radar. COVID Radar users are asked to complete a daily questionnaire consisting of 20 questions assessing their symptoms, social distancing behavior, and COVID-19 status. We describe the ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Cohort Studies; Female; Health Behavior; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mobile Applications; Physical Distancing; Public Health Surveillance; Radar; Self Report; Young Adult","Kiefte-de Jong","Jessica","Department of Public Health &amp",NA
"996","34191825","10.1371/journal.pone.0253715","Impact of the COVID-19 pandemic on biopsychosocial health and quality of life among Danish children and adults with neuromuscular diseases (NMD)-Patient reported outcomes from a national survey.","The purpose was to investigate the impact of the COVID-19 pandemic on biopsychosocial health, daily activities, and quality of life among children and adults with neuromuscular diseases, and to assess the prevalence of COVID-19 infection and the impact of this in patients with neuromuscular diseases. The study was a national questionnaire survey. Responses were obtained from 811 adults (29%) and 67 parents of children (27%) with neuromuscular diseases. Many patients reported decreased health or ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Denmark; Female; Health Surveys; Humans; Male; Mental Health; Middle Aged; Neuromuscular Diseases; Patient Reported Outcome Measures; Quality of Life; Vaccination; Young Adult","Handberg","Charlotte","National Rehabilitation Center for Neuromuscular Diseases, Aarhus, Denmark",NA
"997","34191825","10.1371/journal.pone.0253715","Impact of the COVID-19 pandemic on biopsychosocial health and quality of life among Danish children and adults with neuromuscular diseases (NMD)-Patient reported outcomes from a national survey.","The purpose was to investigate the impact of the COVID-19 pandemic on biopsychosocial health, daily activities, and quality of life among children and adults with neuromuscular diseases, and to assess the prevalence of COVID-19 infection and the impact of this in patients with neuromuscular diseases. The study was a national questionnaire survey. Responses were obtained from 811 adults (29%) and 67 parents of children (27%) with neuromuscular diseases. Many patients reported decreased health or ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Denmark; Female; Health Surveys; Humans; Male; Mental Health; Middle Aged; Neuromuscular Diseases; Patient Reported Outcome Measures; Quality of Life; Vaccination; Young Adult","Werlauff","Ulla","National Rehabilitation Center for Neuromuscular Diseases, Aarhus, Denmark",NA
"998","34191825","10.1371/journal.pone.0253715","Impact of the COVID-19 pandemic on biopsychosocial health and quality of life among Danish children and adults with neuromuscular diseases (NMD)-Patient reported outcomes from a national survey.","The purpose was to investigate the impact of the COVID-19 pandemic on biopsychosocial health, daily activities, and quality of life among children and adults with neuromuscular diseases, and to assess the prevalence of COVID-19 infection and the impact of this in patients with neuromuscular diseases. The study was a national questionnaire survey. Responses were obtained from 811 adults (29%) and 67 parents of children (27%) with neuromuscular diseases. Many patients reported decreased health or ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Denmark; Female; Health Surveys; Humans; Male; Mental Health; Middle Aged; Neuromuscular Diseases; Patient Reported Outcome Measures; Quality of Life; Vaccination; Young Adult","Højberg","Ann-Lisbeth","National Rehabilitation Center for Neuromuscular Diseases, Aarhus, Denmark",NA
"999","34191825","10.1371/journal.pone.0253715","Impact of the COVID-19 pandemic on biopsychosocial health and quality of life among Danish children and adults with neuromuscular diseases (NMD)-Patient reported outcomes from a national survey.","The purpose was to investigate the impact of the COVID-19 pandemic on biopsychosocial health, daily activities, and quality of life among children and adults with neuromuscular diseases, and to assess the prevalence of COVID-19 infection and the impact of this in patients with neuromuscular diseases. The study was a national questionnaire survey. Responses were obtained from 811 adults (29%) and 67 parents of children (27%) with neuromuscular diseases. Many patients reported decreased health or ","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Denmark; Female; Health Surveys; Humans; Male; Mental Health; Middle Aged; Neuromuscular Diseases; Patient Reported Outcome Measures; Quality of Life; Vaccination; Young Adult","Knudsen","Lone F","National Rehabilitation Center for Neuromuscular Diseases, Aarhus, Denmark",NA
"1000","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Woskie","Liana R","Department of Health Policy, London School of Economics, London, United Kingdom",NA
"1001","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Hennessy","Jonathan","Google, LLC, Mountain View, CA, United States of America",NA
"1002","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Espinosa","Valeria","Google, LLC, Mountain View, CA, United States of America",NA
"1003","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Tsai","Thomas C","Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America",NA
"1004","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Vispute","Swapnil","Google, LLC, Mountain View, CA, United States of America",NA
"1005","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Jacobson","Benjamin H","Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America",NA
"1006","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Cattuto","Ciro","University of Turin, Turin, Italy",NA
"1007","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Gauvin","Laetitia","ISI Foundation, Turin, Italy",NA
"1008","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Tizzoni","Michele","ISI Foundation, Turin, Italy",NA
"1009","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Fabrikant","Alex","Google, LLC, Mountain View, CA, United States of America",NA
"1010","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Gadepalli","Krishna","Google, LLC, Mountain View, CA, United States of America",NA
"1011","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Boulanger","Adam","Google, LLC, Mountain View, CA, United States of America",NA
"1012","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Pearce","Adam","Google, LLC, Mountain View, CA, United States of America",NA
"1013","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Kamath","Chaitanya","Google, LLC, Mountain View, CA, United States of America",NA
"1014","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Schlosberg","Arran","Google, LLC, Mountain View, CA, United States of America",NA
"1015","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Stanton","Charlotte","Google, LLC, Mountain View, CA, United States of America",NA
"1016","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Bavadekar","Shailesh","Google, LLC, Mountain View, CA, United States of America",NA
"1017","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Abueg","Matthew","Google, LLC, Mountain View, CA, United States of America",NA
"1018","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Hogue","Michael","Google, LLC, Mountain View, CA, United States of America",NA
"1019","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Oplinger","Andrew","Google, LLC, Mountain View, CA, United States of America",NA
"1020","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Chou","Katherine","Google, LLC, Mountain View, CA, United States of America",NA
"1021","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Corrado","Greg","Google, LLC, Mountain View, CA, United States of America",NA
"1022","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Shekel","Tomer","Google, LLC, Mountain View, CA, United States of America",NA
"1023","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Jha","Ashish K","Brown University School of Public Health, Providence, RI, United States of America",NA
"1024","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Wellenius","Gregory A","Google, LLC, Mountain View, CA, United States of America",NA
"1025","34191818","10.1371/journal.pone.0253071","Early social distancing policies in Europe, changes in mobility &amp; COVID-19 case trajectories: Insights from Spring 2020.","Social distancing have been widely used to mitigate community spread of SARS-CoV-2. We sought to quantify the impact of COVID-19 social distancing policies across 27 European counties in spring 2020 on population mobility and the subsequent trajectory of disease. We obtained data on national social distancing policies from the Oxford COVID-19 Government Response Tracker and aggregated and anonymized mobility data from Google. We used a pre-post comparison and two linear mixed-effects models to f","2021","07","08","PLoS One","PloS one","COVID-19; Europe; Health Policy; Humans; Linear Models; Pandemics; Physical Distancing; Quarantine","Gabrilovich","Evgeniy","Google, LLC, Mountain View, CA, United States of America",NA
"1026","34191771","10.1097/SCS.0000000000007753","Overturning the Impact of COVID-19 on Surgical Outreach Programs Through Innovation: The Role of Telehealth.",NA,"2021","06","30","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Chahine","Elsa M","Global Smile Foundation, Norwood, MA Department of Surgery, Oregon Health &amp",NA
"1027","34191771","10.1097/SCS.0000000000007753","Overturning the Impact of COVID-19 on Surgical Outreach Programs Through Innovation: The Role of Telehealth.",NA,"2021","06","30","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Annan","Beyhan","Global Smile Foundation, Norwood, MA Department of Surgery, Oregon Health &amp",NA
"1028","34191771","10.1097/SCS.0000000000007753","Overturning the Impact of COVID-19 on Surgical Outreach Programs Through Innovation: The Role of Telehealth.",NA,"2021","06","30","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Ramly","Elie P","Global Smile Foundation, Norwood, MA Department of Surgery, Oregon Health &amp",NA
"1029","34191771","10.1097/SCS.0000000000007753","Overturning the Impact of COVID-19 on Surgical Outreach Programs Through Innovation: The Role of Telehealth.",NA,"2021","06","30","J Craniofac Surg","The Journal of craniofacial surgery",NA,"Hamdan","Usama S","Global Smile Foundation, Norwood, MA Department of Surgery, Oregon Health &amp",NA
"1030","34191764","10.1097/DBP.0000000000000988","COVID-19 Pandemic Highlights Access Barriers for Children with Autism Spectrum Disorder.",NA,"2021","06","30","J Dev Behav Pediatr","Journal of developmental and behavioral pediatrics : JDBP",NA,"McNally Keehn","Rebecca","Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN",NA
"1031","34191764","10.1097/DBP.0000000000000988","COVID-19 Pandemic Highlights Access Barriers for Children with Autism Spectrum Disorder.",NA,"2021","06","30","J Dev Behav Pediatr","Journal of developmental and behavioral pediatrics : JDBP",NA,"Tomlin","Angela","Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN",NA
"1032","34191764","10.1097/DBP.0000000000000988","COVID-19 Pandemic Highlights Access Barriers for Children with Autism Spectrum Disorder.",NA,"2021","06","30","J Dev Behav Pediatr","Journal of developmental and behavioral pediatrics : JDBP",NA,"Ciccarelli","Mary R","Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN",NA
"1033","34191758","10.1097/MEG.0000000000002239","Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.","The coronavirus disease 2019 (COVID-19) pandemic raised concerns among inflammatory bowel disease (IBD) patients fearing an increased risk of infection and poor outcomes. We aimed to evaluate the incidence of COVID-19 among IBD patients; its influence on disease severity and outcome; its relationship to medication use and how the pandemic affected IBD management. An anonymous questionnaire was posted online to members of the Israel Crohn's Disease and Ulcerative Colitis Foundation (November 2020","2021","06","30","Eur J Gastroenterol Hepatol","European journal of gastroenterology &amp; hepatology",NA,"Richter","Vered","Gonczarowski Family Gastroenterology and Liver Diseases Institute, Shamir Medical Center Jecheskel Gonczarowski Pediatric Gastroenterology Service, Shamir Medical Center, Zerifin, Israel Sacker School of Medicine, Tel-Aviv University",NA
"1034","34191758","10.1097/MEG.0000000000002239","Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.","The coronavirus disease 2019 (COVID-19) pandemic raised concerns among inflammatory bowel disease (IBD) patients fearing an increased risk of infection and poor outcomes. We aimed to evaluate the incidence of COVID-19 among IBD patients; its influence on disease severity and outcome; its relationship to medication use and how the pandemic affected IBD management. An anonymous questionnaire was posted online to members of the Israel Crohn's Disease and Ulcerative Colitis Foundation (November 2020","2021","06","30","Eur J Gastroenterol Hepatol","European journal of gastroenterology &amp; hepatology",NA,"Bermont","Anton","Gonczarowski Family Gastroenterology and Liver Diseases Institute, Shamir Medical Center Jecheskel Gonczarowski Pediatric Gastroenterology Service, Shamir Medical Center, Zerifin, Israel Sacker School of Medicine, Tel-Aviv University",NA
"1035","34191758","10.1097/MEG.0000000000002239","Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.","The coronavirus disease 2019 (COVID-19) pandemic raised concerns among inflammatory bowel disease (IBD) patients fearing an increased risk of infection and poor outcomes. We aimed to evaluate the incidence of COVID-19 among IBD patients; its influence on disease severity and outcome; its relationship to medication use and how the pandemic affected IBD management. An anonymous questionnaire was posted online to members of the Israel Crohn's Disease and Ulcerative Colitis Foundation (November 2020","2021","06","30","Eur J Gastroenterol Hepatol","European journal of gastroenterology &amp; hepatology",NA,"Cohen","Daniel L","Gonczarowski Family Gastroenterology and Liver Diseases Institute, Shamir Medical Center Jecheskel Gonczarowski Pediatric Gastroenterology Service, Shamir Medical Center, Zerifin, Israel Sacker School of Medicine, Tel-Aviv University",NA
"1036","34191758","10.1097/MEG.0000000000002239","Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.","The coronavirus disease 2019 (COVID-19) pandemic raised concerns among inflammatory bowel disease (IBD) patients fearing an increased risk of infection and poor outcomes. We aimed to evaluate the incidence of COVID-19 among IBD patients; its influence on disease severity and outcome; its relationship to medication use and how the pandemic affected IBD management. An anonymous questionnaire was posted online to members of the Israel Crohn's Disease and Ulcerative Colitis Foundation (November 2020","2021","06","30","Eur J Gastroenterol Hepatol","European journal of gastroenterology &amp; hepatology",NA,"Broide","Efrat","Gonczarowski Family Gastroenterology and Liver Diseases Institute, Shamir Medical Center Jecheskel Gonczarowski Pediatric Gastroenterology Service, Shamir Medical Center, Zerifin, Israel Sacker School of Medicine, Tel-Aviv University",NA
"1037","34191758","10.1097/MEG.0000000000002239","Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.","The coronavirus disease 2019 (COVID-19) pandemic raised concerns among inflammatory bowel disease (IBD) patients fearing an increased risk of infection and poor outcomes. We aimed to evaluate the incidence of COVID-19 among IBD patients; its influence on disease severity and outcome; its relationship to medication use and how the pandemic affected IBD management. An anonymous questionnaire was posted online to members of the Israel Crohn's Disease and Ulcerative Colitis Foundation (November 2020","2021","06","30","Eur J Gastroenterol Hepatol","European journal of gastroenterology &amp; hepatology",NA,"Shirin","Haim","Gonczarowski Family Gastroenterology and Liver Diseases Institute, Shamir Medical Center Jecheskel Gonczarowski Pediatric Gastroenterology Service, Shamir Medical Center, Zerifin, Israel Sacker School of Medicine, Tel-Aviv University",NA
"1038","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Kapp","Meghan E","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1039","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Fogo","Agnes B","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1040","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Roufouse","Candice","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1041","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Najafian","Behzad","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1042","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Radhakrishnan","Jai","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1043","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Mohan","Sumit","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1044","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Miller","Sara E","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1045","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"D'Agati","Vivette D","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1046","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Silberzweig","Jeffrey Irs","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1047","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Barbar","Tarek","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1048","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Gopalan","Tulasi","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1049","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Srivatana","Vesh","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1050","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Mokrzycki","Michele H","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1051","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Benstein","Judith A","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1052","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Ng","Yue-Harn","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1053","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Lentine","Krista L","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1054","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Aggarwal","Vikram","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1055","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Perl","Jeffrey","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1056","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Salenger","Page","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1057","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Coyner","Jay","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1058","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Josephson","Michelle A","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1059","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Heung","Michael","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1060","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Velez","Juan Carlos","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1061","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Ikizler","Alp","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1062","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Vijayan","Anitha","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1063","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"William","Preethi","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1064","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Thajudeen","Bijin","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1065","34191753","10.1097/MAT.0000000000001530","Renal Considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology.","Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has emerged into a worldwide pandemic of epic proportion. Beyond pulmonary involvement in COVID-19, a significant subset of patients experiences acute kidney injury. Patients who die from severe disease most notably show diffuse acute tubular injury on postmortem examination with a possible contribution of focal macro- and microvascular thrombi. Renal biopsies in patients with proteinuria and hematuria have demonstrated a glomerular do","2021","06","30","ASAIO J","ASAIO journal (American Society for Artificial Internal Organs : 1992)",NA,"Slepian","Marvin J","Department of Pathology, Vanderbilt University Medical Center.1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Faculty of Medicine, Consultant histopathologist, Department of Immunology and Inflammation, Imperial college healthcare Department of pathology, University of Washington Medicine, Box 356100, 1959 NE Pacific St., Seattle, WA 98195 Division of Nephrology, Columbia University Medical Center, 622 W 168th St, New York, NY 10032 Department of pathology, Duke University School of Medicine, 40 Medicine Circle, Dhs 3083 - Yellow Zone, Durham, NC 27710 Department of pathology and cell biology, Columbia University, 630 W 168th St, New York, NY 10032 Division of Nephrology, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065 Division of Nephrology, Montefiore Medical Center, Albert Einstein College of Medicine, 3411 Wayne Ave, Suite 5H, Bronx, NY 10467 Department of Medicine, NYU Tisch Hospital, 550 First Avenue, New York, NY 10016 Division of Nephrology, University of Washington, Box 356174, 1959 NE Pacific St. Seattle, WA 98195 Center for Abdominal Transplantation, 1402 S. Grand Blvd., Division of Nephrology (9-FDT), St. Louis, MO 63104 Division of Nephrology, Northwestern Medicine, Olson building Room 4-500, 710 N Fairbanks Ct Ste 500, Chicago Illinois 60611-3013 Divison of Nephrology, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2 Dialysis Clinics Incorporated, Nashville, Tennessee. Department of Nephrology, University of Chicago, 5841 South Maryland Avenue,MC 5100- Suite S-507, Chicago, IL 60637 Division of Nephrology, Department of Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI 48109-5364 Department of Nephrology, Ochsner Health System, 1514 Jefferson Hwy, Clinic Tower, Rm 5E328, New Orleans, LA 70121 Division of Nephrology, Vanderbilt University Medical Center, 1301 Medical Center Drive, Suite 2501A, Nashville, TN 37232 Department of Medicine - Nephrology, Washington University School of Medicine in St Louis, 4921 Parkview Place, Suite C, 5th Floor, St. Louis, MO 63110 Division of Cardiology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Division of Nephrology, Banner University of Arizona, 1501 N Campbell Ave, Tucson , AZ 85724 Departments of Medicine and Biomedical Engineering, Sarver Heart Cente, University of Arizona, 1501 North Campbell Avenue, Tucson, Arizona 85724 Disclosure All the authors declared no competing interests. Source of Funding Statement There is no financial support for the preparation of this manuscript",NA
"1066","34191750","10.2106/JBJS.21.00494","What's Important: Addressing Anti-Asian Discrimination and Violence in the Age of COVID-19.",NA,"2021","06","30","J Bone Joint Surg Am","The Journal of bone and joint surgery. American volume",NA,"Zhang","Dafang","Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts",NA
"1067","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Takorov","Ivelin",NA,NA
"1068","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Lukanova","Tsonka",NA,NA
"1069","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Abrasheva","Maria",NA,NA
"1070","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Arnaudov","Stefan",NA,NA
"1071","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Simeonovski","Stefan",NA,NA
"1072","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Vylcheva","Dimitria",NA,NA
"1073","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Dimitrov","Dimitar",NA,NA
"1074","34191715","10.21614/chirurgia.116.3.339","COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center.","Introduction: There are still debatable facts about estimating the risk and severity of coronavirus disease (COVID-19) in liver transplant recipients, as well as assessing the impact of the immunosuppressive therapy on the clinical course and incidence of liver failure. Material and Methods: We present a prospective study of liver transplant recipients with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection admitted for treatment to the department of First Clinic ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; livertransplantation; COVID-19; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome","Stanimirov","Tsvetan",NA,NA
"1075","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Radulovic","Radosav S",NA,NA
"1076","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Cuk","Vladica V",NA,NA
"1077","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Juloski","Jovan T",NA,NA
"1078","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Arbutina","Dragana D",NA,NA
"1079","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Krdic","Igor D",NA,NA
"1080","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Milic","Ljiljana V",NA,NA
"1081","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Kenic","Marko V",NA,NA
"1082","34191714","10.21614/chirurgia.116.3.331","Is Colorectal Cancer Stage Affected by COVID-19 Pandemic?","Background: Causing healthcare systems overload, COVID-19 pandemic has a huge influence on patients with colorectal cancer. The aim of our study was to assess the potential impact of COVID-19 on the stage of colorectal cancer. Methods: In our retrospective study, two groups of patients operated for colorectal cancer were analyzed at the Clinic for Surgery ""Nikola Spasic"", Zvezdara University Medical Center. The study group consisted of 49 patients operated in the period from March ","2021","07","02","Chirurgia (Bucur)","Chirurgia (Bucharest, Romania : 1990)","COVID-19; cancerstage; colorectalcancer; COVID-19; Colorectal Neoplasms; Humans; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome","Karamarkovic","Aleksandar R",NA,NA
"1083","34191701","10.2174/1573405617666210629130023","Coronavirus Disease (COVID-19) compared with Middle East Respiratory Syndrome (MERS): A Radiological Perspective.","This study aims to describe the radiological findings in chest radiographs (CXRs) of patients with coronavirus disease (COVID-19) and the Middle East respiratory syndrome (MERS) and compare the radiological patterns of the two diseases. A retrospective cohort study was conducted in a tertiary care hospital in the Southern region of Saudi Arabia. The CXRs were evaluated for the presence and distribution of ground-glass opacities (GGO), consolidation, pleural effusions, pneumothorax, cavitation, a","2021","06","30","Curr Med Imaging","Current medical imaging","Middle East respiratory syndrome; chest X-ray; coronavirus; coronavirus disease 2019; covid-19; radiology","Alshumrani","Ghazi","Department of Radiology, College of Medicine, King Khalid University P.O. Box 641, Abha 61421, Saudi Arabia",NA
"1084","34191701","10.2174/1573405617666210629130023","Coronavirus Disease (COVID-19) compared with Middle East Respiratory Syndrome (MERS): A Radiological Perspective.","This study aims to describe the radiological findings in chest radiographs (CXRs) of patients with coronavirus disease (COVID-19) and the Middle East respiratory syndrome (MERS) and compare the radiological patterns of the two diseases. A retrospective cohort study was conducted in a tertiary care hospital in the Southern region of Saudi Arabia. The CXRs were evaluated for the presence and distribution of ground-glass opacities (GGO), consolidation, pleural effusions, pneumothorax, cavitation, a","2021","06","30","Curr Med Imaging","Current medical imaging","Middle East respiratory syndrome; chest X-ray; coronavirus; coronavirus disease 2019; covid-19; radiology","Al Bshabshe","Ali","Department of Medicine, Division of critical care, college of medicine, King Khalid University Abha, Saudi Arabia",NA
"1085","34191701","10.2174/1573405617666210629130023","Coronavirus Disease (COVID-19) compared with Middle East Respiratory Syndrome (MERS): A Radiological Perspective.","This study aims to describe the radiological findings in chest radiographs (CXRs) of patients with coronavirus disease (COVID-19) and the Middle East respiratory syndrome (MERS) and compare the radiological patterns of the two diseases. A retrospective cohort study was conducted in a tertiary care hospital in the Southern region of Saudi Arabia. The CXRs were evaluated for the presence and distribution of ground-glass opacities (GGO), consolidation, pleural effusions, pneumothorax, cavitation, a","2021","06","30","Curr Med Imaging","Current medical imaging","Middle East respiratory syndrome; chest X-ray; coronavirus; coronavirus disease 2019; covid-19; radiology","Mousa","Wesam Faried","Khamis Mushait General Hospital Khamis Mushait, Saudi Arabia",NA
"1086","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Boulkrane","Mohamed Said","International Research Centre ""Biotechnologies of the Third Millennium"", ITMO University, Saint-Petersburg, Russian Federation",NA
"1087","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Ilina","Victoria","International Research Centre ""Biotechnologies of the Third Millennium"", ITMO University, Saint-Petersburg, Russian Federation",NA
"1088","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Melchakov","Roman","International Research Centre ""Biotechnologies of the Third Millennium"", ITMO University, Saint-Petersburg, Russian Federation",NA
"1089","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Arisov","Mikhail","All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plants - a branch of the Federal State Budget Scientific Institution ""Federal Scientific Centre VIEV"", Moscow, Russian Federation",NA
"1090","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Fedotova","Julia","International Research Centre ""Biotechnologies of the Third Millennium"", ITMO University, Saint-Petersburg, Russian Federation",NA
"1091","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Gozzo","Lucia","Department of Biomedical and Biotechnological Sciences, Biological Tower, School of Medicine, University of Catania, Catania, Italy",NA
"1092","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Drago","Filippo","Department of Biomedical and Biotechnological Sciences, Biological Tower, School of Medicine, University of Catania, Catania, Italy",NA
"1093","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Lu","Weihong","Institute of Extreme Environment Nutrition and Protection, Harbin Institute of Technology, Harbin, China",NA
"1094","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Sarapultsev","Alexey","School of Medical Biology, South Ural State University, 76 Lenin prospect, Chelaybinsk, Russian Federation",NA
"1095","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Tceilikman","Vadim","School of Medical Biology, South Ural State University, 76 Lenin prospect, Chelaybinsk, Russian Federation",NA
"1096","34191699","10.2174/1570159X19666210629151303","The impact of SARS-Cov-2 on the Nervous system and Mental Health.","The World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impai","2021","06","30","Curr Neuropharmacol","Current neuropharmacology","COVID-19; SARS-CoV-2; brain disorders; mental health; neuroinvasivepotential; neurological diseases","Baranenko","Denis","International Research Centre ""Biotechnologies of the Third Millennium"", ITMO University, Saint-Petersburg, Russian Federation",NA
"1097","34191697","10.2174/1389557521666210629100630","Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.","Severe Acute Respiratory Syndrome (SARS) is caused by different SARS viruses. In 2020, novel coronavirus (SARS-CoV-2) led to an ongoing pandemic, known as ""Coronavirus Disease 2019 (COVID-19)"". The disease can spread among individuals through direct (via saliva, respiratory secretions or secretion droplets) or indirect (through contaminated objects or surfaces) contact. The pandemic has spread rapidly from Asia to Europe and later to America. It continues to affect all parts of the world at an i","2021","06","30","Mini Rev Med Chem","Mini reviews in medicinal chemistry","COVID-19; SARS-CoV-2; antiviral drugs; neurotoxicity; newborn; olfactory epithelium","Ünlü","Büsra","TOBB University, Bioengineering Department, Ankara, Turkey",NA
"1098","34191697","10.2174/1389557521666210629100630","Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.","Severe Acute Respiratory Syndrome (SARS) is caused by different SARS viruses. In 2020, novel coronavirus (SARS-CoV-2) led to an ongoing pandemic, known as ""Coronavirus Disease 2019 (COVID-19)"". The disease can spread among individuals through direct (via saliva, respiratory secretions or secretion droplets) or indirect (through contaminated objects or surfaces) contact. The pandemic has spread rapidly from Asia to Europe and later to America. It continues to affect all parts of the world at an i","2021","06","30","Mini Rev Med Chem","Mini reviews in medicinal chemistry","COVID-19; SARS-CoV-2; antiviral drugs; neurotoxicity; newborn; olfactory epithelium","Simsek","Rahime","Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Sihhiye 06100, Ankara, Turkey",NA
"1099","34191697","10.2174/1389557521666210629100630","Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.","Severe Acute Respiratory Syndrome (SARS) is caused by different SARS viruses. In 2020, novel coronavirus (SARS-CoV-2) led to an ongoing pandemic, known as ""Coronavirus Disease 2019 (COVID-19)"". The disease can spread among individuals through direct (via saliva, respiratory secretions or secretion droplets) or indirect (through contaminated objects or surfaces) contact. The pandemic has spread rapidly from Asia to Europe and later to America. It continues to affect all parts of the world at an i","2021","06","30","Mini Rev Med Chem","Mini reviews in medicinal chemistry","COVID-19; SARS-CoV-2; antiviral drugs; neurotoxicity; newborn; olfactory epithelium","Köse","Selinay Basak Erdemli","Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Sihhiye 06100, Ankara, Turkey",NA
"1100","34191697","10.2174/1389557521666210629100630","Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.","Severe Acute Respiratory Syndrome (SARS) is caused by different SARS viruses. In 2020, novel coronavirus (SARS-CoV-2) led to an ongoing pandemic, known as ""Coronavirus Disease 2019 (COVID-19)"". The disease can spread among individuals through direct (via saliva, respiratory secretions or secretion droplets) or indirect (through contaminated objects or surfaces) contact. The pandemic has spread rapidly from Asia to Europe and later to America. It continues to affect all parts of the world at an i","2021","06","30","Mini Rev Med Chem","Mini reviews in medicinal chemistry","COVID-19; SARS-CoV-2; antiviral drugs; neurotoxicity; newborn; olfactory epithelium","Yirün","Anil","Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Sihhiye 06100, Ankara, Turkey",NA
"1101","34191697","10.2174/1389557521666210629100630","Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.","Severe Acute Respiratory Syndrome (SARS) is caused by different SARS viruses. In 2020, novel coronavirus (SARS-CoV-2) led to an ongoing pandemic, known as ""Coronavirus Disease 2019 (COVID-19)"". The disease can spread among individuals through direct (via saliva, respiratory secretions or secretion droplets) or indirect (through contaminated objects or surfaces) contact. The pandemic has spread rapidly from Asia to Europe and later to America. It continues to affect all parts of the world at an i","2021","06","30","Mini Rev Med Chem","Mini reviews in medicinal chemistry","COVID-19; SARS-CoV-2; antiviral drugs; neurotoxicity; newborn; olfactory epithelium","Erkekoglu","Pinar","Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Sihhiye 06100, Ankara, Turkey",NA
"1102","34191693","10.1513/AnnalsATS.202105-623LE","Use of Corticosteroid in Persistent Post-COVID 19 Interstitial Lung Disease.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Khaw","Chuen R","Homerton University Hospital NHS Foundation Trust, 4721, Respiratory Medicine, London, United Kingdom of Great Britain and Northern Ireland","chuen.khaw@nhs.net"
"1103","34191693","10.1513/AnnalsATS.202105-623LE","Use of Corticosteroid in Persistent Post-COVID 19 Interstitial Lung Disease.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Richardson","Charlotte","Homerton University Hospital NHS Foundation Trust, 4721, Respiratory Medicine, London, United Kingdom of Great Britain and Northern Ireland",NA
"1104","34191693","10.1513/AnnalsATS.202105-623LE","Use of Corticosteroid in Persistent Post-COVID 19 Interstitial Lung Disease.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Bhowmik","Angshu","Homerton University Hospital NHS Foundation Trust, 4721, Respiratory Medicine, London, London, United Kingdom of Great Britain and Northern Ireland",NA
"1105","34191693","10.1513/AnnalsATS.202105-623LE","Use of Corticosteroid in Persistent Post-COVID 19 Interstitial Lung Disease.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Agbetile","Joshua","Homerton University Hospital NHS Foundation Trust, 4721, Respiratory Medicine, London, United Kingdom of Great Britain and Northern Ireland",NA
"1106","34191693","10.1513/AnnalsATS.202105-623LE","Use of Corticosteroid in Persistent Post-COVID 19 Interstitial Lung Disease.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Rajakulasingam","Raj K","Homerton University Hospital NHS Foundation Trust, 4721, London, London, United Kingdom of Great Britain and Northern Ireland",NA
"1107","34191683","10.1080/17441692.2021.1945124","Sex workers on the frontline: An abridged version of the original ICRSE report: 'The role of sex worker rights groups in providing support during the COVID-19 crisis in Europe'.","Sex workers in Europe have been dramatically impacted by the COVID-19 pandemic and its associated measures. Ignored by most governments, excluded from social and economic measures put in place to protect other workers, sex workers were left to fend for themselves. The article, an abridged version of a previous report by the ICRSE, illustrates the impact of COVID-19 on sex workers by focusing on how the pandemic affected the socio-economic, health and safety conditions of sex worker communities a","2021","06","30","Glob Public Health","Global public health","Europe; Sex work; activism; advocacy; covid-19","Fedorkó","Boglárka","ICRSE, International Committee on the Rights of Sex Workers in Europe",NA
"1108","34191683","10.1080/17441692.2021.1945124","Sex workers on the frontline: An abridged version of the original ICRSE report: 'The role of sex worker rights groups in providing support during the COVID-19 crisis in Europe'.","Sex workers in Europe have been dramatically impacted by the COVID-19 pandemic and its associated measures. Ignored by most governments, excluded from social and economic measures put in place to protect other workers, sex workers were left to fend for themselves. The article, an abridged version of a previous report by the ICRSE, illustrates the impact of COVID-19 on sex workers by focusing on how the pandemic affected the socio-economic, health and safety conditions of sex worker communities a","2021","06","30","Glob Public Health","Global public health","Europe; Sex work; activism; advocacy; covid-19","Stevenson","Luca","ICRSE, International Committee on the Rights of Sex Workers in Europe",NA
"1109","34191683","10.1080/17441692.2021.1945124","Sex workers on the frontline: An abridged version of the original ICRSE report: 'The role of sex worker rights groups in providing support during the COVID-19 crisis in Europe'.","Sex workers in Europe have been dramatically impacted by the COVID-19 pandemic and its associated measures. Ignored by most governments, excluded from social and economic measures put in place to protect other workers, sex workers were left to fend for themselves. The article, an abridged version of a previous report by the ICRSE, illustrates the impact of COVID-19 on sex workers by focusing on how the pandemic affected the socio-economic, health and safety conditions of sex worker communities a","2021","06","30","Glob Public Health","Global public health","Europe; Sex work; activism; advocacy; covid-19","Macioti","P G","ICRSE, International Committee on the Rights of Sex Workers in Europe",NA
"1110","34191682","10.1080/21645515.2021.1940650","Inhaled antibodies: Quality and performance considerations.","The use of antibodies in the treatment of lung diseases is of increasing interest especially as the search for COVID-19 therapies has unfolded. Historically, the use of antibody therapy was based on multiple targets including receptors involved in local hyper-reactivity in asthma, viruses and micro-organisms involved in a variety of pulmonary infectious disease. Generally, protein therapeutics pose challenges with respect to formulation and delivery to retain activity and assure therapy. The spe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Aerosols; antibodies; formulation; lungs; stability; therapeutics","Hickey","Anthony James","RTI International, Research Triangle Park, NC, USA",NA
"1111","34191682","10.1080/21645515.2021.1940650","Inhaled antibodies: Quality and performance considerations.","The use of antibodies in the treatment of lung diseases is of increasing interest especially as the search for COVID-19 therapies has unfolded. Historically, the use of antibody therapy was based on multiple targets including receptors involved in local hyper-reactivity in asthma, viruses and micro-organisms involved in a variety of pulmonary infectious disease. Generally, protein therapeutics pose challenges with respect to formulation and delivery to retain activity and assure therapy. The spe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Aerosols; antibodies; formulation; lungs; stability; therapeutics","Stewart","Ian Edward","RTI International, Research Triangle Park, NC, USA",NA
"1112","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Dhama","Kuldeep","Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India",NA
"1113","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Sharun","Khan","Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India",NA
"1114","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Tiwari","Ruchi","Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, India",NA
"1115","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Dhawan","Manish","Department of Microbiology, Punjab Agricultural University, Ludhiana, India",NA
"1116","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Emran","Talha Bin","Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh",NA
"1117","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Rabaan","Ali A","Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia",NA
"1118","34191680","10.1080/21645515.2021.1926183","COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.","The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive furthe","2021","06","30","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; SARS-CoV-2; vaccination; vaccine hesitancy","Alhumaid","Saad","Administration of Pharmaceutical Care, AlAhsa Health Cluster, Ministry of Health, AlAhsa, Saudi Arabia",NA
"1119","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Reznik","Alexander","Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev, Beer Sheva, Israel",NA
"1120","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Gritsenko","Valentina","Department of Social Psychology, Moscow State University of Psychology and Education, Moscow, Russia",NA
"1121","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Konstantinov","Vsevolod","Department of General Psychology, Penza State University, Penza, Russia",NA
"1122","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Zinurova","Raushaniia","Department of Management and Entrepreneurship, Kazan National Research Technological University, Kazan, Russia",NA
"1123","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Kulesh","Elena","Department of Psychology, Pacific State University, Khabarovsk, Russia",NA
"1124","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Osipenko","Irina","Department of Clinical Psychology, Smolensk State Medical University, Smolensk, Russia",NA
"1125","34191676","10.1080/07399332.2021.1922409","COVID 19 fear impact on Israeli and Russian female student mental health, substance use and resilience.",NA,"2021","06","30","Health Care Women Int","Health care for women international",NA,"Isralowitz","Richard","Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev, Beer Sheva, Israel",NA
"1126","34191659","10.1177/00368504211028373","Disparity between scientific accomplishment and biotechnology availability in Brazil.","Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countrie","2021","07","15","Sci Prog","Science progress","Brazilian biotechnology; Brazilian entrepreneurs; Brazilian scientists; Neglected technological investment; for-profit industries; start-up companies; Biomedical Technology; Biotechnology; Brazil; COVID-19; Humans; Research; SARS-CoV-2","Braz","Lucia Maria Almeida","Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil",NA
"1127","34191659","10.1177/00368504211028373","Disparity between scientific accomplishment and biotechnology availability in Brazil.","Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countrie","2021","07","15","Sci Prog","Science progress","Brazilian biotechnology; Brazilian entrepreneurs; Brazilian scientists; Neglected technological investment; for-profit industries; start-up companies; Biomedical Technology; Biotechnology; Brazil; COVID-19; Humans; Research; SARS-CoV-2","Tahmasebi","Roozbeh","Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil",NA
"1128","34191659","10.1177/00368504211028373","Disparity between scientific accomplishment and biotechnology availability in Brazil.","Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countrie","2021","07","15","Sci Prog","Science progress","Brazilian biotechnology; Brazilian entrepreneurs; Brazilian scientists; Neglected technological investment; for-profit industries; start-up companies; Biomedical Technology; Biotechnology; Brazil; COVID-19; Humans; Research; SARS-CoV-2","da Costa","Antonio Charlys","Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil",NA
"1129","34191659","10.1177/00368504211028373","Disparity between scientific accomplishment and biotechnology availability in Brazil.","Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countrie","2021","07","15","Sci Prog","Science progress","Brazilian biotechnology; Brazilian entrepreneurs; Brazilian scientists; Neglected technological investment; for-profit industries; start-up companies; Biomedical Technology; Biotechnology; Brazil; COVID-19; Humans; Research; SARS-CoV-2","Witkin","Steven S","Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil",NA
"1130","34191651","10.3928/00989134-20210611-01","The Importance of Delirium Before and After COVID-19.",NA,"2021","07","02","J Gerontol Nurs","Journal of gerontological nursing",NA,"Skipper","Alan W","Georgia Southern University, School of Nursing Statesboro, Georgia",NA
"1131","34191651","10.3928/00989134-20210611-01","The Importance of Delirium Before and After COVID-19.",NA,"2021","07","02","J Gerontol Nurs","Journal of gerontological nursing",NA,"Zanetos","Joanne","Georgia Southern University, School of Nursing Statesboro, Georgia",NA
"1132","34191649","10.3928/00989134-20210604-01","Targeting Delirium Risk Factors During a Pandemic: AGS CoCare<sup>®</sup>: HELP<sup>®</sup> in the Era of COVID-19 and Beyond.",NA,"2021","07","02","J Gerontol Nurs","Journal of gerontological nursing",NA,"Hollmann","Peter","American Geriatrics Society",NA
"1133","34191642","10.1080/02646838.2021.1931071","'Pregnant women voice their concerns and delivery method preferences during the COVID-19 pandemic in Turkey'.","Objective: To evaluate pregnant women's voice their concerns and delivery method preferences during the COVID-19 pandemic in Turkey.Methods: A cross-sectional study is survey based using an online survey platform. Three hundred pregnant women were included between 16 May and 12 June 2020 in Turkey. Sociodemographic features, obstetric features, concerns about COVID-19, delivery method preferences, and Brief Measure of Worry Severity were evaluated.Results: It was determined ","2021","07","02","J Reprod Infant Psychol","Journal of reproductive and infant psychology","COVID-19 pandemic; Infant; labour; pregnancy; psychosocial factors","Çalik","Kiymet Yesilçiçek","Faculty of Health Science, Obstetrics and Gynaecology Nursing Department, Karadeniz Technical University, Trabzon, Turkey",NA
"1134","34191642","10.1080/02646838.2021.1931071","'Pregnant women voice their concerns and delivery method preferences during the COVID-19 pandemic in Turkey'.","Objective: To evaluate pregnant women's voice their concerns and delivery method preferences during the COVID-19 pandemic in Turkey.Methods: A cross-sectional study is survey based using an online survey platform. Three hundred pregnant women were included between 16 May and 12 June 2020 in Turkey. Sociodemographic features, obstetric features, concerns about COVID-19, delivery method preferences, and Brief Measure of Worry Severity were evaluated.Results: It was determined ","2021","07","02","J Reprod Infant Psychol","Journal of reproductive and infant psychology","COVID-19 pandemic; Infant; labour; pregnancy; psychosocial factors","Küçük","Ebru","Faculty of Health Science, Obstetrics and Gynaecology Nursing Department, Karadeniz Technical University, Trabzon, Turkey",NA
"1135","34191642","10.1080/02646838.2021.1931071","'Pregnant women voice their concerns and delivery method preferences during the COVID-19 pandemic in Turkey'.","Objective: To evaluate pregnant women's voice their concerns and delivery method preferences during the COVID-19 pandemic in Turkey.Methods: A cross-sectional study is survey based using an online survey platform. Three hundred pregnant women were included between 16 May and 12 June 2020 in Turkey. Sociodemographic features, obstetric features, concerns about COVID-19, delivery method preferences, and Brief Measure of Worry Severity were evaluated.Results: It was determined ","2021","07","02","J Reprod Infant Psychol","Journal of reproductive and infant psychology","COVID-19 pandemic; Infant; labour; pregnancy; psychosocial factors","Beydag","Kerime Derya","Department of Nursing, Faculty of Health Sciences, Istanbul Okan University, Istanbul, Turkey",NA
"1136","34191617","10.1089/omi.2021.0080","Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?","The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is anticipated to transition to an endemic state as vaccines are providing relief in some, but not all, countries. Drug discovery for COVID-19 can offer another tool in the fight against the pandemic. Additionally, COVID-19 impacts multiple organs that call for a systems medicine approach to planetary health and therapeutics innovation. In this context, innovation for","2021","07","16","OMICS","Omics : a journal of integrative biology","COVID-19; SARS-CoV-2; acute respiratory distress syndrome; bradykinin storm; cytokine storm; drug discovery; neprilysin","Rex","Devasahayam Arokia Balaya","Center for Systems Biology and Molecular Medicine, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore, India",NA
"1137","34191617","10.1089/omi.2021.0080","Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?","The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is anticipated to transition to an endemic state as vaccines are providing relief in some, but not all, countries. Drug discovery for COVID-19 can offer another tool in the fight against the pandemic. Additionally, COVID-19 impacts multiple organs that call for a systems medicine approach to planetary health and therapeutics innovation. In this context, innovation for","2021","07","16","OMICS","Omics : a journal of integrative biology","COVID-19; SARS-CoV-2; acute respiratory distress syndrome; bradykinin storm; cytokine storm; drug discovery; neprilysin","Arun Kumar","Sumaithangi Thattai","Center for Systems Biology and Molecular Medicine, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore, India",NA
"1138","34191617","10.1089/omi.2021.0080","Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?","The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is anticipated to transition to an endemic state as vaccines are providing relief in some, but not all, countries. Drug discovery for COVID-19 can offer another tool in the fight against the pandemic. Additionally, COVID-19 impacts multiple organs that call for a systems medicine approach to planetary health and therapeutics innovation. In this context, innovation for","2021","07","16","OMICS","Omics : a journal of integrative biology","COVID-19; SARS-CoV-2; acute respiratory distress syndrome; bradykinin storm; cytokine storm; drug discovery; neprilysin","Modi","Prashant Kumar","Center for Systems Biology and Molecular Medicine, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore, India",NA
"1139","34191617","10.1089/omi.2021.0080","Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?","The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is anticipated to transition to an endemic state as vaccines are providing relief in some, but not all, countries. Drug discovery for COVID-19 can offer another tool in the fight against the pandemic. Additionally, COVID-19 impacts multiple organs that call for a systems medicine approach to planetary health and therapeutics innovation. In this context, innovation for","2021","07","16","OMICS","Omics : a journal of integrative biology","COVID-19; SARS-CoV-2; acute respiratory distress syndrome; bradykinin storm; cytokine storm; drug discovery; neprilysin","Keshava Prasad","Thottethodi Subrahmanya","Center for Systems Biology and Molecular Medicine, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore, India",NA
"1140","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Sagui-Henson","Sara J","Modern Health, San Francisco, California, USA",NA
"1141","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Prescott","Maximo R","Modern Health, San Francisco, California, USA",NA
"1142","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Corcoran","Julia B","Modern Health, San Francisco, California, USA",NA
"1143","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Pillai","Sanil","Modern Health, San Francisco, California, USA",NA
"1144","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Mattila","Lindsey","Modern Health, San Francisco, California, USA",NA
"1145","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Mathur","Somya","Modern Health, San Francisco, California, USA",NA
"1146","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Adkins","Terry","Modern Health, San Francisco, California, USA",NA
"1147","34191616","10.1089/tmj.2020.0555","Effectiveness of Evidence-Based Telecoaching Delivered Through an Employer-Sponsored Mental Health Benefits Platform.","Background: Coaches delivering telemental health services as part of an employer-sponsored benefit may increase access to affordable and effective care. We examined the effectiveness of evidence-based telecoaching delivered via videoconferencing to people requesting mental health services during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: We analyzed data from 1,228 employees (mean age = 35 ± 8 years; 67.2% female) who utilized t","2021","06","30","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","burnout; mental health; presenteeism; telecoaching; well-being; workplace","Altman","Myra","Modern Health, San Francisco, California, USA",NA
"1148","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Golob","Stephanie","Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1149","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Zilinyi","Robert","Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1150","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Godfrey","Sarah","Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1151","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","DeFilippis","Ersilia M","Division of Cardiology, Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1152","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Fried","Justin","Division of Cardiology, Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1153","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Sayer","Gabriel","Division of Cardiology, Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1154","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Blinderman","Craig D","Adult Palliative Care Service, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1155","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Uriel","Nir","Division of Cardiology, Department of Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1156","34191603","10.1089/jpm.2021.0049","The Prevalence of Palliative Care Consultation in Deceased COVID-19 Patients and Its Association with End-of-Life Care.","Background: During the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City, COVID-19 hospitalization was associated with high mortality. It is unknown how palliative care was utilized in this context. Objectives: To describe the frequency of palliative care consultation and its association with end-of-life care for deceased patients with COVID-19. Methods: Adults who were admitted to our institution between February 23, 2020, and ","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; critical illness; end-of-life care; goals of care; palliative care","Nakagawa","Shunichi","Adult Palliative Care Service, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA",NA
"1157","34191595","10.1089/jpm.2021.0027","Expanding the Palliative Care Workforce during the COVID-19 Pandemic: An Evaluation of Core Palliative Care Skills in Health Social Workers.","Background: Meeting the needs of seriously ill SARS-CoV-2 (COVID-19) patients requires novel models of deploying health social workers (SWs) to expand the palliative care workforce. To inform such expansion, understanding the current state of health SWs' core palliative care skills is necessary. Methods: Following minimal training, health SWs in one New York City hospital were surveyed about their frequency, competence, and confidence in using core palliative care ski","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; education; palliative care; social workers","Pelleg","Ayla","Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA",NA
"1158","34191595","10.1089/jpm.2021.0027","Expanding the Palliative Care Workforce during the COVID-19 Pandemic: An Evaluation of Core Palliative Care Skills in Health Social Workers.","Background: Meeting the needs of seriously ill SARS-CoV-2 (COVID-19) patients requires novel models of deploying health social workers (SWs) to expand the palliative care workforce. To inform such expansion, understanding the current state of health SWs' core palliative care skills is necessary. Methods: Following minimal training, health SWs in one New York City hospital were surveyed about their frequency, competence, and confidence in using core palliative care ski","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; education; palliative care; social workers","Chai","Emily","Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA",NA
"1159","34191595","10.1089/jpm.2021.0027","Expanding the Palliative Care Workforce during the COVID-19 Pandemic: An Evaluation of Core Palliative Care Skills in Health Social Workers.","Background: Meeting the needs of seriously ill SARS-CoV-2 (COVID-19) patients requires novel models of deploying health social workers (SWs) to expand the palliative care workforce. To inform such expansion, understanding the current state of health SWs' core palliative care skills is necessary. Methods: Following minimal training, health SWs in one New York City hospital were surveyed about their frequency, competence, and confidence in using core palliative care ski","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; education; palliative care; social workers","Morrison","R Sean","Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA",NA
"1160","34191595","10.1089/jpm.2021.0027","Expanding the Palliative Care Workforce during the COVID-19 Pandemic: An Evaluation of Core Palliative Care Skills in Health Social Workers.","Background: Meeting the needs of seriously ill SARS-CoV-2 (COVID-19) patients requires novel models of deploying health social workers (SWs) to expand the palliative care workforce. To inform such expansion, understanding the current state of health SWs' core palliative care skills is necessary. Methods: Following minimal training, health SWs in one New York City hospital were surveyed about their frequency, competence, and confidence in using core palliative care ski","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; education; palliative care; social workers","Farquhar","Diane W","Department of Social Work Services, Mount Sinai Medical Center, New York, New York, USA",NA
"1161","34191595","10.1089/jpm.2021.0027","Expanding the Palliative Care Workforce during the COVID-19 Pandemic: An Evaluation of Core Palliative Care Skills in Health Social Workers.","Background: Meeting the needs of seriously ill SARS-CoV-2 (COVID-19) patients requires novel models of deploying health social workers (SWs) to expand the palliative care workforce. To inform such expansion, understanding the current state of health SWs' core palliative care skills is necessary. Methods: Following minimal training, health SWs in one New York City hospital were surveyed about their frequency, competence, and confidence in using core palliative care ski","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; education; palliative care; social workers","Berglund","Keisha","Department of Social Work Services, Mount Sinai Medical Center, New York, New York, USA",NA
"1162","34191595","10.1089/jpm.2021.0027","Expanding the Palliative Care Workforce during the COVID-19 Pandemic: An Evaluation of Core Palliative Care Skills in Health Social Workers.","Background: Meeting the needs of seriously ill SARS-CoV-2 (COVID-19) patients requires novel models of deploying health social workers (SWs) to expand the palliative care workforce. To inform such expansion, understanding the current state of health SWs' core palliative care skills is necessary. Methods: Following minimal training, health SWs in one New York City hospital were surveyed about their frequency, competence, and confidence in using core palliative care ski","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; education; palliative care; social workers","Gelfman","Laura P","Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA",NA
"1163","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Asprec","Lawrence","Adult Palliative Care Service, Department of Medicine, Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA",NA
"1164","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Blinderman","Craig D","Adult Palliative Care Service, Department of Medicine, Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA",NA
"1165","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Berlin","Ana","Adult Palliative Care Service, Department of Medicine, Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA",NA
"1166","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Callahan","Mary E","Adult Palliative Care Service, Department of Medicine, Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA",NA
"1167","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Widera","Eric","Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1168","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Periyakoil","Vyjeyanthi S","Department of Medicine, Stanford University, Palo Alto, California, USA",NA
"1169","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Smith","Alexander K","Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1170","34191591","10.1089/jpm.2021.0208","Virtual Interinstitutional Palliative Care Consultation during the COVID-19 Pandemic in New York City.","Context: Amid the COVID-19 surge in New York City, the need for palliative care was highlighted. Virtual consultation was introduced to expand specialist-level care to meet demand. Objectives: To examine the outcomes of COVID-19 patients who received virtual palliative care consultation from outside institutions. Design: This is a retrospective case series. Setting/Subjects: Subjects were 34 patients who received virtual palliative care con","2021","06","30","J Palliat Med","Journal of palliative medicine","COVID-19; digital health; palliative care; telehealth","Nakagawa","Shunichi","Adult Palliative Care Service, Department of Medicine, Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA",NA
"1171","34191580","10.1128/JVI.00687-21","Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.","The emerging coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly spread worldwide resulting in global public health emergencies and economic crises. In this study, a non-infectious and biocontainment level-2 compatible SARS-CoV-2 replicon expressing a nano luciferase (nLuc) reporter was constructed in a bacterial artificial chromosomal (BAC) vector by reverse genetics. The nLuc reporter is highly sensitive, easily quanti","2021","06","30","J Virol","Journal of virology",NA,"Nguyen","Hai Trong","Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1172","34191580","10.1128/JVI.00687-21","Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.","The emerging coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly spread worldwide resulting in global public health emergencies and economic crises. In this study, a non-infectious and biocontainment level-2 compatible SARS-CoV-2 replicon expressing a nano luciferase (nLuc) reporter was constructed in a bacterial artificial chromosomal (BAC) vector by reverse genetics. The nLuc reporter is highly sensitive, easily quanti","2021","06","30","J Virol","Journal of virology",NA,"Falzarano","Darryl","Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1173","34191580","10.1128/JVI.00687-21","Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.","The emerging coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly spread worldwide resulting in global public health emergencies and economic crises. In this study, a non-infectious and biocontainment level-2 compatible SARS-CoV-2 replicon expressing a nano luciferase (nLuc) reporter was constructed in a bacterial artificial chromosomal (BAC) vector by reverse genetics. The nLuc reporter is highly sensitive, easily quanti","2021","06","30","J Virol","Journal of virology",NA,"Gerdts","Volker","Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1174","34191580","10.1128/JVI.00687-21","Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.","The emerging coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly spread worldwide resulting in global public health emergencies and economic crises. In this study, a non-infectious and biocontainment level-2 compatible SARS-CoV-2 replicon expressing a nano luciferase (nLuc) reporter was constructed in a bacterial artificial chromosomal (BAC) vector by reverse genetics. The nLuc reporter is highly sensitive, easily quanti","2021","06","30","J Virol","Journal of virology",NA,"Liu","Qiang","Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1175","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"van den Beld","Maaike J C","Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands",NA
"1176","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Murk","Jean-Luc","Microvida, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands",NA
"1177","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Kluytmans","Jan","Amphia Ziekenhuis Breda, Microvida laboratory for microbiology, Breda, the Netherlands",NA
"1178","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Koopmans","Marion P G","Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands",NA
"1179","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Reimerink","Johan","Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands",NA
"1180","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"van Loo","Inge H M","Department of Medical Microbiology, Maastricht UMC+ and Care and Public Health Research Institute, Maastricht University",NA
"1181","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Wegdam-Blans","Marjolijn C A","Department of Medical Microbiology, Laboratory for Pathology and Medical Microbiology (PAMM), Veldhoven, The Netherlands",NA
"1182","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Zaaijer","Hans","Sanquin Blood Supply Foundation, Amsterdam, the Netherlands",NA
"1183","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"GeurtsvanKessel","Corine","Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands",NA
"1184","34191578","10.1128/JCM.00767-21","Increasing the efficiency of a national laboratory response to COVID-19; a nation-wide multicenter evaluation of 47 commercial SARS-CoV-2 immunoassays by 41 laboratories.","In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent overflowing of the market regarding antibody tests, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data, to allow for the evaluation of a quantity of serological assays for SARS-CoV-2, that exceeds the capacity of each individual laboratory. As of April 2020, these performance data had","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Reusken","Chantal","Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands",NA
"1185","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Jeong","Seri","Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea",NA
"1186","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Lee","Nuri","Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea",NA
"1187","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Lee","Su Kyung","Department of Laboratory Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea",NA
"1188","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Cho","Eun-Jung","Department of Laboratory Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea",NA
"1189","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Hyun","Jungwon","Department of Laboratory Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea",NA
"1190","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Park","Min-Jeong","Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea",NA
"1191","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Song","Wonkeun","Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea",NA
"1192","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Jung","Eun Ju","Division of Infectious Diseases, Department of Internal Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea",NA
"1193","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Woo","Heungjeong","Division of Infectious Diseases, Department of Internal Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea",NA
"1194","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Seo","Yu Bin","Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea",NA
"1195","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Park","Jin Ju","Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea",NA
"1196","34191577","10.1128/JCM.01105-21","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","Reliable results of serologic positivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential to estimate the efficacy of vaccination. We assessed the positivity rates and associated factors using five SARS-CoV-2 antibody assays. A total of 228 paired serum samples (456 samples) were obtained from 228 participants. After baseline sampling, the second sampling was conducted between 11-28 days after the first dose of A","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Kim","Hyun Soo","Department of Laboratory Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea",NA
"1197","34191564","10.12968/hmed.2021.0295","Thoracic incidentaloma in a chest computed tomography scan of a patient with COVID-19.",NA,"2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Adult; COVID-19; Female; Humans; Incidental Findings; Mediastinal Cyst; Teratoma; Tomography, X-Ray Computed","Gokce","Anil","Department of Thoracic Surgery, University of Health Sciences, Ankara City Hospital, Bilkent, Ankara, Turkey",NA
"1198","34191564","10.12968/hmed.2021.0295","Thoracic incidentaloma in a chest computed tomography scan of a patient with COVID-19.",NA,"2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Adult; COVID-19; Female; Humans; Incidental Findings; Mediastinal Cyst; Teratoma; Tomography, X-Ray Computed","Hatipoglu","Merve","Department of Thoracic Surgery, University of Health Sciences, Ankara City Hospital, Bilkent, Ankara, Turkey",NA
"1199","34191564","10.12968/hmed.2021.0295","Thoracic incidentaloma in a chest computed tomography scan of a patient with COVID-19.",NA,"2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Adult; COVID-19; Female; Humans; Incidental Findings; Mediastinal Cyst; Teratoma; Tomography, X-Ray Computed","Kandemir","Nilüfer O","Department of Pathology, University of Health Sciences, Ankara City Hospital, Bilkent, Ankara, Turkey",NA
"1200","34191564","10.12968/hmed.2021.0295","Thoracic incidentaloma in a chest computed tomography scan of a patient with COVID-19.",NA,"2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Adult; COVID-19; Female; Humans; Incidental Findings; Mediastinal Cyst; Teratoma; Tomography, X-Ray Computed","Akkas","Yucel","Department of Thoracic Surgery, University of Health Sciences, Ankara City Hospital, Bilkent, Ankara, Turkey",NA
"1201","34191558","10.12968/hmed.2021.0109","Barotrauma during non-invasive ventilation for acute respiratory distress syndrome caused by COVID-19: a balance between risks and benefits.","Ventilatory support is vital for the management of severe forms of COVID-19. Non-invasive ventilation is often used in patients who do not meet criteria for intubation or when invasive ventilation is not available, especially in a pandemic when resources are limited. Despite non-invasive ventilation providing effective respiratory support for some forms of acute respiratory failure, data about its effectiveness in patients with viral-related pneumonia are inconclusive. Acute respiratory distress","2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Acute respiratory distress syndrome; Barotrauma; COVID-19; Non-invasive ventilation; Severe acute respiratory syndrome-coronavirus 2; Barotrauma; COVID-19; Humans; Noninvasive Ventilation; Risk Assessment; Ventilator-Induced Lung Injury","Gabrielli","M","Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1202","34191558","10.12968/hmed.2021.0109","Barotrauma during non-invasive ventilation for acute respiratory distress syndrome caused by COVID-19: a balance between risks and benefits.","Ventilatory support is vital for the management of severe forms of COVID-19. Non-invasive ventilation is often used in patients who do not meet criteria for intubation or when invasive ventilation is not available, especially in a pandemic when resources are limited. Despite non-invasive ventilation providing effective respiratory support for some forms of acute respiratory failure, data about its effectiveness in patients with viral-related pneumonia are inconclusive. Acute respiratory distress","2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Acute respiratory distress syndrome; Barotrauma; COVID-19; Non-invasive ventilation; Severe acute respiratory syndrome-coronavirus 2; Barotrauma; COVID-19; Humans; Noninvasive Ventilation; Risk Assessment; Ventilator-Induced Lung Injury","Valletta","F","Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1203","34191558","10.12968/hmed.2021.0109","Barotrauma during non-invasive ventilation for acute respiratory distress syndrome caused by COVID-19: a balance between risks and benefits.","Ventilatory support is vital for the management of severe forms of COVID-19. Non-invasive ventilation is often used in patients who do not meet criteria for intubation or when invasive ventilation is not available, especially in a pandemic when resources are limited. Despite non-invasive ventilation providing effective respiratory support for some forms of acute respiratory failure, data about its effectiveness in patients with viral-related pneumonia are inconclusive. Acute respiratory distress","2021","07","14","Br J Hosp Med (Lond)","British journal of hospital medicine (London, England : 2005)","Acute respiratory distress syndrome; Barotrauma; COVID-19; Non-invasive ventilation; Severe acute respiratory syndrome-coronavirus 2; Barotrauma; COVID-19; Humans; Noninvasive Ventilation; Risk Assessment; Ventilator-Induced Lung Injury","Franceschi","F","Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1204","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"McCabe","Holly M","Department of Management Science, University of Strathclyde, Glasgow, United Kingdom",NA
"1205","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Smrke","Alannah","The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom",NA
"1206","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Cowie","Fiona","Scottish Sarcoma Network, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom",NA
"1207","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"White","Jeff","Scottish Sarcoma Network, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom",NA
"1208","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Chong","Peter","Scottish Sarcoma Network, Gartnavel General Hospital, Glasgow, United Kingdom",NA
"1209","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Lo","Steven","Scottish Sarcoma Network, Glasgow Royal Infirmary, Glasgow, United Kingdom",NA
"1210","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Mahendra","Ashish","Scottish Sarcoma Network, Glasgow Royal Infirmary, Glasgow, United Kingdom",NA
"1211","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Gupta","Sanjay","Scottish Sarcoma Network, Glasgow Royal Infirmary, Glasgow, United Kingdom",NA
"1212","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Ferguson","Michelle","Scottish Sarcoma Network, Ninewells Hospital, Dundee, United Kingdom",NA
"1213","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Boddie","David","Scottish Sarcoma Network, Aberdeen Royal Infirmary, Aberdeen, United Kingdom",NA
"1214","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Mmekka","Walter","Scottish Sarcoma Network, Raigmore Hospital, Inverness, United Kingdom",NA
"1215","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Stirling","Lorraine","Scottish Sarcoma Network, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom",NA
"1216","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Campbell","Lindsay","Scottish Sarcoma Network, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom",NA
"1217","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Jones","Robin L","The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom",NA
"1218","34191537","10.1200/GO.20.00599","What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.","In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Ca","2021","07","02","JCO Glob Oncol","JCO global oncology",NA,"Nixon","Ioanna","Department of Management Science, University of Strathclyde, Glasgow, United Kingdom",NA
"1219","34191420","10.6133/apjcn.202106_30(2).0002","Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.","To evaluate the nutritional status of critically ill patients with COVID-19 and to determine which route of nutrition support is advantageous. This retrospective study was conducted in the ICU of a designated COVID-19 hospital. Patients were divided into an enteral nutrition (EN) group and parenteral nutrition (PN) group according to the initial route of nutrition support. NRS-2002 and NUTRIC were used to assess nutritional status. Blood nutritional markers such as albumin, total protein and hem","2021","07","08","Asia Pac J Clin Nutr","Asia Pacific journal of clinical nutrition","Aged; Aged, 80 and over; COVID-19; China; Critical Illness; Enteral Nutrition; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Nutritional Status; Parenteral Nutrition; Prognosis; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Serum Albumin","Wu","Sheng","Department of Neurology, Second Affiliated Hospital of Zhejiang University, Hangzhou, China",NA
"1220","34191420","10.6133/apjcn.202106_30(2).0002","Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.","To evaluate the nutritional status of critically ill patients with COVID-19 and to determine which route of nutrition support is advantageous. This retrospective study was conducted in the ICU of a designated COVID-19 hospital. Patients were divided into an enteral nutrition (EN) group and parenteral nutrition (PN) group according to the initial route of nutrition support. NRS-2002 and NUTRIC were used to assess nutritional status. Blood nutritional markers such as albumin, total protein and hem","2021","07","08","Asia Pac J Clin Nutr","Asia Pacific journal of clinical nutrition","Aged; Aged, 80 and over; COVID-19; China; Critical Illness; Enteral Nutrition; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Nutritional Status; Parenteral Nutrition; Prognosis; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Serum Albumin","Lou","Jian","Department of Respiratory Medicine, Second Affiliated Hospital of Zhejiang University, Hangzhou, China",NA
"1221","34191420","10.6133/apjcn.202106_30(2).0002","Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.","To evaluate the nutritional status of critically ill patients with COVID-19 and to determine which route of nutrition support is advantageous. This retrospective study was conducted in the ICU of a designated COVID-19 hospital. Patients were divided into an enteral nutrition (EN) group and parenteral nutrition (PN) group according to the initial route of nutrition support. NRS-2002 and NUTRIC were used to assess nutritional status. Blood nutritional markers such as albumin, total protein and hem","2021","07","08","Asia Pac J Clin Nutr","Asia Pacific journal of clinical nutrition","Aged; Aged, 80 and over; COVID-19; China; Critical Illness; Enteral Nutrition; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Nutritional Status; Parenteral Nutrition; Prognosis; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Serum Albumin","Xu","Peng","Intensive Care Unit, Second Affiliated Hospital of Zhejiang University, Hangzhou, China",NA
"1222","34191420","10.6133/apjcn.202106_30(2).0002","Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.","To evaluate the nutritional status of critically ill patients with COVID-19 and to determine which route of nutrition support is advantageous. This retrospective study was conducted in the ICU of a designated COVID-19 hospital. Patients were divided into an enteral nutrition (EN) group and parenteral nutrition (PN) group according to the initial route of nutrition support. NRS-2002 and NUTRIC were used to assess nutritional status. Blood nutritional markers such as albumin, total protein and hem","2021","07","08","Asia Pac J Clin Nutr","Asia Pacific journal of clinical nutrition","Aged; Aged, 80 and over; COVID-19; China; Critical Illness; Enteral Nutrition; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Nutritional Status; Parenteral Nutrition; Prognosis; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Serum Albumin","Luo","Rubin","Intensive Care Unit, Second Affiliated Hospital of Zhejiang University, Hangzhou, China. Email: zr_lrb@zju.edu","lrb@zju.edu.cn"
"1223","34191420","10.6133/apjcn.202106_30(2).0002","Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.","To evaluate the nutritional status of critically ill patients with COVID-19 and to determine which route of nutrition support is advantageous. This retrospective study was conducted in the ICU of a designated COVID-19 hospital. Patients were divided into an enteral nutrition (EN) group and parenteral nutrition (PN) group according to the initial route of nutrition support. NRS-2002 and NUTRIC were used to assess nutritional status. Blood nutritional markers such as albumin, total protein and hem","2021","07","08","Asia Pac J Clin Nutr","Asia Pacific journal of clinical nutrition","Aged; Aged, 80 and over; COVID-19; China; Critical Illness; Enteral Nutrition; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Nutritional Status; Parenteral Nutrition; Prognosis; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Serum Albumin","Li","Libin","Intensive Care Unit, Second Affiliated Hospital of Zhejiang University, Hangzhou, China",NA
"1224","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Krumb","Evelien","Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium",NA
"1225","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Fijnvandraat","Karin","Pediatric Hematology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands",NA
"1226","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Makris","Michael","Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK",NA
"1227","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Peyvandi","Flora","Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy",NA
"1228","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Ryan","Aislin","European Association for Haemophilia and Allied Disorders (EAHAD), Brussels, Belgium",NA
"1229","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Athanasopoulos","Angelos","European Association for Haemophilia and Allied Disorders (EAHAD), Brussels, Belgium",NA
"1230","34191397","10.1111/hae.14372","Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey.","Emicizumab, a bispecific monoclonal antibody administered subcutaneously, mimicking the action of activated coagulation factor VIII, has been approved in Europe for use in patients with severe hemophilia of all ages. To assess availability, acceptance, adverse events, efficacy and laboratory monitoring of emicizumab and the effect of the coronavirus disease 2019 (COVID-19) pandemic on its use. Online questionnaire sent to 144 hemophilia treatment centres (November 2020 to January 2021). Forty-si","2021","06","30","Haemophilia","Haemophilia : the official journal of the World Federation of Hemophilia","bispecific antibodies; bleeding; factor VIII; hemophilia A; survey","Hermans","Cedric","Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium",NA
"1231","34191392","10.1111/ijlh.13654","Interference of D-Dimer Levels From Heterophilic Antibody in COVID-19. A Serious Concern in Treatment and Follow-up of Patients.","COVID-19 has become a pandemic since March 11, 2020 and caused devastating effects with high death rates worldwide. COVID-19 has led to severe coagulopathy, and thus routine coagulation assays have been recommended to evaluate coagulation deficiency [1]. D-Dimer has been used as a biomarker of coagulopathy from the beginning of the pandemic which has become an important tool of follow-up in COVID-19 as the elevation of D-Dimer has been directly correlated with poor prognosis [2]. D-Dimer levels ","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; Coagulation; D-Dimer; Heterophilic antibodies","Özbalci","Demircan","Suleyman Demirel University School of Medicine, Department of Hematology",NA
"1232","34191392","10.1111/ijlh.13654","Interference of D-Dimer Levels From Heterophilic Antibody in COVID-19. A Serious Concern in Treatment and Follow-up of Patients.","COVID-19 has become a pandemic since March 11, 2020 and caused devastating effects with high death rates worldwide. COVID-19 has led to severe coagulopathy, and thus routine coagulation assays have been recommended to evaluate coagulation deficiency [1]. D-Dimer has been used as a biomarker of coagulopathy from the beginning of the pandemic which has become an important tool of follow-up in COVID-19 as the elevation of D-Dimer has been directly correlated with poor prognosis [2]. D-Dimer levels ","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; Coagulation; D-Dimer; Heterophilic antibodies","Kumbul Doguç","Duygu","Suleyman Demirel University School of Medicine, Department of Biochemistry",NA
"1233","34191392","10.1111/ijlh.13654","Interference of D-Dimer Levels From Heterophilic Antibody in COVID-19. A Serious Concern in Treatment and Follow-up of Patients.","COVID-19 has become a pandemic since March 11, 2020 and caused devastating effects with high death rates worldwide. COVID-19 has led to severe coagulopathy, and thus routine coagulation assays have been recommended to evaluate coagulation deficiency [1]. D-Dimer has been used as a biomarker of coagulopathy from the beginning of the pandemic which has become an important tool of follow-up in COVID-19 as the elevation of D-Dimer has been directly correlated with poor prognosis [2]. D-Dimer levels ","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; Coagulation; D-Dimer; Heterophilic antibodies","Yilmaz","Gulruhsar","Suleyman Demirel University School of Medicine, Department of Infectious Disease and Clinical Microbiology",NA
"1234","34191392","10.1111/ijlh.13654","Interference of D-Dimer Levels From Heterophilic Antibody in COVID-19. A Serious Concern in Treatment and Follow-up of Patients.","COVID-19 has become a pandemic since March 11, 2020 and caused devastating effects with high death rates worldwide. COVID-19 has led to severe coagulopathy, and thus routine coagulation assays have been recommended to evaluate coagulation deficiency [1]. D-Dimer has been used as a biomarker of coagulopathy from the beginning of the pandemic which has become an important tool of follow-up in COVID-19 as the elevation of D-Dimer has been directly correlated with poor prognosis [2]. D-Dimer levels ","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; Coagulation; D-Dimer; Heterophilic antibodies","Ozturk","Onder","Suleyman Demirel University School of Medicine, Department of Chest Diseases",NA
"1235","34191392","10.1111/ijlh.13654","Interference of D-Dimer Levels From Heterophilic Antibody in COVID-19. A Serious Concern in Treatment and Follow-up of Patients.","COVID-19 has become a pandemic since March 11, 2020 and caused devastating effects with high death rates worldwide. COVID-19 has led to severe coagulopathy, and thus routine coagulation assays have been recommended to evaluate coagulation deficiency [1]. D-Dimer has been used as a biomarker of coagulopathy from the beginning of the pandemic which has become an important tool of follow-up in COVID-19 as the elevation of D-Dimer has been directly correlated with poor prognosis [2]. D-Dimer levels ","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; Coagulation; D-Dimer; Heterophilic antibodies","Sirin","Fevziye Burcu","Suleyman Demirel University School of Medicine, Department of Biochemistry",NA
"1236","34191392","10.1111/ijlh.13654","Interference of D-Dimer Levels From Heterophilic Antibody in COVID-19. A Serious Concern in Treatment and Follow-up of Patients.","COVID-19 has become a pandemic since March 11, 2020 and caused devastating effects with high death rates worldwide. COVID-19 has led to severe coagulopathy, and thus routine coagulation assays have been recommended to evaluate coagulation deficiency [1]. D-Dimer has been used as a biomarker of coagulopathy from the beginning of the pandemic which has become an important tool of follow-up in COVID-19 as the elevation of D-Dimer has been directly correlated with poor prognosis [2]. D-Dimer levels ","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; Coagulation; D-Dimer; Heterophilic antibodies","Akcam","Fusun Zeynep","Suleyman Demirel University School of Medicine, Department of Infectious Disease and Clinical Microbiology",NA
"1237","34191369","10.1002/rmv.2272","Persistence of humoral response upon SARS-CoV-2 infection.","SARS-CoV-2 continues to leave its toll on global health and the economy. Management of the pandemic will rely heavily on the degree of adaptive immunity persistence following natural SARS-CoV-2 infection. Along with the progression of the pandemic, more literature on the persistence of the SARS-CoV-2-specific antibody response is becoming available. Here, we summarize findings on the persistence of the humoral, including neutralizing antibody, response at three to eight months post SARS-CoV-2 in","2021","06","30","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; humoral response; immunity; immunoglobulins; neutralizing antibodies","Knies","Andrea","Department of Scientific Coordination and Management, Danube Private University, Krems/Donau, Austria",NA
"1238","34191369","10.1002/rmv.2272","Persistence of humoral response upon SARS-CoV-2 infection.","SARS-CoV-2 continues to leave its toll on global health and the economy. Management of the pandemic will rely heavily on the degree of adaptive immunity persistence following natural SARS-CoV-2 infection. Along with the progression of the pandemic, more literature on the persistence of the SARS-CoV-2-specific antibody response is becoming available. Here, we summarize findings on the persistence of the humoral, including neutralizing antibody, response at three to eight months post SARS-CoV-2 in","2021","06","30","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; humoral response; immunity; immunoglobulins; neutralizing antibodies","Ladage","Dennis","Department of Internal Medicine, Danube Private University, Krems/Donau, Austria",NA
"1239","34191369","10.1002/rmv.2272","Persistence of humoral response upon SARS-CoV-2 infection.","SARS-CoV-2 continues to leave its toll on global health and the economy. Management of the pandemic will rely heavily on the degree of adaptive immunity persistence following natural SARS-CoV-2 infection. Along with the progression of the pandemic, more literature on the persistence of the SARS-CoV-2-specific antibody response is becoming available. Here, we summarize findings on the persistence of the humoral, including neutralizing antibody, response at three to eight months post SARS-CoV-2 in","2021","06","30","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; humoral response; immunity; immunoglobulins; neutralizing antibodies","Braun","Ralf J","Research Division for Neurodegenerative Diseases, Danube Private University, Krems/Donau, Austria",NA
"1240","34191369","10.1002/rmv.2272","Persistence of humoral response upon SARS-CoV-2 infection.","SARS-CoV-2 continues to leave its toll on global health and the economy. Management of the pandemic will rely heavily on the degree of adaptive immunity persistence following natural SARS-CoV-2 infection. Along with the progression of the pandemic, more literature on the persistence of the SARS-CoV-2-specific antibody response is becoming available. Here, we summarize findings on the persistence of the humoral, including neutralizing antibody, response at three to eight months post SARS-CoV-2 in","2021","06","30","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; humoral response; immunity; immunoglobulins; neutralizing antibodies","Kimpel","Janine","Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria",NA
"1241","34191369","10.1002/rmv.2272","Persistence of humoral response upon SARS-CoV-2 infection.","SARS-CoV-2 continues to leave its toll on global health and the economy. Management of the pandemic will rely heavily on the degree of adaptive immunity persistence following natural SARS-CoV-2 infection. Along with the progression of the pandemic, more literature on the persistence of the SARS-CoV-2-specific antibody response is becoming available. Here, we summarize findings on the persistence of the humoral, including neutralizing antibody, response at three to eight months post SARS-CoV-2 in","2021","06","30","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; humoral response; immunity; immunoglobulins; neutralizing antibodies","Schneider","Miriam","Department of Scientific Coordination and Management, Danube Private University, Krems/Donau, Austria",NA
"1242","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Prahlad","Janani","Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1243","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Struble","Lucas R","Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1244","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Lutz","William E","Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1245","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Wallin","Savanna A","Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1246","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Khurana","Surender","Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA",NA
"1247","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Schnaubelt","Andy","Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1248","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Broadhurst","Mara J","Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1249","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Bayles","Kenneth W","Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1250","34191362","10.1002/pro.4152","CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.","The COVID-19 pandemic caused by SARS-CoV-2 has applied significant pressure on overtaxed healthcare around the world, underscoring the urgent need for rapid diagnosis and treatment. We have developed a bacterial strategy for the expression and purification of a SARS-CoV-2 spike protein receptor binding domain (RBD) that includes the SD1 domain. Bacterial cytoplasm is a reductive environment, which is problematic when the recombinant protein of interest requires complicated folding and/or process","2021","07","16","Protein Sci","Protein science : a publication of the Protein Society","COVID19; CyDisCo; SARS-CoV-2; antigen; protein purification","Borgstahl","Gloria E O","Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA",NA
"1251","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","García-Ayllón","María-Salud","Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain",NA
"1252","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Moreno-Pérez","Oscar","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1253","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","García-Arriaza","Juan","Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain",NA
"1254","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Ramos-Rincón","José-Manuel","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1255","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Cortés-Gómez","María-Ángeles","Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain",NA
"1256","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Brinkmalm","Gunnar","Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden",NA
"1257","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Andrés","Mariano","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1258","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","León-Ramírez","José-Manuel","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1259","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Boix","Vicente","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1260","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Gil","Joan","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1261","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Zetterberg","Henrik","Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden",NA
"1262","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Esteban","Mariano","Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain",NA
"1263","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Merino","Esperanza","Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain",NA
"1264","34191346","10.1096/fj.202100051R","Plasma ACE2 species are differentially altered in COVID-19 patients.","Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID-19 disease, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus. Here, we examine the levels of various plasma species of the SARS-CoV-2 host receptor, the angiotensin-converting enzyme 2 (ACE2), in patients at different phases of the infection. Human plasma ACE2 species were characterized by immunoprecipitation and western blotting employing antibodies against the ectodomain and","2021","07","08","FASEB J","FASEB journal : official publication of the Federation of American Societies for Experimental Biology","ACE2; COVID-19; SARS-CoV-2; biomarker; plasma; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Biomarkers; Brain Chemistry; COVID-19; Colon; Female; Humans; Liver; Male; Middle Aged; SARS-CoV-2; Saliva","Sáez-Valero","Javier","Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain",NA
"1265","34191300","10.1111/all.14995","COVID-19 vaccines - the way forward.","In a health crisis of the calibre of the COVID-19 pandemic, the development of effective and safe vaccines is considered the most powerful measure to save lives and minimise the tremendous negative impact on health, social systems and global economics. Vaccines must be evaluated and approved by the appropriate regulatory and/or health authorities. To date, the worldwide regulatory landscape for vaccines is very broad. Bringing COVID-19 vaccines to the market, the authorities followed at least 51","2021","06","30","Allergy","Allergy",NA,"Klimek","Ludger","Center for Rhinology and Allergology, An den Quellen 10, D-65183, Wiesbaden, Germany",NA
"1266","34191300","10.1111/all.14995","COVID-19 vaccines - the way forward.","In a health crisis of the calibre of the COVID-19 pandemic, the development of effective and safe vaccines is considered the most powerful measure to save lives and minimise the tremendous negative impact on health, social systems and global economics. Vaccines must be evaluated and approved by the appropriate regulatory and/or health authorities. To date, the worldwide regulatory landscape for vaccines is very broad. Bringing COVID-19 vaccines to the market, the authorities followed at least 51","2021","06","30","Allergy","Allergy",NA,"Agache","Ioana","Faculty of Medicine, Transylvania University, Brasov, Romania",NA
"1267","34191300","10.1111/all.14995","COVID-19 vaccines - the way forward.","In a health crisis of the calibre of the COVID-19 pandemic, the development of effective and safe vaccines is considered the most powerful measure to save lives and minimise the tremendous negative impact on health, social systems and global economics. Vaccines must be evaluated and approved by the appropriate regulatory and/or health authorities. To date, the worldwide regulatory landscape for vaccines is very broad. Bringing COVID-19 vaccines to the market, the authorities followed at least 51","2021","06","30","Allergy","Allergy",NA,"Cooke","Emer","European Medicines Agency, Amsterdam, Netherlands",NA
"1268","34191300","10.1111/all.14995","COVID-19 vaccines - the way forward.","In a health crisis of the calibre of the COVID-19 pandemic, the development of effective and safe vaccines is considered the most powerful measure to save lives and minimise the tremendous negative impact on health, social systems and global economics. Vaccines must be evaluated and approved by the appropriate regulatory and/or health authorities. To date, the worldwide regulatory landscape for vaccines is very broad. Bringing COVID-19 vaccines to the market, the authorities followed at least 51","2021","06","30","Allergy","Allergy",NA,"Jutel","Marek","Department of Clinical Immunology, University of Wroclaw, Wroclaw, Poland",NA
"1269","34191300","10.1111/all.14995","COVID-19 vaccines - the way forward.","In a health crisis of the calibre of the COVID-19 pandemic, the development of effective and safe vaccines is considered the most powerful measure to save lives and minimise the tremendous negative impact on health, social systems and global economics. Vaccines must be evaluated and approved by the appropriate regulatory and/or health authorities. To date, the worldwide regulatory landscape for vaccines is very broad. Bringing COVID-19 vaccines to the market, the authorities followed at least 51","2021","06","30","Allergy","Allergy",NA,"Akdis","Cezmi A","Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland",NA
"1270","34191300","10.1111/all.14995","COVID-19 vaccines - the way forward.","In a health crisis of the calibre of the COVID-19 pandemic, the development of effective and safe vaccines is considered the most powerful measure to save lives and minimise the tremendous negative impact on health, social systems and global economics. Vaccines must be evaluated and approved by the appropriate regulatory and/or health authorities. To date, the worldwide regulatory landscape for vaccines is very broad. Bringing COVID-19 vaccines to the market, the authorities followed at least 51","2021","06","30","Allergy","Allergy",NA,"O'Hehir","Robyn","Department of Immunology and Pathology, Monash University, Melbourne, Vic., Australia",NA
"1271","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Pramanick","Angsumita","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1272","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Kanneganti","Abhiram","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1273","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Wong","Jing Lin Jeslyn","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1274","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Li","Sarah Weiling","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1275","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Dimri","Pooja Sharma","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1276","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Mahyuddin","Aniza Puteri","Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore",NA
"1277","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Kumar","Sailesh","Mater Research Institute-University of Queensland, South Brisbane, Queensland, Australia",NA
"1278","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Illanes","Sebastian Enrique","Department of Obstetrics &amp",NA
"1279","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Chan","Jerry Kok Yen","Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore",NA
"1280","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Su","Lin Lin","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1281","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Biswas","Arijit","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1282","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Tambyah","Paul Anantharajah","Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore",NA
"1283","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Huang","Ruby Yun-Ju","School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan",NA
"1284","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Mattar","Citra Nurfarah Zaini","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1285","34191294","10.1002/pd.5985","A reasoned approach towards administering COVID-19 vaccines to pregnant women.","There are over 50 SARS-CoV-2 candidate vaccines undergoing Phase II and III clinical trials. Several vaccines have been approved by regulatory authorities and rolled out for use in different countries. Due to concerns of potential teratogenicity or adverse effect on maternal physiology, pregnancy has been a specific exclusion criterion for most vaccine trials with only two trials not excluding pregnant women. Thus, other than limited animal studies, gradually emerging development and reproductiv","2021","06","30","Prenat Diagn","Prenatal diagnosis",NA,"Choolani","Mahesh","Department of Obstetrics and Gynaecology, National University Hospital Singapore, Singapore",NA
"1286","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Hasan","Mohammad Mehedi","Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh",NA
"1287","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Costa","Ana Carla Dos Santos","Department of Internal Medicine, Federal University of Bahia, Salvador, Bahia, Brazil",NA
"1288","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Xenophontos","Eleni","Department of Medicine, Medical School, University of Cyprus Medical School, Nicosia, Cyprus",NA
"1289","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Mohanan","Parvathy","Department of General Medicine, Medical University Sofia, Sofia, Bulgaria",NA
"1290","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Bassey","Esther Edet","Department of Medical Physiology, Faculty of Basic Medical Sciences, University of Uyo, Uyo, Nigeria",NA
"1291","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Ahmad","Shoaib","Department of Medicine and General Surgery, Punjab Medical College, Faisalabad, Pakistan",NA
"1292","34191292","10.1002/jmv.27169","Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.",NA,"2021","07","06","J Med Virol","Journal of medical virology","Lassa virus &lt; virus classification; coronavirus &lt; virus classification; public policy &lt; social science","Essar","Mohammad Yasir","Department of Medical Research Center, Kateb University, Kabul, Afghanistan",NA
"1293","34191274","10.1007/s43678-021-00155-2","Interactive virtual cases for emergency medicine physicians during the COVID-19 pandemic.","Continuing professional development activities often involve interactive learning modalities, such as simulation. The COVID-19 pandemic limited many in-hospital activities, at a time when practicing high stress procedural scenarios and testing rapidly evolving processes was coveted. Thus, an interactive virtual case curriculum was conceptualized, piloted, and implemented to provide ongoing professional development for emergency medicine (EM) physicians. Each interactive virtual case consisted of","2021","07","02","CJEM","CJEM","Continuing professional development; Simulation; Virtual","Forristal","Chantal","Division of Emergency Medicine, Department of Medicine, Western University, E1-125 Westminster Tower, 800 Commissioners Road East, London, ON, N6A 5W9, Canada. chantal.forristal@gmail","chantal.forristal@gmail.com"
"1294","34191274","10.1007/s43678-021-00155-2","Interactive virtual cases for emergency medicine physicians during the COVID-19 pandemic.","Continuing professional development activities often involve interactive learning modalities, such as simulation. The COVID-19 pandemic limited many in-hospital activities, at a time when practicing high stress procedural scenarios and testing rapidly evolving processes was coveted. Thus, an interactive virtual case curriculum was conceptualized, piloted, and implemented to provide ongoing professional development for emergency medicine (EM) physicians. Each interactive virtual case consisted of","2021","07","02","CJEM","CJEM","Continuing professional development; Simulation; Virtual","Kim","Julie J","Division of Emergency Medicine, Department of Medicine, Western University, E1-125 Westminster Tower, 800 Commissioners Road East, London, ON, N6A 5W9, Canada",NA
"1295","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Polito","Maria Vincenza","Department of Cardiology, Ospedale Evangelico Betania, Naples, Italy",NA
"1296","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Silverio","Angelo","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy. asilverio@unisa","asilverio@unisa.it"
"1297","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Bellino","Michele","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy",NA
"1298","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Iuliano","Giuseppe","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy",NA
"1299","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Di Maio","Marco","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy",NA
"1300","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Alfano","Carmine","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy",NA
"1301","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Iannece","Patrizia","Department of Chemistry and Biology, University of Salerno, Fisciano, Italy",NA
"1302","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Esposito","Nicolino","Department of Cardiology, Ospedale Evangelico Betania, Naples, Italy",NA
"1303","34191268","10.1007/s40119-021-00232-8","Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?","Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on long-term outcome of these patients are still sparse, and the type and real incidence of cardiovascular sequelae are poorly known. It is plausible that myocardial injury may b","2021","07","02","Cardiol Ther","Cardiology and therapy","Acute coronary syndromes; COVID-19; Coronavirus; Long-term outcome; Myocardial injury; Myocarditis; Pericarditis; Pulmonary embolism; SARS-CoV-2","Galasso","Gennaro","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy",NA
"1304","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Poma","A M","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1305","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Bonuccelli","D","Department of Forensic Medicine, Azienda USL Toscana Nordovest, Lucca, Italy",NA
"1306","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Giannini","R","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1307","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Macerola","E","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1308","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Vignali","P","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1309","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Ugolini","C","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1310","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Torregrossa","L","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1311","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Proietti","A","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy",NA
"1312","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Pistello","M","Retrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy",NA
"1313","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Basolo","A","Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy",NA
"1314","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Santini","F","Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy",NA
"1315","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Toniolo","A","Global Virus Network, University of Insubria, Varese, Italy",NA
"1316","34191258","10.1007/s40618-021-01628-y","COVID-19 autopsy cases: detection of virus in endocrine tissues.","The SARS-CoV-2 genome has been detected in a variety of human samples including blood, urine, semen, and faeces. However, evidence of virus presence in tissues other than lung are limited. We investigated whether SARS-CoV-2 could be detected in 50 autoptic specimens of endocrine organs from 29 patients who died of COVID-19. The virus was detected in 25 specimens including ten abdominal subcutaneous adipose tissue samples (62%), six testes (67%), and nine thyroid (36%) samples. The analysis of mu","2021","07","02","J Endocrinol Invest","Journal of endocrinological investigation","Adipose tissue; COVID-19; SARS-CoV-2; Testis; Thyroid","Basolo","F","Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi,10, 56126, Pisa, Italy. fulvio.basolo@med.unipi","fulvio.basolo@med.unipi.it"
"1317","34191247","10.1007/s10729-021-09570-4","Beyond COVID-19 deaths during the COVID-19 pandemic in the United States.","COVID-19 has disrupted society and health care systems, creating a fertile environment for deaths beyond the virus. The year 2020 will prove to be the most deadly year on record in the United States. Direct deaths due to COVID-19 have been well documented and reported. Older people (those over 65) have been hardest hit, with over 80% of the COVID-19 deaths in this age group. What has been less clear is the impact on those under 65 years old, particularly those under 44 years old. This study cons","2021","07","02","Health Care Manag Sci","Health care management science","Covid-19; Odds ratios; Risk analysis","Jacobson","Sheldon H","Department of Computer Science, Carle Illinois School of Medicine, University of Illinois, Urbana, IL, 61801, USA. shj@illinois","shj@illinois.edu"
"1318","34191247","10.1007/s10729-021-09570-4","Beyond COVID-19 deaths during the COVID-19 pandemic in the United States.","COVID-19 has disrupted society and health care systems, creating a fertile environment for deaths beyond the virus. The year 2020 will prove to be the most deadly year on record in the United States. Direct deaths due to COVID-19 have been well documented and reported. Older people (those over 65) have been hardest hit, with over 80% of the COVID-19 deaths in this age group. What has been less clear is the impact on those under 65 years old, particularly those under 44 years old. This study cons","2021","07","02","Health Care Manag Sci","Health care management science","Covid-19; Odds ratios; Risk analysis","Jokela","Janet A","University of Illinois College of Medicine at Urbana, Urbana, IL, 61801, USA",NA
"1319","34191222","10.1186/s43044-021-00187-0","A clinical case series of COVID-19-associated acute limb ischemia: real-world situation.","COVID-19 was a trending topic all year long in 2020. Currently, it is not only a problem for a pulmonologist since it could cause complications to many other organs, including the cardiovascular system. Recent acute COVID-19 infection state has been associated with hypercoagulation and causing microthrombi called immunothrombus. Acute limb ischemia is one of the rare complications but organ-threatening. Unfortunately, unlike coronary artery disease, there is no recent guideline for cardiologists","2021","07","02","Egypt Heart J","The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology","Acute limb ischemia; COVID-19; COVID-19-associated coagulopathy; Case report; Immunothrombus","Surya","Steven Philip","Primaya Hopsital Tangerang, Jl. MH. Thamrin no.3, Kebon Nanas, Cikokol, Tangerang, Indonesia. stevenphilip07@gmail","stevenphilip07@gmail.com"
"1320","34191222","10.1186/s43044-021-00187-0","A clinical case series of COVID-19-associated acute limb ischemia: real-world situation.","COVID-19 was a trending topic all year long in 2020. Currently, it is not only a problem for a pulmonologist since it could cause complications to many other organs, including the cardiovascular system. Recent acute COVID-19 infection state has been associated with hypercoagulation and causing microthrombi called immunothrombus. Acute limb ischemia is one of the rare complications but organ-threatening. Unfortunately, unlike coronary artery disease, there is no recent guideline for cardiologists","2021","07","02","Egypt Heart J","The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology","Acute limb ischemia; COVID-19; COVID-19-associated coagulopathy; Case report; Immunothrombus","Santoso","Rony Marethianto","Department of Cardiology and Vascular Medicine, Primaya Hospital Tangerang, Tangerang, Indonesia",NA
"1321","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Luo","Huanyuan","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK",NA
"1322","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Wang","Yuancheng","Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China",NA
"1323","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Liu","Songqiao","Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China",NA
"1324","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Chen","Ruoling","Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, WV1 1LY, UK",NA
"1325","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Chen","Tao","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK",NA
"1326","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Yang","Yi","Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China",NA
"1327","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Wang","Duolao","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK. Duolao.wang@lstmed.ac","Duolao.wang@lstmed.ac.uk"
"1328","34191219","10.1007/s11739-021-02795-9","Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.","This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: = 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single ons","2021","07","02","Intern Emerg Med","Internal and emergency medicine","2019-nCoV; COVID-19; CT; Coronavirus; Prognosis; Pulmonary opacity","Ju","Shenghong","Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China. jsh0836@hotmail","jsh0836@hotmail.com"
"1329","34191218","10.1007/s11739-021-02793-x","Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines.","The amazing effort of vaccination against COVID-19, with more than 2 billion vaccine doses administered all around the world as of 16 June 2021, has changed the history of this pandemic, drastically reducing the number of severe cases or deaths in countries were mass vaccination campaign have been carried out. However, the people's rising enthusiasm has been blunted in late February 2021 by the report of several cases of unusual thrombotic events in combination with thrombocytopenia after vaccin","2021","07","02","Intern Emerg Med","Internal and emergency medicine","COVID-19; COVID-19 Vaccine Janssen; Heparin-Induced Thrombocytopenia; Vaccine-Induced Thrombotic Thrombocytopenia; Vaxzevria","Marcucci","Rossella","Department of Experimental and Clinical Medicine, ""Careggi"" University Hospital, University of Florence, Florence, Italy",NA
"1330","34191218","10.1007/s11739-021-02793-x","Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines.","The amazing effort of vaccination against COVID-19, with more than 2 billion vaccine doses administered all around the world as of 16 June 2021, has changed the history of this pandemic, drastically reducing the number of severe cases or deaths in countries were mass vaccination campaign have been carried out. However, the people's rising enthusiasm has been blunted in late February 2021 by the report of several cases of unusual thrombotic events in combination with thrombocytopenia after vaccin","2021","07","02","Intern Emerg Med","Internal and emergency medicine","COVID-19; COVID-19 Vaccine Janssen; Heparin-Induced Thrombocytopenia; Vaccine-Induced Thrombotic Thrombocytopenia; Vaxzevria","Marietta","Marco","Hematology Unit, Azienda Ospedaliero-Universitaria, via del Pozzo 71, 41124, Modena, Italy. marco.marietta@unimore","marco.marietta@unimore.it"
"1331","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Tan","Rayner Kay Jin","Saw Swee Hock School of Public Health, Tahir Foundation Building, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore. rayner.tan@u.nus","rayner.tan@u.nus.edu"
"1332","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Ho","Vanessa","Project X, Singapore, Singapore",NA
"1333","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Sherqueshaa","Sherry","Project X, Singapore, Singapore",NA
"1334","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Dee","Wany","Project X, Singapore, Singapore",NA
"1335","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Lim","Jane Mingjie","Saw Swee Hock School of Public Health, Tahir Foundation Building, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore",NA
"1336","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Lo","Jamie Jay-May","Saw Swee Hock School of Public Health, Tahir Foundation Building, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore",NA
"1337","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Teo","Alvin Kuo Jing","Saw Swee Hock School of Public Health, Tahir Foundation Building, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore",NA
"1338","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","O'Hara","Caitlin Alsandria","Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore",NA
"1339","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Ong","Clarence","Saw Swee Hock School of Public Health, Tahir Foundation Building, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore",NA
"1340","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Ching","Ann Hui","Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore",NA
"1341","34191194","10.1007/s10508-021-01951-8","The Impact of the Coronavirus Disease (COVID-19) on the Health and Social Needs of Sex Workers in Singapore.","We evaluated the impact of the coronavirus disease (COVID-19) on the sex work industry and assessed how it has impacted the health and social conditions of sex workers in Singapore. We conducted a sequential exploratory mixed methods study amidst the COVID-19 pandemic from April to October 2020, including in-depth interviews with 24 stakeholders from the sex work industry and surveyor-administered structured surveys with 171 sex workers. COVID-19 had a substantial impact on sex workers' income. ","2021","07","14","Arch Sex Behav","Archives of sexual behavior","COVID-19; Food insecurity; Housing insecurity; Sex workers; Stigma","Wong","Mee Lian","Saw Swee Hock School of Public Health, Tahir Foundation Building, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore",NA
"1342","34191181","10.1007/s10439-021-02819-7","Active Versus Passive Flow Control in UVC FILTERs for COVID-19 Containment.","Ultraviolet radiation as a germicide is widely used in the health field and even in domestic hygiene. Here, we propose an improvement in low-cost portable units of filtration for indoor air, which is based on ultraviolet radiation. In the current technology, to carry out an air filtration with a suspension of aerosols in which there is a likely concentration of pathogens, whether viral, bacterial or molds, the air is forced to pass as close as possible to the ionizing radiation source (near fiel","2021","07","02","Ann Biomed Eng","Annals of biomedical engineering","COMSOL Flow Algebraic yPlus interface; COVID-19; Indoor air purification; Passive flow control; Pathogen inactivation; Photo diodes; SARS-CoV-2; UVC","Moreno","E","Univ Lyon, UJM-Saint-Etienne, CNRS, Institute of Optics Graduate School, Laboratoire Hubert Curien UMR5516, 42023, St-Etienne, France. enrique@moreno","enrique@moreno.ws"
"1343","34191181","10.1007/s10439-021-02819-7","Active Versus Passive Flow Control in UVC FILTERs for COVID-19 Containment.","Ultraviolet radiation as a germicide is widely used in the health field and even in domestic hygiene. Here, we propose an improvement in low-cost portable units of filtration for indoor air, which is based on ultraviolet radiation. In the current technology, to carry out an air filtration with a suspension of aerosols in which there is a likely concentration of pathogens, whether viral, bacterial or molds, the air is forced to pass as close as possible to the ionizing radiation source (near fiel","2021","07","02","Ann Biomed Eng","Annals of biomedical engineering","COMSOL Flow Algebraic yPlus interface; COVID-19; Indoor air purification; Passive flow control; Pathogen inactivation; Photo diodes; SARS-CoV-2; UVC","Klochok","G","Moscow State University of Civil Engineering, National Research University, Yaroslavskoye Shosse, Moscow, Russia",NA
"1344","34191181","10.1007/s10439-021-02819-7","Active Versus Passive Flow Control in UVC FILTERs for COVID-19 Containment.","Ultraviolet radiation as a germicide is widely used in the health field and even in domestic hygiene. Here, we propose an improvement in low-cost portable units of filtration for indoor air, which is based on ultraviolet radiation. In the current technology, to carry out an air filtration with a suspension of aerosols in which there is a likely concentration of pathogens, whether viral, bacterial or molds, the air is forced to pass as close as possible to the ionizing radiation source (near fiel","2021","07","02","Ann Biomed Eng","Annals of biomedical engineering","COMSOL Flow Algebraic yPlus interface; COVID-19; Indoor air purification; Passive flow control; Pathogen inactivation; Photo diodes; SARS-CoV-2; UVC","García","S","EULEN Group, Neurotraumatology and Rehabilitation Hospital, Granada, Spain",NA
"1345","34191146","10.1007/s12032-021-01533-7","Can the host immune response against SARS-CoV2 also cause an anticancer effect?","During the COVID-19 pandemic, it is important to assure the safety and management of cancer patients. Despite preliminary studies revealed that patients with cancer are more susceptible to infection and have poorer prognosis than other infected patients without cancer, mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities. So, we have some comments about the pathogenesis attributed to the COVID-19 disease and cancer relationship and determi","2021","07","12","Med Oncol","Medical oncology (Northwood, London, England)","COVID-19 disease; Immune checkpoint blockage effect; Tumor immune responses; Tumor microenvironment; COVID-19; Cross Reactions; Cytokines; Humans; Immune Checkpoint Inhibitors; Lymphocyte Activation; Neoplasms; SARS-CoV-2; T-Lymphocytes; Tumor Microenvironment","Kahraman","Seda","Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Üniversiteler Mahallesi Bilkent Cad. No: 1 Çankaya, 06800, Ankara, Turkey. sedakayacan.kahraman@gmail","sedakayacan.kahraman@gmail.com"
"1346","34191146","10.1007/s12032-021-01533-7","Can the host immune response against SARS-CoV2 also cause an anticancer effect?","During the COVID-19 pandemic, it is important to assure the safety and management of cancer patients. Despite preliminary studies revealed that patients with cancer are more susceptible to infection and have poorer prognosis than other infected patients without cancer, mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities. So, we have some comments about the pathogenesis attributed to the COVID-19 disease and cancer relationship and determi","2021","07","12","Med Oncol","Medical oncology (Northwood, London, England)","COVID-19 disease; Immune checkpoint blockage effect; Tumor immune responses; Tumor microenvironment; COVID-19; Cross Reactions; Cytokines; Humans; Immune Checkpoint Inhibitors; Lymphocyte Activation; Neoplasms; SARS-CoV-2; T-Lymphocytes; Tumor Microenvironment","Akinci","Muhammed Bulent","Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Üniversiteler Mahallesi Bilkent Cad. No: 1 Çankaya, 06800, Ankara, Turkey",NA
"1347","34191146","10.1007/s12032-021-01533-7","Can the host immune response against SARS-CoV2 also cause an anticancer effect?","During the COVID-19 pandemic, it is important to assure the safety and management of cancer patients. Despite preliminary studies revealed that patients with cancer are more susceptible to infection and have poorer prognosis than other infected patients without cancer, mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities. So, we have some comments about the pathogenesis attributed to the COVID-19 disease and cancer relationship and determi","2021","07","12","Med Oncol","Medical oncology (Northwood, London, England)","COVID-19 disease; Immune checkpoint blockage effect; Tumor immune responses; Tumor microenvironment; COVID-19; Cross Reactions; Cytokines; Humans; Immune Checkpoint Inhibitors; Lymphocyte Activation; Neoplasms; SARS-CoV-2; T-Lymphocytes; Tumor Microenvironment","Sendur","Mehmet Ali Nahit","Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Üniversiteler Mahallesi Bilkent Cad. No: 1 Çankaya, 06800, Ankara, Turkey",NA
"1348","34191146","10.1007/s12032-021-01533-7","Can the host immune response against SARS-CoV2 also cause an anticancer effect?","During the COVID-19 pandemic, it is important to assure the safety and management of cancer patients. Despite preliminary studies revealed that patients with cancer are more susceptible to infection and have poorer prognosis than other infected patients without cancer, mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities. So, we have some comments about the pathogenesis attributed to the COVID-19 disease and cancer relationship and determi","2021","07","12","Med Oncol","Medical oncology (Northwood, London, England)","COVID-19 disease; Immune checkpoint blockage effect; Tumor immune responses; Tumor microenvironment; COVID-19; Cross Reactions; Cytokines; Humans; Immune Checkpoint Inhibitors; Lymphocyte Activation; Neoplasms; SARS-CoV-2; T-Lymphocytes; Tumor Microenvironment","Yalcin","Bulent","Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Üniversiteler Mahallesi Bilkent Cad. No: 1 Çankaya, 06800, Ankara, Turkey",NA
"1349","34191054","10.1007/s00108-021-01071-4","[Inhaled budesonide in the treatment of COVID-19].",NA,"2021","07","23","Internist (Berl)","Der Internist",NA,"Kluge","S","Zentrum für Anästhesiologie und Intensivmedizin, Klinik für Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland. skluge@uke","skluge@uke.de"
"1350","34191054","10.1007/s00108-021-01071-4","[Inhaled budesonide in the treatment of COVID-19].",NA,"2021","07","23","Internist (Berl)","Der Internist",NA,"Nitschmann","S",", Lippetal, Deutschland",NA
"1351","34191054","10.1007/s00108-021-01071-4","[Inhaled budesonide in the treatment of COVID-19].",NA,"2021","07","23","Internist (Berl)","Der Internist",NA,"Scherer","M","Institut und Poliklinik für Allgemeinmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland",NA
"1352","34191039","10.1007/s00134-021-06467-2","Delirium in COVID-19: can we make the unknowns knowns?",NA,"2021","07","02","Intensive Care Med","Intensive care medicine",NA,"Wilcox","M Elizabeth","Interdepartmental Division of Critical Care, University of Toronto and Consultant in Intensive Care Medicine at the Toronto Western Hospital, Toronto, Canada. elizabeth.wilcox@mail.utoronto","elizabeth.wilcox@mail.utoronto.ca"
"1353","34191039","10.1007/s00134-021-06467-2","Delirium in COVID-19: can we make the unknowns knowns?",NA,"2021","07","02","Intensive Care Med","Intensive care medicine",NA,"Shankar-Hari","Manu","School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"1354","34191039","10.1007/s00134-021-06467-2","Delirium in COVID-19: can we make the unknowns knowns?",NA,"2021","07","02","Intensive Care Med","Intensive care medicine",NA,"McAuley","Daniel F","Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Ireland",NA
"1355","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Smith","Rebecca L","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1356","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Gibson","Laura L","Division of Infectious Diseases and Immunology, Departments of Medicine and Pediatrics, University of Massachusetts Medical School, Worcester, MA, USA",NA
"1357","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Martinez","Pamela P","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1358","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Ke","Ruian","T-6, Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA",NA
"1359","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Mirza","Agha","Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA",NA
"1360","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Conte","Madison","Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA",NA
"1361","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Gallagher","Nicholas","Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"1362","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Conte","Abigail","W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"1363","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Wang","Leyi","Veterinary Diagnostic Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1364","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Fredrickson","Richard","Veterinary Diagnostic Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1365","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Edmonson","Darci C","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1366","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Baughman","Melinda E","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1367","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Chiu","Karen K","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1368","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Choi","Hannah","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1369","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Jensen","Tor W","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1370","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Scardina","Kevin R","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1371","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Bradley","Shannon","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1372","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Gloss","Stacy L","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1373","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Reinhart","Crystal","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1374","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Yedetore","Jagadeesh","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1375","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Owens","Alyssa N","Center for Clinical and Translational Research, University of Massachusetts Medical School, Worcester, MA, USA",NA
"1376","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Broach","John","UMass Memorial Medical Center, Worcester, MA, USA",NA
"1377","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Barton","Bruce","Division of Biostatistics and Health Services Research, University of Massachusetts Medical School, Worcester, MA, USA",NA
"1378","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Lazar","Peter","Division of Biostatistics and Health Services Research, University of Massachusetts Medical School, Worcester, MA, USA",NA
"1379","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Henness","Darcy","Carle Foundation Hospital, Urbana, IL, USA",NA
"1380","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Young","Todd","Carle Foundation Hospital, Urbana, IL, USA",NA
"1381","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Dunnett","Alastair","Carle Foundation Hospital, Urbana, IL, USA",NA
"1382","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Robinson","Matthew L","Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA",NA
"1383","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Mostafa","Heba H","Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"1384","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Pekosz","Andrew","W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"1385","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Manabe","Yukari C","Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA",NA
"1386","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Heetderks","William J","National Institute for Biomedical Imaging and Bioengineering, Bethesda, MD, USA",NA
"1387","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","McManus","David D","Division of Cardiology, University of Massachusetts Medical School, Worcester, MA, USA",NA
"1388","34191025","10.1093/infdis/jiab337","Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.","Serial screening is critical for restricting spread of SARS-CoV-2 by facilitating the timely identification of infected individuals to interrupt transmission chains. The variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented. This is a longitudinal study of 43 adults newly infected with SARS-CoV-2. All participants provided daily samples for saliva and nasal swab RTqPCR, Quidel SARS Sofia antigen FIA, and live virus culture. We show t","2021","07","07","J Infect Dis","The Journal of infectious diseases","Diagnostic testing; RTqPCR testing; SARS-CoV-2; antigen testing; test sensitivity","Brooke","Christopher B","Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA",NA
"1389","34191024","10.1093/qjmed/hcab177","A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19 vaccination; Cardiac manifestations; ST-segment elevation","Lee","Edwin","Department of Cardiology, National University Heart Centre, National University Health System, Singapore",NA
"1390","34191024","10.1093/qjmed/hcab177","A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19 vaccination; Cardiac manifestations; ST-segment elevation","Chew","Nicholas Ws","Department of Cardiology, National University Heart Centre, National University Health System, Singapore",NA
"1391","34191024","10.1093/qjmed/hcab177","A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19 vaccination; Cardiac manifestations; ST-segment elevation","Ng","Perryn","Department of Cardiology, National University Heart Centre, National University Health System, Singapore",NA
"1392","34191024","10.1093/qjmed/hcab177","A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19 vaccination; Cardiac manifestations; ST-segment elevation","Yeo","Tee Joo","Department of Cardiology, National University Heart Centre, National University Health System, Singapore",NA
"1393","34191022","10.1093/qjmed/hcab178","The spectrum of SARS-CoV-2 associated polyradiculitis is broad.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19; Guillain-Barre syndrome; SARS-CoV-2; immune response; neuropathy; polyradiculitis","Fiorini","Ana C","Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), Brazil",NA
"1394","34191022","10.1093/qjmed/hcab178","The spectrum of SARS-CoV-2 associated polyradiculitis is broad.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19; Guillain-Barre syndrome; SARS-CoV-2; immune response; neuropathy; polyradiculitis","Finsterer","Josef","Klinik Landstrasse, Messerli Institute, Vienna, Austria",NA
"1395","34191022","10.1093/qjmed/hcab178","The spectrum of SARS-CoV-2 associated polyradiculitis is broad.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians","COVID-19; Guillain-Barre syndrome; SARS-CoV-2; immune response; neuropathy; polyradiculitis","Scorza","Fulvio A","Disciplina de Neurociência. Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brasil",NA
"1396","34191020","10.1093/jalm/jfab081","Evaluation of Inappropriate COVID-19 RT-PCR Test Utilization at an academic medical center.","An evolving COVID-19 testing landscape and issues with test supply allocation, especially in the current pandemic, has made it challenging for ordering providers. We audited orders of the Xpert® Xpress SARS-CoV-2 RT-PCR platform-the fastest of several other testing modalities available-to illuminate these challenges utilizing a multidisciplinary laboratory professional team consisting of a pathology resident and microbiology lab director. Retrospective review of the first five hundred Xpert® Xpr","2021","06","30","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Hardy","Naomi L","Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA",NA
"1397","34191020","10.1093/jalm/jfab081","Evaluation of Inappropriate COVID-19 RT-PCR Test Utilization at an academic medical center.","An evolving COVID-19 testing landscape and issues with test supply allocation, especially in the current pandemic, has made it challenging for ordering providers. We audited orders of the Xpert® Xpress SARS-CoV-2 RT-PCR platform-the fastest of several other testing modalities available-to illuminate these challenges utilizing a multidisciplinary laboratory professional team consisting of a pathology resident and microbiology lab director. Retrospective review of the first five hundred Xpert® Xpr","2021","06","30","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Luethy","Paul M","Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA",NA
"1398","34191014","10.1093/qjmed/hcab179","Letter to the editor, reply re: 'the spectrum of SARS-CoV-2 associated polyradiculitis is broad'.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians",NA,"Wang","Yumin","Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, 100049, People's Republic of China",NA
"1399","34191014","10.1093/qjmed/hcab179","Letter to the editor, reply re: 'the spectrum of SARS-CoV-2 associated polyradiculitis is broad'.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians",NA,"Wang","Yanchao","Department of Neurology, The Affiliated Hospital of Chifeng University, Chifeng, 024005, PR China",NA
"1400","34191014","10.1093/qjmed/hcab179","Letter to the editor, reply re: 'the spectrum of SARS-CoV-2 associated polyradiculitis is broad'.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians",NA,"Li","Xiujun","School of Clinical Medicine, Chifeng University, Chifeng, 024005, PR China",NA
"1401","34191014","10.1093/qjmed/hcab179","Letter to the editor, reply re: 'the spectrum of SARS-CoV-2 associated polyradiculitis is broad'.",NA,"2021","06","30","QJM","QJM : monthly journal of the Association of Physicians",NA,"Wang","Hongquan","Department of Neurology, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, 100049, People's Republic of China",NA
"1402","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Cappola","Anne R","Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia",NA
"1403","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Schriver","Emily R","Data Analytics Center, University of Pennsylvania Health System, Philadelphia",NA
"1404","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Mowery","Danielle L","Institute for Biomedical Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia",NA
"1405","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Wollack","Colin","Information Services, University of Pennsylvania Health System, Philadelphia",NA
"1406","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Ives","Camelot T","Marketing, University of Pennsylvania Health System, Philadelphia",NA
"1407","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Gonzales","Ryan","Marketing, University of Pennsylvania Health System, Philadelphia",NA
"1408","34190999","10.1001/jamanetworkopen.2021.15211","Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial.",NA,"2021","07","07","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Appointments and Schedules; COVID-19; Communication; Correspondence as Topic; Electronic Mail; Female; Humans; Male; Middle Aged; Office Visits; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Telemedicine; Young Adult","Cappella","Joseph N","Annenberg School for Communication, University of Pennsylvania, Philadelphia",NA
"1409","34190978","10.1001/jama.2021.10626","Alcohol-Related Diseases Increased as Some People Drank More During the COVID-19 Pandemic.",NA,"2021","07","21","JAMA","JAMA",NA,"Rubin","Rita",NA,NA
"1410","34190964","10.1001/jama.2021.11007","Another COVID-19 Fallout: Teens' Happy Hour With Parents.",NA,"2021","07","21","JAMA","JAMA",NA,"Slomski","Anita",NA,NA
"1411","34190955","10.1590/S1678-9946202163053","Influence of the COVID-19 pandemic on the incidence of tuberculosis and influenza.","We examined whether the COVID-19 pandemic has affected the incidence of tuberculosis (TB) and influenza in Serbia, a Southeast European country with a low TB incidence rate and a mandatory BCG vaccination at birth. The first case of COVID-19 was registered on March 6, 2020. Despite the need for a sudden adaptation of the health care system, routines of mycobacterial laboratories have never stopped. In 2020, the number of newly diagnosed TB patients was significantly lower than expected (p = 0.04","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","COVID-19; Communicable Disease Control; Humans; Incidence; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Pandemics; SARS-CoV-2; Tuberculosis","Pavlovic","Jovana Milan","Community Health Center Zvezdara, Belgrade, Serbia",NA
"1412","34190955","10.1590/S1678-9946202163053","Influence of the COVID-19 pandemic on the incidence of tuberculosis and influenza.","We examined whether the COVID-19 pandemic has affected the incidence of tuberculosis (TB) and influenza in Serbia, a Southeast European country with a low TB incidence rate and a mandatory BCG vaccination at birth. The first case of COVID-19 was registered on March 6, 2020. Despite the need for a sudden adaptation of the health care system, routines of mycobacterial laboratories have never stopped. In 2020, the number of newly diagnosed TB patients was significantly lower than expected (p = 0.04","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","COVID-19; Communicable Disease Control; Humans; Incidence; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Pandemics; SARS-CoV-2; Tuberculosis","Pesut","Dragica Petar","University of Belgrade, Faculty of Medicine, Internal Medicine Department, Belgrade, Serbia",NA
"1413","34190955","10.1590/S1678-9946202163053","Influence of the COVID-19 pandemic on the incidence of tuberculosis and influenza.","We examined whether the COVID-19 pandemic has affected the incidence of tuberculosis (TB) and influenza in Serbia, a Southeast European country with a low TB incidence rate and a mandatory BCG vaccination at birth. The first case of COVID-19 was registered on March 6, 2020. Despite the need for a sudden adaptation of the health care system, routines of mycobacterial laboratories have never stopped. In 2020, the number of newly diagnosed TB patients was significantly lower than expected (p = 0.04","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","COVID-19; Communicable Disease Control; Humans; Incidence; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Pandemics; SARS-CoV-2; Tuberculosis","Stosic","Maja Borivoje","Public Health Institute of Serbia ""Dr Milan Jovanovic Batut"", Department of HIV, Hepatitis, STDs and TB, Belgrade, Serbia",NA
"1414","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Campos","Karoline Rodrigues","Instituto Adolfo Lutz, Centro de Respostas Rápidas, Laboratório Estratégico, São Paulo, São Paulo, Brazil",NA
"1415","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Sacchi","Cláudio Tavares","Instituto Adolfo Lutz, Centro de Respostas Rápidas, Laboratório Estratégico, São Paulo, São Paulo, Brazil",NA
"1416","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Gonçalves","Cláudia Regina","Instituto Adolfo Lutz, Centro de Respostas Rápidas, Laboratório Estratégico, São Paulo, São Paulo, Brazil",NA
"1417","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Pagnoca","Érica Valessa Ramos Gomes","Instituto Adolfo Lutz, Centro de Respostas Rápidas, Laboratório Estratégico, São Paulo, São Paulo, Brazil",NA
"1418","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Dias","Alana Dos Santos","Instituto Adolfo Lutz, Centro de Respostas Rápidas, Laboratório Estratégico, São Paulo, São Paulo, Brazil",NA
"1419","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Fukasawa","Lucila Okuyama","Instituto Adolfo Lutz, Centro de Imunologia, São Paulo, São Paulo, Brazil",NA
"1420","34190954","10.1590/S1678-9946202163052","COVID-19 laboratory diagnosis: comparative analysis of different RNA extraction methods for SARS-CoV-2 detection by two amplification protocols.","The gold standard for the laboratory diagnosis of COVID-19 is the reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) assay, which searches for SARS-CoV-2 target genes in nasopharyngeal/oropharyngeal (NP/OP) samples, and its performance depends on the quantity and quality of the RNA input. This study compared the performance and cost-effectiveness of three different kits/reagents for RNA extraction used in COVID-19 diagnosis in Sao Paulo, Brazil. A total of 300 NP/OP","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Humans; Laboratories; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sensitivity and Specificity","Caterino-de-Araujo","Adele","Instituto Adolfo Lutz, Centro de Imunologia, São Paulo, São Paulo, Brazil",NA
"1421","34190953","10.1590/S1678-9946202163051","Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia.","In December 2019, several cases of pneumonia of unknown origin were reported in the city of Wuhan, province of Hubei, China. The pathogen was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease was named coronavirus disease 2019 (COVID-19). Acute phase reactans (APRs) are critical in the early diagnosis, treatment, and for monitoring the progression of COVID-19. Seventy two patients were included in the study and infections confirmed by real-time reverse transcr","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Acute-Phase Proteins; COVID-19; China; Female; Humans; Male; Prognosis; Retrospective Studies; SARS-CoV-2","Sayit","Asli Tanrivermis","Ondokuz Mayis University, Faculty of Medicine, Department of Radiology, Samsun, Turkey",NA
"1422","34190953","10.1590/S1678-9946202163051","Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia.","In December 2019, several cases of pneumonia of unknown origin were reported in the city of Wuhan, province of Hubei, China. The pathogen was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease was named coronavirus disease 2019 (COVID-19). Acute phase reactans (APRs) are critical in the early diagnosis, treatment, and for monitoring the progression of COVID-19. Seventy two patients were included in the study and infections confirmed by real-time reverse transcr","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Acute-Phase Proteins; COVID-19; China; Female; Humans; Male; Prognosis; Retrospective Studies; SARS-CoV-2","Elmali","Muzaffer","Ondokuz Mayis University, Faculty of Medicine, Department of Radiology, Samsun, Turkey",NA
"1423","34190953","10.1590/S1678-9946202163051","Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia.","In December 2019, several cases of pneumonia of unknown origin were reported in the city of Wuhan, province of Hubei, China. The pathogen was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease was named coronavirus disease 2019 (COVID-19). Acute phase reactans (APRs) are critical in the early diagnosis, treatment, and for monitoring the progression of COVID-19. Seventy two patients were included in the study and infections confirmed by real-time reverse transcr","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Acute-Phase Proteins; COVID-19; China; Female; Humans; Male; Prognosis; Retrospective Studies; SARS-CoV-2","Deveci","Aydin","Ondokuz Mayis University, Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Samsun, Turkey",NA
"1424","34190953","10.1590/S1678-9946202163051","Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia.","In December 2019, several cases of pneumonia of unknown origin were reported in the city of Wuhan, province of Hubei, China. The pathogen was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease was named coronavirus disease 2019 (COVID-19). Acute phase reactans (APRs) are critical in the early diagnosis, treatment, and for monitoring the progression of COVID-19. Seventy two patients were included in the study and infections confirmed by real-time reverse transcr","2021","07","02","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Acute-Phase Proteins; COVID-19; China; Female; Humans; Male; Prognosis; Retrospective Studies; SARS-CoV-2","Gedikli","Omer","Ondokuz Mayis University, Faculty of Medicine, Department of Cardiology, Samsun, Turkey",NA
"1425","34190946","10.1590/1518-8345.4895.3455","Risks of occupational illnesses among health workers providing care to patients with COVID-19: an integrative review.","to analyze evidence concerning the risks of occupational illnesses to which health workers providing care to patients infected with COVID-19 are exposed. integrative literature review conducted in the following online databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), Web of Science (WoS), Excerpta Medica Data-Base (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus (Elsevier). Original articles published between November 2019 ","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","COVID-19; Cross-Sectional Studies; Health Personnel; Humans; Occupational Diseases; SARS-CoV-2","Vega","Edwing Alberto Urrea","Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil",NA
"1426","34190946","10.1590/1518-8345.4895.3455","Risks of occupational illnesses among health workers providing care to patients with COVID-19: an integrative review.","to analyze evidence concerning the risks of occupational illnesses to which health workers providing care to patients infected with COVID-19 are exposed. integrative literature review conducted in the following online databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), Web of Science (WoS), Excerpta Medica Data-Base (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus (Elsevier). Original articles published between November 2019 ","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","COVID-19; Cross-Sectional Studies; Health Personnel; Humans; Occupational Diseases; SARS-CoV-2","Antoniolli","Liliana","Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil",NA
"1427","34190946","10.1590/1518-8345.4895.3455","Risks of occupational illnesses among health workers providing care to patients with COVID-19: an integrative review.","to analyze evidence concerning the risks of occupational illnesses to which health workers providing care to patients infected with COVID-19 are exposed. integrative literature review conducted in the following online databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), Web of Science (WoS), Excerpta Medica Data-Base (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus (Elsevier). Original articles published between November 2019 ","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","COVID-19; Cross-Sectional Studies; Health Personnel; Humans; Occupational Diseases; SARS-CoV-2","Macedo","Andréia Barcellos Teixeira","Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil",NA
"1428","34190946","10.1590/1518-8345.4895.3455","Risks of occupational illnesses among health workers providing care to patients with COVID-19: an integrative review.","to analyze evidence concerning the risks of occupational illnesses to which health workers providing care to patients infected with COVID-19 are exposed. integrative literature review conducted in the following online databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), Web of Science (WoS), Excerpta Medica Data-Base (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus (Elsevier). Original articles published between November 2019 ","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","COVID-19; Cross-Sectional Studies; Health Personnel; Humans; Occupational Diseases; SARS-CoV-2","Pinheiro","Jéssica Morgana Gediel","Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil",NA
"1429","34190946","10.1590/1518-8345.4895.3455","Risks of occupational illnesses among health workers providing care to patients with COVID-19: an integrative review.","to analyze evidence concerning the risks of occupational illnesses to which health workers providing care to patients infected with COVID-19 are exposed. integrative literature review conducted in the following online databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), Web of Science (WoS), Excerpta Medica Data-Base (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus (Elsevier). Original articles published between November 2019 ","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","COVID-19; Cross-Sectional Studies; Health Personnel; Humans; Occupational Diseases; SARS-CoV-2","Dornelles","Thayane Martins","Hospital Moinhos de Vento, Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS), Porto Alegre, RS, Brazil",NA
"1430","34190946","10.1590/1518-8345.4895.3455","Risks of occupational illnesses among health workers providing care to patients with COVID-19: an integrative review.","to analyze evidence concerning the risks of occupational illnesses to which health workers providing care to patients infected with COVID-19 are exposed. integrative literature review conducted in the following online databases: Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed), Web of Science (WoS), Excerpta Medica Data-Base (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus (Elsevier). Original articles published between November 2019 ","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","COVID-19; Cross-Sectional Studies; Health Personnel; Humans; Occupational Diseases; SARS-CoV-2","Souza","Sônia Beatriz Cócaro de","Universidade Federal do Rio Grande do Sul, Departamento de Enfermagem Médico-Cirúrgica, Porto Alegre, RS, Brazil",NA
"1431","34190945","10.1590/1518-8345.4894.3454","Perception of musculoskeletal pain in the state of confinement: associated factors.","to describe the perception of musculoskeletal pain in the population and how the state of confinement (adopted as a measure to control contagion by COVID-19) has interfered with it, as well as identifying the sociodemographic, occupational, physical, and psychosocial factors involved. an observational, cross-sectional and analytical study, with simple random probabilistic sampling, aimed at residents in Spain over 18 years old during the confinement period. An ad hoc survey was conducted, consis","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Adolescent; COVID-19; Cross-Sectional Studies; Humans; Musculoskeletal Pain; Perception; SARS-CoV-2; Spain; Surveys and Questionnaires","Carpintero-Rubio","Carlos","Colegio Profesional de Practicantes de Reconstrucción Postural, Estrasburgo, France",NA
"1432","34190945","10.1590/1518-8345.4894.3454","Perception of musculoskeletal pain in the state of confinement: associated factors.","to describe the perception of musculoskeletal pain in the population and how the state of confinement (adopted as a measure to control contagion by COVID-19) has interfered with it, as well as identifying the sociodemographic, occupational, physical, and psychosocial factors involved. an observational, cross-sectional and analytical study, with simple random probabilistic sampling, aimed at residents in Spain over 18 years old during the confinement period. An ad hoc survey was conducted, consis","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Adolescent; COVID-19; Cross-Sectional Studies; Humans; Musculoskeletal Pain; Perception; SARS-CoV-2; Spain; Surveys and Questionnaires","Torres-Chica","Bárbara","Clínica Sarua, Madrid, Spain",NA
"1433","34190945","10.1590/1518-8345.4894.3454","Perception of musculoskeletal pain in the state of confinement: associated factors.","to describe the perception of musculoskeletal pain in the population and how the state of confinement (adopted as a measure to control contagion by COVID-19) has interfered with it, as well as identifying the sociodemographic, occupational, physical, and psychosocial factors involved. an observational, cross-sectional and analytical study, with simple random probabilistic sampling, aimed at residents in Spain over 18 years old during the confinement period. An ad hoc survey was conducted, consis","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Adolescent; COVID-19; Cross-Sectional Studies; Humans; Musculoskeletal Pain; Perception; SARS-CoV-2; Spain; Surveys and Questionnaires","Guadrón-Romero","María Alexandra","Hospital de Sierrallana, Servicio Cántabro de Salud, Torrelavega, Cantabria, Spain",NA
"1434","34190945","10.1590/1518-8345.4894.3454","Perception of musculoskeletal pain in the state of confinement: associated factors.","to describe the perception of musculoskeletal pain in the population and how the state of confinement (adopted as a measure to control contagion by COVID-19) has interfered with it, as well as identifying the sociodemographic, occupational, physical, and psychosocial factors involved. an observational, cross-sectional and analytical study, with simple random probabilistic sampling, aimed at residents in Spain over 18 years old during the confinement period. An ad hoc survey was conducted, consis","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Adolescent; COVID-19; Cross-Sectional Studies; Humans; Musculoskeletal Pain; Perception; SARS-CoV-2; Spain; Surveys and Questionnaires","Visiers-Jiménez","Laura","Instituto de Investigación-Grupo de Enfermería-Sanitaria Gregorio Marañón, IiSGM, Madrid, Spain",NA
"1435","34190945","10.1590/1518-8345.4894.3454","Perception of musculoskeletal pain in the state of confinement: associated factors.","to describe the perception of musculoskeletal pain in the population and how the state of confinement (adopted as a measure to control contagion by COVID-19) has interfered with it, as well as identifying the sociodemographic, occupational, physical, and psychosocial factors involved. an observational, cross-sectional and analytical study, with simple random probabilistic sampling, aimed at residents in Spain over 18 years old during the confinement period. An ad hoc survey was conducted, consis","2021","07","02","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Adolescent; COVID-19; Cross-Sectional Studies; Humans; Musculoskeletal Pain; Perception; SARS-CoV-2; Spain; Surveys and Questionnaires","Peña-Otero","David","Instituto de Investigación-Grupo de Enfermería-Sanitaria Gregorio Marañón, IiSGM, Madrid, Spain",NA
"1436","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Escalante-Maldonado","Oscar","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1437","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Vidal-Anzardo","Margot","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1438","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Donaires","Fernando","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1439","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Solis-Sanchez","Gilmer","Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú",NA
"1440","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Gallesi","Italo","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1441","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Pampa-Espinoza","Luis","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1442","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Huaringa","Maribel","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1443","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Rojas-Serrano","Nancy","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1444","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","García","Coralith","Hospital Nacional Cayetano Heredia, Lima, Perú",NA
"1445","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Angles-Yanqui","Eddie","Hospital Nacional Arzobispo Loayza, Lima, Perú",NA
"1446","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Gavilán","Ronnie Gustavo","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1447","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Durães-Carvalho","Ricardo","Universidad de Campinas, Sao Paulo, Brasil",NA
"1448","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Mendez-Rico","Jairo","Organización Panamericana de la Salud, Organización Mundial de la Salud, Washington DC, Estados Unidos de América",NA
"1449","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Cabezas","César","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1450","34190927","10.17843/rpmesp.2021.381.7154","Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.","To standardize and validate an in-house RT-LAMP test for the detection of SARS-CoV-2, based on laboratory and field assays using samples from COVID-19 suspected patients. An in-house SARS-CoV-2 RT-LAMP molecular test was standardized, establishing the detection limit with Vero cells of isolated Peruvian strains of SARS-CoV-2, and the robustness to various concentrations of primers. The laboratory validation was performed with 384 nasal and pharyngeal swab samples (UFH) obtained between March and","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Chlorocebus aethiops; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Sensitivity and Specificity; Vero Cells","Marques-Simas","Paulo Vitor","Universidad de Campinas, Sao Paulo, Brasil",NA
"1451","34190926","10.17843/rpmesp.2021.381.6312","Teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands.","A cross-sectional study was carried out to determine the teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands region in Spain, between May 14 - 18, 2020. A virtual questionnaire based on a validated instrument was applied. We included 1,503 surveys, which showed that teachers are unwilling to work if there is risk of infection at the school (76.6%). However, they state that they would go to work if they had the appropriate hygiene (69.2%) and protection (67.0%) mea","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Pandemics; SARS-CoV-2; Spain; Surveys and Questionnaires","Santana-López","Borja N","Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España",NA
"1452","34190926","10.17843/rpmesp.2021.381.6312","Teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands.","A cross-sectional study was carried out to determine the teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands region in Spain, between May 14 - 18, 2020. A virtual questionnaire based on a validated instrument was applied. We included 1,503 surveys, which showed that teachers are unwilling to work if there is risk of infection at the school (76.6%). However, they state that they would go to work if they had the appropriate hygiene (69.2%) and protection (67.0%) mea","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Pandemics; SARS-CoV-2; Spain; Surveys and Questionnaires","Santana-Padilla","Yeray G","Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España",NA
"1453","34190926","10.17843/rpmesp.2021.381.6312","Teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands.","A cross-sectional study was carried out to determine the teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands region in Spain, between May 14 - 18, 2020. A virtual questionnaire based on a validated instrument was applied. We included 1,503 surveys, which showed that teachers are unwilling to work if there is risk of infection at the school (76.6%). However, they state that they would go to work if they had the appropriate hygiene (69.2%) and protection (67.0%) mea","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Pandemics; SARS-CoV-2; Spain; Surveys and Questionnaires","Santana-Cabrera","Esteban G","Consejería de Educación, Las Palmas de Gran Canaria, Las Palmas, España",NA
"1454","34190926","10.17843/rpmesp.2021.381.6312","Teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands.","A cross-sectional study was carried out to determine the teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands region in Spain, between May 14 - 18, 2020. A virtual questionnaire based on a validated instrument was applied. We included 1,503 surveys, which showed that teachers are unwilling to work if there is risk of infection at the school (76.6%). However, they state that they would go to work if they had the appropriate hygiene (69.2%) and protection (67.0%) mea","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Pandemics; SARS-CoV-2; Spain; Surveys and Questionnaires","Ruiz-Rodríguez","Gloria R","Consejería de Educación, Las Palmas de Gran Canaria, Las Palmas, España",NA
"1455","34190926","10.17843/rpmesp.2021.381.6312","Teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands.","A cross-sectional study was carried out to determine the teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands region in Spain, between May 14 - 18, 2020. A virtual questionnaire based on a validated instrument was applied. We included 1,503 surveys, which showed that teachers are unwilling to work if there is risk of infection at the school (76.6%). However, they state that they would go to work if they had the appropriate hygiene (69.2%) and protection (67.0%) mea","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Pandemics; SARS-CoV-2; Spain; Surveys and Questionnaires","González-Martín","Jesús M","Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España",NA
"1456","34190926","10.17843/rpmesp.2021.381.6312","Teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands.","A cross-sectional study was carried out to determine the teachers' attitudes and knowledge about the COVID-19 pandemic in the Canary Islands region in Spain, between May 14 - 18, 2020. A virtual questionnaire based on a validated instrument was applied. We included 1,503 surveys, which showed that teachers are unwilling to work if there is risk of infection at the school (76.6%). However, they state that they would go to work if they had the appropriate hygiene (69.2%) and protection (67.0%) mea","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Pandemics; SARS-CoV-2; Spain; Surveys and Questionnaires","Santana-Cabrera","Luciano","Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España",NA
"1457","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Dávila-Aliaga","Carmen","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1458","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Hinojosa-Pérez","Rosmary","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1459","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Espinola-Sánchez","Marcos","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1460","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Torres-Marcos","Elsa","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1461","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Guevara-Ríos","Enrique","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1462","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Espinoza-Vivas","Ylia","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1463","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Mendoza-Ibañez","Elina","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1464","34190925","10.17843/rpmesp.2021.381.6358","Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.","The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were prem","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Female; Hospitals; Humans; Infant, Newborn; Peru; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; SARS-CoV-2","Saldaña-Díaz","Claudia","Instituto Nacional Materno Perinatal, Lima, Perú",NA
"1465","34190924","10.17843/rpmesp.2021.381.7312","[2021 and its new challenges in controlling SARS-CoV-2].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Humans; SARS-CoV-2","Solari","Lely","Instituto Nacional de Salud, Lima, Perú",NA
"1466","34190915","10.17843/rpmesp.2021.381.6740","[Social inequalities in mortality during COVID-19 in Lima and Callao].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Humans; SARS-CoV-2; Socioeconomic Factors","Mújica","Oscar J","Departamento de Evidencia e Inteligencia para la Acción en Salud, Organización Panamericana de la Salud/Organización Mundial de la Salud, Washington DC, EE",NA
"1467","34190915","10.17843/rpmesp.2021.381.6740","[Social inequalities in mortality during COVID-19 in Lima and Callao].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Humans; SARS-CoV-2; Socioeconomic Factors","Pachas","Paul E","Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú",NA
"1468","34190914","10.17843/rpmesp.2021.381.6460","[Pediatric multisystemic inflammatory syndrome associated with COVID-19: preliminary report of a hospital in Peru].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Child; Hospitalization; Hospitals; Humans; Peru; SARS-CoV-2","Aguila","Olguita Del","Servicio de Pediatría de Especialidades Clínicas, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú",NA
"1469","34190914","10.17843/rpmesp.2021.381.6460","[Pediatric multisystemic inflammatory syndrome associated with COVID-19: preliminary report of a hospital in Peru].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Child; Hospitalization; Hospitals; Humans; Peru; SARS-CoV-2","Domínguez-Rojas","Jesús","Servicio de Pediatría Clínica, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú",NA
"1470","34190914","10.17843/rpmesp.2021.381.6460","[Pediatric multisystemic inflammatory syndrome associated with COVID-19: preliminary report of a hospital in Peru].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Child; Hospitalization; Hospitals; Humans; Peru; SARS-CoV-2","Garcés-Ghilardi","Raquel","Servicio de Pediatría Clínica, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú",NA
"1471","34190914","10.17843/rpmesp.2021.381.6460","[Pediatric multisystemic inflammatory syndrome associated with COVID-19: preliminary report of a hospital in Peru].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Child; Hospitalization; Hospitals; Humans; Peru; SARS-CoV-2","Estupiñan-Vigil","Matilde","Servicio de Pediatría Clínica, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú",NA
"1472","34190914","10.17843/rpmesp.2021.381.6460","[Pediatric multisystemic inflammatory syndrome associated with COVID-19: preliminary report of a hospital in Peru].",NA,"2021","07","05","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Child; Hospitalization; Hospitals; Humans; Peru; SARS-CoV-2","Alvarado-Gamarra","Giancarlo","Servicio de Pediatría Clínica, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú",NA
"1473","34190912","10.17843/rpmesp.2021.381.6627","[The regulation of COVID-19 clinical trials in Peru].","COVID-19 has affected the conduct of clinical trials worldwide. Once the health emergency began in Peru, the national government took measures to guarantee the conduct of COVID-19 clinical trials. A national research ethics committee was exclusively established for COVID-19 clinical trials; and a regulatory framework was implemented to ensure the ethical and timely conduct of these studies. To december 31, 2020, the Peruvian National Health Institute authorized 29 clinical trials, of which 4 tes","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Ethics Committees, Research; Humans; Peru; SARS-CoV-2","Lope","Paula Cahuina","Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú",NA
"1474","34190912","10.17843/rpmesp.2021.381.6627","[The regulation of COVID-19 clinical trials in Peru].","COVID-19 has affected the conduct of clinical trials worldwide. Once the health emergency began in Peru, the national government took measures to guarantee the conduct of COVID-19 clinical trials. A national research ethics committee was exclusively established for COVID-19 clinical trials; and a regulatory framework was implemented to ensure the ethical and timely conduct of these studies. To december 31, 2020, the Peruvian National Health Institute authorized 29 clinical trials, of which 4 tes","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Ethics Committees, Research; Humans; Peru; SARS-CoV-2","Carracedo","Sarah","Pontificia Universidad Católica del Perú, Lima, Perú",NA
"1475","34190912","10.17843/rpmesp.2021.381.6627","[The regulation of COVID-19 clinical trials in Peru].","COVID-19 has affected the conduct of clinical trials worldwide. Once the health emergency began in Peru, the national government took measures to guarantee the conduct of COVID-19 clinical trials. A national research ethics committee was exclusively established for COVID-19 clinical trials; and a regulatory framework was implemented to ensure the ethical and timely conduct of these studies. To december 31, 2020, the Peruvian National Health Institute authorized 29 clinical trials, of which 4 tes","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Ethics Committees, Research; Humans; Peru; SARS-CoV-2","Romani","Franco","Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú",NA
"1476","34190910","10.17843/rpmesp.2021.381.6471","[Challenges to the continuity of care of people living with HIV throughout the COVID-19 crisis in Peru].","The COVID-19 pandemic and societal response implemented may interact with the ongoing HIV epidemic in multiple ways. There are approximately 87000 people living with HIV (PLWH) who are at risk of developing COVID-19 in Peru and 67,000 of them are on antiretroviral therapy (ART) and at risk of limitations in their access to ART, compromising their adherence and their health during the pandemic. Finally, the potential effect of the pandemic on the mental health of PLWH is not documented. This opin","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Continuity of Patient Care; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Paredes","Jose L","Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú",NA
"1477","34190910","10.17843/rpmesp.2021.381.6471","[Challenges to the continuity of care of people living with HIV throughout the COVID-19 crisis in Peru].","The COVID-19 pandemic and societal response implemented may interact with the ongoing HIV epidemic in multiple ways. There are approximately 87000 people living with HIV (PLWH) who are at risk of developing COVID-19 in Peru and 67,000 of them are on antiretroviral therapy (ART) and at risk of limitations in their access to ART, compromising their adherence and their health during the pandemic. Finally, the potential effect of the pandemic on the mental health of PLWH is not documented. This opin","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Continuity of Patient Care; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Navarro","Rafaella","Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú",NA
"1478","34190910","10.17843/rpmesp.2021.381.6471","[Challenges to the continuity of care of people living with HIV throughout the COVID-19 crisis in Peru].","The COVID-19 pandemic and societal response implemented may interact with the ongoing HIV epidemic in multiple ways. There are approximately 87000 people living with HIV (PLWH) who are at risk of developing COVID-19 in Peru and 67,000 of them are on antiretroviral therapy (ART) and at risk of limitations in their access to ART, compromising their adherence and their health during the pandemic. Finally, the potential effect of the pandemic on the mental health of PLWH is not documented. This opin","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Continuity of Patient Care; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Cabrera","Diego M","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States",NA
"1479","34190910","10.17843/rpmesp.2021.381.6471","[Challenges to the continuity of care of people living with HIV throughout the COVID-19 crisis in Peru].","The COVID-19 pandemic and societal response implemented may interact with the ongoing HIV epidemic in multiple ways. There are approximately 87000 people living with HIV (PLWH) who are at risk of developing COVID-19 in Peru and 67,000 of them are on antiretroviral therapy (ART) and at risk of limitations in their access to ART, compromising their adherence and their health during the pandemic. Finally, the potential effect of the pandemic on the mental health of PLWH is not documented. This opin","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Continuity of Patient Care; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Diaz","Monica M","University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",NA
"1480","34190910","10.17843/rpmesp.2021.381.6471","[Challenges to the continuity of care of people living with HIV throughout the COVID-19 crisis in Peru].","The COVID-19 pandemic and societal response implemented may interact with the ongoing HIV epidemic in multiple ways. There are approximately 87000 people living with HIV (PLWH) who are at risk of developing COVID-19 in Peru and 67,000 of them are on antiretroviral therapy (ART) and at risk of limitations in their access to ART, compromising their adherence and their health during the pandemic. Finally, the potential effect of the pandemic on the mental health of PLWH is not documented. This opin","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Continuity of Patient Care; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Mejia","Fernando","Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú",NA
"1481","34190910","10.17843/rpmesp.2021.381.6471","[Challenges to the continuity of care of people living with HIV throughout the COVID-19 crisis in Peru].","The COVID-19 pandemic and societal response implemented may interact with the ongoing HIV epidemic in multiple ways. There are approximately 87000 people living with HIV (PLWH) who are at risk of developing COVID-19 in Peru and 67,000 of them are on antiretroviral therapy (ART) and at risk of limitations in their access to ART, compromising their adherence and their health during the pandemic. Finally, the potential effect of the pandemic on the mental health of PLWH is not documented. This opin","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","COVID-19; Continuity of Patient Care; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Caceres","Carlos F","Centro de Investigación Interdisciplinaria en Sexualidad, Sida y Sociedad, Lima, Perú",NA
"1482","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","García-Castro","Giovanni","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1483","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Latorre-Galeano","David","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1484","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Giraldo-Montoya","Ángela María","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1485","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Cabrales-Vega","Rodolfo Adrián","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1486","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Isaza-Velásquez","Enrique","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1487","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Gómez-González","José Fernando","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1488","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","González-Corrales","Juan Carlos","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1489","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Ardila-Otero","Álvaro","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1490","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Flórez-Castañeda","Indhira Tatiana","Fundación Universitaria del Área Andina, Pereira, Colombia",NA
"1491","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Chica-Builes","Juan Fernando","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1492","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","Martínez-Ávila","Ángela María","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1493","34190909","10.17843/rpmesp.2021.381.6505","[Mechanical ventilator test protocol for care of patients with COVID-19 in porcine model].","As a result of the SARS-CoV-2 pandemic, health systems globally have seen a dramatic increase in the occupancy of intensive care units, with mechanical ventilators being a resource in high demand in the care of these patients. This article proposes a protocol for testing low-cost mechanical ventilators in pig models, as part of the development of locally manufactured biomedical equipment that can support the health crisis caused by the pandemic. The protocol addresses aspects that include the pr","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine; Ventilators, Mechanical","González-Colonia","Luz Victoria","Universidad Tecnológica de Pereira, Pereira, Colombia",NA
"1494","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Errea","Renato A","Departamento de Salud Global y Medicina Social, Escuela de Medicina de Harvard, Boston, Estados Unidos de América",NA
"1495","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Wong","Milagros","Socios en Salud, Lima, Perú",NA
"1496","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Senador","Liz","Socios en Salud, Lima, Perú",NA
"1497","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Ramos","Alicia","Socios en Salud, Lima, Perú",NA
"1498","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Ramos","Karen","Socios en Salud, Lima, Perú",NA
"1499","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Galea","Jerome T","Escuela de Trabajo Social, Universidad del Sur de Florida, Tampa, Estados Unidos de América",NA
"1500","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Lecca","Leonid","Socios en Salud, Lima, Perú",NA
"1501","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Sánchez","Hugo","Epicentro Salud, Lima, Perú",NA
"1502","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Benites","Carlos","Dirección de Prevención y Control del VIH, ITS y Hepatitis, Ministerio de Salud del Perú, Lima, Perú",NA
"1503","34190908","10.17843/rpmesp.2021.381.6296","[Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru].","Adolescents living with HIV (ALWH) have lower rates of virologic suppression and higher rates of immunologic decline compared to their older counterparts, potentially placing them at high-risk for developing severe SARS-CoV-2 disease. ALWH who are transitioning to adult care face additional challenges to remaining in care and adhering to treatment. In this special section we report the experiences of ALWH in the process of transitioning to adult HIV services during the COVID-19 pandemic. In firs","2021","07","02","Rev Peru Med Exp Salud Publica","Revista peruana de medicina experimental y salud publica","Adolescent; Adult; COVID-19; HIV Infections; Humans; Pandemics; Peru; SARS-CoV-2","Franke","Molly F","Departamento de Salud Global y Medicina Social, Escuela de Medicina de Harvard, Boston, Estados Unidos de América",NA
"1504","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Barros","Fernando C","Universidade Católica de Pelotas. Curso de Pós-Graduação em Saúde no Ciclo Vital. Pelotas, RS, Brasil",NA
"1505","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Hartwig","Fernando P","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1506","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Barros","Aluísio J D","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1507","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Menezes","Ana M B","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1508","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Horta","Bernardo L","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1509","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Struchiner","Cláudio J","Fundação Getúlio Vargas. Escola de Matemática Aplicada. Rio de Janeiro, RJ, Brasil",NA
"1510","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Vidaletti","Luis Paulo","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1511","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Silveira","Mariangela F","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1512","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Mesenburg","Marilia A","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1513","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Delagostin","Odir A","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1514","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Hallal","Pedro C","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1515","34190899","10.11606/s1518-8787.2021055003832","COVID-19 and social distancing among children and adolescents in Brazil.","To estimate the prevalence of SARS-CoV-2 antibodies and the adherence to measures of social distancing in children and adolescents studied in three national surveys conducted in Brazil between May-June 2020. Three national serological surveys were conducted in 133 sentinel cities located in all 27 Federative Units. Multistage probability sampling was used to select 250 individuals per city. The total sample size in age ranges 0-9 and 10-19 years old are of 4,263 and 8,024 individuals, respective","2021","07","02","Rev Saude Publica","Revista de saude publica","Adolescent; Adult; Brazil; COVID-19; Child; Cities; Humans; Physical Distancing; SARS-CoV-2","Victora","Cesar G","Universidade Federal de Pelotas. Faculdade de Medicina. Departamento de Medicina Social. Pelotas, RS, Brasil",NA
"1516","34190892","10.1590/1516-3180.2021.139420052021","Organ transplantation and COVID-19.",NA,"2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"Garcia","Valter Duro","MD, PhD. Director, Department of Kidney and Pancreas Transplantation, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre (RS), Brazil",NA
"1517","34190892","10.1590/1516-3180.2021.139420052021","Organ transplantation and COVID-19.",NA,"2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"Pêgo-Fernandes","Paulo Manuel","MD, PhD. Full Professor, Thoracic Surgery Program, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR. Director, Scientific Department, Associação Paulista de Medicina, São Paulo (SP), Brazil",NA
"1518","34190891","10.1590/1984-0462/2022/40/2020457","RESPONSE TO THE EDITORIAL ""PSYCHO-EMOTIONAL CARE IN A NEONATAL UNIT DURING THE COVID-19 PANDEMIC"".",NA,"2021","07","05","Rev Paul Pediatr","Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo","COVID-19; Humans; Infant, Newborn; Pandemics; SARS-CoV-2","Alfaya","Cristiane Ajnamei Dos Santos","Health Sciences Center, Universidade Federal do Recôncavo da Bahia, Santo Antônio de Jesus, BA, Brazil",NA
"1519","34190877","10.1590/0074-02760210071","HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics.","In the space of four decades, Brazil has faced two serious pandemics: human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and Coronavirus disease 2019 (COVID-19). The country's response to HIV/AIDS was coordinated by several stakeholders and recognised the importance of scientific evidence in guiding decision-making, and a network offering monitoring and antiretroviral treatment was provided through coordinated efforts by the country's universal health system. Conversely, ","2021","07","02","Mem Inst Oswaldo Cruz","Memorias do Instituto Oswaldo Cruz","Acquired Immunodeficiency Syndrome; Brazil; COVID-19; HIV Infections; Humans; Pandemics; SARS-CoV-2","Galvão-Castro","Bernardo","Escola Bahiana de Medicina e Saúde Pública, Curso de Medicina, Salvador, BA, Brasil",NA
"1520","34190877","10.1590/0074-02760210071","HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics.","In the space of four decades, Brazil has faced two serious pandemics: human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and Coronavirus disease 2019 (COVID-19). The country's response to HIV/AIDS was coordinated by several stakeholders and recognised the importance of scientific evidence in guiding decision-making, and a network offering monitoring and antiretroviral treatment was provided through coordinated efforts by the country's universal health system. Conversely, ","2021","07","02","Mem Inst Oswaldo Cruz","Memorias do Instituto Oswaldo Cruz","Acquired Immunodeficiency Syndrome; Brazil; COVID-19; HIV Infections; Humans; Pandemics; SARS-CoV-2","Grassi","Maria Fernanda Rios","Escola Bahiana de Medicina e Saúde Pública, Curso de Medicina, Salvador, BA, Brasil",NA
"1521","34190877","10.1590/0074-02760210071","HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics.","In the space of four decades, Brazil has faced two serious pandemics: human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and Coronavirus disease 2019 (COVID-19). The country's response to HIV/AIDS was coordinated by several stakeholders and recognised the importance of scientific evidence in guiding decision-making, and a network offering monitoring and antiretroviral treatment was provided through coordinated efforts by the country's universal health system. Conversely, ","2021","07","02","Mem Inst Oswaldo Cruz","Memorias do Instituto Oswaldo Cruz","Acquired Immunodeficiency Syndrome; Brazil; COVID-19; HIV Infections; Humans; Pandemics; SARS-CoV-2","Castilho","Euclides Ayres de","Universidade de São Paulo, Faculdade de Medicina, Departamento de Medicina Preventiva, São Paulo, SP, Brasil",NA
"1522","34190877","10.1590/0074-02760210071","HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics.","In the space of four decades, Brazil has faced two serious pandemics: human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and Coronavirus disease 2019 (COVID-19). The country's response to HIV/AIDS was coordinated by several stakeholders and recognised the importance of scientific evidence in guiding decision-making, and a network offering monitoring and antiretroviral treatment was provided through coordinated efforts by the country's universal health system. Conversely, ","2021","07","02","Mem Inst Oswaldo Cruz","Memorias do Instituto Oswaldo Cruz","Acquired Immunodeficiency Syndrome; Brazil; COVID-19; HIV Infections; Humans; Pandemics; SARS-CoV-2","Greco","Dirceu Bartolomeu","Universidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Clínica Médica, Belo Horizonte, MG, Brasil",NA
"1523","34190873","10.1590/1516-3180.2020.0722.R1.2302021","Could serum total cortisol level at admission predict mortality due to coronavirus disease 2019 in the intensive care unit? A prospective study.","Critical diseases usually cause hypercortisolemia via activation of the hypothalamic-pituitary-adrenal axis. To investigate the relationship between serum total cortisol level and mortality among coronavirus disease 2019 (COVID-19) patients in the intensive care unit (ICU), at the time of their admission. Prospective study developed in a pandemic hospital in the city of Sirnak, Turkey. We compared the serum total cortisol levels of 285 patients (141 COVID-19-negative patients and 144 COVID-19-po","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"Güven","Mehmet","MD. Endocrinologist, Department of Endocrinology and Metabolism, Sirnak State Hospital, Sirnak, Turkey",NA
"1524","34190873","10.1590/1516-3180.2020.0722.R1.2302021","Could serum total cortisol level at admission predict mortality due to coronavirus disease 2019 in the intensive care unit? A prospective study.","Critical diseases usually cause hypercortisolemia via activation of the hypothalamic-pituitary-adrenal axis. To investigate the relationship between serum total cortisol level and mortality among coronavirus disease 2019 (COVID-19) patients in the intensive care unit (ICU), at the time of their admission. Prospective study developed in a pandemic hospital in the city of Sirnak, Turkey. We compared the serum total cortisol levels of 285 patients (141 COVID-19-negative patients and 144 COVID-19-po","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"Gültekin","Hamza","MD. Physician, Department of Intensive Care, Sirnak State Hospital, Sirnak, Turkey",NA
"1525","34190872","10.1590/1516-3180.2020.0706.R1.0802021","Frequency of physical activity and stress levels among Brazilian adults during social distancing due to the coronavirus (COVID-19): cross-sectional study.","The COVID-19 pandemic may be having many psychological impacts on people, at both an individual and a community level. To ascertain the relationship between the weekly frequency of physical activity and levels of stress among Brazilian adults during social distancing due to the coronavirus (COVID-19), and the interaction of sex in this association. Cross-sectional study with a descriptive approach conducted at a public university in Curitiba (PR), Brazil. 2,000 Brazilian adults (average age 36.4","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"de Camargo","Edina Maria","PhD. Physical Education Teacher, Postgraduate Program on Physical Education, Universidade Federal do Paraná (UFPR), Curitiba (PR), Brazil",NA
"1526","34190872","10.1590/1516-3180.2020.0706.R1.0802021","Frequency of physical activity and stress levels among Brazilian adults during social distancing due to the coronavirus (COVID-19): cross-sectional study.","The COVID-19 pandemic may be having many psychological impacts on people, at both an individual and a community level. To ascertain the relationship between the weekly frequency of physical activity and levels of stress among Brazilian adults during social distancing due to the coronavirus (COVID-19), and the interaction of sex in this association. Cross-sectional study with a descriptive approach conducted at a public university in Curitiba (PR), Brazil. 2,000 Brazilian adults (average age 36.4","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"Piola","Thiago Silva","PhD. Physical Education Teacher, Postgraduate Program on Physical Education, Universidade Federal do Paraná (UFPR), Curitiba (PR), Brazil",NA
"1527","34190872","10.1590/1516-3180.2020.0706.R1.0802021","Frequency of physical activity and stress levels among Brazilian adults during social distancing due to the coronavirus (COVID-19): cross-sectional study.","The COVID-19 pandemic may be having many psychological impacts on people, at both an individual and a community level. To ascertain the relationship between the weekly frequency of physical activity and levels of stress among Brazilian adults during social distancing due to the coronavirus (COVID-19), and the interaction of sex in this association. Cross-sectional study with a descriptive approach conducted at a public university in Curitiba (PR), Brazil. 2,000 Brazilian adults (average age 36.4","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"Dos Santos","Letícia Pechnicki","MSc. Physical Education Teacher, Postgraduate Program on Physical Education, Universidade Tecnológica Federal do Paraná (UTFPR), Curitiba (PR), Brazil",NA
"1528","34190872","10.1590/1516-3180.2020.0706.R1.0802021","Frequency of physical activity and stress levels among Brazilian adults during social distancing due to the coronavirus (COVID-19): cross-sectional study.","The COVID-19 pandemic may be having many psychological impacts on people, at both an individual and a community level. To ascertain the relationship between the weekly frequency of physical activity and levels of stress among Brazilian adults during social distancing due to the coronavirus (COVID-19), and the interaction of sex in this association. Cross-sectional study with a descriptive approach conducted at a public university in Curitiba (PR), Brazil. 2,000 Brazilian adults (average age 36.4","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"de Borba","Edilson Fernando","PhD. Physical Education Teacher, Postgraduate Program on Physical Education, Universidade Federal do Paraná (UFPR), Curitiba (PR), Brazil",NA
"1529","34190872","10.1590/1516-3180.2020.0706.R1.0802021","Frequency of physical activity and stress levels among Brazilian adults during social distancing due to the coronavirus (COVID-19): cross-sectional study.","The COVID-19 pandemic may be having many psychological impacts on people, at both an individual and a community level. To ascertain the relationship between the weekly frequency of physical activity and levels of stress among Brazilian adults during social distancing due to the coronavirus (COVID-19), and the interaction of sex in this association. Cross-sectional study with a descriptive approach conducted at a public university in Curitiba (PR), Brazil. 2,000 Brazilian adults (average age 36.4","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"de Campos","Wagner","PhD. Physical Education Teacher, Postgraduate Program on Physical Education, Universidade Federal do Paraná (UFPR), Curitiba (PR), Brazil",NA
"1530","34190872","10.1590/1516-3180.2020.0706.R1.0802021","Frequency of physical activity and stress levels among Brazilian adults during social distancing due to the coronavirus (COVID-19): cross-sectional study.","The COVID-19 pandemic may be having many psychological impacts on people, at both an individual and a community level. To ascertain the relationship between the weekly frequency of physical activity and levels of stress among Brazilian adults during social distancing due to the coronavirus (COVID-19), and the interaction of sex in this association. Cross-sectional study with a descriptive approach conducted at a public university in Curitiba (PR), Brazil. 2,000 Brazilian adults (average age 36.4","2021","06","30","Sao Paulo Med J","Sao Paulo medical journal = Revista paulista de medicina",NA,"da Silva","Sergio Gregorio","PhD. Physical Education Teacher, Postgraduate Program on Physical Education, Universidade Federal do Paraná (UFPR), Curitiba (PR), Brazil",NA
"1531","34190864","10.36416/1806-3756/e20210058","Differential diagnosis between lung injury associated with electronic cigarette use and COVID-19 pneumonia.",NA,"2021","07","05","J Bras Pneumol","Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia","COVID-19; Diagnosis, Differential; Electronic Nicotine Delivery Systems; Humans; Lung Injury; SARS-CoV-2; Vaping","Medeiros","Augusto Kreling",". Serviço de Radiologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo (SP) Brasil",NA
"1532","34190864","10.36416/1806-3756/e20210058","Differential diagnosis between lung injury associated with electronic cigarette use and COVID-19 pneumonia.",NA,"2021","07","05","J Bras Pneumol","Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia","COVID-19; Diagnosis, Differential; Electronic Nicotine Delivery Systems; Humans; Lung Injury; SARS-CoV-2; Vaping","Costa","Felipe Marques da",". Serviço de Radiologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo (SP) Brasil",NA
"1533","34190864","10.36416/1806-3756/e20210058","Differential diagnosis between lung injury associated with electronic cigarette use and COVID-19 pneumonia.",NA,"2021","07","05","J Bras Pneumol","Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia","COVID-19; Diagnosis, Differential; Electronic Nicotine Delivery Systems; Humans; Lung Injury; SARS-CoV-2; Vaping","Cerezoli","Milena Tenório",". Serviço de Pneumologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo (SP) Brasil",NA
"1534","34190864","10.36416/1806-3756/e20210058","Differential diagnosis between lung injury associated with electronic cigarette use and COVID-19 pneumonia.",NA,"2021","07","05","J Bras Pneumol","Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia","COVID-19; Diagnosis, Differential; Electronic Nicotine Delivery Systems; Humans; Lung Injury; SARS-CoV-2; Vaping","Chaves","Huylmer Lucena",". Serviço de Radiologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo (SP) Brasil",NA
"1535","34190864","10.36416/1806-3756/e20210058","Differential diagnosis between lung injury associated with electronic cigarette use and COVID-19 pneumonia.",NA,"2021","07","05","J Bras Pneumol","Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia","COVID-19; Diagnosis, Differential; Electronic Nicotine Delivery Systems; Humans; Lung Injury; SARS-CoV-2; Vaping","Torres","Ulysses S",". Departamento de Diagnóstico por Imagem, Grupo Fleury, São Paulo (SP) Brasil",NA
"1536","34190859","10.6061/clinics/2021/e3185","CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Antibodies, Viral; Humans; Immunoglobulin A; Immunoglobulin M; Milk, Human; SARS-CoV-2","Calil","Valdenise Martins Laurindo Tuma","Instituto da Crianca e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1537","34190859","10.6061/clinics/2021/e3185","CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Antibodies, Viral; Humans; Immunoglobulin A; Immunoglobulin M; Milk, Human; SARS-CoV-2","Palmeira","Patricia","Laboratorio de Pediatria Clinica (LIM36), Departamento de Pediatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1538","34190859","10.6061/clinics/2021/e3185","CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Antibodies, Viral; Humans; Immunoglobulin A; Immunoglobulin M; Milk, Human; SARS-CoV-2","Zheng","Yingying","Departamento de Pediatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1539","34190859","10.6061/clinics/2021/e3185","CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Antibodies, Viral; Humans; Immunoglobulin A; Immunoglobulin M; Milk, Human; SARS-CoV-2","Krebs","Vera Lúcia Jornada","Instituto da Crianca e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1540","34190859","10.6061/clinics/2021/e3185","CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Antibodies, Viral; Humans; Immunoglobulin A; Immunoglobulin M; Milk, Human; SARS-CoV-2","Carvalho","Werther Brunow de","Departamento de Pediatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1541","34190859","10.6061/clinics/2021/e3185","CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Antibodies, Viral; Humans; Immunoglobulin A; Immunoglobulin M; Milk, Human; SARS-CoV-2","Carneiro-Sampaio","Magda","Laboratorio de Pediatria Clinica (LIM36), Departamento de Pediatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1542","34190858","10.6061/clinics/2021/e3120","Obstetric Observatory BRAZIL - COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Brazil; COVID-19; Female; Health Services Accessibility; Humans; Maternal Death; Maternal Mortality; Pregnancy; SARS-CoV-2","Francisco","Rossana Pulcineli Vieira","Disciplina de Obstetricia, Departamento de Obstetricia e Ginecologia, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1543","34190858","10.6061/clinics/2021/e3120","Obstetric Observatory BRAZIL - COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Brazil; COVID-19; Female; Health Services Accessibility; Humans; Maternal Death; Maternal Mortality; Pregnancy; SARS-CoV-2","Lacerda","Lucas","Departamento de Estatistica, Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1544","34190858","10.6061/clinics/2021/e3120","Obstetric Observatory BRAZIL - COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Brazil; COVID-19; Female; Health Services Accessibility; Humans; Maternal Death; Maternal Mortality; Pregnancy; SARS-CoV-2","Rodrigues","Agatha S","Disciplina de Obstetricia, Departamento de Obstetricia e Ginecologia, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1545","34190857","10.6061/clinics/2021/e3096","COVID-19 Surveillance of Healthcare Workers during the SARS-CoV-2 Vaccination Period: An Updated Protocol Suggestion.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","COVID-19; COVID-19 Vaccines; Health Personnel; Humans; SARS-CoV-2; Vaccination","Tovani-Palone","Marcos Roberto","Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, BR",NA
"1546","34190857","10.6061/clinics/2021/e3096","COVID-19 Surveillance of Healthcare Workers during the SARS-CoV-2 Vaccination Period: An Updated Protocol Suggestion.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","COVID-19; COVID-19 Vaccines; Health Personnel; Humans; SARS-CoV-2; Vaccination","Siddiqui","Muhammad Farrukh","Liaquat National Hospital and Medical College, Karachi, Pakistan",NA
"1547","34190854","10.6061/clinics/2021/e2907","Mental health and the COVID-19 pandemic: a study of medical residency training over the years.","This study aims to assess the symptoms of burnout, depression, and anxiety in Brazilian medical residents during the COVID-19 pandemic and to compare residents' beliefs and clinical practices related to COVID-19 patients among all six years of medical residency training in Brazil. A quantitative study was conducted in April 2020 with a convenience sample of medical resident volunteers from an anonymous online survey. This investigation collected sociodemographic information and used the Oldenbur","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Brazil; COVID-19; Humans; Internship and Residency; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Mendonça","Vitor S","Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1548","34190854","10.6061/clinics/2021/e2907","Mental health and the COVID-19 pandemic: a study of medical residency training over the years.","This study aims to assess the symptoms of burnout, depression, and anxiety in Brazilian medical residents during the COVID-19 pandemic and to compare residents' beliefs and clinical practices related to COVID-19 patients among all six years of medical residency training in Brazil. A quantitative study was conducted in April 2020 with a convenience sample of medical resident volunteers from an anonymous online survey. This investigation collected sociodemographic information and used the Oldenbur","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Brazil; COVID-19; Humans; Internship and Residency; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Steil","Amanda","Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR",NA
"1549","34190854","10.6061/clinics/2021/e2907","Mental health and the COVID-19 pandemic: a study of medical residency training over the years.","This study aims to assess the symptoms of burnout, depression, and anxiety in Brazilian medical residents during the COVID-19 pandemic and to compare residents' beliefs and clinical practices related to COVID-19 patients among all six years of medical residency training in Brazil. A quantitative study was conducted in April 2020 with a convenience sample of medical resident volunteers from an anonymous online survey. This investigation collected sociodemographic information and used the Oldenbur","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Brazil; COVID-19; Humans; Internship and Residency; Mental Health; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Góis","Aécio F T","Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR",NA
"1550","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Polese","Jessica","Departamento de Pneumologia, Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1551","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Sant'Ana","Larissa","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1552","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Moulaz","Isac Ribeiro","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1553","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Lara","Izabella Cardoso","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1554","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Bernardi","Julia Muniz","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1555","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Lima","Marina Deorce de","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1556","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Turini","Elaína Aparecida Silva","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1557","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Silveira","Gabriel Carnieli","Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1558","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Duarte","Silvana","Departamento de Pneumologia, Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1559","34190851","10.6061/clinics/2021/e2848","Pulmonary function evaluation after hospital discharge of patients with severe COVID-19.","Coronavirus disease 2019 (COVID-19) may be associated with prolonged symptoms and post-recovery health impairment. This study aimed to evaluate the persistence of symptoms, lung function, and pulmonary diffusion for carbon monoxide (DLCO) in patients between 15 and 30 days after hospital discharge after admission for severe COVID-19. The evaluation consisted of 1) comparative analysis between the initial symptoms and symptoms still present at the post-discharge evaluation 2) analysis of the ches","2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adult; Aftercare; Aged; COVID-19; Hospitals; Humans; Lung; Male; Middle Aged; Patient Discharge; SARS-CoV-2","Mill","José Geraldo","Departamento de Ciencias Fisiologicas, Centro de Ciencias da Saude, Universidade Federal do Espirito Santo, Vitoria, ES, BR",NA
"1560","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Marques","Isabela Gouveia","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1561","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Astley","Camilla","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1562","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Sieczkowska","Sofia Mendes","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1563","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Iraha","Amanda Yuri","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1564","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Franco","Tathiane Christine","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1565","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Smaira","Fabiana Infante","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1566","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Mazzolani","Bruna Caruso","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1567","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Miranda","Luana Cristina do Amaral","Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1568","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Ihara","Bianca Pires","Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1569","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Pereira","Rosa Maria R","Divisao de Reumatologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1570","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Queiroz","Ligia Bruni","Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1571","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Silva","Clovis Artur","Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1572","34190848","10.6061/clinics/2021/e2655","Lessons learned from a home-based exercise program for adolescents with pre-existing chronic diseases during the COVID-19 quarantine in Brazil.",NA,"2021","07","05","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Adolescent; Brazil; COVID-19; Chronic Disease; Exercise Therapy; Humans; Quarantine; SARS-CoV-2","Gualano","Bruno","Grupo de Pesquisa em Fisiologia Aplicada e Nutricao, Escola de Educacao Fisica e Esporte, Universidade de Sao Paulo, Sao Paulo, SP, BR",NA
"1573","34190845","10.1590/0001-3765202120201469","Science, Technology and Innovation-oriented health centers, a COVID-19 legacy.",NA,"2021","07","07","An Acad Bras Cienc","Anais da Academia Brasileira de Ciencias","COVID-19; Delivery of Health Care; Humans; SARS-CoV-2; Technology","Silva","Renan G L DA","Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455, 01246-000 São Paulo, SP, Brazil",NA
"1574","34190845","10.1590/0001-3765202120201469","Science, Technology and Innovation-oriented health centers, a COVID-19 legacy.",NA,"2021","07","07","An Acad Bras Cienc","Anais da Academia Brasileira de Ciencias","COVID-19; Delivery of Health Care; Humans; SARS-CoV-2; Technology","Novaes","Hillegonda M D","Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455, 01246-000 São Paulo, SP, Brazil",NA
"1575","34190845","10.1590/0001-3765202120201469","Science, Technology and Innovation-oriented health centers, a COVID-19 legacy.",NA,"2021","07","07","An Acad Bras Cienc","Anais da Academia Brasileira de Ciencias","COVID-19; Delivery of Health Care; Humans; SARS-CoV-2; Technology","Chammas","Roger","Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455, 01246-000 São Paulo, SP, Brazil",NA
"1576","34190830","10.1590/0102-311X00132320","Validity of a 2-item screening tool to identify families at risk for food insecurity in Brazil.","This manuscript aimed to develop a brief 2-item screening tool to identify Brazilian households that include families with children at risk for food insecurity. Psychometric analyses including sensitivity, specificity, positive and negative predictive value, accuracy, and ROC curves were used to test combinations of questions to determine the most effective screener to assess households at risk for food insecurity when compared to a gold standard scale. Participants included Brazilian National S","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Child; Cross-Sectional Studies; Female; Food Insecurity; Food Supply; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors","Poblacion","Ana","Universidade Federal de São Paulo, São Paulo, Brasil",NA
"1577","34190830","10.1590/0102-311X00132320","Validity of a 2-item screening tool to identify families at risk for food insecurity in Brazil.","This manuscript aimed to develop a brief 2-item screening tool to identify Brazilian households that include families with children at risk for food insecurity. Psychometric analyses including sensitivity, specificity, positive and negative predictive value, accuracy, and ROC curves were used to test combinations of questions to determine the most effective screener to assess households at risk for food insecurity when compared to a gold standard scale. Participants included Brazilian National S","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Child; Cross-Sectional Studies; Female; Food Insecurity; Food Supply; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors","Segall-Corrêa","Ana Maria","Programa de Alimentação, Nutrição e Cultura, Fundação Oswaldo Cruz, Brasília, Brasil",NA
"1578","34190830","10.1590/0102-311X00132320","Validity of a 2-item screening tool to identify families at risk for food insecurity in Brazil.","This manuscript aimed to develop a brief 2-item screening tool to identify Brazilian households that include families with children at risk for food insecurity. Psychometric analyses including sensitivity, specificity, positive and negative predictive value, accuracy, and ROC curves were used to test combinations of questions to determine the most effective screener to assess households at risk for food insecurity when compared to a gold standard scale. Participants included Brazilian National S","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Child; Cross-Sectional Studies; Female; Food Insecurity; Food Supply; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors","Cook","John","Boston University, Boston, U",NA
"1579","34190830","10.1590/0102-311X00132320","Validity of a 2-item screening tool to identify families at risk for food insecurity in Brazil.","This manuscript aimed to develop a brief 2-item screening tool to identify Brazilian households that include families with children at risk for food insecurity. Psychometric analyses including sensitivity, specificity, positive and negative predictive value, accuracy, and ROC curves were used to test combinations of questions to determine the most effective screener to assess households at risk for food insecurity when compared to a gold standard scale. Participants included Brazilian National S","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Child; Cross-Sectional Studies; Female; Food Insecurity; Food Supply; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors","Taddei","Jose Augusto de Aguiar Carrazedo","Universidade Federal de São Paulo, São Paulo, Brasil",NA
"1580","34190797","10.1590/S0104-59702021005000004","[Covid-19 in Santa Catarina: a sad population experiment].","Difficulties related to the coronavirus pandemic in the state of Santa Catarina reflect the same dramatic trajectory seen in Brazil as a whole, with increasing numbers of cases and daily fatalities. Several regions of this state are considered to be at very serious or severe risk. The initially successful management of the pandemic was cited as a model to be followed, but gradually lost coherence and effectiveness as it yielded to pressure from political and economic powers, particularly large e","2021","07","15","Hist Cienc Saude Manguinhos","Historia, ciencias, saude--Manguinhos","Brazil; COVID-19; Government; Humans","Caponi","Sandra","Professora, Departamento de Sociologia e Ciências Políticas/Universidade Federal de Santa Catarina. Florianópolis - SC - Brasil sandracaponi@gmail","sandracaponi@gmail.com"
"1581","34190796","10.1590/S0104-59702021005000003","[Covid-19 in Ecuador: political fragility and vulnerability of public health].","The case of covid-19 in Guayaquil shows that the medical and scientific spheres are not divorced from contemporary political, social and economic factors, but that they act upon one another. In particular, the political crises and socioeconomic inequalities that affected Ecuador before the arrival of the pandemic paved the way for the havoc caused by the new coronavirus in the country. El caso de la covid-19 en Guayaquil demuestra que las esferas médica y científica no están divorciadas de los f","2021","07","15","Hist Cienc Saude Manguinhos","Historia, ciencias, saude--Manguinhos","COVID-19; Ecuador; Humans; Politics; Public Health; Socioeconomic Factors","Chauca","Roberto","Profesor invitado, Departamento de Antropología, Historia y Humanidades/Flacso Ecuador. Quito - Pichincha - Ecuador rochauca@flacso.edu","rochauca@flacso.edu.ec"
"1582","34190795","10.1590/S0104-59702021005000002","[Peru and global remembrance of covid-19 victims].","The change in relationships with the victims of coronavirus is one of the most disturbing and least explored consequences of all the ways in which covid-19 has altered our lives over the last year. This essay examines the various strategies Peruvians have developed to compensate for the inability to attend funerals and burials in person due to government-imposed social distancing measures. The use of digital platforms, mainly social media, made it possible to recreate funeral rites and allowed t","2021","07","15","Hist Cienc Saude Manguinhos","Historia, ciencias, saude--Manguinhos","COVID-19; Funeral Rites; Humans; Peru","Ragas","José","Profesor asistente, Instituto de Historia/Pontificia Universidad Católica de Chile. Santiago - Chile jose.ragas@uc",NA
"1583","34190794","10.1590/S0104-59702021005000001","[Covid-19 in Peru: state and social responses].","Despite efforts by the Peruvian state to contain the outbreak and spread of covid-19, including a strict nationwide quarantine for more than one hundred days, Peru had one of the highest numbers of cases and deaths in the world due to the pandemic. The pandemic highlighted the precariousness of the health care system, work, living conditions and transport. The pandemic also demonstrated that until underlying problems in the country's social and economic system are solved (such as inequality and ","2021","07","15","Hist Cienc Saude Manguinhos","Historia, ciencias, saude--Manguinhos","COVID-19; Government; Humans; Peru; Quarantine; Social Problems; Socioeconomic Factors","Lossio","Jorge","Profesor Principal, Facultad de Letras y Ciencias Humanas (Historia)/Pontificia Universidad Católica del Perú. Lima - Perú jorgelossio@gmail","jorgelossio@gmail.com"
"1584","34190772","10.1590/2177-6709.26.3.e21ins3","COVID-19 and orthodontic treatment: current perspectives.","A pandemic was declared by the World Health Organization on 30th January 2020, the coronavirus disease (COVID-19) emerged, and led to standstill of Dentistry and Orthodontics. The COVID-19 is a very multivariant disease. It affects in many different ways; the most reported symptoms resemble very much to that of a seasonal flu. Patients feel rising fever, dry cough and shortness of breath. There are two ways to handle them, the first being remotely guiding and helping them with aid of telecommuni","2021","07","02","Dental Press J Orthod","Dental press journal of orthodontics","COVID-19; Humans; Orthodontics; Pandemics; SARS-CoV-2","Mote","Nilesh","Pravara Institute of Medical Sciences (Ahmednagar/MH, India)",NA
"1585","34190772","10.1590/2177-6709.26.3.e21ins3","COVID-19 and orthodontic treatment: current perspectives.","A pandemic was declared by the World Health Organization on 30th January 2020, the coronavirus disease (COVID-19) emerged, and led to standstill of Dentistry and Orthodontics. The COVID-19 is a very multivariant disease. It affects in many different ways; the most reported symptoms resemble very much to that of a seasonal flu. Patients feel rising fever, dry cough and shortness of breath. There are two ways to handle them, the first being remotely guiding and helping them with aid of telecommuni","2021","07","02","Dental Press J Orthod","Dental press journal of orthodontics","COVID-19; Humans; Orthodontics; Pandemics; SARS-CoV-2","Mani","Shubhangi","Pravara Institute of Medical Sciences (Ahmednagar/MH, India)",NA
"1586","34190772","10.1590/2177-6709.26.3.e21ins3","COVID-19 and orthodontic treatment: current perspectives.","A pandemic was declared by the World Health Organization on 30th January 2020, the coronavirus disease (COVID-19) emerged, and led to standstill of Dentistry and Orthodontics. The COVID-19 is a very multivariant disease. It affects in many different ways; the most reported symptoms resemble very much to that of a seasonal flu. Patients feel rising fever, dry cough and shortness of breath. There are two ways to handle them, the first being remotely guiding and helping them with aid of telecommuni","2021","07","02","Dental Press J Orthod","Dental press journal of orthodontics","COVID-19; Humans; Orthodontics; Pandemics; SARS-CoV-2","Pallan","Kunal","Pravara Institute of Medical Sciences (Ahmednagar/MH, India)",NA
"1587","34190772","10.1590/2177-6709.26.3.e21ins3","COVID-19 and orthodontic treatment: current perspectives.","A pandemic was declared by the World Health Organization on 30th January 2020, the coronavirus disease (COVID-19) emerged, and led to standstill of Dentistry and Orthodontics. The COVID-19 is a very multivariant disease. It affects in many different ways; the most reported symptoms resemble very much to that of a seasonal flu. Patients feel rising fever, dry cough and shortness of breath. There are two ways to handle them, the first being remotely guiding and helping them with aid of telecommuni","2021","07","02","Dental Press J Orthod","Dental press journal of orthodontics","COVID-19; Humans; Orthodontics; Pandemics; SARS-CoV-2","Rathod","Rishikesh","Pravara Institute of Medical Sciences (Ahmednagar/MH, India)",NA
"1588","34190755","10.1590/0102-311X00301620","[Active COVID-19 clusters in Santa Catarina, Brazil, and workplace mobility trends].","The application of spatial analysis to the study of human epidemiological data has gained great momentum in the last two decades. This article approaches the scan statistic for the detection of spatial-temporal clusters of COVID-19 cases in the State of Santa Catarina, Brazil. The aim is to apply the scan statistic to identify active clusters, determining their location, size, and order (priority). Organization of the descriptive based included COVID-19 cases from March 1 to August 31, 2020, ava","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Humans; SARS-CoV-2; Spatial Analysis; Workplace","Merêncio","Ivan","Universidade Federal de Santa Catarina, Florianópolis, Brasil",NA
"1589","34190755","10.1590/0102-311X00301620","[Active COVID-19 clusters in Santa Catarina, Brazil, and workplace mobility trends].","The application of spatial analysis to the study of human epidemiological data has gained great momentum in the last two decades. This article approaches the scan statistic for the detection of spatial-temporal clusters of COVID-19 cases in the State of Santa Catarina, Brazil. The aim is to apply the scan statistic to identify active clusters, determining their location, size, and order (priority). Organization of the descriptive based included COVID-19 cases from March 1 to August 31, 2020, ava","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Humans; SARS-CoV-2; Spatial Analysis; Workplace","Monteiro","Gecielli Martins","Universidade Nove de Julho, Guarulhos, Brasil",NA
"1590","34190755","10.1590/0102-311X00301620","[Active COVID-19 clusters in Santa Catarina, Brazil, and workplace mobility trends].","The application of spatial analysis to the study of human epidemiological data has gained great momentum in the last two decades. This article approaches the scan statistic for the detection of spatial-temporal clusters of COVID-19 cases in the State of Santa Catarina, Brazil. The aim is to apply the scan statistic to identify active clusters, determining their location, size, and order (priority). Organization of the descriptive based included COVID-19 cases from March 1 to August 31, 2020, ava","2021","07","05","Cad Saude Publica","Cadernos de saude publica","Brazil; COVID-19; Humans; SARS-CoV-2; Spatial Analysis; Workplace","Vieira","Carlos Antônio Oliveira","Universidade Federal de Santa Catarina, Florianópolis, Brasil",NA
"1591","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Müller","Werner E G","ERC Advanced Investigator Grant Research Group at the Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55128 Mainz, Germany. wmueller@uni-mainz.de wang013@uni-mainz.de and NanotecMARIN GmbH, D-55128 Mainz, Germany",NA
"1592","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Neufurth","Meik","ERC Advanced Investigator Grant Research Group at the Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55128 Mainz, Germany. wmueller@uni-mainz.de wang013@uni-mainz",NA
"1593","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Lieberwirth","Ingo","Max Planck Institute for Polymer Research, Ackermannweg 10, D-55128 Mainz, Germany",NA
"1594","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Muñoz-Espí","Rafael","Institute of Materials Science (ICMUV), Universitat de València, C/Catedràtic José Beltrán 2, 46980 Paterna, València, Spain",NA
"1595","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Wang","Shunfeng","ERC Advanced Investigator Grant Research Group at the Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55128 Mainz, Germany. wmueller@uni-mainz.de wang013@uni-mainz",NA
"1596","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Schröder","Heinz C","ERC Advanced Investigator Grant Research Group at the Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55128 Mainz, Germany. wmueller@uni-mainz.de wang013@uni-mainz.de and NanotecMARIN GmbH, D-55128 Mainz, Germany",NA
"1597","34190748","10.1039/d1bm00502b","Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents.","Conventional face masks to prevent SARS-CoV-2 transmission are mostly based on a passive filtration principle. Ideally, anti-COVID-19 masks should protect the carrier not only by size exclusion of virus aerosol particles, but also be able to capture and destroy or inactivate the virus. Here we present the proof-of-concept of a filter mat for such a mask, which actively attracts aerosol droplets and kills the virus. The electrospun mats are made of polycaprolactone (PCL) a hydrophilic, functional","2021","06","30","Biomater Sci","Biomaterials science",NA,"Wang","Xiaohong","ERC Advanced Investigator Grant Research Group at the Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55128 Mainz, Germany. wmueller@uni-mainz.de wang013@uni-mainz",NA
"1598","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Atkin","C","Acute Medicine, Birmingham Acute Care Research Group, Institute of Inflammation and Ageing",NA
"1599","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Kamwa","V","Acute Medicine, Birmingham Acute Care Research Group, Institute of Inflammation and Ageing",NA
"1600","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Reddy-Kolanu","V","Acute Medicine, University Hospitals Birmingham NHS Foundation Trust",NA
"1601","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Parekh","D","A. Intensive Care Medicine, University Hospitals Birmingham NHS Foundation Trust",NA
"1602","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Evison","F","Research Analytics, Department of Health Informatics, University Hospitals Birmingham NHS Foundation Trust",NA
"1603","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Nightingale","P","NIHR Clinical Research Facility Statistician, University Hospitals Birmingham NHS Foundation Trust",NA
"1604","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Gallier","S","PIONEER Technical Director, Lead for Research Analytics Department of Health Informatics, University Hospitals Birmingham NHS Foundation Trust",NA
"1605","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Ball","S","A. Chief Medical Officer, University Hospitals Birmingham NHS Foundation Trust",NA
"1606","34190735","","The changing characteristics of COVID-19 presentations. A regional comparison of SARS-CoV-2 hospitalised patients during the first and second wave.","This study assesses COVID-19 hospitalised patient demography and outcomes during wave 1 and wave 2, prior to new variants of the virus. All patients with a positive SARS-CoV-2 swab between 10th March 2020 and 5th July 2020 (wave 1) and 1st September 2020 and 16th November 2020 (wave 2) admitted to University Hospitals Birmingham NHS Foundation Trust were included (n=4856), followed for 28 days. Wave 2 patients were younger, more ethnically diverse, had less co-morbidities and disease presentatio","2021","07","02","Acute Med","Acute medicine","COVID-19; Critical Care; Hospitalization; Humans; SARS-CoV-2","Sapey","E","A. Director of PIONEER: Health Data Research UK (HDRUK) Health Data Research Hub for Acute Care B. Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham",NA
"1607","34190734","","Editorial - Evolve, Adapt, Innovate and Deliver: Acute Medicine post COVID pandemic.","Predictions for acute care in the upcoming months are difficult. There will be challenges: there always are and that to a degree is what makes working in acute care so fulfilling. However, even the most adaptive and innovative acute care systems will toil when these challenges become overwhelming. Back in 2015, the then SAM President Mark Holland described a ""perfect storm"" of events that could lead to a challenging winter period. It was as predicted; but this storm continues to evolve and has n","2021","07","02","Acute Med","Acute medicine","COVID-19; Humans; Medicine; Netherlands; Pandemics; SARS-CoV-2","Lovell","B","Associate Editor, Consultant in Acute Medicine, University College London Hospitals",NA
"1608","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Berrocal","Martina","Friedrich Schiller University, Jena, Germany",NA
"1609","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Kranert","Michael","University of Southhampton, Southhampton, United Kingdom",NA
"1610","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Attolino","Paola","University of Salerno, Salerno, Italy",NA
"1611","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Santos","Júlio Antonio Bonatti","Federal University of São Carlos, São Carlos, Brazil",NA
"1612","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Santamaria","Sara Garcia","Universitat Jaume Castelló, Castelló, Spain",NA
"1613","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Henaku","Nancy","Michigan Technological University, Michigan, USA",NA
"1614","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Koffi","Aimée Danielle Lezou","Université Félix Houphouët-Boigny, Côte d'Ivoire, Ivory Coast",NA
"1615","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Marziani","Camilla","University of Bologna, Bologna, Italy",NA
"1616","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Maeikiene","Viktorija","Mykolas Romeris University Vilnius, Vilnius, Lithuania",NA
"1617","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Pérez","Dasniel Olivera","University of Havana, Havana, Cuba",NA
"1618","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Rajandran","Kumaran","School of Humanities, Universiti Sains Malaysia, George Town, Malaysia",NA
"1619","34190730","10.1057/s41599-021-00841-7","Correction: Constructing collective identities and solidarity in premiers' early speeches on COVID-19: a global perspective.","[This corrects the article DOI: 10.1057/s41599-021-00805-x.].","2021","07","01","Humanit Soc Sci Commun","Humanities &amp; social sciences communications","Language and linguistics; Politics and international relations","Salamurovic","Aleksandra","Friedrich Schiller University, Jena, Germany",NA
"1620","34190711","10.1097/NHH.0000000000000974","A Day in the Life of a Wound Care Nurse in Eastern Indonesia During the COVID-19 Pandemic.",NA,"2021","07","09","Home Healthc Now","Home healthcare now","COVID-19; Female; Health Services Accessibility; Health Services Needs and Demand; Humans; Indonesia; Infection Control; Male; Pandemics; SARS-CoV-2; Wounds and Injuries","Yusuf","Saldy","Saldy Yusuf, PhD, is a Lecturer, School of Nursing, Hasanuddin University, and Director, Griya Afiat, Wound Care &amp",NA
"1621","34190707","10.1097/NHH.0000000000001003","COVID-19 Related Substance Use Disorder in the Older Population.",NA,"2021","07","09","Home Healthc Now","Home healthcare now","Aged; COVID-19; Female; Geriatric Assessment; Humans; Male; Pandemics; Risk Factors; SARS-CoV-2; Substance-Related Disorders; United States","Marshall","Katherine",NA,NA
"1622","34190707","10.1097/NHH.0000000000001003","COVID-19 Related Substance Use Disorder in the Older Population.",NA,"2021","07","09","Home Healthc Now","Home healthcare now","Aged; COVID-19; Female; Geriatric Assessment; Humans; Male; Pandemics; Risk Factors; SARS-CoV-2; Substance-Related Disorders; United States","Hale","Deborah",NA,NA
"1623","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Federman","Alex D",NA,NA
"1624","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Leff","Bruce",NA,NA
"1625","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Brody","Abraham A",NA,NA
"1626","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Lubetsky","Sara",NA,NA
"1627","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Siu","Albert L",NA,NA
"1628","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Ritchie","Christine S",NA,NA
"1629","34190705","10.1097/NHH.0000000000000983","Disruptions in Care and Support for Homebound Adults in Home-Based Primary Care in New York City During the COVID-19 Pandemic.","Homebound older adults are a highly vulnerable population, yet little is known about their experiences with healthcare during the COVID-19 pandemic. We interviewed patients in home-based primary care (HBPC) in New York City by telephone in May and June of 2020. Interviews covered social supports, household activities, self-care, and medical care, and asked participants to compare current with prepandemic experiences. Among 70 participants, 37% were Black and 32% were Hispanic. Disruptions in the","2021","07","09","Home Healthc Now","Home healthcare now","Activities of Daily Living; Aged; Aged, 80 and over; COVID-19; Ethnic Groups; Female; Food Insecurity; Health Services Accessibility; Home Care Services; Homebound Persons; Humans; Male; New York City; Pandemics; Primary Health Care; SARS-CoV-2; Social Support","Ornstein","Katherine A",NA,NA
"1630","34190669","10.1080/13543784.2021.1950687","Low-dose aspirin for early COVID-19: does the early bird catch the worm?",NA,"2021","07","12","Expert Opin Investig Drugs","Expert opinion on investigational drugs",NA,"Rizk","John G","Arizona State University, Edson College, Phoenix, AZ, USA",NA
"1631","34190669","10.1080/13543784.2021.1950687","Low-dose aspirin for early COVID-19: does the early bird catch the worm?",NA,"2021","07","12","Expert Opin Investig Drugs","Expert opinion on investigational drugs",NA,"Lavie","Carl J","John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA, USA",NA
"1632","34190669","10.1080/13543784.2021.1950687","Low-dose aspirin for early COVID-19: does the early bird catch the worm?",NA,"2021","07","12","Expert Opin Investig Drugs","Expert opinion on investigational drugs",NA,"Gupta","Ajay","Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine, School of Medicine, Irvine, CA, USA",NA
"1633","34190654","10.1080/13548506.2021.1946107","The effect of perceived organizational support on the work engagement of Chinese nurses during the COVID-19: the mediating role of psychological safety.","The outbreak of COVID-19 undoubtedly aggravated the pressure and workload of nurses' work, which may bring new challenges to nurses' work engagement. This study aims to explore the factors of nurses' work engagement, and it may provide targeted references for clinical intervention. Convenience sampling was used, and 689 nurses from Hebei and Guangxi Province in China were investigated. The results indicated that both perceived organizational support and psychological safety have direct positive ","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","Perceived organizational support; mediating effect; psychological safety; work engagement","Xu","Dingxin","Department of Nursing, Jinan University, Guangzhou, Guangdong Province, China",NA
"1634","34190654","10.1080/13548506.2021.1946107","The effect of perceived organizational support on the work engagement of Chinese nurses during the COVID-19: the mediating role of psychological safety.","The outbreak of COVID-19 undoubtedly aggravated the pressure and workload of nurses' work, which may bring new challenges to nurses' work engagement. This study aims to explore the factors of nurses' work engagement, and it may provide targeted references for clinical intervention. Convenience sampling was used, and 689 nurses from Hebei and Guangxi Province in China were investigated. The results indicated that both perceived organizational support and psychological safety have direct positive ","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","Perceived organizational support; mediating effect; psychological safety; work engagement","Zhang","Na","School of Economics and Management, Beijing Information Science &amp",NA
"1635","34190654","10.1080/13548506.2021.1946107","The effect of perceived organizational support on the work engagement of Chinese nurses during the COVID-19: the mediating role of psychological safety.","The outbreak of COVID-19 undoubtedly aggravated the pressure and workload of nurses' work, which may bring new challenges to nurses' work engagement. This study aims to explore the factors of nurses' work engagement, and it may provide targeted references for clinical intervention. Convenience sampling was used, and 689 nurses from Hebei and Guangxi Province in China were investigated. The results indicated that both perceived organizational support and psychological safety have direct positive ","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","Perceived organizational support; mediating effect; psychological safety; work engagement","Bu","Xing","School of Economics and Management, University of Science and Technology Beijing, Beijing, China",NA
"1636","34190654","10.1080/13548506.2021.1946107","The effect of perceived organizational support on the work engagement of Chinese nurses during the COVID-19: the mediating role of psychological safety.","The outbreak of COVID-19 undoubtedly aggravated the pressure and workload of nurses' work, which may bring new challenges to nurses' work engagement. This study aims to explore the factors of nurses' work engagement, and it may provide targeted references for clinical intervention. Convenience sampling was used, and 689 nurses from Hebei and Guangxi Province in China were investigated. The results indicated that both perceived organizational support and psychological safety have direct positive ","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","Perceived organizational support; mediating effect; psychological safety; work engagement","He","Jinai","Department of Nursing , The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China",NA
"1637","34190623","10.1177/15579883211029460","Identifying Signs and Symptoms of Obstructive Sleep Apnea in a Men's Health Clinic: The Utility of Home Sleep Apnea Testing During COVID-19.","The objective of the study was to identify symptoms of men presenting for an outpatient urology visit that prompted referral for a Home Sleep Apnea Test (HSAT) to assess for obstructive sleep apnea (OSA) by a single provider. To assess the proportion of patients referred for the HSAT who underwent the test and, out of these patients, the proportion of men diagnosed with sleep apnea, we performed a retrospective chart review of men 18-99 years old seen by a single provider in the Department of Ur","2021","07","08","Am J Mens Health","American journal of men's health","behavioral issues; erectile dysfunction; hypertension; obesity; obstructive sleep apnea; physiological and endocrine disorders; sexuality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Continuous Positive Airway Pressure; Home Care Services; Humans; Male; Male Urogenital Diseases; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Sleep Apnea, Obstructive","Hart","Alexander","Carver College of Medicine, University of Iowa, Iowa City, IA, USA",NA
"1638","34190623","10.1177/15579883211029460","Identifying Signs and Symptoms of Obstructive Sleep Apnea in a Men's Health Clinic: The Utility of Home Sleep Apnea Testing During COVID-19.","The objective of the study was to identify symptoms of men presenting for an outpatient urology visit that prompted referral for a Home Sleep Apnea Test (HSAT) to assess for obstructive sleep apnea (OSA) by a single provider. To assess the proportion of patients referred for the HSAT who underwent the test and, out of these patients, the proportion of men diagnosed with sleep apnea, we performed a retrospective chart review of men 18-99 years old seen by a single provider in the Department of Ur","2021","07","08","Am J Mens Health","American journal of men's health","behavioral issues; erectile dysfunction; hypertension; obesity; obstructive sleep apnea; physiological and endocrine disorders; sexuality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Continuous Positive Airway Pressure; Home Care Services; Humans; Male; Male Urogenital Diseases; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Sleep Apnea, Obstructive","Robertus","Steffanie","Carver College of Medicine, University of Iowa, Iowa City, IA, USA",NA
"1639","34190623","10.1177/15579883211029460","Identifying Signs and Symptoms of Obstructive Sleep Apnea in a Men's Health Clinic: The Utility of Home Sleep Apnea Testing During COVID-19.","The objective of the study was to identify symptoms of men presenting for an outpatient urology visit that prompted referral for a Home Sleep Apnea Test (HSAT) to assess for obstructive sleep apnea (OSA) by a single provider. To assess the proportion of patients referred for the HSAT who underwent the test and, out of these patients, the proportion of men diagnosed with sleep apnea, we performed a retrospective chart review of men 18-99 years old seen by a single provider in the Department of Ur","2021","07","08","Am J Mens Health","American journal of men's health","behavioral issues; erectile dysfunction; hypertension; obesity; obstructive sleep apnea; physiological and endocrine disorders; sexuality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Continuous Positive Airway Pressure; Home Care Services; Humans; Male; Male Urogenital Diseases; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Sleep Apnea, Obstructive","Dyken","Mark","Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA",NA
"1640","34190623","10.1177/15579883211029460","Identifying Signs and Symptoms of Obstructive Sleep Apnea in a Men's Health Clinic: The Utility of Home Sleep Apnea Testing During COVID-19.","The objective of the study was to identify symptoms of men presenting for an outpatient urology visit that prompted referral for a Home Sleep Apnea Test (HSAT) to assess for obstructive sleep apnea (OSA) by a single provider. To assess the proportion of patients referred for the HSAT who underwent the test and, out of these patients, the proportion of men diagnosed with sleep apnea, we performed a retrospective chart review of men 18-99 years old seen by a single provider in the Department of Ur","2021","07","08","Am J Mens Health","American journal of men's health","behavioral issues; erectile dysfunction; hypertension; obesity; obstructive sleep apnea; physiological and endocrine disorders; sexuality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Continuous Positive Airway Pressure; Home Care Services; Humans; Male; Male Urogenital Diseases; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Sleep Apnea, Obstructive","Pearlman","Amy","Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA",NA
"1641","34190621","10.1177/17534666211028077","Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.","Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 51 studies were r","2021","07","09","Ther Adv Respir Dis","Therapeutic advances in respiratory disease","COVID-19; SARS-CoV-2; clinical improvement; convalescent plasma; mortality; COVID-19; Hospital Mortality; Hospitalization; Humans; Immunization, Passive; Recovery of Function; Respiration, Artificial; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome","Abeldaño Zuñiga","Roberto Ariel","University of Sierra Sur, Miahuatlan de Porfirio Diaz, Oaxaca, 70800, Mexico",NA
"1642","34190621","10.1177/17534666211028077","Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.","Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 51 studies were r","2021","07","09","Ther Adv Respir Dis","Therapeutic advances in respiratory disease","COVID-19; SARS-CoV-2; clinical improvement; convalescent plasma; mortality; COVID-19; Hospital Mortality; Hospitalization; Humans; Immunization, Passive; Recovery of Function; Respiration, Artificial; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome","González-Villoria","Ruth Ana María","Post Graduate Department. University of Sierra Sur, Oaxaca, Mexico",NA
"1643","34190621","10.1177/17534666211028077","Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.","Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 51 studies were r","2021","07","09","Ther Adv Respir Dis","Therapeutic advances in respiratory disease","COVID-19; SARS-CoV-2; clinical improvement; convalescent plasma; mortality; COVID-19; Hospital Mortality; Hospitalization; Humans; Immunization, Passive; Recovery of Function; Respiration, Artificial; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome","Elizondo","María Vanesa","Institute of Biomedical Sciences, Catholic University of Cuyo, San Juan, Argentina",NA
"1644","34190621","10.1177/17534666211028077","Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.","Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 51 studies were r","2021","07","09","Ther Adv Respir Dis","Therapeutic advances in respiratory disease","COVID-19; SARS-CoV-2; clinical improvement; convalescent plasma; mortality; COVID-19; Hospital Mortality; Hospitalization; Humans; Immunization, Passive; Recovery of Function; Respiration, Artificial; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome","Osorio","Anel Yaneli Nicolás","Post Graduate Department. University of Sierra Sur, Oaxaca, Mexico",NA
"1645","34190621","10.1177/17534666211028077","Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.","Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 51 studies were r","2021","07","09","Ther Adv Respir Dis","Therapeutic advances in respiratory disease","COVID-19; SARS-CoV-2; clinical improvement; convalescent plasma; mortality; COVID-19; Hospital Mortality; Hospitalization; Humans; Immunization, Passive; Recovery of Function; Respiration, Artificial; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome","Martínez","David Gómez","Public Health Research Institute. University of Sierra Sur, Oaxaca, Mexico",NA
"1646","34190621","10.1177/17534666211028077","Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.","Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. A total of 51 studies were r","2021","07","09","Ther Adv Respir Dis","Therapeutic advances in respiratory disease","COVID-19; SARS-CoV-2; clinical improvement; convalescent plasma; mortality; COVID-19; Hospital Mortality; Hospitalization; Humans; Immunization, Passive; Recovery of Function; Respiration, Artificial; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome","Coca","Silvia Mercedes","Public Health Research Institute. University of Sierra Sur, Oaxaca, Mexico",NA
"1647","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Freytag","Stefanie","Hochschule Fulda, Public Health Zentrum",NA
"1648","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Dammermann","Anna","Universität zu Lübeck, Institut für Sozialmedizin und Epidemiologie",NA
"1649","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Schultes","Kristin","Hochschule Fulda, Public Health Zentrum",NA
"1650","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Bieber","Anja","Institut für Gesundheits- und Pflegewissenschaft, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg",NA
"1651","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Fleischer","Steffen","Institut für Gesundheits- und Pflegewissenschaft, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg",NA
"1652","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Sander","Marco","Institut für Pflegewissenschaft, Medizinische Fakultät der Universität zu Köln",NA
"1653","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Piotrowski","Alexandra","Bergisches Kompetenzzentrum für Gesundheitsökonomik und Versorgungsforschung, Bergische Universität Wuppertal",NA
"1654","34190617","10.1024/1012-5302/a000823","Gewalt und Gewaltprävention in der stationären Altenpflege während der COVID-19-Pandemie.","Violence and Violence Prevention in Nursing Homes during the COVID-19 Pandemic - A partial analysis of Interviews with Managers or Team Leaders Abstract. Background: During the first wave of the COVID-19 pandemic, strict infection control measures were in force in long-term residential care in Germany that burdened staff and isolated residents socially. Both are considered risk factors for violence in long-term residential care. Questions: How does violence develop in nursing homes under pandemi","2021","06","30","Pflege","Pflege","COVID-19; Gewalt; Langzeitpflege; Pandemie; long-term care; pandemics; qualitative Forschung; qualitative research; violence","Blättner","Beate","Hochschule Fulda, Public Health Zentrum",NA
"1655","34190608","10.1128/AEM.00859-21","Biofilms and coronaviruses reservoirs: a perspective review.","Bats are a key reservoir of coronaviruses (CoVs), including the agent of the severe acute respiratory syndrome, SARS-CoV-2, responsible for the recent deadly viral pneumonia pandemic. However, understanding how bats can harbor several microorganisms without developing illnesses is still a matter under discussion. Viruses and other pathogens are often studied as stand-alone even though it is known that, in nature, they mostly live in multi-species associations called biofilms - both externally an","2021","06","30","Appl Environ Microbiol","Applied and environmental microbiology",NA,"Von Borowski","Rafael Gomes","Université de Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, Rennes, France",NA
"1656","34190608","10.1128/AEM.00859-21","Biofilms and coronaviruses reservoirs: a perspective review.","Bats are a key reservoir of coronaviruses (CoVs), including the agent of the severe acute respiratory syndrome, SARS-CoV-2, responsible for the recent deadly viral pneumonia pandemic. However, understanding how bats can harbor several microorganisms without developing illnesses is still a matter under discussion. Viruses and other pathogens are often studied as stand-alone even though it is known that, in nature, they mostly live in multi-species associations called biofilms - both externally an","2021","06","30","Appl Environ Microbiol","Applied and environmental microbiology",NA,"Trentin","Danielle Silva","Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre - RS, Brazil, 90050-170",NA
"1657","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Perkmann","Thomas","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1658","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Perkmann-Nagele","Nicole","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1659","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Koller","Thomas","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1660","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Mucher","Patrick","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1661","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Radakovics","Astrid","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1662","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Marculescu","Rodrig","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1663","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Wolzt","Michael","Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria",NA
"1664","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Wagner","Oswald F","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1665","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Binder","Christoph J","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1666","34190591","10.1128/Spectrum.00247-21","Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.","Reliable quantification of the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly relevant, e.g., for identifying possible vaccine failure and estimating the time of protection. Therefore, we evaluated five different anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies. Sera from 69 SARS-CoV-2-naive individuals 21 ± 1 days after vaccination with a single dose of BNT162b2 (Pfizer/BioNTech) were tested using the followin","2021","06","30","Microbiol Spectr","Microbiology spectrum","SARS-CoV-2; assay standardization; comparison; immunization; quantitative antibody assays; quantitative methods; serology; vaccination","Haslacher","Helmuth","Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria",NA
"1667","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Kostaki","Evangelia Georgia","Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1668","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Pavlopoulos","Georgios A","Center of New Biotechnologies &amp",NA
"1669","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Verrou","Kleio-Maria","Center of New Biotechnologies &amp",NA
"1670","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Ampatziadis-Michailidis","Giannis","Center of New Biotechnologies &amp",NA
"1671","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Harokopos","Vaggelis","Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center ""Alexander Fleming,"" Vari, Greece",NA
"1672","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Hatzis","Pantelis","Center of New Biotechnologies &amp",NA
"1673","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Moulos","Panagiotis","Center of New Biotechnologies &amp",NA
"1674","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Siafakas","Nikolaos","Laboratory of Clinical Microbiology, ATTIKON University Hospital, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1675","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Pournaras","Spyridon","Laboratory of Clinical Microbiology, ATTIKON University Hospital, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1676","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Hadjichristodoulou","Christos","Laboratory of Hygiene and Epidemiology, Faculty of Medicine, Larisa, Greece",NA
"1677","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Chatzopoulou","Fani","Labnet, Laboratories, Thessaloniki, Greece",NA
"1678","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Chatzidimitriou","Dimitrios","Labnet, Laboratories, Thessaloniki, Greece",NA
"1679","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Panagopoulos","Periklis","nd Department of Internal Medicine, General Hospital of Alexandroupoli, Democritus University of Thrace, Alexandroupoli, Greece",NA
"1680","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Lourida","Panagiota","Infectious Diseases Clinic A, Thoracic Diseases General Hospital Sotiria, Athens, Greece",NA
"1681","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Argyraki","Aikaterini","Infectious Diseases Clinic A, Thoracic Diseases General Hospital Sotiria, Athens, Greece",NA
"1682","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Lytras","Theodoros","School of Medicine, European University Cyprus, Nicosia, Cyprus",NA
"1683","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Sapounas","Spyros","National Public Health Organization, Athens, Greece",NA
"1684","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Gerolymatos","Gerasimos","National Public Health Organization, Athens, Greece",NA
"1685","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Panagiotakopoulos","Georgios","National Public Health Organization, Athens, Greece",NA
"1686","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Prezerakos","Panagiotis","Department of Nursing, University of Peloponnese, Tripoli, Greece",NA
"1687","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Tsiodras","Sotirios","th Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1688","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Sypsa","Vana","Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1689","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Hatzakis","Angelos","Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1690","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Anastassopoulou","Cleo","Department of Microbiology, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1691","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Spanakis","Nikolaos","Department of Microbiology, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1692","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Tsakris","Athanasios","Department of Microbiology, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1693","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Dimopoulos","Meletios Athanasios","Center of New Biotechnologies &amp",NA
"1694","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Kotanidou","Anastasia","st Intensive Care Unit, General Hospital Evangelismos, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1695","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Sfikakis","Petros","Center of New Biotechnologies &amp",NA
"1696","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Kollias","Georgios","Center of New Biotechnologies &amp",NA
"1697","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Magiorkinis","Gkikas","Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1698","34190583","10.1128/mSphere.00180-21","Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.","The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly during the first months of 2020 and continues to expand in multiple areas across the globe. Molecular epidemiology has provided an added value to traditional public health tools by identifying SARS-CoV-2 clusters or providing evidence that clusters based on virus sequences and contact tracing are highly concordant. Our aim was to infer the levels of virus importation and to estimate the impact of pu","2021","07","24","mSphere","mSphere","SARS-CoV-2; molecular epidemiology; phylogeography; public health; travel restrictions","Paraskevis","Dimitrios","Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athensgrid.5216.0, Athens, Greece",NA
"1699","34190576","10.1128/JCM.00869-21","Evaluation of the performance of the Associates of Cape Cod STAT assay for the diagnosis of invasive fungal disease in critical-care patients with COVID-19.","During the COVID-19 pandemic, there have been increasing reports of invasive fungal disease (IFD) in critical-care, where rapid access to (1-3)-ß-D-Glucan (BDG) testing may have enhanced diagnosis. The potential benefit of rapidly accessible BDG results is limited by local availability of BDG testing, with low demand resulting in testing being performed in specialist centres. The recent release of the Associates of Cape Cod STAT assay provides a simple, low-throughput BDG platform, potentially ","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"White","P Lewis","Public Health Wales Mycology reference laboratory,UHW, Cardiff, UK",NA
"1700","34190576","10.1128/JCM.00869-21","Evaluation of the performance of the Associates of Cape Cod STAT assay for the diagnosis of invasive fungal disease in critical-care patients with COVID-19.","During the COVID-19 pandemic, there have been increasing reports of invasive fungal disease (IFD) in critical-care, where rapid access to (1-3)-ß-D-Glucan (BDG) testing may have enhanced diagnosis. The potential benefit of rapidly accessible BDG results is limited by local availability of BDG testing, with low demand resulting in testing being performed in specialist centres. The recent release of the Associates of Cape Cod STAT assay provides a simple, low-throughput BDG platform, potentially ","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Price","Jessica S","Public Health Wales Mycology reference laboratory,UHW, Cardiff, UK",NA
"1701","34190576","10.1128/JCM.00869-21","Evaluation of the performance of the Associates of Cape Cod STAT assay for the diagnosis of invasive fungal disease in critical-care patients with COVID-19.","During the COVID-19 pandemic, there have been increasing reports of invasive fungal disease (IFD) in critical-care, where rapid access to (1-3)-ß-D-Glucan (BDG) testing may have enhanced diagnosis. The potential benefit of rapidly accessible BDG results is limited by local availability of BDG testing, with low demand resulting in testing being performed in specialist centres. The recent release of the Associates of Cape Cod STAT assay provides a simple, low-throughput BDG platform, potentially ","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Backx","Matthijs","Public Health Wales Mycology reference laboratory,UHW, Cardiff, UK",NA
"1702","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Ast","Volker","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1703","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Costina","Victor","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1704","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Eichner","Romy","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1705","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Bode","Anna","Reference-Institute for Bioanalytics, German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Bonn, Germany",NA
"1706","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Aida","Sihem","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1707","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Gerhards","Catharina","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1708","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Thiaucourt","Margot","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1709","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Dobler","Gerhard","Bundeswehr Institute of Microbiology, Munich, Germany",NA
"1710","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Geilenkeuser","Wolf-Jochen","Reference-Institute for Bioanalytics, German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Bonn, Germany",NA
"1711","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Wölfel","Roman","Bundeswehr Institute of Microbiology, Munich, Germany",NA
"1712","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Neumaier","Michael","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1713","34190575","10.1128/JCM.00559-21","Assessing the quality of serological testing in the CoViD-19 pandemic: results of a European external quality assessment (EQA) scheme for anti-SARS-CoV-2 antibody detection.","External quality assessment (EQA) is a key instrument for achieving harmonization, and thus a high quality, of diagnostic procedures. As reliable test results are crucial for accurate assessment of SARS-CoV-2 infection prevalence, vaccine response and immunity, and thus for successful management of the ongoing CoViD-19 pandemic, the Reference Institute for Bioanalytics (RfB) was the first EQA provider to offer an open scheme for anti-SARS-CoV-2 antibody detection. The main objectives of this EQA","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Haselmann","Verena","Department of Clinical Chemistry, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany",NA
"1714","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"L'Huillier","Arnaud G","Pediatric Infectious Diseases Unit, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1715","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Lacour","Matthieu","Faculty of Medicine, Geneva, Switzerland",NA
"1716","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Sadiku","Debora","Faculty of Medicine, Geneva, Switzerland",NA
"1717","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Gadiri","Mehdi A","Faculty of Medicine, Geneva, Switzerland",NA
"1718","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"De Siebenthal","Loraine","Faculty of Medicine, Geneva, Switzerland",NA
"1719","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Schibler","Manuel","Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1720","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Eckerle","Isabella","Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1721","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Pinösch","Selina","Division of General Pediatrics, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland",NA
"1722","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Kaiser","Laurent","Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1723","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Gervaix","Alain","Pediatric Emergency Department, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1724","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Glangetas","Alban","Pediatric Emergency Department, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1725","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Galetto-Lacour","Annick","Pediatric Emergency Department, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1726","34190574","10.1128/JCM.00991-21","Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting.","Background. Antigen-based rapid diagnostic tests (RDTs) are used in children despite the lack of data. We evaluated the diagnostic performance of the Panbio<sup>TM</sup>-COVID-19 Ag Rapid Test Device (P-RDT) in children. Methods. Symptomatic and asymptomatic participants 0-16yo had two NPS for both RT-PCR and P-RDT Results. 822 participants completed the study, of which 533 (64.9%) were symptomatic. Among the 119 (14.5%) RT-PCR-positive patients, the P-RDT sensitivity was 0.","2021","06","30","J Clin Microbiol","Journal of clinical microbiology",NA,"Lacroix","Laurence","Pediatric Emergency Department, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland",NA
"1727","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Gluzman","D F","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1728","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Zavelevich","M P","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1729","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Philchenkov","A A","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1730","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Koval","S V","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1731","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Guslitser","L N","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1732","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Zinchenko","V N","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1733","34190509","10.32471/exp-oncology.2312-8852.vol-43-no-2.16434","Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.","For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as <sup>137</sup>Cs, <sup>90</sup>Sr. The previous studies of the Reference Laboratory operating at RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology allowed specifying the effects of the protracted low dose irradiation on the state of the hematopoietic","2021","07","12","Exp Oncol","Experimental oncology","COVID-19; Chernobyl Nuclear Accident; Hematologic Neoplasms; Humans; Radiation Dosage; Radiation, Ionizing; SARS-CoV-2","Bezhenar","T O","RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv 03022, Ukraine",NA
"1734","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Debski","Maciej","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1735","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Abdelaziz","Hesham K","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1736","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Sanderson","Jo","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1737","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Wild","Susan","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1738","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Assaf","Omar","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1739","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Wiper","Andrew","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1740","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Nabi","Amjad","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1741","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Abdelrahman","Amr","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1742","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Eichhofer","Jonas","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1743","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Skailes","Geraldine","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1744","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Gardner","Jim","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1745","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Moynes","Kevin","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1746","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Goode","Grahame","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1747","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Pathan","Tayeem","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1748","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Patel","Billal","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1749","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Kumar","Somnath","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1750","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Taylor","Rebecca","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1751","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Galasko","Gavin","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1752","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"More","Ranjit","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1753","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Chalil","Shajil","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1754","34190508","10.1097/JOM.0000000000002279","Mental health outcomes among British healthcare workers: Lessons from the first wave of the Covid-19 pandemic.","To ascertain the level of psychological distress, using validated psychology tools, amongst British National Health Service workers (HCW) during the first wave of the Covid-19 crisis. A multi-centre, anonymised, all-comer staff survey across 3 hospitals in Lancashire, England during the Covid-19 first wave (April-June 2020), consisting of Patient Health Questionnaire (PHQ-9), Perceived Stress Scale-10 (PSS-10), Generalised Anxiety Disorder-7 (GAD-7) and Impact of Events Scale (IES-6). Among 1113","2021","06","30","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Choudhury","Tawfiq","Division of Medicine, Blackpool Teaching Hospitals, Blackpool, United Kingdom (Debski, Abdelaziz, Assaf, Wiper, Nabi, Abdelrahman, Eichhofer, Goode, Patel, Galasko, More, Chalil, Choudhury)",NA
"1755","34190506","10.17392/1385-21","Predictive factors for noninvasive mechanical ventilation failure among COVID-19 critically ill patients - a retrospective cohort study.","Aim To identify predictive factors related with noninvasive ventilation (NIV) failure that are not based on the patient's respiratory status or acid base gas analyses in COVID-19 critically ill patients, and to create a predictive model of NIV failure. Methods A total of 73 COVID-19 critically ill patients who developed acute respiratory failure and underwent NIV were divided into two groups: Group 1, patients who required endotracheal intubation and invasive mechanical ventilation after NIV and","2021","06","30","Med Glas (Zenica)","Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina","RALES; acute respiratory failure; dyspnoea; urea","Kovacevic","Mirza","Department of Anaesthesiology and Intensive Care Unit, Cantonal Hospital Zenica, Bosnia and Herzegovina",NA
"1756","34190506","10.17392/1385-21","Predictive factors for noninvasive mechanical ventilation failure among COVID-19 critically ill patients - a retrospective cohort study.","Aim To identify predictive factors related with noninvasive ventilation (NIV) failure that are not based on the patient's respiratory status or acid base gas analyses in COVID-19 critically ill patients, and to create a predictive model of NIV failure. Methods A total of 73 COVID-19 critically ill patients who developed acute respiratory failure and underwent NIV were divided into two groups: Group 1, patients who required endotracheal intubation and invasive mechanical ventilation after NIV and","2021","06","30","Med Glas (Zenica)","Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina","RALES; acute respiratory failure; dyspnoea; urea","Rizvanovic","Nermina","Department of Anaesthesiology and Intensive Care Unit, Cantonal Hospital Zenica, Bosnia and Herzegovina",NA
"1757","34190506","10.17392/1385-21","Predictive factors for noninvasive mechanical ventilation failure among COVID-19 critically ill patients - a retrospective cohort study.","Aim To identify predictive factors related with noninvasive ventilation (NIV) failure that are not based on the patient's respiratory status or acid base gas analyses in COVID-19 critically ill patients, and to create a predictive model of NIV failure. Methods A total of 73 COVID-19 critically ill patients who developed acute respiratory failure and underwent NIV were divided into two groups: Group 1, patients who required endotracheal intubation and invasive mechanical ventilation after NIV and","2021","06","30","Med Glas (Zenica)","Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina","RALES; acute respiratory failure; dyspnoea; urea","abanovic Adilovic","Adisa","Department of Anaesthesiology and Intensive Care Unit, Cantonal Hospital Zenica, Bosnia and Herzegovina",NA
"1758","34190478","10.32687/0869-866X-2021-29-3-468-473","[The social factors increasing healthy life longevity (according sociological surveys materials)].","The article discusses the main social factors that can positively effect on increasing the longevity of healthy life in the elderly. The main principles are based on the results of applied studies carried out by the authors in Moscow, Kursk, Velikiy Novgorod and Simferopol in 2019-2020. The respondents were both the elderly themselves and the specialists providing them social services support. The emphasis is made on the factors of healthy lifestyle of the elderly and first of all on feasible ph","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","healthy life; longevity; older people; social factors; Aged; Health Status; Humans; Mental Health; Moscow; Social Factors; Surveys and Questionnaires","Tanatova","D K","The Federal State Budget Educational Institution of Higher Education ""The Russian State Social University"", 129226, Moscow, Russia",NA
"1759","34190478","10.32687/0869-866X-2021-29-3-468-473","[The social factors increasing healthy life longevity (according sociological surveys materials)].","The article discusses the main social factors that can positively effect on increasing the longevity of healthy life in the elderly. The main principles are based on the results of applied studies carried out by the authors in Moscow, Kursk, Velikiy Novgorod and Simferopol in 2019-2020. The respondents were both the elderly themselves and the specialists providing them social services support. The emphasis is made on the factors of healthy lifestyle of the elderly and first of all on feasible ph","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","healthy life; longevity; older people; social factors; Aged; Health Status; Humans; Mental Health; Moscow; Social Factors; Surveys and Questionnaires","Yudina","T N","The Federal State Budget Educational Institution of Higher Education ""The Russian State Social University"", 129226, Moscow, Russia",NA
"1760","34190478","10.32687/0869-866X-2021-29-3-468-473","[The social factors increasing healthy life longevity (according sociological surveys materials)].","The article discusses the main social factors that can positively effect on increasing the longevity of healthy life in the elderly. The main principles are based on the results of applied studies carried out by the authors in Moscow, Kursk, Velikiy Novgorod and Simferopol in 2019-2020. The respondents were both the elderly themselves and the specialists providing them social services support. The emphasis is made on the factors of healthy lifestyle of the elderly and first of all on feasible ph","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","healthy life; longevity; older people; social factors; Aged; Health Status; Humans; Mental Health; Moscow; Social Factors; Surveys and Questionnaires","Vdovina","M V","The Federal State Budget Educational Institution of Higher Education ""The Russian State Social University"", 129226, Moscow, Russia, antigon1922@yandex","antigon1922@yandex.ru"
"1761","34190466","10.32687/0869-866X-2021-29-3-404-409","[The health education of students during COVID-19 pandemic].","The article considers issues of health education in educational institutions during COVID-19 pandemic. The importance of educating health-preserving attitude and sanitary hygienic culture in students is emphasized. In the context of pandemic, the priority task is to develop in students epidemiological culture as a background of healthy behavior. The special educational programs are to be developed to support sanitary-hygienic security in in educational standards. The article determines that the ","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","coronavirus infection; epidemic; epidemiological crisis; health education; hygienic standard; social responsibility; student; COVID-19; Health Education; Humans; Pandemics; SARS-CoV-2; Students","Kabayan","N V","The Federal State Budget Educational Institution of Higher Education ""The Adygeya State University"", 385000, Maykop, the Republic of Adygeya, Russia",NA
"1762","34190466","10.32687/0869-866X-2021-29-3-404-409","[The health education of students during COVID-19 pandemic].","The article considers issues of health education in educational institutions during COVID-19 pandemic. The importance of educating health-preserving attitude and sanitary hygienic culture in students is emphasized. In the context of pandemic, the priority task is to develop in students epidemiological culture as a background of healthy behavior. The special educational programs are to be developed to support sanitary-hygienic security in in educational standards. The article determines that the ","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","coronavirus infection; epidemic; epidemiological crisis; health education; hygienic standard; social responsibility; student; COVID-19; Health Education; Humans; Pandemics; SARS-CoV-2; Students","Kabayan","O S","The Federal State Budget Educational Institution of Higher Education ""The Adygeya State University"", 385000, Maykop, the Republic of Adygeya, Russia, Olgakabayan@yandex","Olgakabayan@yandex.ru"
"1763","34190466","10.32687/0869-866X-2021-29-3-404-409","[The health education of students during COVID-19 pandemic].","The article considers issues of health education in educational institutions during COVID-19 pandemic. The importance of educating health-preserving attitude and sanitary hygienic culture in students is emphasized. In the context of pandemic, the priority task is to develop in students epidemiological culture as a background of healthy behavior. The special educational programs are to be developed to support sanitary-hygienic security in in educational standards. The article determines that the ","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","coronavirus infection; epidemic; epidemiological crisis; health education; hygienic standard; social responsibility; student; COVID-19; Health Education; Humans; Pandemics; SARS-CoV-2; Students","Kabayan","A V","The Branch <U+2116> 3 of The Federal State Official Institution ""The Military Hospital <U+2116> 419"" of the Ministry of Defense of Russia, 385000 Maykop, the Republic of Adygeya, Russia",NA
"1764","34190465","10.32687/0869-866X-2021-29-3-398-403","[The organization of the system of supply and management of stock of individual protection means in conditions of COVID-19 pandemic].","In conditions of increasing of load caused by rapid development of new coronavirus infection (COVID-19) pandemic, health care systems of various countries faced the shortage of basic resources, including individual protection means for medical personnel and population that required taking complex measures to eliminate the situation. In the Tomsk oblast, the unified system of supplying medical organizations with individual protection means was organized. The system provides centralization of mana","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","COVID-19; causes of mortality; individual protection means; infection safety; lean production; pandemic; process standardization; social-demographic consequences; super-infection; COVID-19; Delivery of Health Care; Health Personnel; Humans; Pandemics; SARS-CoV-2","Boykov","V A","The Federal State Budget Educational Institution of Higher Education ""The Siberian State Medical University"" of Minzdrav of Russia, 634050, Tomsk, Russia, boykov85@mail","boykov85@mail.ru"
"1765","34190464","10.32687/0869-866X-2021-29-3-389-397","[The preconditions of occurrence and social demographic consequences of pandemics].","The article considers the historical features of development and theoretical approaches to defining the concept of ""pandemic"" in social sciences. The approaches of demographic science to the study of the consequences of pandemics are outlined. The prerequisites of occurrence of major pandemics at various historical stages of humankind development are highlighted. The particular attention is paid to pandemics in the XXI century. The demographic and social economic consequences of pandemics for th","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","COVID-19; causes of mortality; coronavirus; epidemic; pandemic; resistance; social-demographic consequences; super-infection; vaccination; COVID-19; Demography; Fertility; Humans; Pandemics; SARS-CoV-2","Ryazantsev","S V","The Federal State Autonomous Educational Institution of Higher Education ""Moscow State Institute of International relations (MGIMO University)"" of the Ministry of Foreign Affairs of Russia, 119445 Moscow, Russia, riazan@mail","riazan@mail.ru"
"1766","34190464","10.32687/0869-866X-2021-29-3-389-397","[The preconditions of occurrence and social demographic consequences of pandemics].","The article considers the historical features of development and theoretical approaches to defining the concept of ""pandemic"" in social sciences. The approaches of demographic science to the study of the consequences of pandemics are outlined. The prerequisites of occurrence of major pandemics at various historical stages of humankind development are highlighted. The particular attention is paid to pandemics in the XXI century. The demographic and social economic consequences of pandemics for th","2021","07","01","Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med","Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny","COVID-19; causes of mortality; coronavirus; epidemic; pandemic; resistance; social-demographic consequences; super-infection; vaccination; COVID-19; Demography; Fertility; Humans; Pandemics; SARS-CoV-2","Smirnov","A V","The Institute for Demographic Research - Branch of the Federal Center of Theoretical and Applied Sociology of the Russian Academy of Sciences (IDR FCTAS RAS), 119333 Moscow, Russia",NA
"1767","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Magro","Fernando","Department of Biomedicine, Unit of Pharmacology and Therapeutics, University of Porto, Porto, Portugal",NA
"1768","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Nuzzo","Alexandre","Department of Gastroenterology, IBD &amp",NA
"1769","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Abreu","Cândida","Infectious Diseases Service, Centro Hospitalar São João, Porto, Portugal",NA
"1770","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Libânio","Diogo","Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal",NA
"1771","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Rodriguez-Lago","Iago","Gastroenterology Department, IBD Unit, Hospital de Galdakao, Biocruces Bizkaia Health Research Institute and School of Medicine, University of Deusto, Galdakao, Spain",NA
"1772","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Pawlak","Katarzyna","Department of Gastroenterology, Endoscopy Unit, Hospital of the Ministry of Interior and Administration, Szczecin, Poland",NA
"1773","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Hollenbach","Marcus","Medical Department II, Division of Gastroenterology, University of Leipzig Medical Center, Leipzig, Germany",NA
"1774","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Brouwer","Willem P","Department of Gastroenterology &amp",NA
"1775","34190413","10.1002/ueg2.12115","COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.","The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. At this point, it is important to evaluate the impact of the pandemic on this field to furt","2021","06","30","United European Gastroenterol J","United European gastroenterology journal","COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination","Siau","Keith","Department of Gastroenterology, Dudley Group Hospitals NHS Foundation Trust, Dudley, UK",NA
"1776","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Wu","Ming-Yu","Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, 999077, China",NA
"1777","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Gu","Meijia","Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China",NA
"1778","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Leung","Jong-Kai","Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, 999077, China",NA
"1779","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Li","Xinmei","College of Life Sciences and China Center for Type Culture Collection, Wuhan University, Wuhan, Hubei, 430071, China",NA
"1780","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Yuan","Yuncong","College of Life Sciences and China Center for Type Culture Collection, Wuhan University, Wuhan, Hubei, 430071, China",NA
"1781","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Shen","Chao","College of Life Sciences and China Center for Type Culture Collection, Wuhan University, Wuhan, Hubei, 430071, China",NA
"1782","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Wang","Lianrong","Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China",NA
"1783","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Zhao","Engui","School of Science, Harbin Institute of Technology, Shenzhen, HIT Campus of University Town, Shenzhen, 518055, China",NA
"1784","34190409","10.1002/smll.202101770","A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.","COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is report","2021","06","30","Small","Small (Weinheim an der Bergstrasse, Germany)","aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers","Chen","Sijie","Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, 999077, China",NA
"1785","34190403","10.1111/camh.12488","Debate: The toll of the COVID-19 pandemic on children's risk for suicidal thoughts and behaviors.","The consequences of the COVID-19 pandemic on risk for suicidal thoughts and behaviors (STBs) in children are still not fully known. However, COVID-19 and the mitigation strategies to limit its transmission have affected children and adolescents through increased parental morbidity and mortality, increased poverty and financial strain, social isolation, and lost connectedness to school, peers, and afterschool activities. These are all associated with increased risk for psychiatric disorders and S","2021","06","30","Child Adolesc Ment Health","Child and adolescent mental health","COVID-19; children and adolescents; infections; psychosocial determinants of health; suicidal thoughts and behaviors","Melhem","Nadine M","Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA",NA
"1786","34190403","10.1111/camh.12488","Debate: The toll of the COVID-19 pandemic on children's risk for suicidal thoughts and behaviors.","The consequences of the COVID-19 pandemic on risk for suicidal thoughts and behaviors (STBs) in children are still not fully known. However, COVID-19 and the mitigation strategies to limit its transmission have affected children and adolescents through increased parental morbidity and mortality, increased poverty and financial strain, social isolation, and lost connectedness to school, peers, and afterschool activities. These are all associated with increased risk for psychiatric disorders and S","2021","06","30","Child Adolesc Ment Health","Child and adolescent mental health","COVID-19; children and adolescents; infections; psychosocial determinants of health; suicidal thoughts and behaviors","Brent","David A","Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA",NA
"1787","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Johnson","Austin","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1788","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Shukla","Neha","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1789","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Halley","Meghan","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1790","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Nava","Vanessa","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1791","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Budaraju","Janya","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1792","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Zhang","Lucy","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1793","34190397","10.1111/hex.13229","Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.","The COVID-19 pandemic has accelerated the adoption of telemedicine, including teledermatology. Monitoring skin lesions using teledermatology may become increasingly important for several skin diseases, including low-risk skin cancers. The purpose of this study was to describe the key factors that could serve as barriers or facilitators to skin disease monitoring using mobile health technology (mHealth) in older adults. Older adult dermatology patients 65 years or older and their caregivers who h","2021","06","30","Health Expect","Health expectations : an international journal of public participation in health care and health policy","active surveillance; ageing; dermatology; mobile health; older adults; telemedicine","Linos","Eleni","Department of Dermatology, School of Medicine, Program for Clinical Research and Technology, Stanford University, Stanford, CA, USA",NA
"1794","34190391","10.1111/mcn.13234","The impact of the Covid-19 pandemic on North American milk banks.","This study aims to understand the impact of the Covid-19 pandemic on human milk banking services in North America, with a focus on the United States. We triangulated questionnaire data with interviews and text-based website data. Of the 30 human milk bank services from which data were obtained, the majority faced substantial internal organization change in terms of staffing and protocols and experienced financial hardship in particular because of decreases in donor human milk orders. At the same","2021","06","30","Matern Child Nutr","Maternal &amp; child nutrition","Covid-19 pandemic; NICU; breastfeeding; donor human milk; human milk banks; lactation; neonatal health","Cohen","Mathilde","UConn School of Law, Hartford, Connecticut, USA",NA
"1795","34190391","10.1111/mcn.13234","The impact of the Covid-19 pandemic on North American milk banks.","This study aims to understand the impact of the Covid-19 pandemic on human milk banking services in North America, with a focus on the United States. We triangulated questionnaire data with interviews and text-based website data. Of the 30 human milk bank services from which data were obtained, the majority faced substantial internal organization change in terms of staffing and protocols and experienced financial hardship in particular because of decreases in donor human milk orders. At the same","2021","06","30","Matern Child Nutr","Maternal &amp; child nutrition","Covid-19 pandemic; NICU; breastfeeding; donor human milk; human milk banks; lactation; neonatal health","Cassidy","Tanya","School of Nursing, Psychotherapy and Community Health, Dublin City University, Glasnevin, Dublin 9, Ireland",NA
"1796","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Mayor","Pedro","Departament de Sanitat i d'Anatomia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain",NA
"1797","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","El Bizri","Hani R","ComFauna, Comunidad de Manejo de Fauna Silvestre en la Amazonía y en Latinoamérica, Iquitos, Peru",NA
"1798","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Morcatty","Thais Q","Rede de Pesquisa para Estudos sobre Diversidade, Conservação e Uso da Fauna na Amazônia (REDEFAUNA), Manaus, Amazonas, Brasil",NA
"1799","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Moya","Kelly","Universidad Nacional de la Amazonia Peruana (UNAP), Iquitos, Peru",NA
"1800","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Bendayán","Nora","Universidad Nacional de la Amazonia Peruana (UNAP), Iquitos, Peru",NA
"1801","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Solis","Samantha","Universidad Nacional de la Amazonia Peruana (UNAP), Iquitos, Peru",NA
"1802","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Vasconcelos Neto","Carlos F A","Rede de Pesquisa para Estudos sobre Diversidade, Conservação e Uso da Fauna na Amazônia (REDEFAUNA), Manaus, Amazonas, Brasil",NA
"1803","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Kirkland","Maire","Durham University, Durham, UK",NA
"1804","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Arevalo","Omar","Gerencia Regional de Asuntos Indígenas, Gobierno Regional de Loreto, Iquitos, Peru",NA
"1805","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Fang","Tula G","Museo de Culturas Indígenas Amazónicas, Iquitos, Loreto, Peru",NA
"1806","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Pérez-Peña","Pedro E","Instituto de Investigaciones de la Amazonía Peruana (IIAP), Iquitos, Peru",NA
"1807","34190360","10.1111/cobi.13801","Wild meat trade over the last 45 years in the Peruvian Amazon.","The trade in wild meat is an important economic component for rural people's livelihoods, but it has often been perceived to be amongst the main causes of the decline of wildlife species. Recently, the COVID-19 pandemic has brought to light an additional concern of wildlife markets as a major health challenge for humanity. This study brings data analyses from the largest longitudinal monitoring of wild meat markets in Amazonia, comprising surveys between 1973 and 2018 carried out in the most imp","2021","06","30","Conserv Biol","Conservation biology : the journal of the Society for Conservation Biology","amazonia; bushmeat; mammals; public health; sustainability; urban markets; wildlife trade","Bodmer","Richard E","Museo de Culturas Indígenas Amazónicas, Iquitos, Loreto, Peru",NA
"1808","34190358","10.1002/hpm.3271","Organisation of the State, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020.","The time and type of the States' responses to the COVID-19 pandemic varied with the severity of the epidemiological situation, the perceived risk, the political organisation and the model of health system of the country. We discuss the response of Germany, Spain, France, Italy, Portugal and the United Kingdom during the first months of the COVID-19 epidemic in 2020, considering the political organisation of the country and its health system model. We analyse public health measures implemented to","2021","06","30","Int J Health Plann Manage","The International journal of health planning and management","COVID-19; Europe; State; health systems; political organisation","Simões","Jorge","Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa (IHMT-UNL), Lisboa, Portugal",NA
"1809","34190358","10.1002/hpm.3271","Organisation of the State, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020.","The time and type of the States' responses to the COVID-19 pandemic varied with the severity of the epidemiological situation, the perceived risk, the political organisation and the model of health system of the country. We discuss the response of Germany, Spain, France, Italy, Portugal and the United Kingdom during the first months of the COVID-19 epidemic in 2020, considering the political organisation of the country and its health system model. We analyse public health measures implemented to","2021","06","30","Int J Health Plann Manage","The International journal of health planning and management","COVID-19; Europe; State; health systems; political organisation","Magalhães","João Paulo Moreira","Public Health Unit, Group of Primary Care Centers of Porto Oriental, North Health Regional Administration, Portugal",NA
"1810","34190358","10.1002/hpm.3271","Organisation of the State, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020.","The time and type of the States' responses to the COVID-19 pandemic varied with the severity of the epidemiological situation, the perceived risk, the political organisation and the model of health system of the country. We discuss the response of Germany, Spain, France, Italy, Portugal and the United Kingdom during the first months of the COVID-19 epidemic in 2020, considering the political organisation of the country and its health system model. We analyse public health measures implemented to","2021","06","30","Int J Health Plann Manage","The International journal of health planning and management","COVID-19; Europe; State; health systems; political organisation","Biscaia","André","Marginal Family Health Unit, Group of Primary Care Centers of Cascais, Regional Health Administration of Lisbon and Tagus Valley, Portugal",NA
"1811","34190358","10.1002/hpm.3271","Organisation of the State, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020.","The time and type of the States' responses to the COVID-19 pandemic varied with the severity of the epidemiological situation, the perceived risk, the political organisation and the model of health system of the country. We discuss the response of Germany, Spain, France, Italy, Portugal and the United Kingdom during the first months of the COVID-19 epidemic in 2020, considering the political organisation of the country and its health system model. We analyse public health measures implemented to","2021","06","30","Int J Health Plann Manage","The International journal of health planning and management","COVID-19; Europe; State; health systems; political organisation","da Luz Pereira","António","Family Health Unit of Prelada, ACES Porto Ocidental, Porto, Portugal",NA
"1812","34190358","10.1002/hpm.3271","Organisation of the State, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020.","The time and type of the States' responses to the COVID-19 pandemic varied with the severity of the epidemiological situation, the perceived risk, the political organisation and the model of health system of the country. We discuss the response of Germany, Spain, France, Italy, Portugal and the United Kingdom during the first months of the COVID-19 epidemic in 2020, considering the political organisation of the country and its health system model. We analyse public health measures implemented to","2021","06","30","Int J Health Plann Manage","The International journal of health planning and management","COVID-19; Europe; State; health systems; political organisation","Augusto","Gonçalo Figueiredo","Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa (IHMT-UNL), Lisboa, Portugal",NA
"1813","34190358","10.1002/hpm.3271","Organisation of the State, model of health system and COVID-19 health outcomes in six European countries, during the first months of the COVID-19 epidemic in 2020.","The time and type of the States' responses to the COVID-19 pandemic varied with the severity of the epidemiological situation, the perceived risk, the political organisation and the model of health system of the country. We discuss the response of Germany, Spain, France, Italy, Portugal and the United Kingdom during the first months of the COVID-19 epidemic in 2020, considering the political organisation of the country and its health system model. We analyse public health measures implemented to","2021","06","30","Int J Health Plann Manage","The International journal of health planning and management","COVID-19; Europe; State; health systems; political organisation","Fronteira","Inês","Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa (IHMT-UNL), Lisboa, Portugal",NA
"1814","34190330","10.1093/pubmed/fdab263","Social media as tool for the Church's mission and response to the COVID-19 pandemic.","A recent correspondence claimed that the establishment of community pantries across the Philippines embodies a spirituality of ""Alay Kapwa"" as it connects people, especially in a time of crisis such as the 2019 coronavirus (COVID-19) pandemic, to be persons for others. 1 This article highlights that the rise of community pantries was primarily aided by social media. It claims that if social media is utilized ethically and with positive disposition and perspective, it can be a powerful tool in th","2021","06","30","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; social media; spirituality","Galang","Justine Renus F","Department of Social Sciences, College of Arts and Sciences, Angeles University Foundation, Angeles City, 2009, Philippines",NA
"1815","34190330","10.1093/pubmed/fdab263","Social media as tool for the Church's mission and response to the COVID-19 pandemic.","A recent correspondence claimed that the establishment of community pantries across the Philippines embodies a spirituality of ""Alay Kapwa"" as it connects people, especially in a time of crisis such as the 2019 coronavirus (COVID-19) pandemic, to be persons for others. 1 This article highlights that the rise of community pantries was primarily aided by social media. It claims that if social media is utilized ethically and with positive disposition and perspective, it can be a powerful tool in th","2021","06","30","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; social media; spirituality","Galang","Joseph Renus F","Theology and Religious Education Department, De La Salle University, 2401 Taft Avenue, 0922 Manila, Philippines",NA
"1816","34190327","10.1093/pubmed/fdab261","To wear or not to wear that is the question! The need for 'one voice' in implementing health protocols during the COVID-19 pandemic.",NA,"2021","06","30","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cordero","Dalmacito A","Theology and Religious Education Department, De La Salle University, 1004 Taft Avenue, Manila",NA
"1817","34190322","10.1093/pubmed/fdab250","'Pandemic within a pandemic': a call to end police brutality.","This correspondence points out the excessive use of police force in the Philippines since the outbreak of the pandemic. In a recent correspondence, the authors called for a cooperative, honest and considerate attitude toward the government. However, how can one trust the government if it relies heavily on draconian measures in 'war' against the pandemic?","2021","06","30","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; force; pandemic; police brutality","Corpuz","Jeff Clyde G","Theology and Religious Education Department, De La Salle University, Manila 1004, Philippines",NA
"1818","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Mesias","Vince St Dollente","Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. jqhuang@ust","jqhuang@ust.hk"
"1819","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Zhu","Hongni","Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. jqhuang@ust","jqhuang@ust.hk"
"1820","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Tang","Xiao","Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China",NA
"1821","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Dai","Xin","Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. jqhuang@ust","jqhuang@ust.hk"
"1822","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Guo","Yusong","Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China",NA
"1823","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Liu","Wei","Department of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China",NA
"1824","34190246","10.1039/d1cc02267a","Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.","The infection of coronavirus initiates with the binding between its spike protein receptor binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme 2 (ACE2). Here, we construct truncated ACE2 peptide-conjugated gold nanoparticles as antiviral scaffolds and study their binding with the SARS-CoV-2 RBD using dynamic light scattering (DLS). Systematic DLS analysis identifies the effective peptide-nanoparticle conjugation and its efficient, specific, and long-lasting mu","2021","07","21","Chem Commun (Camb)","Chemical communications (Cambridge, England)","Angiotensin-Converting Enzyme 2; Dynamic Light Scattering; Molecular Dynamics Simulation; Nanoparticles; Peptide Fragments; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Substrate Specificity","Huang","Jinqing","Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. jqhuang@ust","jqhuang@ust.hk"
"1825","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Dong","Yonghai","Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China",NA
"1826","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Li","Zhongjian","Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China",NA
"1827","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Ding","Sheng","Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China",NA
"1828","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Liu","Shulong","Department of Hospital Infection Management, Jiangxi Provincial Chest Hospital, Nanchang, Jiangxi, China",NA
"1829","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Tang","Zhiyuan","Department of Data Collection, Jiangxi Provincial Center for Health Monitoring and Evaluation, Nanchang, Jiangxi, China",NA
"1830","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Jia","Lina","Department of Hospital Accreditation, Jiangxi Provincial Center for Health Development, Nanchang, Jiangxi, China",NA
"1831","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Liu","Jiahong","Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi, China",NA
"1832","34190201","10.1097/MD.0000000000026573","HIV infection and risk of COVID-19 mortality: A meta-analysis.","This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of th","2021","07","05","Medicine (Baltimore)","Medicine","COVID-19; Comorbidity; Data Interpretation, Statistical; Global Health; HIV Infections; Humans; Mortality; Risk Assessment; Risk Factors; SARS-CoV-2","Liu","Yun","Department of Imaging, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, Jiangxi, China",NA
"1833","34190164","10.1097/MD.0000000000026427","Vitamin C and D supplementation and the severity of COVID-19: A protocol for systematic review and meta-analysis.","The COVID-19 pandemic has rapidly spread to other countries, causing numerous deaths and challenges for organizations and health professionals. Diet and nutrition invariably influence the competence of the immune system and determine the risk and severity of infections. Studies have already been published on the relationships through which vitamins C and D can mitigate the severity of infections such as COVID-19. In this context, this protocol describes a systematic review intended to analyze if","2021","07","05","Medicine (Baltimore)","Medicine","Ascorbic Acid; COVID-19; Dietary Supplements; Humans; Meta-Analysis as Topic; Nutritional Status; Pandemics; SARS-CoV-2; Severity of Illness Index; Systematic Reviews as Topic; Vitamin D","Toscano","Gislani Acásia da Silva","Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal/RN",NA
"1834","34190164","10.1097/MD.0000000000026427","Vitamin C and D supplementation and the severity of COVID-19: A protocol for systematic review and meta-analysis.","The COVID-19 pandemic has rapidly spread to other countries, causing numerous deaths and challenges for organizations and health professionals. Diet and nutrition invariably influence the competence of the immune system and determine the risk and severity of infections. Studies have already been published on the relationships through which vitamins C and D can mitigate the severity of infections such as COVID-19. In this context, this protocol describes a systematic review intended to analyze if","2021","07","05","Medicine (Baltimore)","Medicine","Ascorbic Acid; COVID-19; Dietary Supplements; Humans; Meta-Analysis as Topic; Nutritional Status; Pandemics; SARS-CoV-2; Severity of Illness Index; Systematic Reviews as Topic; Vitamin D","de Araújo","Ivani Iasmin","Faculty of Health Science of Trairi, Federal University of Rio Grande do Norte, Santa Cruz/RN",NA
"1835","34190164","10.1097/MD.0000000000026427","Vitamin C and D supplementation and the severity of COVID-19: A protocol for systematic review and meta-analysis.","The COVID-19 pandemic has rapidly spread to other countries, causing numerous deaths and challenges for organizations and health professionals. Diet and nutrition invariably influence the competence of the immune system and determine the risk and severity of infections. Studies have already been published on the relationships through which vitamins C and D can mitigate the severity of infections such as COVID-19. In this context, this protocol describes a systematic review intended to analyze if","2021","07","05","Medicine (Baltimore)","Medicine","Ascorbic Acid; COVID-19; Dietary Supplements; Humans; Meta-Analysis as Topic; Nutritional Status; Pandemics; SARS-CoV-2; Severity of Illness Index; Systematic Reviews as Topic; Vitamin D","de Souza","Talita Araújo","Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal/RN",NA
"1836","34190164","10.1097/MD.0000000000026427","Vitamin C and D supplementation and the severity of COVID-19: A protocol for systematic review and meta-analysis.","The COVID-19 pandemic has rapidly spread to other countries, causing numerous deaths and challenges for organizations and health professionals. Diet and nutrition invariably influence the competence of the immune system and determine the risk and severity of infections. Studies have already been published on the relationships through which vitamins C and D can mitigate the severity of infections such as COVID-19. In this context, this protocol describes a systematic review intended to analyze if","2021","07","05","Medicine (Baltimore)","Medicine","Ascorbic Acid; COVID-19; Dietary Supplements; Humans; Meta-Analysis as Topic; Nutritional Status; Pandemics; SARS-CoV-2; Severity of Illness Index; Systematic Reviews as Topic; Vitamin D","Barbosa Mirabal","Isabelle Ribeiro","Postgraduate Program in Public Health, Federal University of Rio Grande do Norte, Natal/RN, Brazil",NA
"1837","34190164","10.1097/MD.0000000000026427","Vitamin C and D supplementation and the severity of COVID-19: A protocol for systematic review and meta-analysis.","The COVID-19 pandemic has rapidly spread to other countries, causing numerous deaths and challenges for organizations and health professionals. Diet and nutrition invariably influence the competence of the immune system and determine the risk and severity of infections. Studies have already been published on the relationships through which vitamins C and D can mitigate the severity of infections such as COVID-19. In this context, this protocol describes a systematic review intended to analyze if","2021","07","05","Medicine (Baltimore)","Medicine","Ascorbic Acid; COVID-19; Dietary Supplements; Humans; Meta-Analysis as Topic; Nutritional Status; Pandemics; SARS-CoV-2; Severity of Illness Index; Systematic Reviews as Topic; Vitamin D","de Vasconcelos Torres","Gilson","Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal/RN",NA
"1838","34190161","10.1097/MD.0000000000026419","Effects of music therapy on COVID-19 patients' anxiety, depression, and life quality: A protocol for systematic review and meta-analysis.","Whether music therapy improves coronavirus disease 2019 (COVID-19) patients' anxiety, depression, and life quality are still controversial. Therefore, to provide evidence-based medical evidence for clinical non-pharmacological interventions, we performed a meta-analysis of randomized controlled trials of music therapy for COVID-19 patients' anxiety, depression, and life quality. Cochrane Central Register of Controlled Trials Repositories, PubMed, Embase, Web of Science and Chinese Science Citati","2021","07","06","Medicine (Baltimore)","Medicine","Anxiety; COVID-19; Clinical Protocols; Depression; Humans; Meta-Analysis as Topic; Music Therapy; Quality of Life; SARS-CoV-2; Systematic Reviews as Topic","Chen","Xiaomei","Operating Room, Second Affiliated Hospital of Hainan Medical College, Haikou 570311",NA
"1839","34190161","10.1097/MD.0000000000026419","Effects of music therapy on COVID-19 patients' anxiety, depression, and life quality: A protocol for systematic review and meta-analysis.","Whether music therapy improves coronavirus disease 2019 (COVID-19) patients' anxiety, depression, and life quality are still controversial. Therefore, to provide evidence-based medical evidence for clinical non-pharmacological interventions, we performed a meta-analysis of randomized controlled trials of music therapy for COVID-19 patients' anxiety, depression, and life quality. Cochrane Central Register of Controlled Trials Repositories, PubMed, Embase, Web of Science and Chinese Science Citati","2021","07","06","Medicine (Baltimore)","Medicine","Anxiety; COVID-19; Clinical Protocols; Depression; Humans; Meta-Analysis as Topic; Music Therapy; Quality of Life; SARS-CoV-2; Systematic Reviews as Topic","Li","Haiying","Operating Room, Hainan Provincial Children's Hospital, Haikou 570100",NA
"1840","34190161","10.1097/MD.0000000000026419","Effects of music therapy on COVID-19 patients' anxiety, depression, and life quality: A protocol for systematic review and meta-analysis.","Whether music therapy improves coronavirus disease 2019 (COVID-19) patients' anxiety, depression, and life quality are still controversial. Therefore, to provide evidence-based medical evidence for clinical non-pharmacological interventions, we performed a meta-analysis of randomized controlled trials of music therapy for COVID-19 patients' anxiety, depression, and life quality. Cochrane Central Register of Controlled Trials Repositories, PubMed, Embase, Web of Science and Chinese Science Citati","2021","07","06","Medicine (Baltimore)","Medicine","Anxiety; COVID-19; Clinical Protocols; Depression; Humans; Meta-Analysis as Topic; Music Therapy; Quality of Life; SARS-CoV-2; Systematic Reviews as Topic","Zheng","Xiaoying","Cross Infection Control Office, Hospital Office of Hainan Provincial Anning Hospital",NA
"1841","34190161","10.1097/MD.0000000000026419","Effects of music therapy on COVID-19 patients' anxiety, depression, and life quality: A protocol for systematic review and meta-analysis.","Whether music therapy improves coronavirus disease 2019 (COVID-19) patients' anxiety, depression, and life quality are still controversial. Therefore, to provide evidence-based medical evidence for clinical non-pharmacological interventions, we performed a meta-analysis of randomized controlled trials of music therapy for COVID-19 patients' anxiety, depression, and life quality. Cochrane Central Register of Controlled Trials Repositories, PubMed, Embase, Web of Science and Chinese Science Citati","2021","07","06","Medicine (Baltimore)","Medicine","Anxiety; COVID-19; Clinical Protocols; Depression; Humans; Meta-Analysis as Topic; Music Therapy; Quality of Life; SARS-CoV-2; Systematic Reviews as Topic","Huang","Jiaqi","Department of Renal Medicine, Second Affiliated Hospital of Hainan Medical College, Haikou 570311, Hainan Province, China",NA
"1842","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Feng","Tianyu","School of Public Health, Jilin University",NA
"1843","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Sun","Helin","School of Public Health, Jilin University",NA
"1844","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Zhang","He","School of Public Health, Jilin University",NA
"1845","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Sun","Mengzi","School of Public Health, Jilin University",NA
"1846","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Wang","Yudan","Prevention and Cure Center of School Hygiene and Student Common Diseases, Changchun Center for Disease Control, Changchun, Jilin, China",NA
"1847","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Sun","Chong","School of Public Health, Jilin University",NA
"1848","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Li","Kexin","School of Public Health, Jilin University",NA
"1849","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Wang","Yingshuang","School of Public Health, Jilin University",NA
"1850","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Chai","Ruiyu","School of Public Health, Jilin University",NA
"1851","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Zheng","Pingping","School of Public Health, Jilin University",NA
"1852","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Chen","Yang","School of Public Health, Jilin University",NA
"1853","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Pan","Pan","School of Public Health, Jilin University",NA
"1854","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Bi","Chunli","School of Public Health, Jilin University",NA
"1855","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Zhang","Yulong","School of Public Health, Jilin University",NA
"1856","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Yao","Yan","School of Public Health, Jilin University",NA
"1857","34190148","10.1097/MD.0000000000026298","Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.","In this study, corona virus disease 2019 (COVID-19) transmission networks were built to analyze the epidemic situation of COVID-19 in Liaoning and Jilin provinces in early 2020. We explore the characteristics of the spread of COVID-19, and put forward effective recommendations for epidemic prevention and control. We collected demographic characteristics, exposure history, and course of action of COVID-19 cases. We described the demographic and case characteristics of these cases to show the basi","2021","07","06","Medicine (Baltimore)","Medicine","Adolescent; Adult; Age Distribution; Asymptomatic Infections; COVID-19; Child; China; Epidemiologic Studies; Female; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; SARS-CoV-2; Spatio-Temporal Analysis; Travel-Related Illness; Young Adult","Liu","Siyu","School of Public Health, Jilin University",NA
"1858","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Maehata","Tadateru","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1859","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Yasuda","Hiroshi","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1860","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Kiyokawa","Hirofumi","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1861","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Sato","Yoshinori","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1862","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Yamashita","Masaki","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1863","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Matsuo","Yasumasa","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1864","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Nakahara","Kazunari","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1865","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Yamamoto","Hiroyuki","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1866","34190142","10.1097/MD.0000000000026048","A novel mask to prevent aerosolized droplet dispersion in endoscopic procedures during the coronavirus disease pandemic.","Endoscopic procedures increase the risk of transmission of severe acute respiratory syndrome coronavirus 2 to medical staff, because aerosols are generated during upper gastrointestinal endoscopy. There have been several reported studies on devices for infection prevention; however, few reports have validated them. Therefore, we developed a novel mask to prevent the diffusion of aerosol droplets from patients undergoing endoscopy.We compared microdroplet dispersion during coughing episodes when ","2021","07","06","Medicine (Baltimore)","Medicine","Aerosols; COVID-19; Endoscopy; Feasibility Studies; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Masks; Occupational Exposure; Pandemics; SARS-CoV-2","Itoh","Fumio","Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan",NA
"1867","34190045","10.7554/eLife.69336","Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.","Comparing the impact of the COVID-19 pandemic between countries or across time is difficult because the reported numbers of cases and deaths can be strongly affected by testing capacity and reporting policy. Excess mortality, defined as the increase in all-cause mortality relative to the expected mortality, is widely considered as a more objective indicator of the COVID-19 death toll. However, there has been no global, frequently-updated repository of the all-cause mortality data across countrie","2021","07","07","Elife","eLife","epidemiology; global health; human","Karlinsky","Ariel","Economics, Hebrew University, Jerusalem, Israel",NA
"1868","34190045","10.7554/eLife.69336","Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.","Comparing the impact of the COVID-19 pandemic between countries or across time is difficult because the reported numbers of cases and deaths can be strongly affected by testing capacity and reporting policy. Excess mortality, defined as the increase in all-cause mortality relative to the expected mortality, is widely considered as a more objective indicator of the COVID-19 death toll. However, there has been no global, frequently-updated repository of the all-cause mortality data across countrie","2021","07","07","Elife","eLife","epidemiology; global health; human","Kobak","Dmitry","Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany",NA
"1869","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Davic","Alexandra","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1870","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Carey","Erin","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1871","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Lambert","Erin","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1872","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Luckingham","Therese","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1873","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Mongiello","Nikki","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1874","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Peralta","Randi","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1875","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Puccio","Nicolina","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1876","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Rivera","Kimberly","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1877","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Torre","Kirsten","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1878","34190038","10.1017/S1049023X21000571","Disparity in Gender Representation of Speakers at National Emergency Medical Services Conferences: A Current Assessment and Proposed Path Forward.","Gender disparities between Emergency Medicine physicians with regards to salary, promotion, and scholarly recognition as national conference speakers have been well-documented. However, little is known if similar gender disparities impact their out-of-hospital Emergency Medical Services (EMS) colleagues. Although there have been improvements in the ratio of women entering the EMS workforce, gender representation has improved at a slower rate for paramedics compared to emergency medical technicia","2021","07","21","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; conference; female; gender; gender equity; speaker","Maloney","Lauren M","Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, New YorkUSA",NA
"1879","34190018","10.1080/13548506.2021.1944652","Preliminary findings on the associations between personality traits and engagement behavior to the COVID-19 containment measures.","In March 2020, the World Health Organization (WHO) had declared the coronavirus disease 2019 (COVID-19) pandemic. Three weeks after WHO's declaration, almost 900,000 cases of COVID-19 were confirmed, with more than 43,000 deaths worldwide. Containment measures were recommended, such as social distancing and hand hygiene. Although they are known to be helpful to slow down the spread of the COVID-19, the efficiency of these measures depends on people's adherence. We explore whether personality tra","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","SARS-cov-2; compassion; disease outbreaks; neuroticism; personality","de Francisco Carvalho","Lucas","Psychology Department, Universidade São Francisco, Campinas, SP, Brazil",NA
"1880","34190018","10.1080/13548506.2021.1944652","Preliminary findings on the associations between personality traits and engagement behavior to the COVID-19 containment measures.","In March 2020, the World Health Organization (WHO) had declared the coronavirus disease 2019 (COVID-19) pandemic. Three weeks after WHO's declaration, almost 900,000 cases of COVID-19 were confirmed, with more than 43,000 deaths worldwide. Containment measures were recommended, such as social distancing and hand hygiene. Although they are known to be helpful to slow down the spread of the COVID-19, the efficiency of these measures depends on people's adherence. We explore whether personality tra","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","SARS-cov-2; compassion; disease outbreaks; neuroticism; personality","Gonçalves","André Pereira","Psychology Department, Universidade São Francisco, Campinas, SP, Brazil",NA
"1881","34190018","10.1080/13548506.2021.1944652","Preliminary findings on the associations between personality traits and engagement behavior to the COVID-19 containment measures.","In March 2020, the World Health Organization (WHO) had declared the coronavirus disease 2019 (COVID-19) pandemic. Three weeks after WHO's declaration, almost 900,000 cases of COVID-19 were confirmed, with more than 43,000 deaths worldwide. Containment measures were recommended, such as social distancing and hand hygiene. Although they are known to be helpful to slow down the spread of the COVID-19, the efficiency of these measures depends on people's adherence. We explore whether personality tra","2021","06","30","Psychol Health Med","Psychology, health &amp; medicine","SARS-cov-2; compassion; disease outbreaks; neuroticism; personality","Pianowski","Giselle","Psychology Department, Universidade São Francisco, Campinas, SP, Brazil",NA
"1882","34189979","10.1177/1460458221994878","COVID-19 pandemic: An analysis of popular YouTube videos as an alternative health information platform.","Dispersal of COVID-19 related information from YouTube plays a vital role in containing the pandemic and diminishes associated anxiety in the population. This study investigated the characteristics of popular YouTube videos related to COVID-19 outbreak. YouTube videos were searched using the COVID-19 related specific keywords with the eligibility of at least 1 million views. The videos were classified as types of videos (News, TV Shows, Educational, and Documentary) and sentiment-based titled vi","2021","07","01","Health Informatics J","Health informatics journal","COVID-19; Coronavirus; YouTube; health","Shukla","Abhishek","Jaypee University of Engineering and Technology, India",NA
"1883","34189976","10.1177/10497323211027536","Empowering People to Make Healthier Choices: A Critical Discourse Analysis of the Tackling Obesity Policy.","In response to the heightened risk that coronavirus disease 2019 (COVID-19) poses to the health and lives of people with obesity, in 2020 the U.K. government launched a new package of policies intended to stimulate weight loss among the country's population. In this article, I present a critical discourse analysis of the policy paper which announced these new measures. I identify the discourses that are used to represent things, people, and processes in this policy text. These discourses are int","2021","06","30","Qual Health Res","Qualitative health research","COVID-19; United Kingdom; coronavirus; critical discourse analysis; neoliberalism; obesity; policy paper; qualitative","Brookes","Gavin","Lancaster University, Lancaster, United Kingdom",NA
"1884","34189958","10.1177/10760296211027660","Acetylsalicylic Acid and COVID-19 Prevention: A Comment.",NA,"2021","07","05","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID; aspirin; bleeding; thrombosis; Aspirin; COVID-19; Humans; Platelet Aggregation Inhibitors; SARS-CoV-2","Sookaromdee","Pathum","Private Academic Consultant Center, Bangkok, Thailand",NA
"1885","34189958","10.1177/10760296211027660","Acetylsalicylic Acid and COVID-19 Prevention: A Comment.",NA,"2021","07","05","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID; aspirin; bleeding; thrombosis; Aspirin; COVID-19; Humans; Platelet Aggregation Inhibitors; SARS-CoV-2","Wiwanitkit","Viroj","Dr DY Patil University, Pune, India",NA
"1886","34189956","10.1177/10499091211024202","Health Professionals' Perspectives of the Role of Palliative Care During COVID-19: Content Analysis of Articles and Blogs Posted on Twitter.","The COVID-19 pandemic has resulted in health professionals facing unprecedented challenges and changes in practice. Responding to humanitarian crises involves saving lives and reducing suffering and as such, palliative care is an essential component of the response to COVID-19. This study aimed to explore health professionals' perspectives of the role of palliative care during the COVID-19 pandemic by analyzing their views and experiences expressed in articles and blogs located via Twitter. Qual","2021","07","02","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; knowledge and skills; medical staff; naturalistic data; palliative care; qualitative research","Singh","Gursharan K","Faculty of Health, Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia",NA
"1887","34189956","10.1177/10499091211024202","Health Professionals' Perspectives of the Role of Palliative Care During COVID-19: Content Analysis of Articles and Blogs Posted on Twitter.","The COVID-19 pandemic has resulted in health professionals facing unprecedented challenges and changes in practice. Responding to humanitarian crises involves saving lives and reducing suffering and as such, palliative care is an essential component of the response to COVID-19. This study aimed to explore health professionals' perspectives of the role of palliative care during the COVID-19 pandemic by analyzing their views and experiences expressed in articles and blogs located via Twitter. Qual","2021","07","02","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; knowledge and skills; medical staff; naturalistic data; palliative care; qualitative research","Rego","Joanna","Faculty of Health, Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia",NA
"1888","34189956","10.1177/10499091211024202","Health Professionals' Perspectives of the Role of Palliative Care During COVID-19: Content Analysis of Articles and Blogs Posted on Twitter.","The COVID-19 pandemic has resulted in health professionals facing unprecedented challenges and changes in practice. Responding to humanitarian crises involves saving lives and reducing suffering and as such, palliative care is an essential component of the response to COVID-19. This study aimed to explore health professionals' perspectives of the role of palliative care during the COVID-19 pandemic by analyzing their views and experiences expressed in articles and blogs located via Twitter. Qual","2021","07","02","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; knowledge and skills; medical staff; naturalistic data; palliative care; qualitative research","Chambers","Shirley","Faculty of Health, Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia",NA
"1889","34189956","10.1177/10499091211024202","Health Professionals' Perspectives of the Role of Palliative Care During COVID-19: Content Analysis of Articles and Blogs Posted on Twitter.","The COVID-19 pandemic has resulted in health professionals facing unprecedented challenges and changes in practice. Responding to humanitarian crises involves saving lives and reducing suffering and as such, palliative care is an essential component of the response to COVID-19. This study aimed to explore health professionals' perspectives of the role of palliative care during the COVID-19 pandemic by analyzing their views and experiences expressed in articles and blogs located via Twitter. Qual","2021","07","02","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; knowledge and skills; medical staff; naturalistic data; palliative care; qualitative research","Fox","Jennifer","Faculty of Health, Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia",NA
"1890","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Luo","Bangyu","Cancer Institute, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1891","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Li","Jixi","Cancer Institute, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1892","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Hou","Xianhua","Department of Neurology, First Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1893","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Yang","Qiao","Department of Ultrasound, 941 Hospital of The Chinese People's Liberation Army, Xining, China",NA
"1894","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Zhou","Yi","Cancer Institute, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1895","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Ye","Jun","Department of Gastroenterology, First Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1896","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Wu","Xiaocheng","Department of Emergency, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1897","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Feng","Yimei","Department of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1898","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Hu","Tianyu","Department of Nosocomial Infection Control, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1899","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Xu","Zhi","Institute of Respiratory Diseases, Key Laboratory of Respiratory Diseases Research, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1900","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","He","Ying","Department of Neurology, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1901","34189948","10.2217/fon-2021-0288","Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination.","The novel coronavirus disease 2019 (COVID-19) pandemic has lasted over 1 year and will not disappear in a short time. There is no specific remedy against the virus as yet. Vaccination is thus far one of the most important strategies for preventing COVID-19. Cancer patients with COVID-19 have a higher mortality because of immunosuppression. Immune checkpoint inhibitors (ICIs) are a novel anticancer strategy for blocking inhibitory pathways, which are related to the immune response. There is a que","2021","07","03","Future Oncol","Future oncology (London, England)","COVID-19; cancer; efficacy; immune checkpoint inhibitor; vaccination","Sun","Jianguo","Cancer Institute, Second Affiliated Hospital, Army Medical University, Chongqing, China",NA
"1902","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Szmulewicz","Alejandro","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1903","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Öngür","Dost","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1904","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Shinn","Ann K","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1905","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Carol","Emily E","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1906","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Dow","Jacqueline","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1907","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Yilmaz","Nergiz","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1908","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Durning","Peter T","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1909","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Sastry","Jayram M","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1910","34189932","10.1176/appi.ps.202100114","Impact of the COVID-19 Pandemic on the Employment and Educational Outcomes of Individuals in a First-Episode Psychosis Clinic.","A central objective of early psychosis therapy is to restore social functioning (e.g., through employment and education). Employment and educational outcomes during the COVID-19 pandemic were examined in a well-defined cohort of patients receiving care in an early psychosis clinic. Data were extracted from the electronic health records of 128 patients receiving care at McLean Hospital's first-episode psychosis (FEP) clinic between January 1 and September 21 in 2019 and 2020. Using a generalized ","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; Coronavirus; Early intervention; Education; Psychoses; Vocational rehabilitation","Hsu","John","Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston (Szmulewicz)",NA
"1911","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Dickerson","Faith","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1912","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Katsafanas","Emily","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1913","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Newman","Theresa","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1914","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Origoni","Andrea","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1915","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Rowe","Kelly","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1916","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Squire","Amalia","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1917","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Ziemann","Rita S","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1918","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Khushalani","Sunil","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1919","34189930","10.1176/appi.ps.202100130","Experiences of Persons With Serious Mental Illness During the COVID-19 Pandemic.","This study aimed to characterize the experiences of persons with serious mental illness during the COVID-19 pandemic. Adults with schizophrenia, bipolar disorder, major depression, or no psychiatric disorder (N=195) were interviewed between July 2020 and January 2021. All were previously enrolled in a cohort study. The interviews focused on mental distress and suicidal thoughts, the impact of the pandemic and pandemic-related worries, tobacco and alcohol use, and access to care. Responses of per","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Public health; Schizophrenia; bipolar disorder; depression; pandemic","Yolken","Robert","Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore",NA
"1920","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Nagata","Jason M","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1921","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Ganson","Kyle T","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1922","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Bonin","Sydell L","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1923","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Twadell","Kaitlyn L","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1924","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Garcia","Maria E","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1925","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Langrock","Olivia","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1926","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Vittinghoff","Eric","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1927","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Tsai","Alexander C","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1928","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Weiser","Sheri D","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1929","34189929","10.1176/appi.ps.202100111","Prevalence and Sociodemographic Correlates of Unmet Need for Mental Health Counseling Among Adults During the COVID-19 Pandemic.","This study aimed to determine the prevalence and correlates of unmet need for mental health counseling among U.S. adults during the COVID-19 pandemic. Data from the December 9-21, 2020, cross-sectional Household Pulse Survey (N=69,944) were analyzed. Overall, 12.8% of adults reported an unmet need for mental health counseling in the past month, including 25.2% of adults with a positive screen for depression or anxiety. Among adults with a positive screen, risk factors associated with an unmet ne","2021","06","30","Psychiatr Serv","Psychiatric services (Washington, D.C.)","COVID-19; SARS-CoV-2; counseling; mental health; severe acute respiratory syndrome coronavirus 2; therapy; unmet need","Abdel Magid","Hoda S","Department of Pediatrics (Nagata), Department of Medicine (Garcia, Weiser), and Department of Epidemiology and Biostatistics (Vittinghoff), University of California, San Francisco",NA
"1930","34189901","","Post Covid-19 Gullain-Barre Syndrome: An Emerging Neurological Complication.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Guillain-Barre Syndrome; Humans; Nervous System Diseases; SARS-CoV-2","Tk","Athira","Post graduate student Medicine,VSS institute of Medical Sciences and Research, Burla, Sambalpur, Odisha",NA
"1931","34189901","","Post Covid-19 Gullain-Barre Syndrome: An Emerging Neurological Complication.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Guillain-Barre Syndrome; Humans; Nervous System Diseases; SARS-CoV-2","Ms","Balamuralee Krishna","Post graduate student Medicine, VSS institute of Medical Sciences and Research, Burla, Sambalpur, Odisha",NA
"1932","34189901","","Post Covid-19 Gullain-Barre Syndrome: An Emerging Neurological Complication.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Guillain-Barre Syndrome; Humans; Nervous System Diseases; SARS-CoV-2","Patra","Soumya Ranjan","Post PG resident,VSS institute of Medical Sciences and Research, Burla, Sambalpur, Odisha",NA
"1933","34189901","","Post Covid-19 Gullain-Barre Syndrome: An Emerging Neurological Complication.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Guillain-Barre Syndrome; Humans; Nervous System Diseases; SARS-CoV-2","Sahu","Pravash Chandra","Asst. Professor Medicine,VSS institute of Medical Sciences and Research, Burla, Sambalpur, Odisha",NA
"1934","34189901","","Post Covid-19 Gullain-Barre Syndrome: An Emerging Neurological Complication.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Guillain-Barre Syndrome; Humans; Nervous System Diseases; SARS-CoV-2","Mohapatra","Manoj Kumar","Professor Medicine, VSS institute of Medical Sciences and Research, Burla, Sambalpur, Odisha",NA
"1935","34189900","","The Case for Tocilizumab.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Antibodies, Monoclonal, Humanized; COVID-19; Humans","Gokhale","Yojana","Professor of Medicine In-charge of Rheumatology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, Maharashtra",NA
"1936","34189899","","Structure of COVID-19 Isolation Wards and the Use of Inpatient Telemedicine in a Corporate Hospital in Urban India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospitals; Humans; India; Inpatients; SARS-CoV-2; Telemedicine","Kedlaya","Indira","Consultant Physician, Columbia Asia Hospital, Whitefield, Bangalore, Karnataka",NA
"1937","34189897","","COVID-19 Crisis-Are Administrative Issues Usurping Health Concerns.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; SARS-CoV-2","Acharya","Vishak","Professor, Kasturba Medical College, Mangalore, MAHE, Manipal, Karnataka",NA
"1938","34189897","","COVID-19 Crisis-Are Administrative Issues Usurping Health Concerns.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; SARS-CoV-2","Krishnan","Unni","Professor, Kasturba Medical College, Mangalore, MAHE, Manipal, Karnataka",NA
"1939","34189896","","Human to Animal Transmission of COVID-19: A Two-Way Road.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Animals; COVID-19; Humans; SARS-CoV-2","Garg","Prerna","Junior Resident, Department of Medicine,All India Institute of Medical Sciences, Delhi",NA
"1940","34189896","","Human to Animal Transmission of COVID-19: A Two-Way Road.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Animals; COVID-19; Humans; SARS-CoV-2","Arora","Umang","Junior Resident, Department of Medicine,All India Institute of Medical Sciences, Delhi",NA
"1941","34189896","","Human to Animal Transmission of COVID-19: A Two-Way Road.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Animals; COVID-19; Humans; SARS-CoV-2","Garg","Shreya","Junior Resident, Department of ENT, All India Institute of Medical Sciences, Delhi",NA
"1942","34189896","","Human to Animal Transmission of COVID-19: A Two-Way Road.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Animals; COVID-19; Humans; SARS-CoV-2","Soneja","Manish","Additional Professor, Department of Medicine, All India Institute of Medical Sciences, Delhi",NA
"1943","34189895","","A Prospective Analysis of PTSD Development in Admitted COVID-19 Patients in Indian Scenario.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Stress Disorders, Post-Traumatic","Gupta","Prakhar","Assistant Professor, LN Medical College, Bhopal, Madhya Pradesh",NA
"1944","34189895","","A Prospective Analysis of PTSD Development in Admitted COVID-19 Patients in Indian Scenario.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Stress Disorders, Post-Traumatic","Ishteyaq","Arshi","Junior Resident, Dept. of General Medicine, LN Medical College, Bhopal, Madhya Pradesh",NA
"1945","34189895","","A Prospective Analysis of PTSD Development in Admitted COVID-19 Patients in Indian Scenario.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Stress Disorders, Post-Traumatic","Khan","Shahwar","Junior Resident, Dept. of General Medicine, LN Medical College, Bhopal, Madhya Pradesh",NA
"1946","34189895","","A Prospective Analysis of PTSD Development in Admitted COVID-19 Patients in Indian Scenario.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Stress Disorders, Post-Traumatic","Singh","Mehak","Assistant Professor, Dept. of Dermatology, LN Medical College, Bhopal, Madhya Pradesh",NA
"1947","34189894","","An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as ""Recurrent Cytokine Storm'' following COVID-19 Infection.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Cytokine Release Syndrome; Humans; Immunocompromised Host; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2","Chakravarthy","K Kalyan","Consultant, SHRI Hospital",NA
"1948","34189894","","An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as ""Recurrent Cytokine Storm'' following COVID-19 Infection.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Cytokine Release Syndrome; Humans; Immunocompromised Host; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2","Cherukuri","Bharath","Assistant Professor, NRI Academy of Sciences, Guntur, Andhra Pradesh",NA
"1949","34189894","","An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as ""Recurrent Cytokine Storm'' following COVID-19 Infection.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Cytokine Release Syndrome; Humans; Immunocompromised Host; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2","Anne","Suresh","Director, NRI Academy of Sciences, Guntur, Andhra Pradesh",NA
"1950","34189894","","An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as ""Recurrent Cytokine Storm'' following COVID-19 Infection.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Cytokine Release Syndrome; Humans; Immunocompromised Host; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2","Shankar","T Uma","Consultant, SHRI Hospital",NA
"1951","34189894","","An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as ""Recurrent Cytokine Storm'' following COVID-19 Infection.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Cytokine Release Syndrome; Humans; Immunocompromised Host; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2","Mohan Reddy","G Murali","Assistant Professor, Mamatha Medical College, Khammam, Telangana",NA
"1952","34189894","","An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as ""Recurrent Cytokine Storm'' following COVID-19 Infection.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Cytokine Release Syndrome; Humans; Immunocompromised Host; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2","Guttikonda","Neeraj","Postgraduate, NRI Academy of Sciences, Guntur, Andhra Pradesh",NA
"1953","34189891","","COVID-19 and its Implication on Gasteroenterology: An Overview.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; SARS-CoV-2","Lakhani","Amit","Professor, Maharishi Markandeshwar Medical College and Hospital, Kumarhatti Solan",NA
"1954","34189891","","COVID-19 and its Implication on Gasteroenterology: An Overview.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; SARS-CoV-2","Singh","Pukraj","Senior Resident, Maharishi Markandeshwar Institute of Medical Sciences Mullana, Ambala",NA
"1955","34189891","","COVID-19 and its Implication on Gasteroenterology: An Overview.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; SARS-CoV-2","Sharma","Ena","Associate Professor, Maharishi Markandeshwar College of Dental Sciences and Research, Mullana, Ambala",NA
"1956","34189891","","COVID-19 and its Implication on Gasteroenterology: An Overview.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; SARS-CoV-2","Kapila","Savita","Professor, Maharishi Markandeshwa Institute of Medical Sciences, Mullana, Ambala",NA
"1957","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Mehfooz","Nazia","Assistant Professor Pulmonary Medicine, SKIMS, Soura, Jammu and Kashmir",NA
"1958","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Siraj","Farhana","Assistant Profesor, Department of Internal Medicne,SKIMS, Soura, Jammu and Kashmir",NA
"1959","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Shabir","Afshan","Assistant Professor, Department of Geriatrics,SKIMS, Soura, Jammu and Kashmir",NA
"1960","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Mantoo","Suhail","Assistant Profesor, Department of Internal Medicne, SKIMS, Soura, Jammu and Kashmir",NA
"1961","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Hussain","Tajamul","Senior Resident, Pulmonary Medicine,SKIMS, Soura, Jammu and Kashmir",NA
"1962","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Hafiz","Umar","Associate Professor, Department of Geriatrics,SKIMS, Soura, Jammu and Kashmir",NA
"1963","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Bindroo","Muzaffar","Assistant Professor, Department of Rheumatology,SKIMS, Soura, Jammu and Kashmir",NA
"1964","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Qadri","Mudasir","Associate Professor, Department of Internal Medicine, SKIMS, Soura, Jammu and Kashmir",NA
"1965","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Dangroo","Mushtaq","Additional Professor, Department of Rheumatology, SKIMS, Soura, Jammu and Kashmir",NA
"1966","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Koul","Ajaz Nabi","Additional Professor, Department of Internal Medicine (Infectious Division),SKIMS, Soura, Jammu and Kashmir",NA
"1967","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Jan","Rafi","Professor, Pulmonary Medicine, SKIMS, Soura, Jammu and Kashmir",NA
"1968","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Shah","Sanaullah","Professor, Pulmonary Medicine,SKIMS, Soura, Jammu and Kashmir",NA
"1969","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Sofi","Fayaz","Professor, Rheumatology,SKIMS, Soura, Jammu and Kashmir",NA
"1970","34189888","","Assessment of Risk Factors for Severe Illness in Hospitalized CovId-19 Patients at a Tertiary Care Hospital.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Humans; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Tertiary Care Centers","Wani","Faizan","Postgraduate Student, Department of Internal Medicine, SKIMS, Soura, Jammu and Kashmir",NA
"1971","34189887","","Practice Pattern of Critical Care Physicians in India for Use of Corticosteroids in COVID-19.","Steroids are recommended as the standard of care in managing severe COVID-19. However, several questions remain unanswered regarding the prescription of steroids which led to differing opinions and practice. We surveyed practice patterns of critical care physicians in India for the use of corticosteroids in COVID-19. This was a nationwide, cross-sectional, online, knowledge attitude practice-based survey, among intensivists for corticosteroid use in COVID-19. The survey questionnaire had seven q","2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adrenal Cortex Hormones; COVID-19; Critical Care; Cross-Sectional Studies; Humans; India; Physicians; Practice Patterns, Physicians'; SARS-CoV-2","Juneja","Deven","Associate Director, Max Super specialty Hospital, Saket, New Delhi",NA
"1972","34189887","","Practice Pattern of Critical Care Physicians in India for Use of Corticosteroids in COVID-19.","Steroids are recommended as the standard of care in managing severe COVID-19. However, several questions remain unanswered regarding the prescription of steroids which led to differing opinions and practice. We surveyed practice patterns of critical care physicians in India for the use of corticosteroids in COVID-19. This was a nationwide, cross-sectional, online, knowledge attitude practice-based survey, among intensivists for corticosteroid use in COVID-19. The survey questionnaire had seven q","2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adrenal Cortex Hormones; COVID-19; Critical Care; Cross-Sectional Studies; Humans; India; Physicians; Practice Patterns, Physicians'; SARS-CoV-2","Jain","Ravi","Assistant Professor, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan",NA
"1973","34189887","","Practice Pattern of Critical Care Physicians in India for Use of Corticosteroids in COVID-19.","Steroids are recommended as the standard of care in managing severe COVID-19. However, several questions remain unanswered regarding the prescription of steroids which led to differing opinions and practice. We surveyed practice patterns of critical care physicians in India for the use of corticosteroids in COVID-19. This was a nationwide, cross-sectional, online, knowledge attitude practice-based survey, among intensivists for corticosteroid use in COVID-19. The survey questionnaire had seven q","2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adrenal Cortex Hormones; COVID-19; Critical Care; Cross-Sectional Studies; Humans; India; Physicians; Practice Patterns, Physicians'; SARS-CoV-2","Singh","Omender","Senior Director, Max Super Specialty Hospital, Saket, New Delhi",NA
"1974","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Rao","C Mohan","Associate Professor and HOD, Dept. of Respiratory Medicine",NA
"1975","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Jena","Sunil Kumar","Assistant Professor, Dept. of Critical Care Medicine",NA
"1976","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Patnaik","Sibabratta","Associate Professor, Department of Pediatrics, In-charge Paediatric ICU",NA
"1977","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Singh","Nipa","Associate professor, Department of Microbiology,Corresponding Author",NA
"1978","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Gupta","Saurabh","Junior Resident, Dept. of Respiratory Medicine",NA
"1979","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Priyadarshini","Subhadra","Research Associate (Biostatistics), Department of Research and Development",NA
"1980","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Pradhan","Sujit","Consultant Critical Care Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, Orissa",NA
"1981","34189886","","Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; SARS-CoV-2","Das","Sidhartha","Ex-Dean and Principal, SCB Medical College and Hospital, Cuttack, Odisha",NA
"1982","34189884","","The Clinical Characteristics of Coinfection of COVID19 and Influenza A Viruses - A Case Series.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Coinfection; Humans; Influenza A virus; Influenza, Human; SARS-CoV-2","Agarwal","Arun","Director and Head,Department of Internal Medicine, Fortis Escorts Hospital, Jaipur, Rajasthan",NA
"1983","34189884","","The Clinical Characteristics of Coinfection of COVID19 and Influenza A Viruses - A Case Series.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Coinfection; Humans; Influenza A virus; Influenza, Human; SARS-CoV-2","Sharma","Ambika","Department of Internal Medicine, Fortis Escorts Hospital, Jaipur, Rajasthan",NA
"1984","34189884","","The Clinical Characteristics of Coinfection of COVID19 and Influenza A Viruses - A Case Series.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Coinfection; Humans; Influenza A virus; Influenza, Human; SARS-CoV-2","Agarwal","Mudit","Intern, All India Institute of Medical Sciences, New Delhi",NA
"1985","34189884","","The Clinical Characteristics of Coinfection of COVID19 and Influenza A Viruses - A Case Series.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Coinfection; Humans; Influenza A virus; Influenza, Human; SARS-CoV-2","Jakhar","Rekha","Resident, Department of Internal Medicine, Fortis Escorts Hospital, Jaipur, Rajasthan",NA
"1986","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Manudhane","Ganesh","HOD, Deparment of Cardiology, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1987","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Kumbhar","Maharudra","Officer on Special Duty, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1988","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Yadav","Ankit","Physician Assistant,Seven Hills Hospital, Mumbai, Maharashtra",NA
"1989","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Manudhane","Roopali","Consultant Pathology, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1990","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Adsul","Balkrishna","Dean, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1991","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Chavan","Smita","Assistant Dean, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1992","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Rakh","Walmik","Senior Resident,Seven Hills Hospital, Mumbai, Maharashtra",NA
"1993","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Jadhav","Sandip","Consultant Medicine, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1994","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Sansi","Rima","Consultant Radiology, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1995","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Pal","Jay Prakash","Neuroassistant,Seven Hills Hospital, Mumbai, Maharashtra",NA
"1996","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Chole","Bappasaheb","Cardioassistant, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1997","34189883","","To Study Role of Remdesivir in COVID 19 Patients at a Tertiary Referral Hospital in Mumbai, India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; India; SARS-CoV-2; Tertiary Care Centers","Maurya","Sandeep","Physician Assistant, Seven Hills Hospital, Mumbai, Maharashtra",NA
"1998","34189882","","High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Diabetes Mellitus; Humans; India; Pandemics; Retrospective Studies; SARS-CoV-2; Steroids","Aggarwal","Ramesh","Professor of Medicine, Lady Hardinge Medical College, New Delhi",NA
"1999","34189882","","High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Diabetes Mellitus; Humans; India; Pandemics; Retrospective Studies; SARS-CoV-2; Steroids","Agrawal","Aparna","Director Professor Head of Department of Medicine, Lady Hardinge Medical College, New Delhi",NA
"2000","34189882","","High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Diabetes Mellitus; Humans; India; Pandemics; Retrospective Studies; SARS-CoV-2; Steroids","Gurtoo","Anil","Director Professor of Medicine, Lady Hardinge Medical College, New Delhi",NA
"2001","34189882","","High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Diabetes Mellitus; Humans; India; Pandemics; Retrospective Studies; SARS-CoV-2; Steroids","Suman","Vivek","Professor of Medicine, Lady Hardinge Medical College, New Delhi",NA
"2002","34189882","","High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Diabetes Mellitus; Humans; India; Pandemics; Retrospective Studies; SARS-CoV-2; Steroids","Meena","Shivraj","Professor of Medicine, Lady Hardinge Medical College, New Delhi",NA
"2003","34189882","","High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Diabetes Mellitus; Humans; India; Pandemics; Retrospective Studies; SARS-CoV-2; Steroids","Prakash","Anupam","Professor of Medicine Head of Accident Emergency, Lady Hardinge Medical College, New Delhi",NA
"2004","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Jothimani","Dinesh","Director, Hepatology and Liver Transplantation, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2005","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Kailasam","Ezhilarasan","Clinical Chemist, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2006","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Nallathambi","Balaji","Junior Resident, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2007","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Danielraj","Silas","Junior Resident, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2008","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Ramachandran","Hemalatha","Bio statistician, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2009","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Narayanan","Kirthika","Vaccine Nodal Officer,Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2010","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Rajakumar","Akila","Clinical Lead, Critical Care Services, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2011","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Kaliamoorthy","Ilankumaran","Clinical Lead, Liver Anesthesia,Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2012","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Narasimhan","Gomathy","Senior Transplant Surgeon, 9Director, Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2013","34189880","","COVID 19: Elevated von Willibrand Factor at Hospital Admission Predicts Clinical Outcomes.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; SARS-CoV-2","Rela","Mohamed","Director, Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu",NA
"2014","34189879","","COVID-19: Mental Health and Addictive Disorders.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","Behavior, Addictive; COVID-19; Humans; Mental Disorders; Mental Health; SARS-CoV-2; Substance-Related Disorders","Singh","Yatan Pal","Additional Professor of Psychiatry, National Drug Dependence Treatment Center and Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi",NA
"2015","34189878","","COVID 19 in India: Waves, Variants of Concern, Airborne Transmission.",NA,"2021","07","02","J Assoc Physicians India","The Journal of the Association of Physicians of India","COVID-19; Humans; India; SARS-CoV-2","Joshi","Shashank R","Member, Maharashtra Covid-19 Task Force, Consultant Endocrinologist, Lilavati Hospital, Mumbai, Maharashtra",NA
"2016","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Abdalrhman","Abdallatif Satti","Department of Civil &amp",NA
"2017","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Wang","Chengjin","Department of Civil &amp",NA
"2018","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Manalac","Angelica","Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada",NA
"2019","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Weersink","Madrigal","Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada",NA
"2020","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Yassine","Abdul-Amir","Department of Electrical &amp",NA
"2021","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Betz","Vaughn","Department of Electrical &amp",NA
"2022","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Barbeau","Benoit","Department of Civil, Geological and Mining Engineering, Polytechnique, Montreal, Quebec, Canada",NA
"2023","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Lilge","Lothar","Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada",NA
"2024","34189862","10.1002/jbio.202100135","Modeling the efficiency of UV at 254 nm for disinfecting the different layers within N95 respirators.","The study presented a Monte Carlo simulation of light transport in eight commonly used filtered facepiece respirators (FFRs) to assess the efficacy of UV at 254 nm for the inactivation of SARS-CoV-2. The results showed different fluence rates across the thickness of the eight different FFRs, implying that some FFR models may be more treatable than others, with the following order being (from most to least treatable): models 1512, 9105s, 1805, 9210, 1870+, 8210, 8110s and 1860, for single side il","2021","07","12","J Biophotonics","Journal of biophotonics","Monte Carlo; N95 reuse; SARS-CoV-2; UV; decontamination; filtering facepiece respirators","Hofmann","Ron","Department of Civil &amp",NA
"2025","34189840","10.1002/jia2.25724","The continuing role of communities affected by HIV in sustained engagement in health and rights.","The meaningful involvement of persons affected by a disease is a unique aspect of the HIV response that places people living with (PLHIV) and those directly affected by HIV (peers) at the centre of the design, development and implementation of service delivery and research and policy making. The principle of greater involvement of PLHIV (GIPA) has and will increasingly ensure equitable access to services and engagement of marginalized groups in the HIV response, and to health services more broad","2021","07","07","J Int AIDS Soc","Journal of the International AIDS Society","accountability; community engagement; people living with HIV; research; service delivery; universal health coverage; Africa South of the Sahara; COVID-19; Government Programs; HIV Infections; HIV-1; Health Equity; Health Services; Health Services Accessibility; Human Rights; Humans; Peer Group; SARS-CoV-2; Social Responsibility","Caswell","Georgina","Global Network of People Living with HIV, Cape Town, South Africa",NA
"2026","34189840","10.1002/jia2.25724","The continuing role of communities affected by HIV in sustained engagement in health and rights.","The meaningful involvement of persons affected by a disease is a unique aspect of the HIV response that places people living with (PLHIV) and those directly affected by HIV (peers) at the centre of the design, development and implementation of service delivery and research and policy making. The principle of greater involvement of PLHIV (GIPA) has and will increasingly ensure equitable access to services and engagement of marginalized groups in the HIV response, and to health services more broad","2021","07","07","J Int AIDS Soc","Journal of the International AIDS Society","accountability; community engagement; people living with HIV; research; service delivery; universal health coverage; Africa South of the Sahara; COVID-19; Government Programs; HIV Infections; HIV-1; Health Equity; Health Services; Health Services Accessibility; Human Rights; Humans; Peer Group; SARS-CoV-2; Social Responsibility","Dubula","Vuyiseka","Centre for Civil Society, University of KwaZulu-Natal, Durban, South Africa",NA
"2027","34189840","10.1002/jia2.25724","The continuing role of communities affected by HIV in sustained engagement in health and rights.","The meaningful involvement of persons affected by a disease is a unique aspect of the HIV response that places people living with (PLHIV) and those directly affected by HIV (peers) at the centre of the design, development and implementation of service delivery and research and policy making. The principle of greater involvement of PLHIV (GIPA) has and will increasingly ensure equitable access to services and engagement of marginalized groups in the HIV response, and to health services more broad","2021","07","07","J Int AIDS Soc","Journal of the International AIDS Society","accountability; community engagement; people living with HIV; research; service delivery; universal health coverage; Africa South of the Sahara; COVID-19; Government Programs; HIV Infections; HIV-1; Health Equity; Health Services; Health Services Accessibility; Human Rights; Humans; Peer Group; SARS-CoV-2; Social Responsibility","Baptiste","Solange","International Treatment Preparedness Coalition, Johannesburg, South Africa",NA
"2028","34189840","10.1002/jia2.25724","The continuing role of communities affected by HIV in sustained engagement in health and rights.","The meaningful involvement of persons affected by a disease is a unique aspect of the HIV response that places people living with (PLHIV) and those directly affected by HIV (peers) at the centre of the design, development and implementation of service delivery and research and policy making. The principle of greater involvement of PLHIV (GIPA) has and will increasingly ensure equitable access to services and engagement of marginalized groups in the HIV response, and to health services more broad","2021","07","07","J Int AIDS Soc","Journal of the International AIDS Society","accountability; community engagement; people living with HIV; research; service delivery; universal health coverage; Africa South of the Sahara; COVID-19; Government Programs; HIV Infections; HIV-1; Health Equity; Health Services; Health Services Accessibility; Human Rights; Humans; Peer Group; SARS-CoV-2; Social Responsibility","Etya'ale","Helen","International Treatment Preparedness Coalition, Johannesburg, South Africa",NA
"2029","34189840","10.1002/jia2.25724","The continuing role of communities affected by HIV in sustained engagement in health and rights.","The meaningful involvement of persons affected by a disease is a unique aspect of the HIV response that places people living with (PLHIV) and those directly affected by HIV (peers) at the centre of the design, development and implementation of service delivery and research and policy making. The principle of greater involvement of PLHIV (GIPA) has and will increasingly ensure equitable access to services and engagement of marginalized groups in the HIV response, and to health services more broad","2021","07","07","J Int AIDS Soc","Journal of the International AIDS Society","accountability; community engagement; people living with HIV; research; service delivery; universal health coverage; Africa South of the Sahara; COVID-19; Government Programs; HIV Infections; HIV-1; Health Equity; Health Services; Health Services Accessibility; Human Rights; Humans; Peer Group; SARS-CoV-2; Social Responsibility","Syarif","Omar","Global Network of People Living with HIV, Amsterdam, The Netherlands",NA
"2030","34189840","10.1002/jia2.25724","The continuing role of communities affected by HIV in sustained engagement in health and rights.","The meaningful involvement of persons affected by a disease is a unique aspect of the HIV response that places people living with (PLHIV) and those directly affected by HIV (peers) at the centre of the design, development and implementation of service delivery and research and policy making. The principle of greater involvement of PLHIV (GIPA) has and will increasingly ensure equitable access to services and engagement of marginalized groups in the HIV response, and to health services more broad","2021","07","07","J Int AIDS Soc","Journal of the International AIDS Society","accountability; community engagement; people living with HIV; research; service delivery; universal health coverage; Africa South of the Sahara; COVID-19; Government Programs; HIV Infections; HIV-1; Health Equity; Health Services; Health Services Accessibility; Human Rights; Humans; Peer Group; SARS-CoV-2; Social Responsibility","Barr","David","The Fremont Center, New York, United States of America",NA
"2031","34189829","10.1002/smi.3076","Temporal associations among loneliness, anxiety, and depression during the COVID-19 pandemic period.","Numerous studies have reported that individuals' loneliness, anxiety, and depression levels increased during the COVID-19 pandemic period. However, reciprocal associations among loneliness, anxiety, and depression, as well as gender differences in these associations, have not been investigated. Therefore, temporal associations among loneliness, anxiety, and depression and gender differences in these associations were examined in a longitudinal study during the COVID-19 pandemic period. The lonel","2021","07","07","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","COVID-19 pandemic period; anxiety; depression; loneliness; longitudinal design","Wu","Jianfen","School of Education, Hangzhou Normal University, Hangzhou, China",NA
"2032","34189829","10.1002/smi.3076","Temporal associations among loneliness, anxiety, and depression during the COVID-19 pandemic period.","Numerous studies have reported that individuals' loneliness, anxiety, and depression levels increased during the COVID-19 pandemic period. However, reciprocal associations among loneliness, anxiety, and depression, as well as gender differences in these associations, have not been investigated. Therefore, temporal associations among loneliness, anxiety, and depression and gender differences in these associations were examined in a longitudinal study during the COVID-19 pandemic period. The lonel","2021","07","07","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","COVID-19 pandemic period; anxiety; depression; loneliness; longitudinal design","Wu","Yunpeng","School of Teacher Education, Dezhou University, Dezhou, China",NA
"2033","34189829","10.1002/smi.3076","Temporal associations among loneliness, anxiety, and depression during the COVID-19 pandemic period.","Numerous studies have reported that individuals' loneliness, anxiety, and depression levels increased during the COVID-19 pandemic period. However, reciprocal associations among loneliness, anxiety, and depression, as well as gender differences in these associations, have not been investigated. Therefore, temporal associations among loneliness, anxiety, and depression and gender differences in these associations were examined in a longitudinal study during the COVID-19 pandemic period. The lonel","2021","07","07","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","COVID-19 pandemic period; anxiety; depression; loneliness; longitudinal design","Tian","Yu","Department of Marxism, Qingdao University of Science and Technology, Qingdao, China",NA
"2034","34189800","10.1111/resp.14104","Letter from South Africa-COVID-19: The good, the bad and the ugly.",NA,"2021","06","30","Respirology","Respirology (Carlton, Vic.)","COVID-19; HIV; South Africa; children; tuberculosis","Gray","Diane M","Associate Professor and Clinical Head Division of Paediatric Pulmonology, Department of Paediatrics and Child Health and MRC Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa",NA
"2035","34189780","10.1111/tme.12803","Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research.","Despite scientific advances, there is no effective medical therapy for coronavirus disease 2019 (COVID-19). This systematic review and meta-analysis aimed to evaluate the safety and efficacy of convalescent plasma therapy in COVID-19. This review was carried out in accordance with Cochrane methodology including risk of bias assessment and grading of the quality of evidence. Only prospective clinical trials randomly assigning COVID-19 patients to convalescent plasma plus standard of care therapy ","2021","06","30","Transfus Med","Transfusion medicine (Oxford, England)","antibody; convalescent; coronavirus; plasma; randomised; therapeutics","Gupta","Tejpal","Department of Radiation Oncology, Clinical Research Centre, Advanced Centre for Treatment Research &amp",NA
"2036","34189780","10.1111/tme.12803","Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research.","Despite scientific advances, there is no effective medical therapy for coronavirus disease 2019 (COVID-19). This systematic review and meta-analysis aimed to evaluate the safety and efficacy of convalescent plasma therapy in COVID-19. This review was carried out in accordance with Cochrane methodology including risk of bias assessment and grading of the quality of evidence. Only prospective clinical trials randomly assigning COVID-19 patients to convalescent plasma plus standard of care therapy ","2021","06","30","Transfus Med","Transfusion medicine (Oxford, England)","antibody; convalescent; coronavirus; plasma; randomised; therapeutics","Kannan","Sadhana","Clinical Research Secretariat, Clinical Research Centre, Advanced Centre for Treatment Research &amp",NA
"2037","34189780","10.1111/tme.12803","Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research.","Despite scientific advances, there is no effective medical therapy for coronavirus disease 2019 (COVID-19). This systematic review and meta-analysis aimed to evaluate the safety and efficacy of convalescent plasma therapy in COVID-19. This review was carried out in accordance with Cochrane methodology including risk of bias assessment and grading of the quality of evidence. Only prospective clinical trials randomly assigning COVID-19 patients to convalescent plasma plus standard of care therapy ","2021","06","30","Transfus Med","Transfusion medicine (Oxford, England)","antibody; convalescent; coronavirus; plasma; randomised; therapeutics","Kalra","Babusha","Department of Radiation Oncology, Clinical Research Centre, Advanced Centre for Treatment Research &amp",NA
"2038","34189780","10.1111/tme.12803","Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research.","Despite scientific advances, there is no effective medical therapy for coronavirus disease 2019 (COVID-19). This systematic review and meta-analysis aimed to evaluate the safety and efficacy of convalescent plasma therapy in COVID-19. This review was carried out in accordance with Cochrane methodology including risk of bias assessment and grading of the quality of evidence. Only prospective clinical trials randomly assigning COVID-19 patients to convalescent plasma plus standard of care therapy ","2021","06","30","Transfus Med","Transfusion medicine (Oxford, England)","antibody; convalescent; coronavirus; plasma; randomised; therapeutics","Thakkar","Prafulla","Division of Internal Medicine, Clinical Research Centre, Advanced Centre for Treatment Research &amp",NA
"2039","34189771","10.1111/1468-0009.12525","Oral Health Stakeholders: A Time for Alignment and Action.","Policy Points Since the Surgeon General's report in 2000, multiple stakeholder groups have engaged in advocacy to expand access to oral health coverage, integrate medicine and dentistry, and to improve the dental workforce. Using a stakeholder map across these three policy priorities, we describe how stakeholder groups are shaping the oral health policy landscape in this century. While the stakeholders are numerous, policy has changed little despite invested efforts and resources. To achieve cha","2021","06","30","Milbank Q","The Milbank quarterly",NA,"Ticku","Shenam","Harvard School of Dental Medicine",NA
"2040","34189771","10.1111/1468-0009.12525","Oral Health Stakeholders: A Time for Alignment and Action.","Policy Points Since the Surgeon General's report in 2000, multiple stakeholder groups have engaged in advocacy to expand access to oral health coverage, integrate medicine and dentistry, and to improve the dental workforce. Using a stakeholder map across these three policy priorities, we describe how stakeholder groups are shaping the oral health policy landscape in this century. While the stakeholders are numerous, policy has changed little despite invested efforts and resources. To achieve cha","2021","06","30","Milbank Q","The Milbank quarterly",NA,"Barrow","Jane","Harvard School of Dental Medicine",NA
"2041","34189771","10.1111/1468-0009.12525","Oral Health Stakeholders: A Time for Alignment and Action.","Policy Points Since the Surgeon General's report in 2000, multiple stakeholder groups have engaged in advocacy to expand access to oral health coverage, integrate medicine and dentistry, and to improve the dental workforce. Using a stakeholder map across these three policy priorities, we describe how stakeholder groups are shaping the oral health policy landscape in this century. While the stakeholders are numerous, policy has changed little despite invested efforts and resources. To achieve cha","2021","06","30","Milbank Q","The Milbank quarterly",NA,"Fuccillo","Ralph","Cambridge Concord Associates",NA
"2042","34189771","10.1111/1468-0009.12525","Oral Health Stakeholders: A Time for Alignment and Action.","Policy Points Since the Surgeon General's report in 2000, multiple stakeholder groups have engaged in advocacy to expand access to oral health coverage, integrate medicine and dentistry, and to improve the dental workforce. Using a stakeholder map across these three policy priorities, we describe how stakeholder groups are shaping the oral health policy landscape in this century. While the stakeholders are numerous, policy has changed little despite invested efforts and resources. To achieve cha","2021","06","30","Milbank Q","The Milbank quarterly",NA,"McDonough","John E","Harvard TH.Chan School of Public Health",NA
"2043","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Horve","Patrick F","Biology and the Built Environment Center, University of Oregon, Eugene, OR, USA",NA
"2044","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Dietz","Leslie G","Biology and the Built Environment Center, University of Oregon, Eugene, OR, USA",NA
"2045","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Fretz","Mark","Institute for Health in the Built Environment, University of Oregon, Portland, OR, USA",NA
"2046","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Constant","David A","Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA",NA
"2047","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Wilkes","Andrew","Healthcare Facilities, Oregon Health and Science University, Portland, OR, USA",NA
"2048","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Townes","John M","Division of Infectious Diseases, Department of Medicine, School of Medicine, Oregon Health and Science University, Portland, OR, USA",NA
"2049","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Martindale","Robert G","Division of Gastrointestinal and General Surgery, School of Medicine, Oregon Health and Science University, Portland, OR, USA",NA
"2050","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Messer","William B","Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA",NA
"2051","34189769","10.1111/ina.12898","Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units.","Evidence continues to grow supporting the aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where coronavirus disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of sample","2021","06","30","Indoor Air","Indoor air","COVID-19; HVAC; MERV; SARS-CoV-2; aerosols; filtration; healthcare","Van Den Wymelenberg","Kevin G","Biology and the Built Environment Center, University of Oregon, Eugene, OR, USA",NA
"2052","34189763","10.1111/ced.14823","Personal Health Records (PHRs) as a tool to support Patient Initiated Follow Up (PIFU): a dermatology perspective.","One of the few positives of the COVID-19 pandemic has been an unprecedented flexibility and willingness to embrace innovation in the delivery of healthcare services in the NHS. This change in mindset has presented a unique opportunity to rethink and transform outdated models of delivering outpatient care. There were 125 million recorded outpatient appointments in England in 2019-2020 (an increase of 66.9% from a decade ago), of which 3 million were for dermatology, the sixth-highest specialty by","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Hussain","K","Department of Dermatology, Charing Cross Hospital, Imperial College NHS Healthcare Trust",NA
"2053","34189763","10.1111/ced.14823","Personal Health Records (PHRs) as a tool to support Patient Initiated Follow Up (PIFU): a dermatology perspective.","One of the few positives of the COVID-19 pandemic has been an unprecedented flexibility and willingness to embrace innovation in the delivery of healthcare services in the NHS. This change in mindset has presented a unique opportunity to rethink and transform outdated models of delivering outpatient care. There were 125 million recorded outpatient appointments in England in 2019-2020 (an increase of 66.9% from a decade ago), of which 3 million were for dermatology, the sixth-highest specialty by","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Patel","N P","Department of Dermatology, Charing Cross Hospital, Imperial College NHS Healthcare Trust",NA
"2054","34189756","10.1111/ced.14819","Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination.","A 73-year-old male presented with left shin ulceration two weeks after receiving his first dose of the ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccine. He had a background of atrial fibrillation with ischemic cardiomyopathy and had been on several longstanding medication, including apixaban. Within 24 hours of vaccination, the patient became generally unwell with fever and headache. After resolution of these systemic symptoms, on the third day after vaccination, he developed left shin erythema and ","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Ramessur","R","Department of Dermatology, Watford General Hospital, Hertfordshire Hospitals NHS Trust, Watford, Hertfordshire, UK",NA
"2055","34189756","10.1111/ced.14819","Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination.","A 73-year-old male presented with left shin ulceration two weeks after receiving his first dose of the ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccine. He had a background of atrial fibrillation with ischemic cardiomyopathy and had been on several longstanding medication, including apixaban. Within 24 hours of vaccination, the patient became generally unwell with fever and headache. After resolution of these systemic symptoms, on the third day after vaccination, he developed left shin erythema and ","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Saffar","N","Department of Dermatology, Watford General Hospital, Hertfordshire Hospitals NHS Trust, Watford, Hertfordshire, UK",NA
"2056","34189756","10.1111/ced.14819","Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination.","A 73-year-old male presented with left shin ulceration two weeks after receiving his first dose of the ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccine. He had a background of atrial fibrillation with ischemic cardiomyopathy and had been on several longstanding medication, including apixaban. Within 24 hours of vaccination, the patient became generally unwell with fever and headache. After resolution of these systemic symptoms, on the third day after vaccination, he developed left shin erythema and ","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Czako","B","Department of Clinical haematology, Watford General Hospital, Hertfordshire Hospitals NHS Trust, Watford, Hertfordshire, UK",NA
"2057","34189756","10.1111/ced.14819","Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination.","A 73-year-old male presented with left shin ulceration two weeks after receiving his first dose of the ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccine. He had a background of atrial fibrillation with ischemic cardiomyopathy and had been on several longstanding medication, including apixaban. Within 24 hours of vaccination, the patient became generally unwell with fever and headache. After resolution of these systemic symptoms, on the third day after vaccination, he developed left shin erythema and ","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Agarwal","A","Department of Histopathology, Watford General Hospital, Hertfordshire Hospitals NHS Trust, Watford, Hertfordshire, UK",NA
"2058","34189756","10.1111/ced.14819","Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination.","A 73-year-old male presented with left shin ulceration two weeks after receiving his first dose of the ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccine. He had a background of atrial fibrillation with ischemic cardiomyopathy and had been on several longstanding medication, including apixaban. Within 24 hours of vaccination, the patient became generally unwell with fever and headache. After resolution of these systemic symptoms, on the third day after vaccination, he developed left shin erythema and ","2021","06","30","Clin Exp Dermatol","Clinical and experimental dermatology",NA,"Batta","K","Department of Dermatology, Watford General Hospital, Hertfordshire Hospitals NHS Trust, Watford, Hertfordshire, UK",NA
"2059","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Taylor","E H","Global Surgery Division, University of Cape Town, Cape Town, South Africa",NA
"2060","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Marson","E J","College of Medical and Dental Sciences, Birmingham, UK",NA
"2061","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Elhadi","M","Faculty of Medicine, University of Tripoli, Tripoli, Libya",NA
"2062","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Macleod","K D M","Glasgow Royal Infirmary, Glasgow, UK",NA
"2063","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Yu","Y C","Department of Anaesthesiology and Critical Care, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa",NA
"2064","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Davids","R","Department of Anaesthesiology and Critical Care, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa",NA
"2065","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Boden","R","Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa",NA
"2066","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Overmeyer","R C","Department of Anaesthesiology and Critical Care, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa",NA
"2067","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Ramakrishnan","R","National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK",NA
"2068","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Thomson","D A","Division of Critical Care, University of Cape Town, Cape Town, South Africa",NA
"2069","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Coetzee","J","Department of Anaesthesiology and Critical Care, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa",NA
"2070","34189735","10.1111/anae.15532","Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.","Identification of high-risk patients admitted to intensive care with COVID-19 may inform management strategies. The objective of this meta-analysis was to determine factors associated with mortality among adults with COVID-19 admitted to intensive care by searching databases for studies published between 1 January 2020 and 6 December 2020. Observational studies of COVID-19 adults admitted to critical care were included. Studies of mixed cohorts and intensive care cohorts restricted to a specific","2021","06","30","Anaesthesia","Anaesthesia","COVID-19; critical care; meta-analysis; mortality","Biccard","B M","Department of Anaesthesia and Peri-operative Medicine, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa",NA
"2071","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Kirby","Leslie D","Peabody College, Vanderbilt University, Nashville, TN, USA",NA
"2072","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Qian","Weiqiang","Peabody College, Vanderbilt University, Nashville, TN, USA",NA
"2073","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Adiguzel","Zafer","Istanbul Medipol University, Istanbul, Turkey",NA
"2074","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Afshar Jahanshahi","Asghar","CENTRUM Catølica Graduate Business School (CCGBS), Pontificia Universidad Católica del Perú (PUCP), Lima, Peru",NA
"2075","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Bakracheva","Margarita","Sofia University St. Kliment Ohridski, Sofia, Bulgaria",NA
"2076","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Orejarena Ballestas","María C","Universidad de La Sabana, Chía, Colombia",NA
"2077","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Cruz","José Fernando A","Psychology Research Centre (CiPsi/UM)|School of Psychology, University of Minho, Braga, Portugal",NA
"2078","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Dash","Arobindu","Leuphana University, Lüneburg, Germany and International University of Business Agriculture &amp",NA
"2079","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Dias","Claudia","Centre of Research, Education, Innovation and Intervention in Sport (CIFI2D), Faculty of Sport, Porto, Portugal",NA
"2080","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Ferreira","Maria J","HEI-Lab: Digital Human-Environment Interaction Lab, Faculty of Psychology, Education and Sports, Lusófona University, Porto, Portugal",NA
"2081","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Goosen","Johanna G","Leiden University, The Netherlands and Knowledge Centre Psychology and Economic Behaviour, Leiden, The Netherlands",NA
"2082","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Kamble","Shanmukh V","Karnatak University, Dharwad, India",NA
"2083","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Mihaylov","Nikolay L","Medical University Varna, Varna, Bulgaria",NA
"2084","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Pan","Fada","Nantong University, Nantong, China",NA
"2085","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Sofia","Rui","Centre of Research, Education, Innovation and Intervention in Sport (CIFI2D), Faculty of Sport, Porto, Portugal",NA
"2086","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Stallen","Mirre","Leiden University, The Netherlands and Knowledge Centre Psychology and Economic Behaviour, Leiden, The Netherlands",NA
"2087","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Tamir","Maya","The Hebrew University of Jerusalem, Jerusalem, Israel",NA
"2088","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","van Dijk","Wilco W","Leiden University, The Netherlands and Knowledge Centre Psychology and Economic Behaviour, Leiden, The Netherlands",NA
"2089","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Vittersø","Joar","UIT, The Arctic University, Tromsø, Norway",NA
"2090","34189731","10.1002/ijop.12770","Appraisal and coping predict health and well-being during the COVID-19 pandemic: An international approach.","COVID-19 has had a devastating impact on people worldwide. We conducted an international survey (n = 3646) examining the degree to which people's appraisals and coping activities around the pandemic predicted their health and well-being. We obtained subsamples from 12 countries-Bangladesh, Bulgaria, China, Colombia, India, Israel, the Netherlands, Norway, Peru, Portugal, Turkey and the United States. For each, we assessed appraisals and coping strategies as well as indicators of physical and men","2021","07","22","Int J Psychol","International journal of psychology : Journal international de psychologie","Appraisal theory; COVID-19; Coping; Health; International; Pandemic; Well-being","Smith","Craig A","Peabody College, Vanderbilt University, Nashville, TN, USA",NA
"2091","34189719","10.1007/s00415-021-10663-x","Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.","Recent observations suggest a lack of humoral response after SARS-CoV-2 vaccination in multiple sclerosis (MS) patients treated with fingolimod or ocrelizumab OBJECTIVES: To assess serological response to SARS-CoV-2 vaccination in MS patients receiving these disease-modifying treatments (DMTs) in a real-life setting. Retrospective clinical data collection from MS patients followed at San Raffaele Hospital MS Centre (Milan, Italy). All patients treated with fingolimod or ocrelizumab who had recei","2021","07","02","J Neurol","Journal of neurology","COVID-19; Fingolimod; Multiple sclerosis; Ocrelizumab; SARS-CoV-2 vaccination","S","Guerrieri","Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"2092","34189719","10.1007/s00415-021-10663-x","Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.","Recent observations suggest a lack of humoral response after SARS-CoV-2 vaccination in multiple sclerosis (MS) patients treated with fingolimod or ocrelizumab OBJECTIVES: To assess serological response to SARS-CoV-2 vaccination in MS patients receiving these disease-modifying treatments (DMTs) in a real-life setting. Retrospective clinical data collection from MS patients followed at San Raffaele Hospital MS Centre (Milan, Italy). All patients treated with fingolimod or ocrelizumab who had recei","2021","07","02","J Neurol","Journal of neurology","COVID-19; Fingolimod; Multiple sclerosis; Ocrelizumab; SARS-CoV-2 vaccination","S","Lazzarin","Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"2093","34189719","10.1007/s00415-021-10663-x","Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.","Recent observations suggest a lack of humoral response after SARS-CoV-2 vaccination in multiple sclerosis (MS) patients treated with fingolimod or ocrelizumab OBJECTIVES: To assess serological response to SARS-CoV-2 vaccination in MS patients receiving these disease-modifying treatments (DMTs) in a real-life setting. Retrospective clinical data collection from MS patients followed at San Raffaele Hospital MS Centre (Milan, Italy). All patients treated with fingolimod or ocrelizumab who had recei","2021","07","02","J Neurol","Journal of neurology","COVID-19; Fingolimod; Multiple sclerosis; Ocrelizumab; SARS-CoV-2 vaccination","C","Zanetta","Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"2094","34189719","10.1007/s00415-021-10663-x","Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.","Recent observations suggest a lack of humoral response after SARS-CoV-2 vaccination in multiple sclerosis (MS) patients treated with fingolimod or ocrelizumab OBJECTIVES: To assess serological response to SARS-CoV-2 vaccination in MS patients receiving these disease-modifying treatments (DMTs) in a real-life setting. Retrospective clinical data collection from MS patients followed at San Raffaele Hospital MS Centre (Milan, Italy). All patients treated with fingolimod or ocrelizumab who had recei","2021","07","02","J Neurol","Journal of neurology","COVID-19; Fingolimod; Multiple sclerosis; Ocrelizumab; SARS-CoV-2 vaccination","A","Nozzolillo","Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"2095","34189719","10.1007/s00415-021-10663-x","Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.","Recent observations suggest a lack of humoral response after SARS-CoV-2 vaccination in multiple sclerosis (MS) patients treated with fingolimod or ocrelizumab OBJECTIVES: To assess serological response to SARS-CoV-2 vaccination in MS patients receiving these disease-modifying treatments (DMTs) in a real-life setting. Retrospective clinical data collection from MS patients followed at San Raffaele Hospital MS Centre (Milan, Italy). All patients treated with fingolimod or ocrelizumab who had recei","2021","07","02","J Neurol","Journal of neurology","COVID-19; Fingolimod; Multiple sclerosis; Ocrelizumab; SARS-CoV-2 vaccination","M","Filippi","Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"2096","34189719","10.1007/s00415-021-10663-x","Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.","Recent observations suggest a lack of humoral response after SARS-CoV-2 vaccination in multiple sclerosis (MS) patients treated with fingolimod or ocrelizumab OBJECTIVES: To assess serological response to SARS-CoV-2 vaccination in MS patients receiving these disease-modifying treatments (DMTs) in a real-life setting. Retrospective clinical data collection from MS patients followed at San Raffaele Hospital MS Centre (Milan, Italy). All patients treated with fingolimod or ocrelizumab who had recei","2021","07","02","J Neurol","Journal of neurology","COVID-19; Fingolimod; Multiple sclerosis; Ocrelizumab; SARS-CoV-2 vaccination","L","Moiola","Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Moiola.lucia@hsr","Moiola.lucia@hsr.it"
"2097","34189678","10.1007/s11906-021-01153-6","Hypertension, Obesity, and COVID-19: a Collision of Pandemics.","To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also be","2021","07","05","Curr Hypertens Rep","Current hypertension reports","ACE2 receptor; COVID-19; Hypertension; Obesity; RAAS; COVID-19; Humans; Hypertension; Obesity; Pandemics; Renin-Angiotensin System; SARS-CoV-2","Perez","Annalisa","Department of Internal Medicine, Section of Nephrology and Hypertension, Louisiana State University, 1542 Tulane Avenue Suite 330, New Orleans, LA, 70112, USA. apere5@lsuhsc","apere5@lsuhsc.edu"
"2098","34189678","10.1007/s11906-021-01153-6","Hypertension, Obesity, and COVID-19: a Collision of Pandemics.","To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also be","2021","07","05","Curr Hypertens Rep","Current hypertension reports","ACE2 receptor; COVID-19; Hypertension; Obesity; RAAS; COVID-19; Humans; Hypertension; Obesity; Pandemics; Renin-Angiotensin System; SARS-CoV-2","Naljayan","Mihran","Department of Internal Medicine, Section of Nephrology and Hypertension, Louisiana State University, 1542 Tulane Avenue Suite 330, New Orleans, LA, 70112, USA",NA
"2099","34189678","10.1007/s11906-021-01153-6","Hypertension, Obesity, and COVID-19: a Collision of Pandemics.","To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also be","2021","07","05","Curr Hypertens Rep","Current hypertension reports","ACE2 receptor; COVID-19; Hypertension; Obesity; RAAS; COVID-19; Humans; Hypertension; Obesity; Pandemics; Renin-Angiotensin System; SARS-CoV-2","Shuja","Imran","Department of Internal Medicine, Section of Nephrology and Hypertension, Louisiana State University, 1542 Tulane Avenue Suite 330, New Orleans, LA, 70112, USA",NA
"2100","34189678","10.1007/s11906-021-01153-6","Hypertension, Obesity, and COVID-19: a Collision of Pandemics.","To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also be","2021","07","05","Curr Hypertens Rep","Current hypertension reports","ACE2 receptor; COVID-19; Hypertension; Obesity; RAAS; COVID-19; Humans; Hypertension; Obesity; Pandemics; Renin-Angiotensin System; SARS-CoV-2","Florea","Andre","Department of Internal Medicine, Section of Nephrology and Hypertension, Louisiana State University, 1542 Tulane Avenue Suite 330, New Orleans, LA, 70112, USA",NA
"2101","34189678","10.1007/s11906-021-01153-6","Hypertension, Obesity, and COVID-19: a Collision of Pandemics.","To highlight the epidemiology and pathophysiology of hypertension and obesity in COVID-19 infection RECENT FINDINGS: Hypertension and obesity have emerged as significant risk factors for contracting the COVID-19 virus and the subsequent severity of illness. ACE2 receptor expression and dysregulation of the RAAS pathway play important roles in the pathophysiology of these associations, as do the pro-inflammatory state and cytokine dysregulation seen in obesity. Some of these patterns have also be","2021","07","05","Curr Hypertens Rep","Current hypertension reports","ACE2 receptor; COVID-19; Hypertension; Obesity; RAAS; COVID-19; Humans; Hypertension; Obesity; Pandemics; Renin-Angiotensin System; SARS-CoV-2","Reisin","Efrain","Department of Internal Medicine, Section of Nephrology and Hypertension, Louisiana State University, 1542 Tulane Avenue Suite 330, New Orleans, LA, 70112, USA",NA
"2102","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Gamboa-Cárdenas","Rocío-V","Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru. rvgc1@yahoo","rvgc1@yahoo.com"
"2103","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Barzola-Cerrón","Silvia","Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen EsSalud, Lima, Peru",NA
"2104","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Toledo-Neira","Denisse","Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen EsSalud, Lima, Peru",NA
"2105","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Reátegui-Sokolova","Cristina","Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen EsSalud, Lima, Peru",NA
"2106","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Pimentel-Quiroz","Víctor","Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru",NA
"2107","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Zevallos-Miranda","Francisco","Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen EsSalud, Lima, Peru",NA
"2108","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Alarcón","Graciela S","Division of Clinical Immunology and Rheumatology, Department of Medicine, School of Medicine, The University of Alabama At Birmingham, Birmingham, AL, USA",NA
"2109","34189675","10.1007/s10067-021-05833-1","Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.","The identification of risk factors for COVID-19 adverse course in autoimmune rheumatic diseases (ARDs) is of the utmost importance when approaching patient management; however, data are scarce in relation to the Latin American population. The objective of this study was to determine predictors of hospitalization for COVID-19 patients from an ARD community cohort. A real setting longitudinal study (March to November 2020) in an ARD community cohort was carried out. Potential predictors of hospita","2021","07","02","Clin Rheumatol","Clinical rheumatology","Autoimmune rheumatic disease; COVID-19; COVID-19 adverse predictors; SARS-CoV-2","Ugarte-Gil","Manuel","Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru",NA
"2110","34189674","10.1007/s10067-021-05830-4","Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.","We assessed the factors associated with COVID-19, clinical manifestations, and a 30-day-prognosis of COVID-19 in a cohort of rheumatoid arthritis (RA) patients compared with the index population. In a cross-sectional study, RA patients were followed in rheumatology clinics of Tabriz University of Medical Sciences, and a group of patients diagnosed with COVID-19 from index population were recruited. Outcomes of COVID-19 were assessed by the hospitalization rate and need to intensive care unit (IC","2021","07","02","Clin Rheumatol","Clinical rheumatology","COVID-19; Clinical manifestations; Outcomes; Rheumatoid arthritis; Risk factors","Malek Mahdavi","Aida","Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"2111","34189674","10.1007/s10067-021-05830-4","Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.","We assessed the factors associated with COVID-19, clinical manifestations, and a 30-day-prognosis of COVID-19 in a cohort of rheumatoid arthritis (RA) patients compared with the index population. In a cross-sectional study, RA patients were followed in rheumatology clinics of Tabriz University of Medical Sciences, and a group of patients diagnosed with COVID-19 from index population were recruited. Outcomes of COVID-19 were assessed by the hospitalization rate and need to intensive care unit (IC","2021","07","02","Clin Rheumatol","Clinical rheumatology","COVID-19; Clinical manifestations; Outcomes; Rheumatoid arthritis; Risk factors","Varshochi","Mojtaba","Department of Infectious Diseases, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"2112","34189674","10.1007/s10067-021-05830-4","Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.","We assessed the factors associated with COVID-19, clinical manifestations, and a 30-day-prognosis of COVID-19 in a cohort of rheumatoid arthritis (RA) patients compared with the index population. In a cross-sectional study, RA patients were followed in rheumatology clinics of Tabriz University of Medical Sciences, and a group of patients diagnosed with COVID-19 from index population were recruited. Outcomes of COVID-19 were assessed by the hospitalization rate and need to intensive care unit (IC","2021","07","02","Clin Rheumatol","Clinical rheumatology","COVID-19; Clinical manifestations; Outcomes; Rheumatoid arthritis; Risk factors","Hajialilo","Mehrzad","Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"2113","34189674","10.1007/s10067-021-05830-4","Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.","We assessed the factors associated with COVID-19, clinical manifestations, and a 30-day-prognosis of COVID-19 in a cohort of rheumatoid arthritis (RA) patients compared with the index population. In a cross-sectional study, RA patients were followed in rheumatology clinics of Tabriz University of Medical Sciences, and a group of patients diagnosed with COVID-19 from index population were recruited. Outcomes of COVID-19 were assessed by the hospitalization rate and need to intensive care unit (IC","2021","07","02","Clin Rheumatol","Clinical rheumatology","COVID-19; Clinical manifestations; Outcomes; Rheumatoid arthritis; Risk factors","Dastgiri","Saeed","Tabriz Health Services Management Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"2114","34189674","10.1007/s10067-021-05830-4","Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.","We assessed the factors associated with COVID-19, clinical manifestations, and a 30-day-prognosis of COVID-19 in a cohort of rheumatoid arthritis (RA) patients compared with the index population. In a cross-sectional study, RA patients were followed in rheumatology clinics of Tabriz University of Medical Sciences, and a group of patients diagnosed with COVID-19 from index population were recruited. Outcomes of COVID-19 were assessed by the hospitalization rate and need to intensive care unit (IC","2021","07","02","Clin Rheumatol","Clinical rheumatology","COVID-19; Clinical manifestations; Outcomes; Rheumatoid arthritis; Risk factors","Khabbazi","Raha","Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"2115","34189674","10.1007/s10067-021-05830-4","Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.","We assessed the factors associated with COVID-19, clinical manifestations, and a 30-day-prognosis of COVID-19 in a cohort of rheumatoid arthritis (RA) patients compared with the index population. In a cross-sectional study, RA patients were followed in rheumatology clinics of Tabriz University of Medical Sciences, and a group of patients diagnosed with COVID-19 from index population were recruited. Outcomes of COVID-19 were assessed by the hospitalization rate and need to intensive care unit (IC","2021","07","02","Clin Rheumatol","Clinical rheumatology","COVID-19; Clinical manifestations; Outcomes; Rheumatoid arthritis; Risk factors","Khabbazi","Alireza","Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. dr_khabbazi@yahoo","khabbazi@yahoo.com"
"2116","34189662","10.1007/s10072-021-05427-4","Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.","With recent availability of COVID-19 vaccine, post-vaccination neurological complications had been occasionally reported. Here, we reported for the first time a case of neuromyelitis optica spectrum disorder (NMOSD) that developed after the first dose of inactivated virus vaccine for COVID-19. The patient developed mild fever, vomiting, diarrhea, and cough after receiving the first dose of inactivated virus vaccine. Two months later, she experienced dizziness and unsteady walking. MRI scanning o","2021","07","02","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","AQP4; Autoimmune response; COVID-19; NMOSD; Vaccine","Chen","Shuai","Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, 450003, Henan, China",NA
"2117","34189662","10.1007/s10072-021-05427-4","Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.","With recent availability of COVID-19 vaccine, post-vaccination neurological complications had been occasionally reported. Here, we reported for the first time a case of neuromyelitis optica spectrum disorder (NMOSD) that developed after the first dose of inactivated virus vaccine for COVID-19. The patient developed mild fever, vomiting, diarrhea, and cough after receiving the first dose of inactivated virus vaccine. Two months later, she experienced dizziness and unsteady walking. MRI scanning o","2021","07","02","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","AQP4; Autoimmune response; COVID-19; NMOSD; Vaccine","Fan","Xiao-Rui","Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, 450003, Henan, China",NA
"2118","34189662","10.1007/s10072-021-05427-4","Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.","With recent availability of COVID-19 vaccine, post-vaccination neurological complications had been occasionally reported. Here, we reported for the first time a case of neuromyelitis optica spectrum disorder (NMOSD) that developed after the first dose of inactivated virus vaccine for COVID-19. The patient developed mild fever, vomiting, diarrhea, and cough after receiving the first dose of inactivated virus vaccine. Two months later, she experienced dizziness and unsteady walking. MRI scanning o","2021","07","02","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","AQP4; Autoimmune response; COVID-19; NMOSD; Vaccine","He","Shuang","Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, 450003, Henan, China",NA
"2119","34189662","10.1007/s10072-021-05427-4","Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.","With recent availability of COVID-19 vaccine, post-vaccination neurological complications had been occasionally reported. Here, we reported for the first time a case of neuromyelitis optica spectrum disorder (NMOSD) that developed after the first dose of inactivated virus vaccine for COVID-19. The patient developed mild fever, vomiting, diarrhea, and cough after receiving the first dose of inactivated virus vaccine. Two months later, she experienced dizziness and unsteady walking. MRI scanning o","2021","07","02","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","AQP4; Autoimmune response; COVID-19; NMOSD; Vaccine","Zhang","Jie-Wen","Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, 450003, Henan, China. zhangjw9900@126","zhangjw9900@126.com"
"2120","34189662","10.1007/s10072-021-05427-4","Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.","With recent availability of COVID-19 vaccine, post-vaccination neurological complications had been occasionally reported. Here, we reported for the first time a case of neuromyelitis optica spectrum disorder (NMOSD) that developed after the first dose of inactivated virus vaccine for COVID-19. The patient developed mild fever, vomiting, diarrhea, and cough after receiving the first dose of inactivated virus vaccine. Two months later, she experienced dizziness and unsteady walking. MRI scanning o","2021","07","02","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","AQP4; Autoimmune response; COVID-19; NMOSD; Vaccine","Li","Shu-Jian","Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, 450003, Henan, China. lsjdoctor@126","lsjdoctor@126.com"
"2121","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Riccioni","Luigi","Anesthesia and Intensive Care, San Camillo-Forlanini Hospital, Circonvallazione Gianicolense, 87, 00152, Rome, Italy. luigiriccioni@yahoo","luigiriccioni@yahoo.it"
"2122","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Ingravallo","Francesca","Legal Medicine, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy",NA
"2123","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Grasselli","Giacomo","Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"2124","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Mazzon","Davide","UOC Anesthesia and Intensive Care, Belluno Hospital, Belluno, Italy",NA
"2125","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Cingolani","Emiliano","Anesthesia and Intensive Care, San Camillo-Forlanini Hospital, Circonvallazione Gianicolense, 87, 00152, Rome, Italy",NA
"2126","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Forti","Gabrio","Criminal Law, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"2127","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Zagrebelsky","Vladimiro","Laboratorio dei Diritti Fondamentali, Collegio Carlo Alberto, Turin, Italy",NA
"2128","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Zoja","Riccardo","Institute of Legal Medicine, Department of Biomedical Sciences of Health, University of Milan, President of SIMLA, Milan, Italy",NA
"2129","34189634","10.1186/s13613-021-00888-4","The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic.","In early 2020, the Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI) published clinical ethics recommendations for the allocation of intensive care during COVID-19 pandemic emergency. Later the Italian National Institute of Health (ISS) invited SIAARTI and the Italian Society of Legal and Insurance Medicine to prepare a draft document for the definition of triage criteria for intensive care during the emergency, to be implemented in case of complete saturation of","2021","07","03","Ann Intensive Care","Annals of intensive care","COVID-19; Pandemic; Resource allocation; Triage","Petrini","Flavia","President of SIAARTI, Chieti, Italy",NA
"2130","34189588","10.1007/s00113-021-01032-4","[Video consultation in an orthopedic trauma surgery outpatient clinic : Effective adjunctive interventions in lockdown and post-lockdown scenarios-a prospective pilot study].","With the regulation of the Saxon State Government and the Saxon State Ministry for Social Affairs and Social Responsibility on the modification of the Infection Protection Act of March 2020 coming into force, a video-based outpatient consultation was implemented to maintain patient care. In order to allow communication with minimized contact, this was continued after the lockdown. The aim of this prospective pilot study was to assess the effectiveness of a video-based outpatient consultation ser","2021","07","02","Unfallchirurg","Der Unfallchirurg","COVID-19; Clinical examination; Digitalisation; Telemedicine; Video consultation","Theopold","Jan","Klinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Bereich für arthroskopische und spezielle Gelenkchirurgie/ Sportverletzungen, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland. jan.theopold@medizin.uni-leipzig","jan.theopold@medizin.uni"
"2131","34189588","10.1007/s00113-021-01032-4","[Video consultation in an orthopedic trauma surgery outpatient clinic : Effective adjunctive interventions in lockdown and post-lockdown scenarios-a prospective pilot study].","With the regulation of the Saxon State Government and the Saxon State Ministry for Social Affairs and Social Responsibility on the modification of the Infection Protection Act of March 2020 coming into force, a video-based outpatient consultation was implemented to maintain patient care. In order to allow communication with minimized contact, this was continued after the lockdown. The aim of this prospective pilot study was to assess the effectiveness of a video-based outpatient consultation ser","2021","07","02","Unfallchirurg","Der Unfallchirurg","COVID-19; Clinical examination; Digitalisation; Telemedicine; Video consultation","Osterhoff","Georg","Klinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Bereich für arthroskopische und spezielle Gelenkchirurgie/ Sportverletzungen, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland",NA
"2132","34189588","10.1007/s00113-021-01032-4","[Video consultation in an orthopedic trauma surgery outpatient clinic : Effective adjunctive interventions in lockdown and post-lockdown scenarios-a prospective pilot study].","With the regulation of the Saxon State Government and the Saxon State Ministry for Social Affairs and Social Responsibility on the modification of the Infection Protection Act of March 2020 coming into force, a video-based outpatient consultation was implemented to maintain patient care. In order to allow communication with minimized contact, this was continued after the lockdown. The aim of this prospective pilot study was to assess the effectiveness of a video-based outpatient consultation ser","2021","07","02","Unfallchirurg","Der Unfallchirurg","COVID-19; Clinical examination; Digitalisation; Telemedicine; Video consultation","Melcher","Peter","Klinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Bereich für arthroskopische und spezielle Gelenkchirurgie/ Sportverletzungen, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland",NA
"2133","34189588","10.1007/s00113-021-01032-4","[Video consultation in an orthopedic trauma surgery outpatient clinic : Effective adjunctive interventions in lockdown and post-lockdown scenarios-a prospective pilot study].","With the regulation of the Saxon State Government and the Saxon State Ministry for Social Affairs and Social Responsibility on the modification of the Infection Protection Act of March 2020 coming into force, a video-based outpatient consultation was implemented to maintain patient care. In order to allow communication with minimized contact, this was continued after the lockdown. The aim of this prospective pilot study was to assess the effectiveness of a video-based outpatient consultation ser","2021","07","02","Unfallchirurg","Der Unfallchirurg","COVID-19; Clinical examination; Digitalisation; Telemedicine; Video consultation","Henkelmann","Ralf","Klinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Bereich für arthroskopische und spezielle Gelenkchirurgie/ Sportverletzungen, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland",NA
"2134","34189588","10.1007/s00113-021-01032-4","[Video consultation in an orthopedic trauma surgery outpatient clinic : Effective adjunctive interventions in lockdown and post-lockdown scenarios-a prospective pilot study].","With the regulation of the Saxon State Government and the Saxon State Ministry for Social Affairs and Social Responsibility on the modification of the Infection Protection Act of March 2020 coming into force, a video-based outpatient consultation was implemented to maintain patient care. In order to allow communication with minimized contact, this was continued after the lockdown. The aim of this prospective pilot study was to assess the effectiveness of a video-based outpatient consultation ser","2021","07","02","Unfallchirurg","Der Unfallchirurg","COVID-19; Clinical examination; Digitalisation; Telemedicine; Video consultation","Hepp","Pierre","Klinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Bereich für arthroskopische und spezielle Gelenkchirurgie/ Sportverletzungen, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland",NA
"2135","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Ghione","Paola","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2136","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Gu","Juan J","KSL Diagnostics, Buffalo, New York, United States",NA
"2137","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Attwood","Kristopher","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2138","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Torka","Pallawi","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2139","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Goel","Shipra","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2140","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Sundaram","Suchitra","Mount Sinai Icahn School Of Medicine, New York, New York, United States",NA
"2141","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Mavis","Cory","RoswellPark Cancer Institute, Buffalo, New York, United States",NA
"2142","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Johnson","Michael","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2143","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Thomas","Roshneke","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2144","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"McWhite","Kenneth Michael","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2145","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Darrall","Andrea","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2146","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"DeMarco","Joseph","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2147","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Kostrewa","Jessica","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2148","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Mohr","Alice","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2149","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Rivas","Leah","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2150","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Neiders","Mirdza","KSL Diagnostics, Buffalo, New York, United States",NA
"2151","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Suresh","Lakshmanan","KSL Diagnostics, Buffalo, New York, United States",NA
"2152","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Segal","Brahm H","SUNY at Buffalo, Roswell Park Cancer Institute, Buffalo, New York, United States",NA
"2153","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Griffiths","Elizabeth A","Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States",NA
"2154","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Ramsperger","Vincent","KSL Diagnostics, Buffalo, New York, United States",NA
"2155","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Shen","Long","KSL Diagnostics, Williamsville, New York, United States",NA
"2156","34189565","10.1182/blood.2021012443","Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies.",NA,"2021","07","03","Blood","Blood",NA,"Hernandez-Ilizaliturri","Francisco J","Roswell Park Cancer Institute, Buffalo, New York, United States",NA
"2157","34189550","10.31128/AJGP-11-20-5745","General practitioner management of mental health during the COVID-19 pandemic.","Psychological issues are common presentations in general practice. The COVID-19 pandemic has created a 'perfect storm' for the deterioration of mental health. General practitioners (GPs) are ideally placed to provide supports for people with mental health issues. The objective of this article is to provide an overview of management approaches for mental health issues, paying attention to fostering resilience and lifestyle factors, particularly during the COVID-19 pandemic period. While feelings ","2021","07","14","Aust J Gen Pract","Australian journal of general practice","Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; General Practice; Humans; Male; Mental Disorders; Middle Aged; Young Adult","Munindradasa","Ashvini","MChD, MPH, Academic General Practice Registrar, Rural Clinical School, Australian National University, ACT",NA
"2158","34189550","10.31128/AJGP-11-20-5745","General practitioner management of mental health during the COVID-19 pandemic.","Psychological issues are common presentations in general practice. The COVID-19 pandemic has created a 'perfect storm' for the deterioration of mental health. General practitioners (GPs) are ideally placed to provide supports for people with mental health issues. The objective of this article is to provide an overview of management approaches for mental health issues, paying attention to fostering resilience and lifestyle factors, particularly during the COVID-19 pandemic period. While feelings ","2021","07","14","Aust J Gen Pract","Australian journal of general practice","Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; General Practice; Humans; Male; Mental Disorders; Middle Aged; Young Adult","Blashki","Grant","MBBS, MD, FRACGP, Lead Clinical Advisor, Beyond Blue, Vic",NA
"2159","34189550","10.31128/AJGP-11-20-5745","General practitioner management of mental health during the COVID-19 pandemic.","Psychological issues are common presentations in general practice. The COVID-19 pandemic has created a 'perfect storm' for the deterioration of mental health. General practitioners (GPs) are ideally placed to provide supports for people with mental health issues. The objective of this article is to provide an overview of management approaches for mental health issues, paying attention to fostering resilience and lifestyle factors, particularly during the COVID-19 pandemic period. While feelings ","2021","07","14","Aust J Gen Pract","Australian journal of general practice","Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; General Practice; Humans; Male; Mental Disorders; Middle Aged; Young Adult","Hall Dykgraaf","Sally","RN, Grad Cert Clin Man, PhD Scholar, Action Research, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, ACT",NA
"2160","34189550","10.31128/AJGP-11-20-5745","General practitioner management of mental health during the COVID-19 pandemic.","Psychological issues are common presentations in general practice. The COVID-19 pandemic has created a 'perfect storm' for the deterioration of mental health. General practitioners (GPs) are ideally placed to provide supports for people with mental health issues. The objective of this article is to provide an overview of management approaches for mental health issues, paying attention to fostering resilience and lifestyle factors, particularly during the COVID-19 pandemic period. While feelings ","2021","07","14","Aust J Gen Pract","Australian journal of general practice","Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; General Practice; Humans; Male; Mental Disorders; Middle Aged; Young Adult","Desborough","Jane","RN, RM, MPH, PhD, Action Research, COVID-19 Primary Care Response Group (seconded), Primary Care Division, Australian Government Department of Health, ACT",NA
"2161","34189550","10.31128/AJGP-11-20-5745","General practitioner management of mental health during the COVID-19 pandemic.","Psychological issues are common presentations in general practice. The COVID-19 pandemic has created a 'perfect storm' for the deterioration of mental health. General practitioners (GPs) are ideally placed to provide supports for people with mental health issues. The objective of this article is to provide an overview of management approaches for mental health issues, paying attention to fostering resilience and lifestyle factors, particularly during the COVID-19 pandemic period. While feelings ","2021","07","14","Aust J Gen Pract","Australian journal of general practice","Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; General Practice; Humans; Male; Mental Disorders; Middle Aged; Young Adult","Kidd","Michael","AM MBBS (Hons), MD, DCCH, DipRACOG, MCFP, FAHMS, Principal Medical Advisor and Deputy Chief Medical Officer, Australian Government Department of Health, ACT",NA
"2162","34189546","10.31128/AJGP-12-20-5764","SARS-CoV-2 and the kidney.","COVID-19 has been at the forefront of public and scientific attention since the initial report in December 2019. The kidney is one of the target organs of the causative SARS-CoV-2 virus. The aim of this article is to discuss the current understanding of COVID-19 renal disease from a primary care perspective, with the caveat that our knowledge of the pathogenesis, clinical course and outcome of the disease is still rapidly evolving. The kidney is one of the target organs of the causative SARS-CoV","2021","07","14","Aust J Gen Pract","Australian journal of general practice","COVID-19; Humans; Kidney Diseases","Titus","Thomas","MBBS, MD, MRCP,@ D.Phil, FRACP, Senior Staff Specialist, Gold Coast University Hospital, Qld",NA
"2163","34189546","10.31128/AJGP-12-20-5764","SARS-CoV-2 and the kidney.","COVID-19 has been at the forefront of public and scientific attention since the initial report in December 2019. The kidney is one of the target organs of the causative SARS-CoV-2 virus. The aim of this article is to discuss the current understanding of COVID-19 renal disease from a primary care perspective, with the caveat that our knowledge of the pathogenesis, clinical course and outcome of the disease is still rapidly evolving. The kidney is one of the target organs of the causative SARS-CoV","2021","07","14","Aust J Gen Pract","Australian journal of general practice","COVID-19; Humans; Kidney Diseases","Rahman","Atifur","MBBS, FRACP, FCSANZ, Interventional Cardiologist, Gold Coast University Hospital, Qld",NA
"2164","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Zhang","Sai",NA,NA
"2165","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Cooper-Knock","Johnathan",NA,NA
"2166","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Weimer","Annika K",NA,NA
"2167","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Harvey","Calum",NA,NA
"2168","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Julian","Thomas H",NA,NA
"2169","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wang","Cheng",NA,NA
"2170","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Li","Jingjing",NA,NA
"2171","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Furini","Simone",NA,NA
"2172","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Frullanti","Elisa",NA,NA
"2173","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fava","Francesca",NA,NA
"2174","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Renieri","Alessandra",NA,NA
"2175","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Pan","Cuiping",NA,NA
"2176","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Song","Jina",NA,NA
"2177","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Billing-Ross","Paul",NA,NA
"2178","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gao","Peng",NA,NA
"2179","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Shen","Xiaotao",NA,NA
"2180","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Timpanaro","Ilia Sarah",NA,NA
"2181","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kenna","Kevin P",NA,NA
"2182","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Davis","Mark M",NA,NA
"2183","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Tsao","Philip S",NA,NA
"2184","34189540","10.1101/2021.06.15.21258703","Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.","The determinants of severe COVID-19 in non-elderly adults are poorly understood, which limits opportunities for early intervention and treatment. Here we present novel machine learning frameworks for identifying common and rare disease-associated genetic variation, which outperform conventional approaches. By integrating single-cell multiomics profiling of human lungs to link genetic signals to cell-type-specific functions, we have discovered and validated over 1,000 risk genes underlying severe","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Snyder","Michael P",NA,NA
"2185","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gibbs","Hamish",NA,NA
"2186","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Waterlow","Naomi R",NA,NA
"2187","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Cheshire","James",NA,NA
"2188","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Danon","Leon",NA,NA
"2189","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Liu","Yang",NA,NA
"2190","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Grundy","Chris",NA,NA
"2191","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kucharski","Adam J",NA,NA
"2192","34189539","10.1101/2021.06.22.21259336","Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic.","Mobility data have demonstrated major changes in human movement patterns in response to COVID-19 and associated interventions in many countries. This can involve sub-national redistribution, short-term relocations as well as international migration. In this paper, we combine detailed location data from Facebook measuring the location of approximately 6 million daily active Facebook users in 5km <sup>2</sup> tiles in the UK with census-derived population estimates to measure population mobility a","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Eggo","Rosalind M",NA,NA
"2193","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Swanson","Phillip A",NA,NA
"2194","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Padilla","Marcelino",NA,NA
"2195","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hoyland","Wesley",NA,NA
"2196","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"McGlinchey","Kelly",NA,NA
"2197","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fields","Paul A",NA,NA
"2198","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bibi","Sagida",NA,NA
"2199","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Faust","Saul N",NA,NA
"2200","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"McDermott","Adrian B",NA,NA
"2201","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lambe","Teresa",NA,NA
"2202","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Pollard","Andrew J",NA,NA
"2203","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Durham","Nicholas M",NA,NA
"2204","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kelly","Elizabeth J",NA,NA
"2205","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Adlou","Syed",NA,NA
"2206","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Aley","Parvinder K",NA,NA
"2207","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Angus","Brian",NA,NA
"2208","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Anslow","Rachel",NA,NA
"2209","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Baker","Philip",NA,NA
"2210","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bansal","Himanshu",NA,NA
"2211","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Beveridge","Amy",NA,NA
"2212","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bridges-Webb","Alice",NA,NA
"2213","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ching","Steven",NA,NA
"2214","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Cicconi","Paola",NA,NA
"2215","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Clutterbuck","Elizabeth A",NA,NA
"2216","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Collins","Andrea M",NA,NA
"2217","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Darton","Thomas C",NA,NA
"2218","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Demissie","Tesfaye",NA,NA
"2219","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Dinesh","Tanya",NA,NA
"2220","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Douglas","Alexander D",NA,NA
"2221","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Duncan","Christopher J A",NA,NA
"2222","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ewer","Katie J",NA,NA
"2223","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Felle","Sally",NA,NA
"2224","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Finn","Adam",NA,NA
"2225","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Folegatti","Pedro M",NA,NA
"2226","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fuskova","Michelle",NA,NA
"2227","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gilbert","Sarah C",NA,NA
"2228","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Goodman","Anna",NA,NA
"2229","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Green","Christopher A",NA,NA
"2230","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Harbolick","Elizabeth",NA,NA
"2231","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hart","Thomas C",NA,NA
"2232","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hayes","Susana",NA,NA
"2233","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hill","Adrian V S",NA,NA
"2234","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Jenkin","Daniel",NA,NA
"2235","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Jepson","Brett M",NA,NA
"2236","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kasanyinga","Mwila",NA,NA
"2237","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kerridge","Simon",NA,NA
"2238","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Libri","Vincenzo",NA,NA
"2239","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lillie","Patrick J",NA,NA
"2240","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"McGregor","Alastair C",NA,NA
"2241","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Minassian","Angela M",NA,NA
"2242","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mujadidi","Yama F",NA,NA
"2243","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Pilataxi","Fernanda",NA,NA
"2244","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Plested","Emma",NA,NA
"2245","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Provstgaard-Morys","Samuel",NA,NA
"2246","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ramasamy","Maheshi",NA,NA
"2247","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Robinson","Hannah",NA,NA
"2248","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Sanders","Katherine",NA,NA
"2249","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Smith","Andrew",NA,NA
"2250","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Snape","Matthew D",NA,NA
"2251","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Song","Rinn",NA,NA
"2252","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Sutherland","Rebecca K",NA,NA
"2253","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Thomson","Emma C",NA,NA
"2254","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Toshner","Mark",NA,NA
"2255","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Turner","David P J",NA,NA
"2256","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Voysey","Merryn",NA,NA
"2257","34189538","10.1101/2021.06.17.21259027","T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.","AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18-85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Williams","Christopher J",NA,NA
"2258","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gu","Haogao",NA,NA
"2259","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Xie","Ruopeng",NA,NA
"2260","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Adam","Dillon C",NA,NA
"2261","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Tsui","Joseph L-H",NA,NA
"2262","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Chu","Daniel K",NA,NA
"2263","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Chang","Lydia D J",NA,NA
"2264","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Cheuk","Sammi S Y",NA,NA
"2265","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gurung","Shreya",NA,NA
"2266","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Krishnan","Pavithra",NA,NA
"2267","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ng","Daisy Y M",NA,NA
"2268","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Liu","Gigi Y Z",NA,NA
"2269","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wan","Carrie K C",NA,NA
"2270","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Edwards","Kimberly M",NA,NA
"2271","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Leung","Kathy S M",NA,NA
"2272","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wu","Joseph T",NA,NA
"2273","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Tsang","Dominic N C",NA,NA
"2274","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Leung","Gabriel M",NA,NA
"2275","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Cowling","Benjamin J",NA,NA
"2276","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Peiris","Malik",NA,NA
"2277","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lam","Tommy T Y",NA,NA
"2278","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Dhanasekaran","Vijaykrishna",NA,NA
"2279","34189537","10.1101/2021.06.19.21259169","SARS-CoV-2 under an elimination strategy in Hong Kong.","Hong Kong utilized an elimination strategy with intermittent use of public health and social measures and increasingly stringent travel regulations to control SARS-CoV-2 transmission. By analyzing &gt;1700 genome sequences representing 17% of confirmed cases from 23-January-2020 to 26-January-2021, we reveal the effects of fluctuating control measures on the evolution and epidemiology of SARS-CoV-2 lineages in Hong Kong. Despite numerous importations, only three introductions were responsible fo","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Poon","Leo L M",NA,NA
"2280","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ghosh","Arnab K",NA,NA
"2281","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Venkatraman","Sara",NA,NA
"2282","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Soroka","Orysya",NA,NA
"2283","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Reshetnyak","Evgeniya",NA,NA
"2284","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Rajan","Mangala",NA,NA
"2285","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"An","Anjile",NA,NA
"2286","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Chae","John K",NA,NA
"2287","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gonzalez","Christopher",NA,NA
"2288","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Prince","Jonathan",NA,NA
"2289","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"DiMaggio","Charles",NA,NA
"2290","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ibrahim","Said",NA,NA
"2291","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Safford","Monika M",NA,NA
"2292","34189536","10.1101/2021.06.14.21258904","Association between overcrowded households, multigenerational households, and COVID-19: a cohort study.","The role of overcrowded and multigenerational households as a risk factor for COVID-19 remains unmeasured. The objective of this study is to examine and quantify the association between overcrowded and multigenerational households, and COVID-19 in New York City (NYC). We conducted a Bayesian ecological time series analysis at the ZIP Code Tabulation Area (ZCTA) level in NYC to assess whether ZCTAs with higher proportions of overcrowded (defined as proportion of estimated number of housing units ","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hupert","Nathaniel",NA,NA
"2293","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Douaud","Gwenaëlle",NA,NA
"2294","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lee","Soojin",NA,NA
"2295","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alfaro-Almagro","Fidel",NA,NA
"2296","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Arthofer","Christoph",NA,NA
"2297","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wang","Chaoyue",NA,NA
"2298","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lange","Frederik",NA,NA
"2299","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Andersson","Jesper L R",NA,NA
"2300","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Griffanti","Ludovica",NA,NA
"2301","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Duff","Eugene",NA,NA
"2302","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Jbabdi","Saad",NA,NA
"2303","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Taschler","Bernd",NA,NA
"2304","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Winkler","Anderson",NA,NA
"2305","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Nichols","Thomas E",NA,NA
"2306","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Collins","Rory",NA,NA
"2307","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Matthews","Paul M",NA,NA
"2308","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Allen","Naomi",NA,NA
"2309","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Miller","Karla L",NA,NA
"2310","34189535","10.1101/2021.06.11.21258690","Brain imaging before and after COVID-19 in UK Biobank.","There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients. It remains unknown however whether the impact of COVID-19 can be detected in milder cases, in a quantitative and automated manner, and whether this can reveal a possible mechanism for the spread of the di","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Smith","Stephen M",NA,NA
"2311","34189534","10.1101/2021.06.19.21259181","White Blood Cell and Platelet Dynamics Define Human Inflammatory Recovery.","Inflammation is the physiologic reaction to cellular and tissue damage caused by pathologic processes including trauma, infection, and ischemia <sup>1</sup> . Effective inflammatory responses integrate molecular and cellular functions to prevent further tissue damage, initiate repair, and restore homeostasis, while futile or dysfunctional responses allow escalating injury, delay recovery, and may hasten death <sup>2</sup> . Elevation of white blood cell count (WBC) and altered levels of other ac","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Foy","Brody H",NA,NA
"2312","34189534","10.1101/2021.06.19.21259181","White Blood Cell and Platelet Dynamics Define Human Inflammatory Recovery.","Inflammation is the physiologic reaction to cellular and tissue damage caused by pathologic processes including trauma, infection, and ischemia <sup>1</sup> . Effective inflammatory responses integrate molecular and cellular functions to prevent further tissue damage, initiate repair, and restore homeostasis, while futile or dysfunctional responses allow escalating injury, delay recovery, and may hasten death <sup>2</sup> . Elevation of white blood cell count (WBC) and altered levels of other ac","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Sundt","Thor",NA,NA
"2313","34189534","10.1101/2021.06.19.21259181","White Blood Cell and Platelet Dynamics Define Human Inflammatory Recovery.","Inflammation is the physiologic reaction to cellular and tissue damage caused by pathologic processes including trauma, infection, and ischemia <sup>1</sup> . Effective inflammatory responses integrate molecular and cellular functions to prevent further tissue damage, initiate repair, and restore homeostasis, while futile or dysfunctional responses allow escalating injury, delay recovery, and may hasten death <sup>2</sup> . Elevation of white blood cell count (WBC) and altered levels of other ac","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Carlson","Jonathan C T",NA,NA
"2314","34189534","10.1101/2021.06.19.21259181","White Blood Cell and Platelet Dynamics Define Human Inflammatory Recovery.","Inflammation is the physiologic reaction to cellular and tissue damage caused by pathologic processes including trauma, infection, and ischemia <sup>1</sup> . Effective inflammatory responses integrate molecular and cellular functions to prevent further tissue damage, initiate repair, and restore homeostasis, while futile or dysfunctional responses allow escalating injury, delay recovery, and may hasten death <sup>2</sup> . Elevation of white blood cell count (WBC) and altered levels of other ac","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Aguirre","Aaron D",NA,NA
"2315","34189534","10.1101/2021.06.19.21259181","White Blood Cell and Platelet Dynamics Define Human Inflammatory Recovery.","Inflammation is the physiologic reaction to cellular and tissue damage caused by pathologic processes including trauma, infection, and ischemia <sup>1</sup> . Effective inflammatory responses integrate molecular and cellular functions to prevent further tissue damage, initiate repair, and restore homeostasis, while futile or dysfunctional responses allow escalating injury, delay recovery, and may hasten death <sup>2</sup> . Elevation of white blood cell count (WBC) and altered levels of other ac","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Higgins","John M",NA,NA
"2316","34189533","10.1101/2021.06.18.21259156","Factors affecting the transmission of SARS-CoV-2 in school settings.","Several studies have reported SARS-CoV-2 outbreaks in schools, with a wide range of secondary attack rate (SAR; range: 0-100%). We aimed to examine the key risk factors to better understand transmission in school settings. We collected records of SARS-CoV-2 school outbreaks globally published from January 2020 to January 2021 and compiled information on hypothesized risk factors. We utilized the directed acyclic graph (DAG) to conceptualize the risk mechanisms, used logistic regression to examin","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Reynolds","Connor",NA,NA
"2317","34189533","10.1101/2021.06.18.21259156","Factors affecting the transmission of SARS-CoV-2 in school settings.","Several studies have reported SARS-CoV-2 outbreaks in schools, with a wide range of secondary attack rate (SAR; range: 0-100%). We aimed to examine the key risk factors to better understand transmission in school settings. We collected records of SARS-CoV-2 school outbreaks globally published from January 2020 to January 2021 and compiled information on hypothesized risk factors. We utilized the directed acyclic graph (DAG) to conceptualize the risk mechanisms, used logistic regression to examin","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ng","Sydney",NA,NA
"2318","34189533","10.1101/2021.06.18.21259156","Factors affecting the transmission of SARS-CoV-2 in school settings.","Several studies have reported SARS-CoV-2 outbreaks in schools, with a wide range of secondary attack rate (SAR; range: 0-100%). We aimed to examine the key risk factors to better understand transmission in school settings. We collected records of SARS-CoV-2 school outbreaks globally published from January 2020 to January 2021 and compiled information on hypothesized risk factors. We utilized the directed acyclic graph (DAG) to conceptualize the risk mechanisms, used logistic regression to examin","2021","06","30","medRxiv","medRxiv : the preprint server for health sciences",NA,"Yang","Wan",NA,NA
"2319","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alavi","Arash",NA,NA
"2320","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bogu","Gireesh K",NA,NA
"2321","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wang","Meng",NA,NA
"2322","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Rangan","Ekanath Srihari",NA,NA
"2323","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Brooks","Andrew W",NA,NA
"2324","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wang","Qiwen",NA,NA
"2325","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Higgs","Emily",NA,NA
"2326","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Celli","Alessandra",NA,NA
"2327","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mishra","Tejaswini",NA,NA
"2328","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Metwally","Ahmed A",NA,NA
"2329","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Cha","Kexin",NA,NA
"2330","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Knowles","Peter",NA,NA
"2331","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alavi","Amir A",NA,NA
"2332","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bhasin","Rajat",NA,NA
"2333","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Panchamukhi","Shrinivas",NA,NA
"2334","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Celis","Diego",NA,NA
"2335","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Aditya","Tagore",NA,NA
"2336","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Honkala","Alexander",NA,NA
"2337","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Rolnik","Benjamin",NA,NA
"2338","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hunting","Erika",NA,NA
"2339","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Dagan-Rosenfeld","Orit",NA,NA
"2340","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Chauhan","Arshdeep",NA,NA
"2341","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Li","Jessi W",NA,NA
"2342","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Li","Xiao",NA,NA
"2343","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bahmani","Amir",NA,NA
"2344","34189532","10.1101/2021.06.13.21258795","Real-time Alerting System for COVID-19 Using Wearable Data.","Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, an","2021","07","06","medRxiv","medRxiv : the preprint server for health sciences",NA,"Snyder","Michael P",NA,NA
"2345","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Schultz","David C",NA,NA
"2346","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Johnson","Robert M",NA,NA
"2347","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Ayyanathan","Kasirajan",NA,NA
"2348","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Miller","Jesse",NA,NA
"2349","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Whig","Kanupriya",NA,NA
"2350","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Kamalia","Brinda",NA,NA
"2351","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Dittmar","Mark",NA,NA
"2352","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Weston","Stuart",NA,NA
"2353","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Hammond","Holly L",NA,NA
"2354","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Dillen","Carly",NA,NA
"2355","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Castellana","Lauren",NA,NA
"2356","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Lee","Jae Seung",NA,NA
"2357","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Li","Minghua",NA,NA
"2358","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Lee","Emily",NA,NA
"2359","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Constant","Samuel",NA,NA
"2360","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Ferrer","Marc",NA,NA
"2361","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Thaiss","Christoph A",NA,NA
"2362","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Frieman","Matthew B",NA,NA
"2363","34189531","10.1101/2021.06.24.449811","Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.","The ongoing COVID-19 pandemic has highlighted the dearth of approved drugs to treat viral infections, with only ~90 FDA approved drugs against human viral pathogens. To identify drugs that can block SARS-CoV-2 replication, extensive drug screening to repurpose approved drugs is underway. Here, we screened ~18,000 drugs for antiviral activity using live virus infection in human respiratory cells. Dose-response studies validate 122 drugs with antiviral activity and selectivity against SARS-CoV-2. ","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Cherry","Sara",NA,NA
"2364","34189530","10.1101/2021.06.22.449395","Super.Complex: A supervised machine learning pipeline for molecular complex detection in protein-interaction networks.","Protein complexes can be computationally identified from protein-interaction networks with community detection methods, suggesting new multi-protein assemblies. Most community detection algorithms tend to be un- or semi-supervised and assume that communities are dense network subgraphs, which is not always true, as protein complexes can exhibit diverse network topologies. The few existing supervised machine learning methods are serial and can potentially be improved in terms of accuracy and scal","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Palukuri","Meghana V",NA,NA
"2365","34189530","10.1101/2021.06.22.449395","Super.Complex: A supervised machine learning pipeline for molecular complex detection in protein-interaction networks.","Protein complexes can be computationally identified from protein-interaction networks with community detection methods, suggesting new multi-protein assemblies. Most community detection algorithms tend to be un- or semi-supervised and assume that communities are dense network subgraphs, which is not always true, as protein complexes can exhibit diverse network topologies. The few existing supervised machine learning methods are serial and can potentially be improved in terms of accuracy and scal","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Marcotte","Edward M",NA,NA
"2366","34189529","10.1101/2021.06.21.449165","Integrative analysis of multi-omics reveals gene regulatory networks across brain regions from risk variants to phenotypes of Alzheimer's disease and Covid-19.","Genome-wide association studies have found many genetic risk variants associated with Alzheimer's disease (AD). However, how these risk variants affect deeper phenotypes such as disease progression and immune response remains elusive. Also, our understanding of cellular and molecular mechanisms from disease risk variants to various phenotypes is still limited. To address these problems, we performed integrative multi-omics analysis from genotype, transcriptomics, and epigenomics for revealing ge","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Khullar","Saniya",NA,NA
"2367","34189529","10.1101/2021.06.21.449165","Integrative analysis of multi-omics reveals gene regulatory networks across brain regions from risk variants to phenotypes of Alzheimer's disease and Covid-19.","Genome-wide association studies have found many genetic risk variants associated with Alzheimer's disease (AD). However, how these risk variants affect deeper phenotypes such as disease progression and immune response remains elusive. Also, our understanding of cellular and molecular mechanisms from disease risk variants to various phenotypes is still limited. To address these problems, we performed integrative multi-omics analysis from genotype, transcriptomics, and epigenomics for revealing ge","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wang","Daifeng",NA,NA
"2368","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Zhang","Jason Z",NA,NA
"2369","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Yeh","Hsien-Wei",NA,NA
"2370","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Walls","Alexandra C",NA,NA
"2371","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wicky","Basile I M",NA,NA
"2372","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Sprouse","Kaiti",NA,NA
"2373","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"VanBlargan","Laura A",NA,NA
"2374","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Treger","Rebecca",NA,NA
"2375","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Quijano-Rubio","Alfredo",NA,NA
"2376","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Pham","Minh N",NA,NA
"2377","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Kraft","John C",NA,NA
"2378","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Haydon","Ian C",NA,NA
"2379","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Yang","Wei",NA,NA
"2380","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"DeWitt","Michelle",NA,NA
"2381","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Chow","Cameron",NA,NA
"2382","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Carter","Lauren",NA,NA
"2383","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wener","Mark H",NA,NA
"2384","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Stewart","Lance",NA,NA
"2385","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Veesler","David",NA,NA
"2386","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Diamond","Michael S",NA,NA
"2387","34189528","10.1101/2021.06.22.449355","Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.","With global vaccination efforts against SARS-CoV-2 underway, there is a need for rapid quantification methods for neutralizing antibodies elicited by vaccination and characterization of their strain dependence. Here, we describe a designed protein biosensor that enables sensitive and rapid detection of neutralizing antibodies against wild type and variant SARS-CoV-2 in serum samples. More generally, our thermodynamic coupling approach can better distinguish sample to sample differences in analyt","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Baker","David",NA,NA
"2388","34189527","10.1101/2021.06.23.449544","CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.","A lipid nanoparticle (LNP) formulation is a state-of-the-art delivery system for genetic drugs such as DNA, mRNA, and siRNA, which is successfully applied to COVID-19 vaccines and gains tremendous interest in therapeutic applications. Despite its importance, a molecular-level understanding of the LNP structures and dynamics is still lacking, which makes a rational LNP design almost impossible. In this work, we present an extension of CHARMM-GUI Membrane Builder to model and simulate all-a","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Park","Soohyung",NA,NA
"2389","34189527","10.1101/2021.06.23.449544","CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.","A lipid nanoparticle (LNP) formulation is a state-of-the-art delivery system for genetic drugs such as DNA, mRNA, and siRNA, which is successfully applied to COVID-19 vaccines and gains tremendous interest in therapeutic applications. Despite its importance, a molecular-level understanding of the LNP structures and dynamics is still lacking, which makes a rational LNP design almost impossible. In this work, we present an extension of CHARMM-GUI Membrane Builder to model and simulate all-a","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Choi","Yeol Kyo",NA,NA
"2390","34189527","10.1101/2021.06.23.449544","CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.","A lipid nanoparticle (LNP) formulation is a state-of-the-art delivery system for genetic drugs such as DNA, mRNA, and siRNA, which is successfully applied to COVID-19 vaccines and gains tremendous interest in therapeutic applications. Despite its importance, a molecular-level understanding of the LNP structures and dynamics is still lacking, which makes a rational LNP design almost impossible. In this work, we present an extension of CHARMM-GUI Membrane Builder to model and simulate all-a","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Kim","Seonghoon",NA,NA
"2391","34189527","10.1101/2021.06.23.449544","CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.","A lipid nanoparticle (LNP) formulation is a state-of-the-art delivery system for genetic drugs such as DNA, mRNA, and siRNA, which is successfully applied to COVID-19 vaccines and gains tremendous interest in therapeutic applications. Despite its importance, a molecular-level understanding of the LNP structures and dynamics is still lacking, which makes a rational LNP design almost impossible. In this work, we present an extension of CHARMM-GUI Membrane Builder to model and simulate all-a","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Lee","Jumin",NA,NA
"2392","34189527","10.1101/2021.06.23.449544","CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.","A lipid nanoparticle (LNP) formulation is a state-of-the-art delivery system for genetic drugs such as DNA, mRNA, and siRNA, which is successfully applied to COVID-19 vaccines and gains tremendous interest in therapeutic applications. Despite its importance, a molecular-level understanding of the LNP structures and dynamics is still lacking, which makes a rational LNP design almost impossible. In this work, we present an extension of CHARMM-GUI Membrane Builder to model and simulate all-a","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Im","Wonpil",NA,NA
"2393","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Smith","Shirley L",NA,NA
"2394","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Anderson","Enyia R",NA,NA
"2395","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Cansado-Utrilla","Cintia",NA,NA
"2396","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Prince","Tessa",NA,NA
"2397","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Farrell","Sean",NA,NA
"2398","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Brant","Bethaney",NA,NA
"2399","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Smyth","Stephen",NA,NA
"2400","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Noble","Peter-John M",NA,NA
"2401","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Pinchbeck","Gina L",NA,NA
"2402","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Marshall","Nikki",NA,NA
"2403","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Roberts","Larry",NA,NA
"2404","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Hughes","Grant L",NA,NA
"2405","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Radford","Alan D",NA,NA
"2406","34189526","10.1101/2021.06.23.449594","SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom.","Companion animals are susceptible to SARS-CoV-2 infection and sporadic cases of pet infections have occurred in the United Kingdom. Here we present the first large-scale serological survey of SARS-CoV-2 neutralising antibodies in dogs and cats in the UK. Results are reported for 688 sera (454 canine, 234 feline) collected by a large veterinary diagnostic laboratory for routine haematology during three time periods; pre-COVID-19 (January 2020), during the first wave of UK human infections (April-","2021","07","04","bioRxiv","bioRxiv : the preprint server for biology",NA,"Patterson","Edward I",NA,NA
"2407","34189525","10.1101/2021.06.20.449191","The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.","Native mass spectrometry (MS) enjoyed tremendous success in the past two decades in a wide range of studies aiming at understanding the molecular mechanisms of physiological processes underlying a variety of pathologies and accelerating the drug discovery process. However, the success record of native MS has been surprisingly modest with respect to the most recent challenge facing the biomedical community â"" the novel coronavirus infection (COVID-19). The major reason for the paucity of success","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Yang","Yang",NA,NA
"2408","34189525","10.1101/2021.06.20.449191","The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.","Native mass spectrometry (MS) enjoyed tremendous success in the past two decades in a wide range of studies aiming at understanding the molecular mechanisms of physiological processes underlying a variety of pathologies and accelerating the drug discovery process. However, the success record of native MS has been surprisingly modest with respect to the most recent challenge facing the biomedical community â"" the novel coronavirus infection (COVID-19). The major reason for the paucity of success","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Ivanov","Daniil G",NA,NA
"2409","34189525","10.1101/2021.06.20.449191","The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor.","Native mass spectrometry (MS) enjoyed tremendous success in the past two decades in a wide range of studies aiming at understanding the molecular mechanisms of physiological processes underlying a variety of pathologies and accelerating the drug discovery process. However, the success record of native MS has been surprisingly modest with respect to the most recent challenge facing the biomedical community â"" the novel coronavirus infection (COVID-19). The major reason for the paucity of success","2021","06","30","bioRxiv","bioRxiv : the preprint server for biology",NA,"Kaltashov","Igor A",NA,NA
